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Abstract 
 
Because most antibiotics are potentially lethal to the producing organism, there must 
be mechanisms to ensure that the machinery responsible for export of the mature 
antibiotic is in place at the time of biosynthesis. Simocyclinone D8 is a potent DNA 
gyrase inhibitor produced by Streptomyces antibioticus Tü 6040. Within the 
simocyclinone biosynthetic cluster are two divergently transcribed genes, simR and 
simX, encoding proteins that resemble the TetR/TetA repressor-efflux pump pair that 
cause widespread resistance to clinically important tetracyclines. In this thesis, I 
show that engineered expression of simX from a strong, heterologous promoter 
confers high level simocyclinone D8 resistance on Streptomyces lividans, showing 
that simX encodes a simocyclinone efflux pump. Transcription of simX is controlled 
by SimR, which directly represses the simX and simR promoters by binding to two 
operator sites in the simX-simR intergenic region. Simocyclinone D8 abolishes DNA 
binding by SimR, providing a mechanism that couples the biosynthesis of 
simocyclinone to its export. In addition, an intermediate in the biosynthetic pathway, 
simocyclinone C4, which is essentially inactive as a DNA gyrase inhibitor, also 
induces simX expression in vivo and relieves simX repression by SimR in vitro. 
I also report the crystal structures of SimR alone and in complex with either 
simocyclinone D8 or simocyclinone C4. The ligand-binding pocket is unusual 
compared to those of other characterized TetR-family transcriptional regulators: the 
structures show an extensive ligand-binding pocket spanning both monomers in the 
functional dimeric unit, with the aminocoumarin moiety of simocyclinone D8 buried 
in the protein core, while the angucyclic polyketide moiety is partially exposed to 
bulk solvent. Through comparisons of the structures, I postulate a derepression 
mechanism for SimR that invokes rigid-body motions of the subunits relative to one 
another, coupled with a putative locking mechanism to restrict further 
conformational change. 
The DNA-binding domain of SimR has a classical helix-turn-helix motif, but it also 
carries an arginine-rich N-terminal extension. The structures of SimR alone or in 
complex with ligands showed that this N-terminal extension is disordered in the 
absence of DNA. Here I show that the N-terminal extension is sensitive to protease, 
but becomes protease-resistant upon binding DNA. I demonstrate by deletion 
analysis that the extension contributes to DNA binding, and describe the crystal 
structure of SimR bound to its operator sequence, revealing that the N-terminal 
extension binds in the minor groove. Bioinformatic analysis shows that an N-
terminal extension rich in positively charged residues is a feature of the majority of 
TetR family members. Comparison of the SimR-DNA and SimR-simocyclinone 
complexes reveals that the conformational changes associated with ligand-mediated 
derepression indeed result primarily from rigid-body rotation of the subunits about 
the dimer interface.  
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1.1 Self-resistance to antibiotics in the producing organisms 
 
By definition, “antibiosis” means “against-life”. Antibiotics are toxins. They can 
potentially kill the producing hosts. Therefore, in order for antibiotic-producing 
organisms to survive, they should have a self-resistance mechanism to counteract the 
potential toxicity of their own products (Cundliffe and Demain, 2010). Academically, 
it is interesting to discover the self-resistance mechanism.  
 
Outside the context of the producing organism, antibiotic resistance in clinical 
pathogens poses numerous challenges. The rise of antibiotic resistance and the wide 
dissemination of resistant determinants is a major threat to public health. It is widely 
held that the resistance determinants found in clinical pathogens are ultimately 
derived from the organisms that produce the corresponding antibiotics (Davies, 1994; 
Wright, 2007). Therefore, there is a need to expand research into resistance in 
antibiotic-producing organisms. In doing so, it might be possible to predict resistance 
before it emerges clinically and to develop diagnostic techniques and future 
therapeutic strategies.  
 
1.2 Mechanisms of antibiotic resistance and antibiotic export 
1.2.1 Mechanisms of antibiotic resistance 
There are five major mechanisms of antibiotic resistance. They are: 
1. Decreased permeability and uptake. 
2. Export. 
3. Enzymatic inactivation of the antibiotic. 
4. Modification or overexpression of the target of the antibiotic. 
5. Induced lost of the target of the antibiotic. 
 
The first mechanism is decreased permeability and uptake. For example, Neisseria 
gonorrhoea can acquire mutations in the gene encoding the porin channel and these 
mutations cause reduced penicillin and tetracycline permeability, thereby conferring 
resistance to these compounds (Olesky et al., 2006). The second mechanism of 
resistance is efflux. The first determinant of this kind to be discovered was the TetA 
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tetracycline efflux pump, which is described in more detail in section 1.6 (McMurry 
et al., 1980; Ball et al., 1980).  The third mechanism is the enzymatic inactivation of 
the antibiotic such as the inactivation of penicillins by β-lactamases, which cleave the 
β-lactam ring (Holt and Stewart, 1964). Other examples of this type of resistance 
mechanism are aminoglycoside modifying enzymes that inactivate the antibiotic by 
catalysing the addition of an acetyl or phosphoryl group (for example in the case of 
apramycin or kanamycin resistance) (Skeggs et al., 1987). The fourth mechanism 
involves altering the target of the antibiotic. This is typical for vancomycin resistance. 
Under susceptible conditions, vancomycin prevents peptidoglycan crosslinking by 
binding to the D-Ala-D-Ala termini of lipid-attached peptidoglycan precursors on the 
outside of the cytoplasmic membrane (reviewed in Buttner et al., 2008). Bacteria 
(mostly Gram-positive) acquire resistance by reprogramming cell wall biosynthesis 
such that their peptidoglycan precursors terminate in D-Ala-D-Lactate rather than in 
D-Ala-D-Ala, which blocks vancomycin binding (Buttner et al., 2008). The last 
mechanism of antibiotic resistance is relatively newly discovered. In this mechanism, 
the antibiotic is a pro-drug that requires enzymatic activation to generate the active 
antibacterial compound. Metronidazole is a prodrug that is activated by the 
nitroreductase RdxA and null mutations in the rdxA gene therefore cause resistance 
to metronidazole (Jenks and Edwards, 2002). 
 
Other physiological states of bacteria, beyond the scope of this thesis, can also 
contribute to antibiotic tolerance, such as biofilm formation, or the presence of 
persisters in the bacteria population (Cos et al., 2010; Lewis, 2010). 
 
1.2.2 Antibiotic resistance mediated by efflux pumps 
Efflux pump-mediated export, both for specific drugs or for multi-drugs, is an 
important intrinsic or acquired mechanism of resistance to antimicrobials (Poole, 
2005). Multi-drug efflux systems are conserved among bacteria, are usually 
chromosomally encoded, and in clinical isolates their expression often arises through 
the inactivation of linked repressor genes (Poole, 2005). In contrast, drug-specific 
efflux pumps are often encoded on plasmids or other kinds of mobile genetic 
elements in pathogenic bacteria.  
 
Chapter 1 General Introduction 
4 
Efflux as mechanism for antibiotic resistance was first described in the early 1980s, 
when the mechanism of tetracycline resistance was discovered (McMurry et al., 
1980; Ball et al., 1980). Since then, numerous chromosomal and plasmid-encoded 
efflux mechanisms has been identified and characterised. Bacterial efflux systems 
that are capable of transporting antimicrobials can be divided into different classes: 
the major facilitator superfamily (MF), the ATP-binding cassette (ABC) family, the 
resistance-nodulation-division family (RND), the small multi-drug resistance (SMR) 
family and the multi-drug and toxic compound extrusion (MATE) family (Poole, 
2005) (Fig. 1.1). With the exception of the ABC family, all these types of efflux 
systems function as secondary transporters i.e. they are antiporters using a gradient 
of ions (H
+
 or Na
+
), rather than the hydrolysis of ATP, to drive the export of drugs 
(Poole, 2005).  
 
1.3 DNA topoisomerases 
 
DNA topoisomerases are enzymes that regulate the topological state of DNA.  
 
Regulated DNA topology is essential for the following biological processes: genome 
compaction, DNA replication, gene expression, transcription, recombination and 
thermal stability of DNA. The vital role of topoisomerases in bacterial physiology is 
also reflected in the fact that topoisomerases are an established target for 
antibacterials and chemotherapeutics.  
 
DNA topoisomerase can catalyse supercoiling/relaxing, knotting/unknotting and 
catenating/decatenating reactions (Bates and Maxwell, 2005). The majority of DNA 
topoisomerases can relax negatively and positively supercoiled DNA. However, only 
DNA gyrase can use ATP to introduce negative supercoils into DNA, since this 
reaction is unfavourable without the input of energy (Schoeffler and Berger, 2008).  
 
DNA topoisomerases can be divided into 5 different classes: IA/IB/IC/IIA/IIB 
(Schoeffler and Berger, 2008). Type I topoisomerases work via the introduction of a 
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Fig 1.1. Representative drug exporting systems in Gram-positive bacteria (A) and in 
Gram-negative bacteria (B), showing different families of pumps involved in 
resistance to antibiotics. FQ: fluoroquinolones; CM: chloramphenicol; TC: 
tetracycline; ML: macrolides; MD: multi-drugs; BL: beta-lactam. OM: outer 
membrane; PP: periplasm; CM: cell membrane (Poole, 2005). 
A 
B 
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single-stranded break into the DNA, whereas Type II topoisomerases work via the 
introduction of a double-stranded break. Topoisomerases can be further divided into 
type IA/IB/IC and type IIA/IIB depending on their structures and mechanisms 
[reviewed in Schoeffler and Berger, 2008). 
 
1.3.1 DNA gyrase 
DNA gyrase belongs to the type IIA class of topoisomerases and is capable of using 
energy derived from ATP hydrolysis to drive the introduction of negative supercoils 
into DNA (Gellert et al., 1976). The other topoisomerases of this class are 
topoisomerase II and topoisomerase IV. Topoisomerases are widely distributed in all 
kingdoms of life. 
 
DNA gyrase is a hetero-tetramer, having two gyrase A (GyrA) subunits and two 
gyrase B (GyrB) subunits (Fig. 1.2). The crystal structure of the complete hetero-
tetramer has not been determined, however crystal structures of several subunits and 
constituent domains of the Escherichia coli enzyme are available (Brino et al., 2000; 
Fu et al., 2009; Morais Cabral et al., 1997; Ruthenburg et al., 2005). The N-terminal 
domain of the GyrA subunit in its dimeric state forms the DNA-binding saddle. This 
is known as the "DNA breakage-reunion domain". Within this domain, there is a 30 
Å cavity which is sufficient in volume to accommodate a DNA duplex (Berger, 
1998). This is located in between the primary and secondary dimerisation interface. 
The C-terminal domain of GyrA forms a β-pinwheel fold (similar to the β-propeller 
fold) (Corbett et al., 2004) and shows a basic surface on the outside of the structure 
that is probably involved in DNA wrapping (Corbettt et al., 2004). The N-terminal 
domain of GyrB forms a dimer that has a central cavity of 20 Å in diameter, which is 
also large enough to accommodate a DNA duplex (Wigley et al., 1991). The N-
terminal domain of GyrB contains the GHKL ATPase motif. The structure of the C-
terminal domain of GyrB of Mycobacterium tuberculosis DNA gyrase has also been 
solved (Fu et al., 2009). E. coli GyrB has a 170-amino acid insertion in this domain 
in comparison to other type IIA topoisomerases and this insertion has been shown to 
be important for DNA binding in E. coli DNA gyrase (Chatterji et al., 2000).  
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Fig. 1.2. General domain organisation of type IIA topoisomerases, of which DNA 
gyrase is a member. Conserved domains are highlighted in colour.  
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1.3.2 The mechanism of action of DNA gyrase 
The first step in the mechanism of DNA gyrase is the introduction of a double-strand 
break, through which the second strand of a DNA duplex is passed (Fig. 1.3). This 
action introduces negative supercoiling into the circular DNA. The first segment of 
DNA where the double-strand break is introduced is termed the gate segment or G-
segment. The double strand break is introduced by nucleophilic attack on the DNA 
phosphate backbone and the subsequent formation of a covalent bond between the 
active site Tyr in each monomer with the 5'-phosphate backbone (Roca and Wang, 
1992; Roca, 1995). The next step is the separation of the broken G-segment and the 
passage of the intact DNA segment through the gap (Roca and Wang, 1992). The 
segment to be transferred is termed the transport segment or T-segment. The passage 
of the T-segment is achieved through the conformational changes induced by ATP 
binding. These conformational changes are transmitted throughout gyrase, enabling 
both the capture of the T-segment through the closing of the N-terminal gate, the 
separation of the broken ends of the G-segment, and the closing of the C-terminal 
gate (Corbett and Berger, 2004; Dong and Berger, 2007). Once the T-segment is 
transported through the G-segment, the broken ends of the G-segment are re-ligated 
(Corbett and Berger, 2003). The N-terminal gate then opens to allow the T segment 
to exit from the enzyme (Corbett and Berger, 2004). The T and G segments can be 
on the same DNA molecule, resulting in the introduction of negative supercoils, or 
they can be on different DNA molecules, in which case DNA gyrase action leads to 
catenation or decantenation of these molecules (Roca, 1995). 
 
1.4 Aminocoumarins 
 
The aminocoumarin family of antibiotics comprises three classical members: 
novobiocin, chlorobiocin and coumermycin A1 (Fig. 1.4) (Berger and Batcho, 1978; 
Li and Heide, 2006), each produced by different Streptomyces species. Novobiocin is 
produced by Streptomyces spheroides, chlorobiocin is produced by Streptomyces 
roseochromogenes and coumermycin by Streptomyces rishiriensis (Berger and 
Batcho, 1978; Li and Heide, 2006). These antibiotics are characterised by their 3-
amino-4,7-dihydroxycoumarin moiety (Fig. 1.4). The appearance of this moiety in 
non-streptomycete natural products has 
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Fig. 1.3. The two gate mechanism of the type IIA class of topoisomerases, of which 
DNA gyrase is a member (Dong and Berger, 2007). The ATPase domain in shown in 
orange, the Toprim domain in blue and the DNA-binding domain in green. 
 
 
 
 
 
 
Fig. 1.4. Structures of members of the aminocoumarin class of antibiotics 
(coumermycin A1, chlorobiocin, novobiocin and simocyclinone D8) with the 
characteristic aminocoumarin ring boxed (Berger and Batcho, 1978; Schimana et al., 
2001).  
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not been reported. Aminocoumarins are known as potent DNA gyrase inhibitors 
(Maxwell and Lawson, 2003). Their equilibrium dissociation constants are in the nM 
range, which is considerably lower than that of clinically important fluoroquinolone 
antibiotics (Gormley et al., 1996). Aminocoumarins are not used clinically, although 
novobiocin has been licensed for treatment of infections caused by multi-resistant 
Gram-positive bacteria. Novobiocin, chlorobiocin and coumermycin A1 are 
competitive inhibitors that compete for the ATP-binding site in GyrB (Lamour et al., 
2002). 
 
The biosynthetic gene clusters for all three classical aminocoumarins have been 
cloned and sequenced (Pojer et al., 2002; Steffensky et al., 2000; Wang et al., 2000). 
The biosynthesis of novobiocin and chlorobiocin are among the best-understood 
secondary metabolic pathways, and nearly all the steps within these two biosynthetic 
pathways have been investigated biochemically and genetically (Pojer et al., 2002; 
Steffensky et al., 2000; Wang et al., 2000). 
 
1.4.1 Self-resistance to aminocoumarin antibiotics 
Novobiocin, chlorobiocin and coumermycin A1 are potent inhibitors of DNA gyrase 
and can potentially kill the producer cells. Thus the producing organisms must have a 
self-resistance mechanism to protect their own gyrases from the inhibitory effect of 
these compounds.  
 
The principal self-resistance mechanism in the novobiocin producer, S. spheroides, is 
the de novo biosynthesis of a resistant form of DNA gyrase B subunit (Thiara and 
Cundliffe, 1988, 1989, 1993; Schmutz et al., 2003). The gene encoding the resistant 
form of DNA gyrase subunit B (gyrB
R
) is associated with the biosynthetic cluster for 
novobiocin (at the right border of the cluster), while the gene encoding the sensitive 
“host” gyrase subunit B (gyrBS) is located elsewhere on the chromosome (Fig. 1.5). 
Thus, the novobiocin-producing organism has a constitutively expressed sensitive 
gyrB
S
 gene, and a resistant gyrB
R
 gene that is only expressed when novobiocin 
biosynthesis is activated. The promoter of gyrB
R
 seems to be regulated by the 
superhelical density of the DNA (Thiara and Cundliffe, 1988, 1989, 1993; Schmutz  
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Fig. 1.5. Biosynthetic clusters for novobiocin (top), clorobiocin (middle) and coumermycin A1 (bottom) with genes involved in self-
resistance coloured black (Schmutz et al., 2003). 
Chapter 1 General Introduction 
12 
et al., 2003). This might constitute a feed-back mechanism to turn on self-resistance 
when the organism in exposed to novobiocin. The resistant GyrB
R
 protein replaces 
the sensitive GyrR
S
 subunit in the active GyrA-GyrB heterotetramer giving an 
enzyme that is no longer sensitive to novobiocin.  
 
On the left border of the novobiocin cluster there is novA, encoding an ABC 
transporter suggested to be involved in transport of, and possibly resistance to, 
novobiocin (Fig. 1.5) (Schmutz et al., 2003). After the biosynthetic clusters for 
chlorobiocin and coumermycin A1 were sequenced, the self-resistance mechanisms 
for these aminocoumarin compounds were also investigated by Schmutz et al. (2003). 
As for novobiocin, these two biosynthetic clusters were found to contain a gyrB
R
 
resistance gene, encoding a resistant GyrB
R
 subunit (Fig. 1.5). 
 
An aminocoumarin-resistant topoisomerase IV subunit, ParY
R
, encoded within the 
clorobiocin and coumermycin A1 biosynthetic clusters (but not the novobiocin 
biosynthetic cluster) (Fig. 1.5), also confers resistance to these antibiotics when 
introduced into a naïve host, presumably by an analogous mechanism (Schmutz et al., 
2003). A putative transporter, CouR5, is also encoded in the biosynthetic cluster for 
coumermycin A1 (Fig. 1.5). Expression of this putative transporter in S. lividans 
resulted in moderate levels of resistance against coumermycin A1, suggesting that it 
might be involved in antibiotic export and possibly in antibiotic resistance (Schmutz 
et al., 2003). 
 
1.5 Simocyclinones 
 
Simocyclinones represent a new class of topoisomerase inhibitors with a novel mode 
of action. Simocyclinones are naturally produced by Streptomyces antibioticus Tü 
6040 (Schimana et al., 2000). The main simocyclinone produced by S. antibioticus is 
simocyclinone D8 (SD8) (Fig. 1.6) (Schimana et al., 2000).  
 
In addition to SD8, there are ~13 other simocyclinone-related compounds that have 
been isolated from S. antibioticus. They represent either variants of the end product  
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Fig. 1.6. The chemical structure of simocyclinone D8 (SD8) (Holzenkämpfer et al., 
2002). 
 
 
 
Fig. 1.7. Simocyclinone-related compounds that have been isolated from S. 
antibioticus Tü 6040. These compounds represent either variants of the end product 
or naturally occurring biosynthetic intermediates of SD8 (Schimana et al., 2001). 
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or naturally-occurring biosynthetic intermediates of SD8. These 13 compounds can 
be classified into four different groups based on their chemical structure (Fig. 1.7). 
The proportion of each simocyclinone produced can be dramatically affected by the 
media composition and fermentation conditions (Schimana et al., 2001). 
 
SD8 has a linear and modular chemical structure. The core structure consists of an 
aminocoumarin (AC) moiety and an angucyclinone polyketide (PK) moiety linked 
together by the tetraene dicarboxylic linker and a D-olivose sugar (Holzenkämpfer et 
al., 2002) (Fig. 1.6).  
 
The simocyclinones appear to be „natural hybrid‟ antibiotics, with moieties related to 
antibiotics produced by other Streptomyces species. The AC ring of SD8 resembles 
the same moiety in novobiocin, produced by S. spheroides (Steffensky et al., 2000), 
the PK moiety is similar to the angucyclic antibiotic aquayamycin, produced by 
Streptomyces misawanensis (Rohr and Thiericke, 1992), and the tetraene linker 
resembles the conjugated double bond segment of the polyene antibiotic 
amphotericin, produced by Streptomyces nodosus (Caffrey et al., 2001).   
 
The hybrid nature of simocyclinone is also reflected in the biosynthetic cluster (Fig. 
1.8), which appears to result from the integration of four smaller clusters, each 
responsible for the biosynthesis of one chemical moiety (Galm et al., 2002; Trefzer 
et al., 2002). These observations raise interesting questions about the evolution of 
simocyclinone biosynthesis. 
 
1.5.1 The simocyclinone biosynthetic pathway in S. antibioticus 
The biosynthetic cluster for simocyclinones (the sim cluster) has been cloned and 
sequenced (Fig. 1.8) (Galm et al., 2002; Trefzer et al., 2002). Analysis of the cluster 
revealed ~50 open reading frames. They are responsible for the biosynthesis of the 
four different chemical moieties of SD8, for the export of the simocyclinones and 
also for the regulation of the biosynthetic pathway (Galm et al., 2002; Trefzer et al., 
2002). Genes putatively responsible for the biosynthesis of each chemical moiety are 
largely grouped together to form sub-clusters within the total ~84 kb sim cluster. In 
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Fig. 1.8. The organisation of the biosynthetic cluster for SD8 (Galm et al., 2002; Trefzer et al., 2002). Analysis of the cluster revealed 
~50 open reading frames. The gene products are responsible for the biosynthesis of the four different chemical moieties of SD8, for the 
export of the simocyclinones and also for the regulation of the sim cluster. Genes proposed to be involved in the biosynthesis of each of 
the four chemical moiety are colour-coded separately, as are genes encoding transporters and regulatory proteins. Genes of unknown 
function are coloured turquoise. 
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addition there are several genes with unknown functions. Three regulatory genes are 
distributed in the sim cluster. Based on sequence similarity and knowledge of natural 
product biosynthesis, a biosynthetic pathway for SD8 has been proposed (Fig. 1.9) 
(Galm et al., 2002; Trefzer et al., 2002).  
 
Since the sim biosynthetic cluster has been cloned and sequenced, it should be 
possible to generate novel simocyclinones through pathway engineering and by 
feeding the producer with chemically modified intermediates. These approaches have 
been successful for generating novel novobiocin-like compounds (Heide, 2009). 
 
1.5.2 The mode of action of simocyclinone 
Simocyclinones display inhibitory activity against the growth of Gram-positive 
bacteria but not against Gram-negative ones. Work described in Chapter 3 suggests 
that Gram-negative bacteria like E. coli are resistant to SD8 because the outer 
membrane is impermeable to the antibiotic. Oppegard et al. (2009) suggested that 
efflux pumps such as the AcrB multidrug efflux pump may also contribute to the 
ineffectiveness of SD8 against Gram-negative bacteria. SD8 does not inhibit the 
growth of yeast or filamentous fungi up to the concentration of 100 µg/ml (Schimana 
et al., 2000).  
 
When the structure of SD8 was first determined, the similarity between the 
simocyclinones and other aminocoumarin antibiotics was immediately apparent (Fig. 
1.4). Based on this similarity, SD8 was assayed against E. coli DNA gyrase, the 
target of the previously known aminocoumarin antibiotics, and was shown to be a 
potent inhibitor (Flatman et al., 2005). It was initially thought that SD8 would have 
the same mode of inhibition as the aminocoumarins, inhibiting the ATPase activity 
of GyrB. However, Flatman et al. (2005) demonstrated that SD8, unlike novobiocin, 
does not inhibit the ATPase activity of GyrB, which was surprising given that SD8 
and novobiocin are both aminocoumarins. However, close inspection of the structure 
of the GyrB-novobiocin complex showed that the majority of interactions between 
novobiocin and GyrB involve the noviose sugar of the drug rather that the 
aminocoumarin ring that is common between novobiocin and SD8 (Lamour et al., 
2002).   
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Fig. 1.9. The proposed biosynthetic pathway for SD8 (Galm et al., 2002; Trefzer et 
al., 2002). Domain designations: KS: ketosynthase; AT: acyltransferase; ACP: acyl 
carrier protein; DH: dehydratase; KR: ketoreductase; ER: enoyl reductase; TE: 
thioesterase. Single enzymatic steps are indicated by a single arrow, and multiple 
reactions steps are indicated by two arrows. 
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Flatman et al. (2005) subsequently showed by surface plasmon resonance and 
isothermal titration calorimetry that SD8 has an entirely novel mode of action, 
binding to the N-terminal domain of the GyrA subunit of DNA gyrase and 
preventing DNA binding.  
 
Following the work by Flatman et al. (2005), a full biochemical dissection of the 
interaction between the N-terminal of the GyrA and SD8 was reported, including the 
crystal structure of the complex (Edwards et al., 2009).  The structure of the complex 
revealed two distinct binding pockets that separately accommodate the AC and PK 
moieties of the antibiotic (Fig. 1.10). Biochemical studies showed that the individual 
AC and PK moieties of SD8 are very weak inhibitors of gyrase but, covalently linked, 
they generate a much more potent inhibitor (Edwards et al., 2009).  
 
1.6 The TetR family of transcriptional regulators 
 
The TetR-family transcriptional regulators (TFRs) are named after the founding 
member of the group, the TetR repressor, which has been thoroughly characterised 
genetically, biochemically and structurally (Helbl et al., 1995; Hillen and Berens, 
1994; Hinrichs et al., 1994; Kamionka et al., 2004; Kisker et al., 1995; Orth et al., 
2000). This transcriptional regulator controls the expression of the TetA efflux pump, 
which confers resistance to the antibiotic tetracycline (Hillen and Berens, 1994). 
TFRs are known principally because well-characterized members control genes 
whose products are involved in antibiotic resistance. Other TFRs regulate genes 
involved in diverse processes, including the biosynthesis of secondary metabolites 
(e.g. Streptomyces coelicolor CprB) and the pathogenicity of both Gram-negative 
(e.g. Vibrio cholerae HapR) and Gram-positive bacteria (e.g. Bacillus cereus HlyIIR) 
(Ramos et al., 2005).  TFRs are present in Gram-positive bacteria, α-, β- and γ-
proteobacteria, cyanobacteria and archaea, suggesting that TFRs have an ancient 
origin (Ramos et al., 2005). Their numerical abundance and wide taxonomic 
distribution make them an important family of regulators. 
 
TFRs are found to be particularly abundant in microbes that are exposed to changing 
environments or to multi-stress insults. This is particularly true for soil-dwelling 
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Fig. 1.10. A cross-section through the GyrA-SD8 complex showing the two separate 
binding pockets for the polyketide (PK) end of SD8 (in purple) and for the 
aminocoumarin (AC) end (in yellow). The SD8 molecule is in red stick 
representation. Key residues that lie close to the SD8 molecule are also displayed 
(Edwards et al., 2009). 
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bacteria such as Streptomyces, Bradyrhizhobium and Norcadia (Ramos et al., 2005). 
TFRs are also relatively abundant in plant and animal pathogens (such as 
Pseudomonas, Salmonella spp.) and in extremophiles (such as Deinococcus) (Ramos 
et al., 2005). However, TFRs do not appear to be widely used in intracellular 
pathogens such as Chlamydia or Mycoplasma (Ramos et al., 2005), possibly 
reflecting the relatively constant life style of those bacteria. It is interesting to note 
that bacteria which have abundant extracytoplasmic function sigma factors also 
possess a large number of TFRs (Cases et al., 2003; Mahren and Braun, 2003; 
Martinez-Bueno et al., 2002). TFR genes are found not only on the chromosome but 
also on plasmids and mobile genetic elements, suggesting that horizontal transfer 
also contributes to the wide-spread distribution of this family (Heuer et al., 2004; 
Szczepanowski et al., 2004).   
 
TFRs consist of an N-terminal DNA-binding domain (DBD) and a C-terminal 
ligand-binding domain (LBD) (Ramos et al., 2005). TFRs exhibit a high sequence 
similarity in their DBDs. In contrast to the conservation of the DBD, the LBDs show 
little or no sequence similarity (Ramos et al., 2005), reflecting the diversity of 
ligands these domains sense. Despite this, the overall three-dimensional structures of 
TFRs are strikingly conserved (Ramos et al., 2005; Yu et al., 2010).   
 
1.6.1 Tetracycline resistance and TetR 
Tetracyclines are among the most widely used broad-spectrum bacteriostatic 
antibiotics (Levy, 1984, 1988). They act by binding to the small subunit of the 
ribosome, thereby inhibiting polypeptide chain elongation, although the exact details 
of this mechanism are still unknown. Many Gram-negative bacteria have developed 
resistance to tetracyclines. The most common mechanism of resistance is the use of 
an efflux pump protein (TetA) to export the antibiotic out of the cell (Fig. 1.11A) 
(Kaneko et al., 1985; Tauch et al., 2000; Zhao and Aoki, 1992). Divergently 
transcribed from tetA is tetR, whose product functions to control the expression of 
both genes (George and Levy, 1983; Hillen and Berens, 1994; Hinrichs et al., 1994). 
The intergenic region in between tetR and tetA houses two TetR operator sequences, 
separated by 11 bp (Hillen and Berens, 1994) (Fig. 1.11B).  
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Fig. 1.11. (A) A schematic representation of the tetracycline resistance system 
specified by tetAR. (B) Nucleotide sequence of the tetAR intergenic region showing 
the sequences of the tetO1 and tetO2 operators (boxed) and the -10 and -35 regions of 
the tetA and tetR promoters. The direction of transcription is marked with arrows 
(Adapted from Saenger et al., 2000). 
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In each operator, there is a core inverted repeat 15 bp long (Hillen and Berens, 1994), 
with the two half-sites separated by a central base pair (Fig. 1.11B). These operators 
overlap with the core promoters of tetA and tetR (Fig. 1.11B). When the cell is not 
exposed to tetracyclines, TetR functions as a repressor, binding to both operators and 
blocking the access of RNA polymerase to the tetA and tetR promoters (Hillen and 
Berens, 1994). TetR functions as a homodimer. When the cell is exposed to drug, 
tetracycline in complex with Mg
2+
 binds to TetR, capturing a conformation of the 
protein that is unable to bind DNA, thereby allowing RNA polymerase access to the 
tetR and tetA promoters (Fig. 1.11A) (Hillen and Berens, 1994; Kisker et al., 1995; 
Orth et al., 2000; Ramos et al., 2005). As a consequence, the TetA efflux pump is 
produced and exports tetracycline from the cell (Fig. 1.11A). The tetA promoter is 
stronger than the tetR promoter, resulting in higher expression of TetA than TetR. As 
a result of TetA action, the intracellular concentration of tetracycline is reset to a sub-
lethal concentration, also resulting in the re-repression of the tetA and tetR promoters 
(Hillen and Berens, 1994).  
 
Each monomer within the TetR homodimer has 10 α-helices connected together via 
turns and loops (Fig. 1.12) (Hinrichs et al., 1994; Orth et al., 2000). TetR is all α-
helical, and this is a shared feature among TFRs. The three-dimensional structure of 
TetR is mainly stabilised by the hydrophobic packing between helices. The DBD 
consists of helices α1 to α3 with helices α2 and α3 and a connecting loop forming the 
HTH motif. Helix α1 packs against α2 and α3 in order to stabilise the DBD. Helix α4 
connects the DBD to the LBD. The LBD spans from helix α5 to α10. The LBD is 
also responsible for dimerisation. The diagonal helices α8 and α10 form the 
dimerisation interface together with their counterparts in the opposing subunit, α8' 
and α10' (Fig. 1.12). Dimerisation is further enhanced by the wrapping arm α9 which 
embraces the opposing subunit (Fig. 1.12) (Hinrichs et al., 1994; Orth et al., 2000). 
The LBD houses the tetracycline-binding pocket (Fig. 1.12). In the original model 
for tetracycline-mediated derepression, tetracycline was interpreted to induce (rather 
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Fig. 1.12. The structure of the TetR homodimer with one subunit shown in blue and 
one in red (Hinrichs et al., 1994). The DBD consists of helices α1 to α3 and the LBD 
consists of helices α5 to α10, with helix α4 connecting the two domains together. 
Two tetracycline molecules, one bound to each TetR subunit, are shown in grey 
(adapted from Ramos et al., 2005). 
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than capture) the observed conformational changes (Hinrichs et al., 1994; Orth et al., 
2000), as follows. The opening of this pocket is controlled by helix α9', by the C-
terminal end of helix α8' and by the loop that connects the two helices together (Fig. 
1.12). The exit of the tetracycline binding pocket is closed by the loop that connects 
helices α4 and α5. When the complex of tetracycline and Mg2+ enters the binding 
pocket, the distal ring of tetracycline contacts the α4-α5 loop and thereby triggers 
conformational changes. The magnesium atom contacts His100 and Thr103 on α6 
(Fig. 1.13). This causes a displacement in α6. This causes the C-terminus of α6 to 
form a β-turn (Fig. 1.13). The α6-α7 loop is also drawn closer to the tetracycline 
molecule so that Arg104 and Pro105 can establish contact with it (Fig. 1.13). The 
translation of α6 causes helix α4 to move in the same direction due to the van der 
Waals contacts. Residue His64 of α4, which contacts α5 and tetracycline, acts as a 
pivot point through which α4 moves as a pendulum (Fig. 1.14). Since the DBD is 
connected to the LBD via α4, the pendulum movement of α4 causes the DBD to 
rotate with it. As a consequence, the recognition helices α3 and α3' of the HTH motif 
move further apart, disrupting their interaction with the DNA operator (Fig. 1.14) 
(Hinrichs et al., 1994). Upon binding to tetracycline, the binding pocket closes and 
prevents the drug from escaping the binding cavity. This ligand-bound TetR is no 
longer able to bind DNA (Hinrichs et al., 1994; Orth et al., 2000).  
 
However, certain aspects of TetR function were not explained by the originally 
proposed mechanism of tetracycline-induced derepression. For example, if 
tetracycline binding was responsible for inducing conformational changes in TetR, 
thus driving the recognition helices of the HTH motif apart, then one would expect 
the apo-TetR structure to resemble the structure of TetR in the TetR-DNA complex, 
but it did not. Moreover, a number of amino acids residues were identified that, when 
mutated, affected the binding affinity for tetracycline or affected the allosteric 
response, but were found to reside outside the tetracycline binding pocket or were 
not involved in conformational changes seen upon tetracycline binding (Hecht et al., 
1993; Muller et al., 1995). Further, there is a group of non-inducible mutant proteins 
that are not subjected to tetracycline-induced derepression, although they still bind to 
tetracycline with wild-type affinity (Hecht et al., 1993; Muller et al., 1995). Finally, 
there is also a group of TetR mutant proteins that bind to DNA with a higher affinity 
in the presence of tetracycline than in its absence (Scholz et al., 2004). Addressing 
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Fig. 1.13. The ligand-binding cavity of TetR in the absence (left panel) and presence 
of tetracycline-Mg
2+
 (right panel). Relevant residues involved in interactions with 
Tetracycline-Mg
2+
 are shown in stick representation (adapted from Ramos et al., 
2005). 
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Fig. 1.14. The superimposition of a TetR monomer with (red) and without (grey) 
tetracycline bound, showing the pendulum-like movement of helix α4, which is 
translated to the DBD. The increase in distance between the recognition helices α3 
and α3' results in the inability of TetR-tetracycline to bind to its DNA operator 
(adapted from Ramos et al., 2005). 
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these issues, Reichheld et al. (2009) performed equilibrium protein unfolding on 
wild-type TetR and on mutants with altered allosteric behaviours, and then proposed 
a new model to explain TetR allostery. It was found that the DBD of TetR is 
relatively flexible and unfolds independently of the LBD in the absence of 
tetracycline (Fig. 1.15) (Reichheld et al., 2009). However, in the presence of bound 
tetracycline, the unfolding of the DBD is coupled to that of the LBD and, as a result, 
the DBD increases in stability upon ligand-binding (Reichheld et al., 2009) (Fig. 
1.15). On the other hand, the non-inducible TetR mutants displayed less interdomain 
stabilisation upon tetracycline binding (Reichheld et al., 2009). They proposed that 
the thermodynamic coupling between the LBD and the DBD resulted from 
tetracycline-induced rigidification of TetR, locking the protein into a conformation 
which is no longer capable of DNA binding. This rigidification and locking 
mechanism by bound ligand was proposed to be the cause of the allosteric response 
in TetR, rather than the originally proposed mechanism in which tetracycline induces 
conformational changes that are transmitted to the DNA-binding domain (Reichheld 
et al., 2009). In this new model, TetR is thought to be in equilibrium between DNA-
binding compatible and incompatible states, and the DNA or antibiotic captures TetR 
in one state or the other (Reichheld et al., 2009). In a recent comprehensive analysis 
of structural and sequence conservation of TFRs, it was found that for all members 
where structures of the apo-protein and the protein-ligand complex are available, the 
distances between the recognition helices are not significantly different between the 
two structures (and thus both the apo structures and the TFR-ligand structures are 
incompatible with DNA binding) (Fig. 1.16) (Yu et al., 2010). The authors suggested 
that all apo-TetR family members probably sample DNA-binding compatible and 
incompatible conformations in solution, but crystallisation only traps them in the 
incompatible conformation. This also suggests that the derepression mechanism by 
interdomain stabilisation, rigidification and ligand-locking may be widespread in 
members of this family (Yu et al., 2010). 
 
1.6.2 DNA binding by TetR and derepression by tetracycline 
The crystal structure of TetR in complex with its DNA operator has been solved, 
allowing a detailed molecular description of the interaction between protein and 
DNA (Orth et al., 2000). TetR binds perpendicularly to the DNA as a homodimer 
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Fig. 1.15. Protein unfolding of wild-type TetR (WT) and of the non-inducible mutant (ninTetR) in the presence or absence of 
tetracycline (Tc) or anhydrotetracycline (Atc). Urea denaturation profiles of WT (A) and ninTetR (B) in their unliganded form or in the 
presence of Tc or Atc were monitored by measuring CD ellipticity at increasing concentrations of urea. In (B) a close-up of the 
pretransition region is shown and the lines denoting the WT profiles from A are shown for comparison (Adapted from Reichheld et al., 
2009). 
A B 
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Protein 
name/locus ID 
Recognition DNA 
 
Helix α3–helix α3′ (Å)* 
  
  Apo- 
DNA-
bound 
Ligand-
bound 
BC5000 AAACTAATnnnATTAGTTT 48.3     
CgmR GTAACTGTACCGAnnnnTCGTTACAGTTAC 41.7 36.3 41.9 
CprB CGGGAnnnTCCAG 38   
DhaS GGACACATnnnnnnATTTGTCC 63.4   
DesT AGTGAACnnnnGTTGACT  36.7 41.9 
EF0787 TTTATnAAAAA 38.3   
EthR TCAACnnnnnGTCGA 41.3  48.1 
HlyIIR TTTAAAnnnnnnnTTTAAA 33.3   
PA3133 AGGGCCATTCCnnnnnGGAATGGCCCT 40.4   
PksA GCGCACnnnnnnnnGTGCGC 37.9   
PsrA CAAACAnnTGTTTG 44.1   
QacR TTATAGACCGATCGATCGGTCTATAA  36.9 44.5 
Rha04620 AATCGAAnnnnnTTCGATT 45.1   
Rha06780 TCCTACAnnCGTAGAG 37.7   
RHA1_ro03468 TTGTTTGTnnnACAAACAA 37   
RHA1_ro04212 GGTGAAnnnnnnTTTACC 44.5   
Sco7222 TGGAACGnCGTTCCA 54.2   
Sco7704 CGAACnnGTTCG 37.2   
TetR(D) TCTATCAnTGATAGA 38.8 34.7 37.4 
YbiH TTAATCAAnnnnTTGATTAA 36   
Ycdc AACGGTnnnnACAGTT 45.7   
YsiA/Yer0 AATGAATnnnnATTCATT   41.5 
          
* Distances are measured between Cα atoms on each monomer of the positions equivalent to Tyr42 in TetR. 
Fig. 1.16 Operator sequences and 
distances between recognition 
helices (helix α3 to helix α3′) for 
TetR-family members where 
structures of the apo-form and 
ligand-bound form are available 
(Adapted from Yu et al., 2010). 
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(Fig. 1.17A) and the two HTH motifs engage on two consecutive major grooves of 
the 15-bp DNA operator (Orth et al., 2000). The detailed interactions between the 
HTH and the DNA are summarised in Fig. 1.17B. One TetR subunit binds to the 
leading DNA strand from deoxynucleotide number -4 to -7 and also interacts with 
those on the lagging strand from position +4 to +2. Since the TetR is a homodimer 
and the DNA operator is itself palindromic, the opposing subunit makes symmetrical 
contacts to DNA, namely with residues +2 to +4 on the leading strand and -4 to -7 on 
the lagging strand.  
 
From the crystal structure of the TetR-DNA complex, it is clear that helix α3 is the 
recognition helix, which is responsible for sequence-specific interactions (Orth et al., 
2000). In the case of TetR, all the residues in helix α3 except Leu41 interact with 
DNA. Nevertheless, Leu41 is an important residue, contributing to the hydrophobic 
core that stabilises the α1, α2 and α3 helix bundle. Among the α3 residues, Thr40 
directly contacts the base pairs T(-7) and C(-6) on the leading strand and Tyr43 
interacts with T(-7) on the leading strand. Pro39 interacts with both strands, at bases 
T(-5) and A(-4) of the leading strand and at T (+4) on the lagging strand. Tyr42 
makes contact with T(+4) and Gln38 with A(+3) on the lagging strand. Residues 
outside the recognition helix also contribute to the protein-DNA interaction. Arg28 
in helix α2 interacts with G(+2) and Lys48, which lies outside the HTH motif at the 
N-terminus of α4, also interacts with the DNA operator. This lysine residue is 
relatively well-conserved between among TFRs, which suggest that the equivalent 
residue in different TFRs might play the same role in DNA interaction.  
 
The interaction between DNA and the DBD of TetR also leads to conformational 
changes in the HTH motif and in the DNA (Orth et al., 2000). The most apparent 
change in the DBD is the conversion of α3 into a 310 helical conformation. The 
overall bending of the DNA in the complex is ~17
o
, with the DNA kinked away from 
TetR at position +2 in both operator strands. This is compensated by the bending 
toward TetR in the area corresponding to positions +3 to +6.  
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Fig. 1.17. Binding of TetR to its operator site (Orth et al., 2000). (A) The tetR 
operator and contacts made by TetR. The tetR operator is palindromic. Horizontal 
bars show nucleotides which are contacted by monomers of the TetR dimer. (B) 
Interaction of TetR residues with specific nucleotides (arrows) and the phosphate 
backbone (blue lines) in the operator region. The amino acids involved in DNA 
binding extend from residues 27 to 48. (C) Representation of each homodimer bound 
to the tet operator in a double-helical representation. The LBD of TetR dimer is 
omitted for clarity (Orth et al., 2000). 
 
C 
 
 
A 
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1.7 Other members of the TetR family  
 
1.7.1 QacR 
QacR from Staphylococcus aureus controls the expression of a divergently 
transcribed gene, qacA (Grkovic et al., 1998). QacA is an efflux pump which confers 
resistance to monovalent and bivalent cationic lipophilic antiseptics and disinfectants  
such as quaternary ammonium compounds (Brown and Skurray, 2001; Paulsen et al., 
1996). In the absence of the inducers, the QacR protein represses the expression of 
qacR by binding to the two nested inverted repeats that overlap with the qacR 
transcription start site, downstream from the core promoter (Fig. 1.18A) (Grkovic et 
al., 1998). QacR seems to inhibit transcription by hindering the transition of the 
closed RNA polymerase-promoter complex into a productively transcribing complex 
rather than by blocking the binding of RNA polymerase to DNA, as in the TetR case. 
The two nested inverted repeats bound by QacR are different from the two separated 
operators bound by TetR (Grkovic et al., 1998). 
 
Structures of QacR, alone, in complex with its inducers and with its DNA operators 
have been determined, revealing the same domain organisation as in TetR. 
(Schumacher et al., 2001, 2002). The monomers of each dimer have been referred to 
as proximal or distal, referring to their positions with respect to the qacA gene (Fig. 
1.18A). The operator to which each QacR dimer binds is symmetrical, and partially 
overlaps with that bound by the other dimer (Schumacher et al., 2002). This nested 
organisation of two operators is different from the TetR case. However, considering 
one operator at a time, the operator bound by QacR is equivalent to that bound by 
TetR except for the spacer between the two inverted repeat half-sites. The spacer for 
the inverted repeat is 1 bp in the case of TetR, while it is 4 bp in the case of QacR. 
The related architecture of the operators suggests that the binding of TFRs to DNA is 
similar, leaving aside the number of dimers involved. 
 
In the DNA-binding domain of QacR, the recognition helix, α3, establishes most of 
the specific contacts with the operator (Fig. 1.18) (Schumacher et al., 2002). Tyr41 
of the distal monomer A establishes a hydrophobic interaction with the base 
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Fig. 1.18.  Binding of QacR to its operator site. (A) Interaction of QacR with the qac 
operator. (B) Contacts established by residues of helix α3 of QacR homodimers A 
and B with specific nucleotides (arrows) and the phosphate backbone (blue lines) in 
the qacR operator. (C) Representation of the two QacR homodimers bound to the qac 
operator in a double-helical representation (adapted from Schumacher et al., 2002 
and Ramos et al., 2005). 
 
  
A 
B C 
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T(-10) and with the phosphate group at position (-11) on the leading strand.  Tyr40 
contacts the T at position +7. Interaction with DNA is facilitated by hydrogen bonds 
between Lys36 and G(+6) on the lagging strand and between Gly37 and the base of 
G(-8) on the leading strand. G(-8) is the transcription start site for qacA and 
interaction between Gly37 and this base is considered to be important. The proximal 
monomer A and B also establish important contacts with DNA. Tyr41 of the 
proximal B monomer contacts the C(-6) base, while Tyr40 contacts base T(+3) and 
the phosphate group at position +2. Gly37 in the proximal A monomer contacts G(-
4) in the lagging strand, while Lys36 contact G(+1) in the leading strand. A number 
of residues outside the recognition helix α3 also enhance DNA-binding affinity 
through interactions with the phosphate groups (Schumacher et al., 2002).  
 
Since the two operators are nested in the case of QacR, the two QacR dimers bind on 
almost opposing faces of the DNA, with the angle between the two dimers only 
slightly less than 180 degrees (Schumacher et al., 2002). QacR binds to DNA 
cooperatively. The structure of the QacR-DNA complex suggests that this 
cooperativity does not arise from protein-protein interaction, since the closest 
distance between the two dimers is 5 Å. Rather, the cooperativity arises from the 
modification of the bound DNA from a B-DNA conformation to a high-affinity 
under-twisted conformation, as observed in the crystal of the QacR-DNA complex. 
This unwinding of the DNA is necessary to allow optimal QacR binding since the 
distance between the recognition helices in the QacR dimer is 37 Å, greater than the 
34 Å between successive major grooves of canonical B-DNA. The untwisting leads 
to the increase in the distance between successive major grooves required. It is 
possible that the binding of the first QacR dimer induces the energetically-
unfavourable DNA conformational changes that permit the second QacR dimer to 
bind subsequently (Schumacher et al., 2002). While TetR bends the DNA by 17
o
 
through two local kinks to optimise for the distance between their recognition helices, 
QacR bends the bound DNA smoothly and by a total of just 3
o 
(Orth et al., 2000; 
Schumacher et al., 2002). Overall, although QacR and TetR are structural similar, 
detailed analysis shows that they bind DNA in quite different ways. 
 
Unlike TetR, which is extremely specific for tetracyclines, QacR responds to a wide 
range of inducers (Grkovic et al, 1998, Schumacher et al., 2001). QacR can be 
Chapter 1 General Introduction 
35 
derepressed by a number of cationic lipophilic compounds such as rhodamine 6G, 
crystal violet and ethidium, and by bivalent cationic dyes and plant alkaloids. QacR 
can therefore be considered as a model for multidrug recognition. Also, whereas one 
tetracycline molecule is bound in each monomer of the TetR dimer, only one inducer 
molecule is bound per QacR dimer. This was seen in the crystal structure of the 
QacR-rhodamine 6G complex and was confirmed by isothermal titration calorimetry 
and equilibrium dialysis (Schumacher et al., 2001). The inducer-binding pockets in 
QacR are extensive, with a volume of ~1,100 A
3
,
 
and can be divided into several sub-
pockets. Each sub-pocket can accommodate a different inducer. The binding pocket 
does not require a sophisticated recognition mechanism to bind inducers. The entry 
to the binding pocket is through a small opening formed by helices α6, α7, α8 and α8'. 
Since only one monomer in the QacR dimer binds the drug, the structural changes 
are asymmetrical, occurring only in the drug-bound monomer. Superimposition of 
the QacR-ligand and QacR-DNA structures reveals the coil-to-helix transition of 
residues 89 to 93 in helix α5, which extends this helix by another turn. This 
conformational change forces the drug-surrogate Tyr92 and Tyr93 from the 
hydrophobic core of the protein. The removal of those residues leads to the 
relocation of the nearby helix α6 which becomes tethered to the DBD. As a result, 
the DBD translates by 9 Å and rotates by 37
o
, thereby rendering the structure of 
QacR incompatible with DNA binding (Schumacher et al., 2001, 2002).  
 
1.7.2 EthR 
Ethionamide is a second-line drug, used in the treatment of tuberculosis patients who 
have already developed resistance to first-line drugs such as isoniazid or rifampin. 
Ethionamide is a pro-drug that has to be converted into an active compound in a 
reaction catalysed by EthA, a flavin-containing monooxygenase. EthR controls the 
expression of ethA, which is divergently transcribed from ethR (Baulard et al., 2000; 
Engohang-Ndong et al., 2004). In the absence of ethionamide, EthR binds to the 
intergenic region in between ethR and ethA and represses the transcription of ethA. 
The intergenic EthR operator sequence is 55 bp long, significantly longer than the 
15-bp binding site for TetR. This suggests that multiple dimers of EthR bind to the 
overlapping and tandemly-repeated palindromic sequences. Surface plasmon  
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resonance suggested that four EthR dimers bind to the operator (Engohang-Ndong et 
al., 2004).  
 
The structures of EthR-apo and EthR-drug bound are available (Dover et al., 2004, 
Frenois et al., 2004). EthR shares the same domain organisation with TetR (Fig. 
1.19). The LBD is most similar to QacR since EthR and QacR do not possess the 
wrapping arm that embraces the opposite monomer. The dimerisation interface is 
principally formed through the diagonal pairs of helices α8, α9 and α8', α9' (Fig. 
1.19). The most striking feature of EthR is its ligand-binding pocket (Fig. 1.19). The 
helices α4, α5, α7 and α8 in each monomer form a narrow tunnel-like passage that 
opens from the bottom to the top of each EthR monomer (Frenois et al., 2004). The 
tunnel is 20 Å long and is lined predominantly by aromatic residues. When the 
crystal structure of EthR was solved, a compound was fortuitously found to be bound 
in this long tunnel-like cavity, which was identified as hexadecyl octanoate (Frenois 
et al., 2004). The binding of hexadecyl octanoate induces a conformational state 
which is incompatible with DNA binding. This leads to the derepression of the ethA, 
and consequently increases sensitivity of the cell to ethionamide or other thioamides 
through activation of pro-drug processing. 
 
1.7.3 ActR 
Actinorhodin is a blue-pigmented antibiotic produced by S. coelicolor that is 
exported out of the cell by the ActA efflux pump (Hopwood, 2007). Analogous to 
tetAR, expression of actA is under control of a repressor, ActR, actR and actA are 
divergently transcribed, and ActR binds to the intergenic region and represses 
transcription of actA (Tahlan et al., 2007). Actinorhodin itself, or the biosynthetic 
intermediate (S)-DNPA [4-dihydro-9-hydroxy-1-methyl-10-oxo-3-H-naptho-[2,3-c]-
pyran-3-(S)-acetic acid], can cause derepression of ActR, which leads to expression 
of the efflux pump ActA (Fig. 1.20A) (Tahlan et al., 2007).  
 
The antibiotic actinorhodin is a hexacyclic polyketide (Fig. 1.20A). The biosynthesis 
of actinorhodin is accomplished through a type II polyketide synthase, resulting first 
in the tricyclic intermediate S-(DNPA), which does not have antibiotic activity 
(Keatinge-Clay et al., 2004). The tricyclic intermediate is then “dimerised” to form 
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Fig. 1.19. (A) The structure of EthR in complex with a fortuitous ligand, hexadecyl 
octanoate. The EthR dimer is shown with ribbon representation, with the DBD 
coloured in blue and the LBD in red. The hexadecyl octanoate ligand, shown in 
yellow, runs parallel to the 2-fold dimer axis. (B) Superimposition of the binding 
pocket of EthR (in blue) and that of QacR (in red). Although the two proteins 
superpose well with each other, they have a divergent binding pocket. The ligand for 
EthR (green) resides deep in the hydrophobic core of the dimer and runs parallel to 
the axis of helices α4 and α7. In contrast, the pocket of QacR is closer to the DBD 
and is parallel to helix α6 instead (adapted from Frenois et al., 2004). 
A 
B 
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Fig. 1.20 (cont next page)
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Fig 1.20. (A) Schematic representation of actinorhodin biosynthesis and export. An 
initial polyketide is enzymatically transformed into the 3-ring intermediate (S)-
DNPA, and two molecules of (S)-DNPA “dimerise” to form the 6-ring final product, 
actinorhodin, which is then exported from the cell by the ActA efflux pump. Both 
actinorhodin and the intermediate (S)-DNPA can efficiently derepress ActR. (B) The 
binding pocket of ActR, showing the alternating, polar-hydrophobic-polar, pattern of 
regions. The actinorhodin and (S)-DNPA ligands are shown in blue and magenta, 
respectively. Residues within the polar (green) and hydrophobic (yellow) regions are 
shown with stick representation (Willems et al., 2008). 
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the mature hexacyclic product, actinorhodin (Fig. 1.20A) (Taguchi et al., 2000). 
Recent studies by Tahlan et al. (2007) have established that the tricyclic intermediate 
is more effective in derepressing ActR than the mature antibiotic actinorhodin. The 
fact that ActR responds to an inactive biosynthetic intermediate potentially allows 
the producing cells to activate the downstream process (i.e. assembly of the 
actinorhodin export machinery) before the upstream process (i.e. biosynthesis of 
mature actinorhodin) has been completed, in a „feed-forward‟ mechanism (Tahlan et 
al., 2007). The structures of ActR in complex with actinorhodin or with its tricyclic 
intermediate explained why the intermediate was active in depression (Willems et al., 
2008).  
 
The overall structure of ActR is very similar to the classical TetR protein. Hence, 
only the binding pocket is described in detail here. The binding pocket of ActR has 
an alternated hydrophilic/hydrophobic/hydrophilic pattern of lining residues 
(Willems et al., 2008). This pocket can accommodate one hexacyclic actinorhodin 
molecule or two back-to-back tricyclic (S)-DNPA molecules (Fig. 1.20B). The 
bilateral symmetry of the pocket environment correlates well with the symmetry seen 
in actinorhodin. The central hydrophobic region of actinorhodin (C9, C10, C9' and 
C10') mirrors the hydrophobic midpoint of the ligand-binding tunnel. In contrast, the 
more polar oxygen-containing side groups of actinorhodin reside in the more 
hydrophilic proximal and distal half-sites of the binding tunnel (Fig. 1.20B). This 
structure provides a potential explanation for the potency of the intermediate S-
DNPA for derepression of ActR. In the proximal site (close to the tunnel opening), 
actinorhodin and S-DNPA are reasonably well superimposed. However, at the distal 
binding site, actinorhodin and S-DNPA occupy distinct positions. It is not physically 
possible for the distal-half of actinorhodin to adopt the same position as S-DNPA, 
due to the constraint imposed by the covalent bond that links the two halves of 
actinorhodin together. It is therefore possible that S-DNPA can interact more 
favourably with ActR and thereby induce derepression more efficiently.  
 
1.7.4 MphR(A)  
Macrolide antibiotics are among the most widely used drugs to combat bacterial 
infections. Examples of clinically important macrolides include the natural product 
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erythromycin, produced by the actinomycete Saccharopolyspora erythraea, and 
semisynthetic derivatives of erythromycin such as clarithromycin or azithromycin. 
Resistance to this family of antibiotics can be achieved through various mechanisms 
including efflux pump-mediated export and target modification (Leclercq and 
Courvalin, 1991; Ross et al., 1990; Weisblum, 1995). Another resistance strategy is 
the enzymatic inactivation of the antibiotic by a macrolide 2'-phosphotransferase, 
encoded by mphA (Noguchi et al., 1995). MphA phosphorylates the 2'-hydroxyl 
position on the desosamine sugar of erythromycin (Fig. 1.21A), which renders the 
antibiotic inactive because the 2'-hydroxyl position mediates the key interaction with 
the ribosome. The expression of mphA is under the control of a TetR family member 
MphR(A). MphR(A) normally binds to the 35-bp operator region upstream of the 
mphA start codon and represses the expression of mphA in the absence of 
erythromycin (Noguchi et al., 2000). In the presence of erythromycin, MphR(A) 
dissociates from the DNA and allows the expression of the MphA 
phosphotransferase. In contrast to the classical tetRA system where the two genes are 
transcribed divergently, mphR lies downstream of mphA and they are co-transcribed 
in an operon (Fig. 1.21B). This gene cassette has been isolated in several different 
clinical and environment sources, appearing to be part of a mobile element that 
contributes to antibiotic resistance (Szczepanowski et al., 2004, 2007).  
 
Again the overall structure of MphR(A) is highly similar to TetR so only the 
erythromycin-binding pocket of MphR(A) is discussed here in detail. MphR(A) 
binds one molecule of erythromycin per monomer in a large hydrophobic binding 
pocket (Zheng et al., 2009). The binding pocket is lined by residues from helices α4- 
α8 and by residues from the dimerisation interface of the opposite monomer (Fig. 
1.21C and D). The binding pocket encloses most of the ligand including the majority 
of the desosamine and the cladinose sugars. The entrance to the pocket is lined with 
17 residues, most of which are hydrophobic. These residues interact extensively with 
the erythromycin ligand. The interactions are summarised in Fig. 1.21.D. Zheng et al. 
(2009) also noted the presence of the ε-nitrogen of Lys21 4.6 Å away from the 2'-
hydroxyl of the desosamine sugar, the site of modification by the MphA 
phosphotransferase. It is possible that the product of MphA action - phosphorylated 
erythromycin - would be a better ligand for MphR than erythromycin itself, due to a 
favourable interaction between the 2'-O-phosphate and Lys21. If this were true, it  
Chapter 1 General Introduction 
42 
                
Fig. 1.21 (cont next page)
Chapter 1 General Introduction 
43 
Fig. 1.21. (A) Chemical structure of erythromycin. Note the 2'-hydroxyl group on the 
desosamine sugar, the site that is phophorylated by the MphA phosphotransferase 
enzyme to inactivate the antibiotic. (B) The organisation of the erythromycin 
resistance cassette is different from that of the tetR/tetA cassette. Here, mphR lies 
downstream of mphA and they form part of an operon. (C) The structure of the 
MphR(A) dimer with erythromycin bound. (D) The ligand-binding pocket of 
MphR(A) with erythromycin bound (adapted from Zheng et al., 2009).  
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would impose positive feed back on the system. The binding of erythromycin closes 
the ligand-binding pocket, reducing its volume and impeding the release of the bound 
ligand.  
 
1.7.5 DesT 
In the examples above, we have mainly seen the role of TFRs in regulating the 
export of secondary metabolites. However, TFRs are also widely involved in 
controlling important primary metabolic processes. An example is DesT, which is 
involved in the regulation of membrane lipid homeostasis in Pseudomonas 
aeruginosa (Zhu et al., 2006). DesT regulates the ratio of unsaturated and saturated 
fatty acids available for membrane lipid biosynthesis by controlling the expression of 
the desCB operon (Zhu et al., 2006). This operon encodes an oxygen-dependent acyl-
CoA desaturase that converts saturated fatty acids (16:0 or 18:0-CoA) into Δ9 
unsaturated fatty acids (16:1 Δ9- or 18:1 Δ9-CoA). P. aeruginosa is able to convert 
extracellular fatty acids into their CoA thioesters and incorporates them into 
membrane phospholipids (Zhu et al., 2006). The membrane of P. aeruginosa 
normally contains a high proportion of unsaturated fatty acids and therefore the 
incorporation of an abundant extracellular saturated fatty acid could potentially 
disturb membrane homeostasis. The regulated expression of desCB serves to 
modulate membrane lipid composition to avoid this potential problem. The CoA 
thioesters of saturated fatty acids induce DesT dissociation from the DNA, and hence 
the expression of desBC (Zhang et al., 2007). In contrast, the CoA thioesters of 
unsaturated fatty acids promote association of DesT to the DNA (Zhang et al., 2007). 
Since DesT binds saturated and unsaturated fatty acid-CoA with equal affinity, it has 
been postulated that DesT senses the ratio of saturated and unsaturated fatty acid 
thioesters, rather than absolute concentrations (Zhang et al., 2007).  Two structures 
of DesT have been solved, one in complex with an unsaturated fatty acid-CoA and 
DNA, the other in complex with a saturated fatty acid-CoA.  These structures 
elucidated the DNA-binding mechanism and also explained how the protein could 
differentiate between ligands that differ only by the presence or absence of a double 
bond, and why they have opposing effects on DNA binding (Miller et al., 2010). 
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The overall structure of DesT is most similar to the structures of QacR and EthR (Fig. 
1.22) (Miller et al., 2010). Unlike TetR, DesT does not possess the dimerisation 
wrapping arm. Helices α4, α5, α7, α8 and α9 of DesT run parallel to each other and 
perpendicular to the bound DNA. These helices form the long tunnel for ligand 
binding. The L-shaped oleoyl (18:1) moiety of the ligand is buried in this tunnel and 
complements the hydrophobic lining of the tunnel (Fig. 1.22). The CoA moiety is not 
seen, presumably due to disorder. The kink at the 18:1 chain due to the presence of 
the double bond bends the rest of the chain towards the periphery. This distal end is 
projected between α4 and α7. In the crystal structure of DesT and 16:0-CoA, the 
whole ligand is visible, including the CoA moiety. The entrance of the ligand-
binding pocket does not change on swapping the unsaturated fatty acid-CoA for the 
saturated one. This is because the first seven carbons of the 18:0 saturated chain form 
the same interactions with the binding pocket as the first seven carbons of the 16:1 
unsaturated fatty acid-CoA. However, since the saturated chain is essentially linear, 
the distal part of it inserts directly into the hydrophobic core of DesT without kinking 
(Fig. 1.22) (Miller et al., 2010). This action creates the new binding pocket for the 
saturated ligand. This pocket is now very similar to the pocket of EthR with bound 
hexadecyl octanoate in that both ligands run directly from top to bottom of the TFR, 
perpendicular to the bound DNA. This action by the saturated ligand but not by the 
unsaturated ligand captures the DNA-binding incompatible conformation of DesT, in 
which helix α4 and α7 are forced to pack closer together, and the recognition helices 
α3 and α3' rotate by ~5o with a concomitant increase in the distance between them 
from 36.7 Å (DesT in complex with unsaturated ligand and DNA) to 41.9 Å (DesT in 
complex with saturated ligand) (Miller et al., 2010). This is similar to the movement 
seen in other TFRs.  
 
DesT-oleoyl-CoA binds to a 30-bp duplex that contains an 18-bp pseudo-
palindromic operator (Miller et al., 2010) (Fig. 1.22) with helix α3 again functioning 
as the recognition helix. Unlike in TetR or QacR, the N-terminal residue of α1 in 
DesT interacts with the minor groove. In other TFRs, helix α1 only serves as a 
structural element to stabilise the HTH core. Conversely, the N-terminus of helix α4 
lacks the conserved lysine residue seen in TetR, and therefore this helix is not 
involved in DNA binding in DesT. DesT interacts with DNA mainly through the 
phosphate backbone, except for specific interactions with a pair of guanines in each  
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D Fig. 1.22. (A) Structural overview of the DesT–18:1Δ9-
CoA–DNA complex. The protein dimer is cyan, the DNA 
duplex is magenta with a semi-transparent surface and the 
18:1Δ9 acyl chain is orange. (B) The ligand-binding 
pocket in the DesT–18:1Δ9-CoA–DNA complex (C) The 
ligand-binding pocket in the DesT–16:0-CoA complex. 
The ligands, 18:1Δ9-CoA and 16:0-CoA, are shown in 
orange and yellow ball-and-stick representation, 
respectively. Note the difference in binding pockets due to 
the different shapes of the bound ligands. (D) Schematic 
representation of the desCB half-site and its interactions 
with DesT. Base-specific hydrogen bonds are coloured in 
magenta, phosphate hydrogen bonds are in green and van 
der Waals interactions are in orange. 
 
C 
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half-site (Fig. 1.22). The DNA is bent by only 3.3
o
 and is slightly deformed from the 
canonical B conformation, with the DNA unwound such that the major groove is 
widened 0.4 to 1.7 Å and the helical repeat is increased from 34 Å to 36Å (Miller et 
al., 2010).  
 
1.7.6 CgmR 
CgmR controls expression of the multi-drug transporter CgmA in Corynebacterium 
glutamicum, and the structures of CgmR in complex with two distinct inducers 
(methylene blue and ethidium bromide) have been solved (Fig. 1.23) (Itou et al., 
2010). In the CgmR-ligand complexes the ligand is proposed to act as a rigidifying 
„wedge‟ that traps the repressor in a state incompatible with DNA binding (Itou et al., 
2010). The authors suggest that any ligand with sufficient volume and a favourable 
interaction with the binding pocket would lock CgmR in the derepressed state. The 
structure of the CgmR-operator complex shows that CgmR dimers bind to opposite 
faces of the nested DNA operator (Fig. 1.23) (Itou et al., 2010) in a manner 
reminiscent of the QacR system (Schumacher et al., 2002). The length of the spacer 
between the inverted repeats within the CgmR operators is 5 bp, compared to 4 bp in 
the case of QacR. 
 
1.7.7 Other TFRs 
Approximately 234 TetR-like structures from various organisms have been deposited 
in the Protein Database Bank (PDB). However, because almost all of these structures 
are of the apo-form, and because in almost all cases their biological ligands are not 
known, they do not contribute significantly to our understanding of ligand 
recognition, DNA-binding, or the mechanism of derepression. As a result, these 
structures are not discussed here.  
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Fig. 1.23. (A) The overall structure of the CgmR dimer in complex with its ligands: 
methylene blue (left panel) and ethidium bromide (right panel). The overall structure 
of CgmR is more similar to QacR than TetR due to the missing helical wrapping arm. 
(B) The structure of two CgmR dimers bound to the nested operator DNA sequence. 
This is reminiscent of the QacR system in which two dimers are also bound to nested 
operator sequences (adapted from Itou et al., 2010).  
 
A 
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1.8 Aims of this project 
 
 To investigate the mechanism of self-resistance to the DNA gyrase inhibitor, 
simocyclinone D8, in the producing organism S. antibioticus.  
 To investigate the role of a TetR-like repressor, SimR, in coupling the 
biosynthesis and the export of simocyclinones in S. antibioticus. 
 To investigate at the molecular level, using X-ray crystallography, how SimR 
recognises simocyclinones and its cognate DNA-binding sites, and to 
elucidate the mechanism of ligand-mediated derepression.  
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2.1 Bacterial strains and plasmids  
 
2.1.1 E. coli strains  
Derivatives of E. coli K12 
Strain Genotype 
Source/ 
Reference 
DH5  F’ supE44 lacU169 ( 80lacZ M15) hsdR17 recA1 
endA1 gyrA96 thi-1 relA1 
Hanahan 
(1983) 
ET12567 F’ dam13::Tn9 dcm6 hsdM hsdR recF143::Tn10 
galK2 galT22 ara-14 
lacY1 xyl-5 leuB6 thi-1 tonA31 rpsL 
hisG4 tsx-78 mtl-1 glnV44 
MacNeil et al 
(1992) 
ET12567 
/pUZ8002 
ET12567 containing helper plasmid pUZ8002 Paget et al 
(1999a) 
 
BW25113 (araD-araB)567 lacZ4787(::rrnB-4)lacIp-
4000(lacI
Q
) λ-rpoS369(Am) rph-1 (rhaD-rhaB)568 
hsdR514 
 
Datsenko and 
Wanner, 
(2000) 
BL21 (DE3)    
/pLysS 
F
–
 ompT gal dcm lon hsdSB(rB
-
 mB
-
) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) pLysS (Cam
R
) 
 
Studier and 
Moffatt  
(1986)      
 
2.1.2 Streptomyces strains  
Strain Genotype 
Source/ 
Reference 
Streptomyces 
lividans 1326               
Wild type SLP2
+
 SLP3
+             
 Kieser et al. 
(2000) 
Streptomyces 
antibioticus Tü 
6040   
Environmental isolate; original producer of 
simocyclinone D8 
Schimana et 
al (2000) 
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Streptomyces 
antibioticus  
Tü 6040 ΔsimX 
simX::apr                               This thesis 
 
2.1.3 Plasmids  
 
   Plasmid Description  
Source/ 
Reference 
pIJ773 pBluescript KS (+) containing the apramycin 
resistance gene apr and oriT of plasmid RP4, 
flanked by FRT sites (Apr
R
) 
Gust et al  
(2003) 
pIJ790  Modified  λ RED recombination plasmid 
pKD20 (Cam
R
) 
Gust et al 
(2003) 
pSET152 Plasmid cloning vector for the conjugal transfer 
of DNA from E. coli to Streptomyces spp. 
Integrates site-specifically at the C31 
attachment site (Apr
R
) 
Bierman et al 
(1992) 
pUC19  E. coli multicopy cloning vector with lacZ 
selection (Bla
R
) 
Yanisch-
Perron et al 
(1985) 
pUZ8002 Non-transmissible oriT-mobilising plasmid 
(Kan
R
) 
Paget et al 
(1999a) 
pMS82 Plasmid cloning vector for the conjugal transfer 
of DNA from E. coli to Streptomyces spp. 
integrates site-specifically at the BT1 
attachment site (Hyg
R
) 
Gregory et al. 
(2003) 
 
pIJ10469 pMS82 carrying simR under the control of its 
native promoter 
This thesis 
 
pIJ10257 Plasmid integrating at the ΦBT1 attB 
attachment site of S. coelicolor and containing 
the strong ermEp
*
  promoter (Hyg
R
) 
Hong et al. 
(2005) 
pIJ10480   pIJ10257 ermEp*-simX This thesis 
pIJ10481 pIJ10257 ermEp*-simEX2 This thesis 
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pIJ5972 Integrative Streptomyces promoter-probe 
plasmid based on TTA codon-free derivatives 
of the luxAB reporter genes 
This thesis 
pIJ10465 pIJ5972 simXp-luxAB                                     This thesis 
pIJ10466 pIJ5972 simRp-luxAB                                       
pET28a Plasmid for overexpression of N-terminally 
His-tagged and Thrombin cleavage tagged 
protein (Kan
R
) 
Novagen 
 
pET20b Plasmid for overexpression of C-terminally 
His-tagged protein (Bla
R
) 
Novagen 
pIJ10490                     pET28a derivative expressing His6-tagged 
SimR 
This thesis 
pIJ10499 pET20b derivative expressing full-length wild-
type SimR (residue 1-259) with C-terminal 
His-tag 
This thesis 
pIJ10500 pET20b derivative expressing SimR-ΔN10   
(residue 11-259) with C-terminal His-tag. 
This thesis 
pIJ10501 pET20b derivative expressing SimR-ΔN15              
(residue 16-259) with C-terminal His-tag. 
This thesis 
pIJ10502 pET20b derivative expressing SimR-ΔN22              
(residue 23-259) with C-terminal His-tag. 
This thesis 
pIJ10503 pET20b derivative expressing SimR-ΔN25  
(residue 26-259) with C-terminal His-tag. 
This thesis 
 
 
2.2 Growth conditions and storage of bacterial strains 
 
2.2.1 E. coli strains  
E. coli was grown on solid or in liquid media at 37 C (Sambrook et al., 1989). 
Glycerol stocks were made from fresh overnight cultures by adding 40% (v/v) 
glycerol to an equal volume of culture and storing at -80 C. 
 
2.2.2 Streptomyces strains 
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Streptomyces lividans cultures were grown on SFM for the preparation of spores. 
MYMTAP or OBM media were used for culturing Streptomyces antibioticus. A 
single colony was resuspended in 500 µl dH2O and briefly vortexed and spun. The 
supernatant was spread on a solid media to yield a confluent lawn. The plates were 
incubated at 30 C for about six days or until confluent lawns of grey spores were 
visible. The plates were not left for more than two weeks to prevent significant loss 
of spore viability. The spores were harvested as described by Kieser et al. (2000) and 
stored at -20 C. The viable spore concentration was determined by plating out a 
dilution series on SFM plates. All Streptomyces strains were grown on solid media at 
30 C, and were grown in liquid media at 30 C with shaking at 240 rpm (Kieser et al., 
2000).  
 
2.2.3 Antibiotic concentrations for E. coli and Streptomyces strains 
The references for antibiotic concentrations are Sambrook et al. (1989) and Kieser et 
al.  
(2000). 
 
Antibiotic  Stock (mg/ml)   Final concentration ( g/ml) 
  
                                                                         S. lividans     S. antibioticus       E. coli 
                  SFM         MYMTAP          L          
LB  
 
Carbenicillin 200                   -             -                   100        100 
Chloramphenicol 25 (in ethanol)                  -   -                    25         25 
Kanamycin  50                   -   -                    50         50 
Nalicidic acid 50 (in 0.25 M NaOH)     25  12.5                -            - 
Apramycin  50                  50   25                  50         50 
Hygromycin 40                  50   50                  50          - 
 
 
2.3 Culture media, buffers, solutions 
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2.3.1 Solid media 
Unless otherwise stated, the reference for all media is Kieser et al. (2000). 
 
SFM medium (Soya flour mannitol medium)  
This medium is used to prepare spores of Streptomyces lividans strains. 
            Agar .............................................................................................20 g 
            Mannitol ......................................................................................20 g 
            Soya flour ....................................................................................20 g 
            Tap water to …………………………………………………….1000 ml 
The mannitol was dissolved in the water and poured (100 ml) into 250 ml 
Erlenmeyer flasks each containing 1 g agar and 1 g soya flour. The flasks were 
closed and autoclaved twice (115 C, 15 min), with gentle shaking between the two 
runs.  
 
MYMTAP medium 
This medium is used to prepare spores of Streptomyces antibioticus strains. 
Maltose……………………………………………………….4 g 
Yeast Extract………………………………………………….4 g 
Malt Extract…………………………………………………..10 g 
Bacto Agar……………………………………………………20 g 
Made up in 50% tap water and 50% distilled water. After autoclaving 0.4 ml of R2 
trace elements per were added for 200ml MYM 
 
OBM medium (Oat-bran meal medium) 
This medium is used to prepare spores of Streptomyces antibioticus strains. 
 Rolled Oat....................................................................................30g 
            Bacto agar.....................................................................................15g 
            Tap water to …………………………………………………….1000 ml 
The oat-bran meal was autoclaved twice in tap water (115 C, 15 min), with gentle 
shaking and addition of agar after the first run. 
 
R2 medium  
The following solutions were made up:  
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            Sucrose ………………………………………………………….103 g 
 K2SO4 …………………………………………………………...0.25 g 
 MgCl2.6H2O …………………………………………………….0.12 g 
 Glucose  …………………………………………………………10 g 
 Difco Casamino acids ……………………………………………0.1 g 
 dH2O (Distilled water) to ………………………………………..800 ml 
80 ml of the solution was poured into 250 ml Erlenmeyer flasks each containing 2.2 
g Difco Bacto agar. The flasks were closed and autoclaved. At the time of use, the 
medium was re-melted and the following autoclaved solutions were added into each 
flask in the order listed: 
  
            KH2PO4 (0.5% w/v in dH2O) .......................................................1 ml 
 CaCl2.2H2O (3.68% w/v) ……………..…………………………8 ml 
 L-proline (20% w/v) …………………………………………….1.5 ml 
 TES buffer (5.73% w/v, pH 7.2) ………………………………...10 ml 
 Trace element solution ………………………………………….0.2 ml 
 NaOH (1M) (unsterilised) ………………………………………0.5 ml 
 Required growth factors for auxotrophs ……………………….0.75 ml 
 
DNA (Difco nutrient agar) 
4.6 g Difco Nutrient Agar was placed in each 250 ml Erlenmeyer flask and added 
with  200 ml distilled water. The flasks were closed and autoclaved. 
 
L Agar 
This is used for E. coli culture. 
 Agar………………………………………………………….. 10 g 
 Difco Bacto tryptone………………………………………….5 g 
 Difco yeast extract…....……………………………………….5 g 
 NaCl ………………………………………………………….5 g 
 Glucose… …………………………………………………….1 g 
 dH2O to..………………………………………………….. ….1000 ml 
The ingredients, except agar, were added in the distilled water and 200 ml was 
poured into 250 ml Erlenmeyer flasks each containing 2 g agar. The flasks were 
closed and autoclaved. When required, X-gal and IPTG were added to final 
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concentrations of 40 µg/ml and 200 µM, respectively. 
 
2.3.2 Liquid Media 
 
2 PG (Double strength germination medium) 
Used for germinating Streptomyces spores. 
Difco Casaminoacids..……………………………………….10 g 
 Difco yeast extract..…………………………………………..10 g 
 CaCl2 (added after autoclaving)..…………………………….1.1 g 
 dH2O to..……………………………………………………..1000 ml 
The ingredients were dissolved, except CaCl2, in the distilled water and 10 ml was 
aliquoted into universal bottle and autoclave. CaCl2 was prepared and autoclaved 
separately as 1M solution and 100 l was added to 10 ml yeast 
extract/Casaminoacids solution at time of use.  
 
NMMP (Minimal liquid medium)  
This medium is used to obtain dispersed growth, with specific carbon sources.  
The following solutions were made up: 
(NH4)2SO4  ………………………………………………….. 2 g 
 Difco Casaminoacids  ……………………………………… 5 g 
MgSO4.7H2O  ……………………………………………….0.6 g 
 PEG 6000 …………………………………………………… 50 g 
Minor elements solution ……………………………………. 1 ml 
 dH2O to ………………………………………………………800 ml 
80 ml aliquots were dispensed and autoclaved.  At time of use, the following 
solutions were added: 
NaH2PO4/K2HPO4 buffer (0.1M, pH6.8) ……………………15 ml 
 Carbon source (20%) ………………………………………...2.5 ml 
 Any required growth factors  ……………………………… ..2.5 ml 
 Spore inoculum (a heavy inoculum, usually pre-germinated) 
 
 Lennox broth (L broth) 
 Difco Bacto tryptone …………………………………………10 g 
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 Difco yeast extract ……………………………………………5 g 
 NaCl …………………………………………………………..5 g 
 Glucose ……………………………………………………….1 g 
 dH2O to ……………………………………………………….1000 ml 
The mixture was dispensed in 100 ml volumes and then autoclaved. 
 
YEME (Yeast extract-malt extract medium) 
Difco Bacto-peptone …………………………………………3 g 
 Difco yeast extract …………………………………………...5 g 
 Oxoid malt extract ……………………………………………5 g 
 Glucose ………………………………………………………10 g  
 Sucrose ……………………………………………………..340 g (34% final) 
 dH2O to …………………………………………………….1000 ml 
 
After autoclaving, the following solution was added: 
MgCl2.6H2O (2.5 M) ……………………………………………….2 ml/litre (5mM 
final) 
 
TSB (Tryptone soya broth) 
Used for growing S. lividans on a small scale. 
 Oxoid Tryptone Soya Broth powder (CM129) ……………..30 g 
 dH2O to ……………………………………………………..1000 ml 
 
Tu6040-TSB broth 
Used for growing S. antibioticus for chromosomal DNA isolation or for conjugation 
with E. coli.  
            Oxoid Tryptone Soya Broth powder (CM129) ……………..30 g 
             Succrose.................................................................................100 g 
             L-Glycine................................................................................4 g 
             Tap water added to................................................................. 1000 ml 
   
2.3.3 Buffers and solutions 
 
Trace element solution  
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 ZnCl2 ……………………………………………………….40 mg 
 FeCl3.6H2O ………………………………………………...200 mg 
 CuCl2.2H2O ………………………………………………..10 mg 
 MnCl2.4H2O ………………………………………………..10 mg 
 Na2B4O7.10H2O ……………………………………………10 mg 
 (NH4)6Mo7O24.4H2O ………………………………………10 mg 
 dH2O to …………………………………………………….1000 ml 
 
10 TBE 
 Trizma base ………………………………………………….108 g 
 Boric acid …………………………………………………….55 g 
 0.5 M EDTA (pH 8) ………………………………………….40 ml 
 dH2O to ………………………………………………………1000 ml  
 
This gave a solution of pH 8.3. 
 
2.4 Fermentation, isolation and purification of SD8 and SC4 
 
SD8 was isolated as described by Schimana et al. (2000). Briefly, S. antibioticus Tü 
6040 was fermented in a complex medium consisting of 2% (w/v) mannitol and 2% 
(w/v) soybean meal in a 20 l fermentor, and simocyclinones were extracted from the 
mycelium with methanol. Pure SD8 was obtained after reversed-phase HPLC using 
Nucleosil-10 C-18 material and 0.01% trifluoroacetic acid-acetonitrile gradient 
elution, resulting in a dark yellow powder after drying. Pure SC4 was isolated using 
essentially the same procedure, but fermentation was carried out in a defined medium 
containing 20% (v/v) glycerol and 0.15% (w/v) L-arginine to maximise SC4 
production (Theobald et al., 2000). Prof. Hans-Peter Fiedler (Mikrobiologisches 
Institut, Eberhard-Karls-Universität Tübingen, Auf der Morgenstelle 28, D-72076 
Tübingen, Germany) kindly supplied us with purified SD8 and its biosynthetic 
intermediate SC4.  
 
2.5 Nucleic acid isolation 
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2.5.1 Isolation of plasmid or cosmid DNA from E. coli 
E. coli strains were grown overnight at 37
o
C in 10 ml LB broth containing the 
appropriate antibiotic for plasmid or cosmid selection, and harvested by 
centrifugation (5 min at 3000 rpm), resuspended in 200 µl of solution I (50 mM Tris-
HCl pH 8, 10 mM EDTA), 400 µl 0.2 M NaOH, 1% (w/v) SDS were added and the 
mixture was left at room temperature for 5 min. 300 µl 3M potassium acetate (pH 
5.5) were added, and the mixture was inverted a few times, and microcentrifuged for 
5 min at top speed. The supernatant was extracted with an equal volume of 
phenol:chloroform (1:1, v/v), and the nucleic acid precipitated by adding an equal 
volume of isopropanol and left on ice for 10 min. The nucleic acid was harvested by 
centrifugation, washed in 70% (v/v) ethanol, dried, and resuspended in sterile water. 
Plasmids are routinely isolated from 3ml of overnight E. coli cultures, using Qiaprep 
Spin Miniprep Kit (Qiagen). 
 
2.5.2 Isolation of chromosomal DNA from Streptomyces 
Streptomyces cultures grown in a mixture of 4 ml of YEME containing 34% sucrose 
and 6 ml TSB for one day were harvested by centrifugation (10 min at 3000 rpm). 
The cells were washed in dH2O and resuspended in 2 ml SET buffer (75 mM NaCl, 
20 mM Tris-HCl, 25 mM EDTA pH 8), containing 68 µl of lysozyme (30 mg/ml). 
The suspension was incubated at 37
o
C for 30 min (or until the cells lysed if this 
occurred first). 56 µl of Proteinase K (20 mg/ml) and 240 µl of SDS (10% w/v) were 
added and the mixture was left at 55
o
C for 2 h. 800 µl 5 M NaCl and 2 ml 
chloroform were added, and the mixture was mixed on a wheel rotator for 30 min, 
and centrifuged for 15 min at 6000 rpm. The supernatant was extracted with 0.6 
volumes of isopropanol, and the nucleic acid was spooled by using a sterilize glass 
rod. The nucleic acid was washed in 70% (v/v) ethanol, dried, and redissolved in 
sterile water.  
 
2.5.3 Isolation of total RNA from Streptomyces antibioticus 
For RNA preparation, approximately 10
9 
S. antibioticus spores were germinated by 
heat-shock treatment in 5 ml TES buffer (0.05 M, pH 8) at 50
o
C for 10 min, then 
diluted with an equal volume of double-strength germination medium [1% (w/v) 
Difco yeast extract, 1% (w/v) Difco casaminoacids, 0.01 M CaCl2] and incubated 
with shaking at 37
o
C for 6 h (modified from Kieser et al., 2000). Germinated spores 
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were inoculated into NMMP (Kieser et al., 2000) and incubated with shaking for a 
further 15 h at 30
o
C. RNA was prepared essentially as described by Hesketh et al. 
(2007), but with minor modifications taken from the Qiagen RNA Extraction Kit 
procedure (Qiagen). Essentially, 5 ml samples were collected and mixed with 10 ml 
of RNA protect bacteria solution (Qiagen) in Falcon tubes. The mixture was vortexed, 
incubated at room temperature for 5 min and spun down at 3000 rpm for 5 min. The 
pellet was resuspended in 1ml TE (10 mM Tris, pH 8, 1 mM EDTA, 15 mg/ml 
lysozyme) and incubated at room temperature for 60 min. 4 ml RLT buffer (Qiagen) 
was added and the samples were sonicated on ice for 3 cycles (20 s ON and 20 s 
OFF) with 18 microns amplitude. Samples were extracted twice with 2 ml phenol-
chloroform-isoamylalcohol pH 8 (Sigma), and once with 4 ml chloroform. The upper 
layer was removed and mixed with 2.8 ml 100% ethanol and applied to a Qiagen 
Rneasy midi column and centrifuged at 3000 rpm for 1 min. The column was washed 
with 2 ml RW1 buffer (Qiagen) and DNA on the column was digested with DNaseI 
(Qiagen) for 60 min at room temperature. The column was then washed with 2 ml 
RW1 buffer (Qiagen) and centrifuged at 3000 rpm for 5 min. RNA on the column 
was washed twice with 2.5 ml RPE buffer (Qiagen) by spinning at 3000 rpm for 5 
min each time. The ethanol was removed from the column by spinning without any 
buffer and RNA was eluted with 300 μl RNase-free water. The flow-through was re-
applied to the column and centrifuged at 3000 rpm for 5 min to have more 
concentrated RNA. 
 
2.6 Genetic manipulations 
 
2.6.1 Preparation of electro-competent E. coli cells 
A single colony or glycerol stock of the desired E. coli strain was used to inoculate 
10 ml of L broth supplemented with the appropriate antibiotic and grown overnight 
at 37
o
C with shaking (300 rpm). The overnight culture was diluted 100-fold in 100 
ml of fresh media and grown at 37
o
C with shaking to an OD600 of 0.2-0.4. After 
chilling on ice for 10 min, the cells were harvested by centrifugation at 4000 rpm for 
5 min at 4
o
C. The supernatant fluid was discarded and the pellet resuspended in 50 
ml ice-cold 10% glycerol and centrifuged as above. The pellet was resuspended in 25 
ml ice-cold 10% glycerol and centrifuged as above. The supernatant was discarded 
and the pellet was resuspended in the remaining 500 µl supernatant. 50 µl aliquots 
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were frozen and stored at -80
o
C . 
 
2.6.2 Transformation of commercial E. coli DH5α competent cells 
For transformation, the frozen commercial competent cells (Invitrogen) were quickly 
thawed. DNA was added to 50 µl of competent cells, which were incubated on ice 
for 30 min. The suspension was heat-shocked at 42
o
C for 25 s, then transferred to ice 
for 2 min. 0.6 ml of warm L broth was added to the suspension, which was incubated 
for 1 h at 37
o
C. The transformed cells were plated out onto L agar plates containing 
the appropriate antibiotic and incubated at 37
o
C. 
 
2.6.3 Conjugation between E. coli and Streptomyces spp. 
DH5α was used as the primary E. coli cloning host and constructs were then 
transferred to the methylation-deficient E. coli strain ET12567 (MacNeil et al., 1992) 
containing the helper plasmid pUZ8002 (Paget et al., 1999a) by transformation. 
ET12567/pUZ8002 was grown under chloramphenicol and kanamycin selection. 
Donor cultures of ET12567/pUZ8002 carrying the conjugation vectors or their 
derivatives were grown at 37
o
C to an OD600 of 0.4 - 0.6 in L broth supplemented 
with chloramphenicol (25 µg/ml), kanamycin (50 µg/ml) and apramycin (50 µg/ml; 
to select for the integrative vector pSET152) or hygromycin (40 µg/ml; to select for 
the integrative vector pMS82 or pIJ10257). The bacteria were washed twice and 
resuspended with approximately 10
8
 Streptomyces spores that had been activated for 
rapid germination by heating to 50
o
C for 10 min in 2 YT and then cooled. In the 
case of S. antibioticus, young mycelium (grown for 12 hours in Tu6040-TSB broth) 
was used instead. Donors (500 µl; 2 10
8 
E. coli) and recipients (500 µl mycelial 
suspension, or 10
8
 Streptomyces spores) were spread on SFM (or OBM for S. 
antibioticus) containing 10 mM MgCl2 and incubated at 30
o
C overnight. Plates were 
flooded with 1 ml dH2O containing 0.5 mg nalidixic acid and 1 mg apramycin and 
incubated at 30
o
C. Exconjugants were picked from the plates 4 days (or 2 weeks for 
S. antibioticus) later and streaked for single colonies on SFM or OBM plates 
containing 25 µg/ml nalidixic acid (or 12.5 µg/ml for S. antibioticus) and 50 µg/ml 
apramycin (or 25 µg/ml for S. antibioticus). 50 µg/ml hygromycin was used to select 
for pMS82 and pIJ10257. 
 
Chapter 2 Materials and Methods 
 
64 
2.7 In vitro manipulations of DNA 
 
2.7.1 Agarose gel electrophoresis of DNA 
DNA was subjected to electrophoresis on agarose gels after addition of 1/5 volume 
5  loading dye. Agarose gels were prepared and run submerged with 1 TBE buffer. 
For most routine work, 1% agarose was used, but concentrations down to 0.5% and 
up to 2% were used for analysis of large or small fragments, respectively. EtBr at 
0.5-1 µg/ml in 1 TBE buffer was used to stain gels for approximately 10 min. Gels 
were photographed using UV illumination at a wavelength of 254 nm. The DNA size 
marker was the 1 kb or 500 bp ladder. 
DNA loading dye: 0.25% (w/v) Bromophenol Blue, 0.25% (w/v) Xylene Cyanol FF, 
30% (w/v) glycerol. 
 
2.7.2 Isolation of DNA fragments from agarose 
Restriction fragments were isolated from agarose gels that were run and loaded as 
described above. Bands were visualised using long-wavelength UV light (310 nm) to 
minimise nicking of the DNA molecules. Fragments were excised with a cleaned 
razor blade. The DNA fragments were then extracted using the QIAquick Gel 
Extraction Kit from Qiagen, using a microcentrifuge. Recovery was estimated by 
Nanodrop (Thermo Scientific). 
 
2.7.3 Ligation of DNA 
Vector and insert DNA were mixed at a molar ratio of 1:2, respectively, with 1/10 
volume 10  ligation buffer and 5 U T4 DNA ligase in 10 l total volume. The 
mixture was incubated at 4
o
C overnight. The ligated DNA was used to transform 
commercial E. coli DH5α competent cells. 
 
2.7.4  Polymerase Chain Reaction (PCR) 
Synthetic oligonucleotides primers (Genosys or Sigma) were used in the PCR. The 
reaction mixture contained 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgC12, 
200 M final concentration of each of the four dNTPs, 2.5 U Phusion polymerase, 50 
pmol each primer, and 50 ng template DNA in a final volume of 50 µl. After 
denaturation at 98
o
C for 30s, the samples were subjected to 25 cycles of denaturation 
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(98
o
C, 45 s), annealing (55-62
o
C, 45 s), and extension (72
o
C, 60 s) and then 
incubated for 5 min at 72
o
C. The annealing temperature varied with the primers. Also 
the annealing and extension time varied; 15 s was used for PCR products between 
200 and 500 bp, 30s was used for PCR products between 500 bp and 1 kb, and 60 s 
was used for PCR product between 1kb and 2 kb.PCR products were analysed by 
agarose (1% w/v) gel electrophoresis. 
 
Table of primers used in this work  
 
Name                   Sequence (5΄-3΄)    
  
pX-F-EcoRI GAATTCGAGCACGAACTCCTGCTGGC 
pX-R-BamHI GGATCCGACCACCACTTCCTCGGACTGG 
pR-F-BamHI GGATCCTCCCCAGCTGCTCTGGCGTACACC 
pR-R-EcoRI GAATTCGTGAACGTACCGACCATCAGGCCG 
MS82-simR-F-HindIII GGCAAGCTTTCAAGCCAGTGCTGGACGTTCC 
MS82-simR-R-KpnI AACGGTACCAACGGCATCCTCATCTGGCATGACC 
intRX-138-F AAAGATATCCTCGTTCATCCACACTCCCC 
intRX-138-R AAAGGATCCATCTGGCATGACCACCACTTC 
intOX-123-F CCAATTGCGCTACGCTCCTTC 
intOX-123-R CCTGCGCGGAGCCTCCGGAC 
intOR-130-F CACCCTCGGTGTCGGCCACC  
intOR-130-R AACGAGAACGAACCCGTCAG 
simEX1-F-NdeI GAGCATATGCCAGATGAGGATGCCGTTGC 
simEX1-R-HindIII TAGAAGCTTCTATCCGGCATTCCGAGCCG 
simEX2-F-NdeI GGGCATATGACCAGTTTCCAAGTCCAG 
simEX2-R-HindIII GGGAAGCTTACCTCCCGGCCGCAGTAGACC 
DelsimX-F ATGAATACGACGCGCCAGTCCGAGGAAGTGGTGGTCAT
GATT CCG GGG ATC CGT CGA CC 
DelsimX-R CTAGTAGCCCGCTAATTCGACTTAGCGCTCCACTAGCTA
TGT AGG CTG GAG CTG CTT C 
simR-int-simX-R  CTATCCGGCATTCCGAGCCG 
S1-probeX-F GTAGAGGGACATCGTGCCGGC 
Chapter 2 Materials and Methods 
 
66 
S1-probeX-R GGCCGAGCAGTACGGCCAGC 
S1-probeR-F GTGTCGGCCACCTTGACGGC 
S1-probeR-R CCACCGAGCTCTCCGACGATCG 
Invitro1-F GAACGATCTGGTCACGGCTC 
Invitro1-R AGCAGTACGGCCAGCACCCC 
Invitro2-R GCAGCGCCGTACCGACGATCACC 
Invitro3-F CATCGACGCCGCCTCGACACCC 
R2-full-CtagHis-F GATCATATGAACGAAAACGAACCGGTGAG 
R2-full-CtagHis-R GATCTCGAGCGCCAGCGCCGGGCGTTCGC 
R2-M10-trunc-F-NdeI GCCCATATGATGCATCCGGAACCGGCCGG 
R2-A15-trunc-F-NdeI GCCCATATGGCCGGTCGTCGCAGCGCGCG 
R2-S22-trunc-F-NdeI GCCCATATGAGCCACCGTACCCTGAGCCG 
R2-T25-trunc-F-NdeI GCCCATATGACCCTGAGCCGCGATCAGATTG 
               
      
2.7.4 Polyacrylamide gel electrophoresis (PAGE) 
Polyacrylamide gels were prepared by mixing 40 ml acrylamide/bis-acrylamide [6% 
(w/v), ratio 19:1], 7 M urea, 1 TBE solution (Severn Biotech Ltd., UK) with 200 µl 
ammonium persulphate 10% (w/v) and 80 µl TEMED to promote polymerisation. 
Sequencing reactions were denatured at 90
o
C for 5 min and resolved on 40 cm long 
gels run in 1 TBE at a constant power of 1.2 kV. The gels were transferred to 
Whatman 3MM paper and dried on a vacuum drier. The sequencing ladder was 
visualised by autoradiography for 1 to 3 days. 
 
2.7.5 S1 nuclease protection analysis 
The isolation of RNA for S1 mapping was described in 2.5.3. For all assays, 30 µg 
RNA and 25 pmol labelled probe were dissolved in 20 µl NaTCA buffer and 
hybridized at 45
o
C overnight, following denaturation at 65
o
C for 10 min. Probes for 
S1 nuclease protection analysis were generated by PCR using a 5′ end-labelled 
oligonucleotide internal to the ORF and an unlabelled upstream primer [for simXp, 
primers S1-probeX-F and S1-probeX-R; for simRp, primers S1-probeR-F and S1-
probeR-R; (section 2.7.4)]. A G+A sequencing ladder was generated by chemical 
sequencing (Maxam and Gilbert, 1980). 
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2.7.6 In vitro run-off transcription  
This technique is useful to confirm the identification of a promoter. RNA polymerase 
containing a mixture of sigma factors was purified as described previously (Buttner 
et al., 1988) from S. coelicolor M600 grown to exponential phase in YEME (Kieser, 
2000). Three different templates for in vitro run-off transcription were generated by 
PCR that differed in their left or right ends, to allow the simR and simX transcripts to 
be identified unambiguously. Templates were generated using the following primers: 
Template 1, Invitro1-F and Invitro1-R; Template 2, Invitro1-F and Invitro2-R; 
Template 3, Invitro3-F and Invitro1-R (section 2.7.4). Transcripts were analyzed on a 
6% polyacrylamide-7 M urea gel using a heat-denatured, 
32
P-labelled HinfI digest of 
ΦX174 as size standards (Kieser et al. 2000).  
 
In vitro transcription was carried out as described in Buttner et al. (1987). Essentially, 
7 l water and 5 l DNA solution were mixed with 25 l reaction mix and incubated 
at 30
o
C for 2 min. 1 l of RNA polymerase was added to the mixture and incubated 
at 30
o
C for 5 min. After the incubation, 1 l  (=10 Ci) [ -
32
P] CTP (>600 Ci/mmol: 
Perkin Elmer) and 1 l RTP mix were added and incubated at 30
o
C for 2 min. 1 l 5 
mg/ml heparin was added and incubated at 30
o
C for 5 min. 2 l CTP mix was added 
and incubated at 30
o
C for 10 min. The sample was moved onto ice, 10 l 
precipitation mix and 70 l isopropanol were added and the sample was left at -20
o
C 
for at least 1 h. The precipitated sample was then centrifuged at 13,000rpm, 4°C for 
30 minutes and the supernatant was discarded. The pellet was washed with 100ul 
70% ethanol and air- dried before being resuspended in 6 μl formamide loading dye. 
Sample was heated at 95°C for 2 minutes. Only 3 μl was loaded on 6% 
polyacrylamide gel /urea sequencing gel with appropriate radiolabelled DNA size 
markers. 
 
2 Master mix: 1.21 g Tris base, 9.3 mg Na2EDTA and 487.2 mg MgCl2·6H2O were 
dissolved in 35 ml water and the pH was adjusted to pH 7.9 with HCl. 25 ml 4 mM 
potassium phosphate (pH 7.5) was added and pH was adjusted again to pH 7.9. 
Water was added to 70 ml as a final volume and filtered and stored in 1 ml aliquots 
at -20
o
C. 
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Reaction mix: 115 l of 2 Master mix, 6 l BSA (RNase-free, 50 mg/ml), 6 l 100 
mM DTT, 2 l 100 mM EDTA, 80 l glycerol (sterilised by autoclaving), 41 l 
water. 
RTP mix: RTP mix is an equal mixture of 30 mg/ml ATP, 30 mg/ml GTP, 30 mg/ml 
UTP. 
CTP mix: 15 mg/ml CTP 
Precipitation mix: 10 l tRNA (10 mg/ml), 53 l 3M sodium acetate (pH 6.0), 17 l 
water. 
 
2.7.7 PCR for ABI automated sequencing 
The PTC-100 Programmable Thermo Controller (MJ Research, Inc.) was used in all 
PCR reactions. PCR sequencing reactions were prepared by adding 0.2 to 2 g of 
plasmid DNA, or 15 to 30 ng of PCR product DNA, 1 to 5 pmol of primer, 0.5 l of 
100% DMSO, 2 l of 5x sequencing buffer, 1 l of Big Dye reaction mix (Big Dye 
Terminator v3.1, Applied Biosystems) and 1 l Half Term, with the total volume 
made up to 10 l in 200 l tubes. The PCR program was 25 cycles of 30 s at 96 C, 
30 s at 50 C, and 4 min at 60 C. When the PCR was finished, the reactions were sent 
for automated sequencing (TGAC, Norwich). 
 
2.7.8 Analysis of sequences 
Sequences were compiled and analysed using VectorNTI (Invitrogen). 
2.7.9 Phosphorylation of DNA primers 
Primers were phosphorylated using T4 Polynucleotide kinase (T4 PNK). The 
reaction mix contained: 2 µl 100 µM primers, 2 mM ATP or 2 mM [γ-32P] ATP for 
radioactive labelling, 2 µl 10x T4 PNK buffer and 2 units of T4 PNK. The reaction 
volume was brought up to 20 µl with dH2O. The mixture was incubated at 37
o
C for 1 
h followed by incubation at 65
o
C for 20 min for deactivation of the enzyme. 1 µl of 
primer was used for PCR reactions directly from the phosphorylation mix.  
 
2.8 PCR-targeted mutagenesis for simX knock-out in S. antibioticus 
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2.8.1 Introduction 
This system has been adapted for use in S. antibioticus from the method developed 
for S. coelicolor (Gust et al., 2004) and originally for E. coli (Datsenko and Wanner, 
2000). Many bacteria are not readily transformable with linear DNA because of the 
presence of an intracellular exonuclease that degrades linear DNA. However, the λ 
RED (gam, bet, exo) functions promote a greatly enhanced rate of recombination 
when using linear DNA. The method of Datsenko and Wanner (2000) allows the 
disruption of genes in E. coli chromosome using a selectable marker generated by 
PCR using primers that have long extensions homologous to the targeted genes. The 
linear product can then be introduced directly into a strain expressing the λ RED 
recombinase.  
 
The strategy for PCR-targeting for mutagenesis of S. antibioticus is to replace a 
chromosomal sequence within a S. antibioticus SupercosI-derived cosmid (Galm et 
al., 2002) by a selectable marker that has been generated by PCR using primers with 
39 nt extensions homologous to the target gene. The inclusion of oriT (RK2) in the 
disruption cassette allows conjugation to be used to introduce the PCR-targeted 
cosmid DNA into S. antibioticus. Conjugation is much more efficient than 
transformation of protoplasts and it is readily applicable to many actinomycetes 
(Matsushima et al., 1994). The potential methyl-specific restriction system of S. 
antibioticus is circumvented by passing DNA through a methylation-deficient E. coli 
host ET12567 (Paget et al., 1999a). Vectors containing oriT (RK2; Pansegrau et al., 
1994) are mobilisable in trans in E. coli by the non-transmissible pUZ8002, which 
lacks a cis-acting function for its own transfer (Paget et al., 1999a). 
 
To adapt the procedure of λ RED-mediated recombination for Streptomyces, cassettes 
for gene disruption were constructed (Gust et al., 2004) that can be selected both in E. 
coli and in Streptomyces. The λ RED recombination plasmid pKD20 (E. coli Genetic 
Stock Centre CGSC Strain # 7637) was modified by replacing the ampicillin-
resistance gene bla with the chloramphenicol-resistance gene cam, generating pIJ790, 
to permit selection in the presence of SupercosI-derived cosmids (carrying ampicillin 
and kanamycin resistance). Figure 2.1 illustrates the PCR-targeted gene disruption 
method. 
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2.8.2 Introduction of the S. antibioticus cosmid into E. coli BW25113/pIJ790 by 
electroporation 
An overnight culture of E. coli BW25113 containing the λ RED recombination 
plasmid pIJ790 was grown in LB containing 25 µg/ml chloramphenicol at 30 C. The 
overnight culture was diluted 1:100 in SOB (Hanahan, 1983) containing 20 mM 
MgSO4 and 25 µg/ml chloramphenicol and incubated for 3-4 h at 30 C with shaking 
at 250 rpm until the culture reached an OD600 of 0.6. The cells were pelleted by 
centrifugation for 5 min at 4,000 rpm at 4 C and resuspended by gentle mixing in 10 
ml ice-cold 10% glycerol. The centrifugation step was repeated twice more, the 
supernatant removed and the cells resuspended in the remaining about 100 µl 10% 
glycerol. The cell suspension was mixed with 100 ng cosmid DNA (VII-8g cosmid) 
(Galm et al., 2002) and electroporation was carried out in a 0.2 cm ice-cold 
electroporation cuvette using a BioRad GenePulse II set to 200 Ω, 25 µF and 2.5 kV. 
1 ml ice-cold LB was immediately added to the shocked cells and they were 
incubated with shaking at 30 C for 1 h. The cells were spread onto L agar containing 
100 µg/ml carbenicillin, 50 µg/ml kanamycin and 25 µg/ml chloramphenicol and 
incubated overnight at 37 C. 
 
2.8.3 PCR amplification of the extended resistance cassette 
 
PCR amplification of the extended resistance cassette was performed using the 
Expand High Fidelity PCR system (Roche). The reaction contained 1 buffer 2, 50 ng 
template DNA, 50 pmol of each primer (delsimX-F and delsimX-R) (section 2.7.4), 
5% DMSO, 250 µM final concentration of each of the four dNTPs, and 2.5 U DNA 
polymerase mix in a total volume of 50 µl. The cycle conditions consisted of an 
initial denaturation step of 94 C for 2 min and then 10 cycles of denaturation at 94 C 
for 45 s, primer annealing at 50 C for 45 s and extension at 72 C for 90 s followed 
by another 10 cycles of denaturation at 94 C for 45 s, primer annealing at 55 C for 
45 s and extension at 72 C for 90 s before a final extension step of 72 C for 5 min. 
The PCR product was purified using a Qiaquick PCR purification Kit (Qiagen) and 
eluted in 30 µl deionised water. 
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2.8.4 PCR-targeting of the S. antibioticus cosmid 
A single colony of E. coli BW25113/pIJ790 containing the S. antibioticus cosmid 
VII-8g (Galm et al., 2002) from section 2.8.3 was used to inoculate 5 ml LB 
containing 100 µg/ml carbenicillin, 50 µg/ml kanamycin and 25 µg/ml 
chloramphenicol and was incubated overnight at 30 C. The overnight culture was 
diluted 1:100 in SOB lacking MgSO4 but containing 100 µg/ml carbenicillin, 50 
µg/ml kanamycin, 25 µg/ml chloramphenicol and 10 mM L-arabinose and incubated 
for 3-4 h at 30 C with shaking at 250 rpm until the culture reached an OD600 of 0.6. 
The cells were recovered and washed with 10% glycerol as before (section 2.8.3). 
The cell suspension was mixed with 1-2 µl of the PCR product and electroporation 
was carried out as before (section 2.8.3). 1 ml of LB was immediately added to the 
shocked cells and they were incubated with shaking at 37 C for 1 h. The cells were 
spread onto L agar containing 100 µg/ml carbenicillin, 50 µg/ml kanamycin and 50 
µg/ml apramycin and incubated overnight at 37 C. 
 
2.9 Site-Directed Mutagenesis 
The coding region of simR was PCR amplified using  primers R2-full-CtagHis-F and 
R2-full-CtagHis-R (Section 2.7.4) and cloned into SmaI site of pUC19. The correct 
sequence of the insert was confirmed by sequencing. Abutting primers were designed 
to amplify the entire construct with the sense primer carrying the new codon at its 5´ 
end. The primers were phosphorylated (as described in 2.7.9) prior to PCR 
amplification. Hi-fidelity Phusion Taq polymerase (Finzymes) was used to generate 
the linearised blunt-end product and the PCR product was gel-purified and self-
ligated overnight (Fig. 2.2). DpnI was added to the ligation mix to remove any 
template DNA (plasmid purified from E. coli is always methylated) carried over from 
the gel purification step. Competent E. coli DH5α was transformed with 5 µl of the 
ligation mix and plated on LB-carbenicillin for selection (section 2.6.2). 
Transformants were grown either for 8 hours or overnight and plasmids were purified 
by miniprep column (Qiagen). The replacement (or deletion) of the targeted codons 
was confirmed by sequencing.  
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Fig.2.1. Gene disruption in S. antibioticus  by PCR-targeting (Modified from Gust et 
al., 2003). 
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2.10 Antibiotic sensitivity assays 
 
2.10.1 Construction of simX and simEX2 expression plasmids  
simX and simEX2 were amplified by PCR using primers carrying NdeI (upstream) 
and HindIII (downstream) sites [for simX, simEX1-F-NdeI and simEX1-R-HindIII; 
for simEX2, simEX2-F-NdeI and simEX2-R-HindIII (section 2.7.4)]. The simX and 
simEX2 fragments were cloned into NdeI-HindIII-cut pIJ10257 to generate pIJ10480 
and pIJ10481, respectively, and transferred by conjugation into S. lividans. 
 
2.10.2 Minimal inhibitory concentration (MIC) determinations 
For MIC determinations, approximately 5x10
4
 spores were added to each well of a 
96-well microtiter plate (Sterilin), containing a two-fold SD8 dilution series in 
SMMS medium (Kieser et al., 2000). The plates were evaluated everyday for five 
days after inoculation, and the MIC was defined as the lowest concentration at which 
no growth was observed. SD8 was dissolved in DMSO with the final concentration 
of DMSO in the agar not to exceed 1% (v/v). 
 
2.11 Luciferase activity assays 
 
2.11.1 Construction of luxAB reporter plasmids and luciferase activity 
measurements. 
To probe simXp and simRp activities in the absence of SimR, the promoter regions 
(500 bp upstream of the translation start codons) were amplified by PCR using 
upstream primers carrying an EcoRI site and downstream primers carrying a BamHI 
site [primers pX-F-EcoRI and pX-R-BamHI for simXp; pR-F-BamHI and pR-R-
EcoRI for simRp (section 2.7.4)]. The simXp and simRp promoter fragments were 
cloned into EcoRI-BamHI-cut pIJ5972, an integrative, Streptomyces promoter-probe 
plasmid based on TTA codon-free derivatives of the luxAB reporter genes (Aigle et 
al., 2000; M. Paget, pers. comm.), to create plasmids pIJ10465 and pIJ10466, 
respectively, and these reporter constructs were transferred by conjugation into S. 
lividans. To probe simXp and simRp activities in the presence of SimR, a plasmid 
carrying simR under the control of its own promoter (pIJ10469) was transferred by 
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Fig. 2.2.  Illustration for the site-directed mutagenesis strategy. 
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conjugation into strains already harbouring the promoter-probe plasmids pIJ0465 and 
pIJ10466. To construct pIJ10469, simR with its promoter was amplified by PCR 
using an upstream primer carrying a HindIII site and a downstream primer carrying a 
KpnI site [primers MS82-simR-F-HindIII and MS82-simR-R-KpnI (section 2.7.4)] 
and the fragment was cloned into HindIII-KpnI-cut pMS82. 
 
Plasmid-containing strains were grown on Difco Nutrient Agar in single wells of a 
96-well microtiter plate (Sterilin) for three days. Each well was inoculated with 
approximately 5x10
4
 spores. Plates were exposed to filter paper impregnated with n-
decanal for 5 min and luciferase activities were quantified using a NightOwl camera 
(Berthold) equipped with WinLight software (Berthold) using a 1 min exposure time. 
Values given correspond to the average of three biological replicates from three 
different spore stocks.  
 
2.12 Protein-related experiments 
 
2.12.1 Overexpression and purification of native SimR 
The simR gene of S. antibioticus Tü 6040 encoding a 259 amino acid protein was 
chemically synthesized with codon optimization (Genscript) for expression in E. coli 
and ligated into pET28a (Novagen) to give pIJ10490. This encodes a protein with an 
additional 26 amino acids at the N-terminus of the native sequence (with sequence 
MK-H6-PMSDYDIPTTENLYFQGA), giving a total molecular weight of 32,222 Da. 
For expression of SimR with a C-terminal His-tag, the gene was amplified by PCR 
using an upstream primer carrying an NdeI site: R2-full-CtagHis-F (section 2.7.4) 
and a downstream primer carrying a XhoI site: R2-full-CtagHis-R (section 2.7.4). 
The amplified DNA fragment was 5'-phosphorylated, cloned into SmaI-cut pUC18 
and verified by DNA sequencing. The simR coding sequence was excised by 
NdeI/XhoI digestion and cloned into NdeI-XhoI-cut pET20b, giving rise to the 
overexpression plasmid pIJ10499. This encodes a protein with an additional 8 amino 
acids at the C-terminus of the native sequence (with sequence LE-H6), giving a total 
molecular weight of 30,197 Da.  
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For N-terminally His-tagged SimR expression, vector pIJ10495 was introduced into 
E. coli BL21(DE3)/pLysS and a 7 ml overnight culture was used to inoculate 500 ml 
Luria-Bertani medium containing 50 mg kanamycin and 15 mg chloramphenicol. 
The cells were grown at 37
o
C to OD600 of ~0.4. The culture was cooled to 20
o
C and 
0.7 ml dimethylsulfoxide (DMSO) was added before induction of protein expression 
by the addition of isopropyl-β-D-thiogalactopyranoside (IPTG) to a final 
concentration of 0.3 mM. The addition of DMSO was essential for a high yield of 
soluble SimR, presumably because it artificially induces expression of chaperones 
that assist in the folding of SimR in vivo. The culture was left shaking for 3 h at 
30
o
C. Harvested cells were resuspended in 50 mM Tris-HCl (pH 8.4), 300 mM NaCl, 
5% (v/v) glycerol, containing a Complete EDTA-free protease inhibitor cocktail 
(Roche) and lysed by sonication (three cycles of 20 s with 40 s resting on ice in 
between each cycle). The cell debris was removed by centrifugation at 84,000g for 
30 min and the supernatant was filtered through a 0.45 µm membrane before being 
applied to a 1-ml Ni-loaded Hi-Trap Chelating HP column (GE Healthcare) that had 
been equilibrated with buffer A [50 mM Tris-HCl (pH 8.4), 300 mM NaCl, 50 mM 
imidazole]. Protein was eluted from the column using an increasing (50 mM to 500 
mM) imidazole gradient in the same buffer. SimR fractions were identified using 
SDS-PAGE, pooled together, and concentrated to approximately 5-10 mg ml
-1
 using 
a Vivaspin 6 10-kDa cut-off concentrator (Vivascience). The concentrated protein 
was immediately exchanged into crystallization buffer [25 mM Tris-HCl (pH 8.4), 
300 mM NaCl] using a Zeba desalting micro-column (Thermo Scientific).  
 
2.12.2 Overexpression and purification of Selenomethionine-labelled SimR 
Selenomethionine-(SeMet)-labelled SimR was obtained by the metabolic inhibition 
method. E. coli BL21(pLysS) cells containing pIJ10495 were grown in 2 l of M9 
medium at 37
o
C. When OD600 reached ~0.4, lysine, phenylalanine, and threonine 
were added to a final concentration of 100 mg l
-1
 each, and isoleucine, leucine, valine 
and SeMet were added to a final concentration of 50 mg l
-1
 each. The culture was 
incubated for a further 30 min at 37
o
C and then induced with 1 mM IPTG for 3 h. 
The purification of SeMet-labelled SimR followed the protocol described above 
except that all buffers were degassed and contained 0.5 mM DTT to prevent protein 
oxidation. C-terminally His-tagged SimR was produced from the overexpression 
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plasmid pIJ10499 using the same procedure as for the N-terminally His-tagged 
protein, except that the medium was supplemented with 25 mg carbenicillin in place 
of kanamycin.  
 
2.12.3 SDS-PAGE 
Resolving gels (12.5% w/v) were prepared by mixing acrylamide/bis-acrylamide 
(30% w/v), 2 ml 1.5 M Tris-HCl (pH 8.8), 50 μl SDS (20% w/v) and dH2O to make 
up 10 ml. 100 μl ammonium persulphate [10% (w/v)] and 10 μl TEMED was added 
to promote polymerisation. The resolving gel was overlayed with isopropanol at 
room temperature. After 20 min, the isopropanol was poured off and the gel was 
rinsed gently with dH2O before addition of stacking gel (4% w/v). Stacking gels 
were prepared by mixing 0.67 ml acrylamide/bis-acrylamide (30% w/v), 0.625 ml 1 
M Tris-HCl (pH 6.8), 20 μl SDS 20% (w/v) and dH2O to make up 5 ml. 100 μl 
ammonium persulphate [10% (w/v)] and 10 μl TEMED were added to promote 
polymerisation. The stacking gel was poured on the resolving gel and a comb was 
inserted to create wells. The gel was left at room temperature for at least 30 min 
before use. 
 
2.12.4 Electrophoretic mobility shift assays (EMSAs) and determination of 
dissociation constants (Kds) 
The EMSA DNA probe spanning the entire simR-simX intergenic region was 
amplified by PCR using primers intRX-138-F and intRX-138-R (section 2.7.4) and 
then 5′-end labelled using [γ32-P] ATP and T4 polynucleotide kinase (New England 
Biolabs). The competitor DNA carrying only OR was amplified using primers intOR-
130-F and intOR-130-R, and the competitor DNA carrying only OX was amplified 
using primers intOX-123-F and intOX-123-R  (section 2.7.4). Binding of SimR to 
DNA was carried out in 20 μl EMSA Buffer [20 mM Tris, pH 8.0, 1 μg poly(dI-dC), 
1 mM EDTA, 100 mM NaCl, 0.5 mM DTT, 8% (v/v) glycerol] containing 0.1 nM 
radiolabelled DNA (approximately 8000 cpm) and varying amounts of SimR. After 
incubation at 30
o
C for 5 min, the binding reaction mixtures were loaded on 5% (w/v) 
native polyacrylamide gels and run in TBE buffer at 120 V for 45 min. The effect of 
SD8 and SC4 on the ability of SimR to bind DNA was tested by adding the 
compounds to the EMSA Buffer. The SD8 and SC4 stock solutions were made up in 
100% DMSO.  
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EMSA data were collected and analysed on a PhosphoImager (FujiFilm) using Multi 
Gauge image analysis software (FujiFilm). Two independent EMSAs were carried 
out for each probe and mean values were calculated. In order to calculate Kds for 
SimR binding to each operator  when the two operator sites were separated, 
saturation curves (percentage of probe bound against concentration of protein) were 
fitted using SigmaPlot (one site saturation model). For Kds of each operator when the 
two sites were coupled, a random-order binding model was used, where: Y = 
[S]/(2*(Kd1 + [S])) + [S]/(2*(Kd2 + [S])), in which Y is the fractional saturation, Kd1 
and Kd2 are dissociation constant of SimR binding to OX and OR operators, 
respectively, and [S] is the concentration of protein. The fractional saturation was 
calculated from intensities of EMSA bands in each lane as followed, Y = 
(0.5*intensity of middle band + intensity of top band) / (intensity of all bands in a 
lane). The equation was then fitted using SigmaPlot to determine Kds. 
 
2.12.5 DNaseI footprinting 
Templates for DNaseI footprinting were amplified by PCR using one unlabelled 
primer and one primer 5′-end labelled using [γ32-P] ATP and T4 polynucleotide 
kinase (New England Biolabs). The primers were intRX-138-F and intRX-138-R 
(section 2.7.4), the same pair used to generate the simR-simX intergenic region probe 
for the EMSA experiments. DNaseI footprinting assays were performed in 40 μl 
EMSA Buffer containing approximately 180,000 cpm radiolabelled DNA and 
varying amounts of SimR. After incubation at room temperature for 5 min, 10 μl 
DNaseI (10 units in 10 mM CaCl2) was added and the incubation was continued for a 
further 60 s. Reactions were stopped by adding 140 μl DNaseI stop solution (200 
mM unbuffered sodium acetate, 30 mM EDTA, 0.15% SDS and 0.1 mg/ml yeast 
tRNA), the samples were precipitated with ethanol, and the pellets were dried and 
dissolved in 5 μl Sequencing Loading Dye [80% (v/v) formamide, 10 mM NaOH, 1 
mM EDTA, 0.1% (w/v) xylene cyanol and 0.1% (w/v) bromophenol blue]. After 
heating at 80
o
C for 3 min and cooling on ice, the samples were run on a 6% (w/v) 
polyacrylamide/8 M urea sequencing gel, which was dried and analysed using a 
PhosphoImager (FujiFilm). A G+A sequencing ladder was generated from the 
template DNA by chemical sequencing (Maxam and Gilbert, 1980). 
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2.12.6 Limited proteolysis and protease protection assays 
For limited proteolysis assays, 1 nmol of wild-type SimR was incubated with 1 pmol 
bovine trypsin (Sigma) in a total volume of 100 µl buffer [50 mM Tris (pH 8.0), 20 
mM CaCl2 and 150 mM NaCl] at 4 
o
C. For protease protection assays, 1 nmol wild-
type SimR was incubated with equimolar amounts of 15mer, 25mer or 31mer 
double-stranded oligonucleotide containing the SimR OX operator in a total reaction 
volume of 100 µl for 5 min at 4
 o
C before addition of 1 pmol bovine trypsin. 20 µl 
samples were then taken at 5 min time intervals. Reactions were stopped by adding 
SDS-PAGE loading buffer, boiled for 5 min, and analysed using SDS-PAGE. 
Proteins were transferred to PVDF membrane by electroblotting, stained with 
Coomasie blue, and proteolytically-resistant species were identified by N-terminal 
sequencing at the Protein & Nucleic Acid Chemistry Facility, University of 
Cambridge. 
 
2.13 Protein crytallography: crystal methods 
 
2.13.1 Protein crystallization and cryoprotection of SimR-apo and the SimR-
SD8 and SimR-SC4 complexes 
Prior to crystallisation, dynamic light scattering (DLS) was used to monitor the 
solution properties of the purified SimR sample. For this purpose, approximately 30 
μl protein was centrifuged through a 0.1 μm Ultrafree filter (Millipore) to remove 
particulate material before introduction into a 12 μl microsampling cell. The cell was 
inserted into a DynaPro-Titan molecular-sizing instrument at 20 
o
C (Wyatt 
Technology). A minimum of 10 scattering measurements were taken and the 
resulting data were analysed using the DYNAMICS software package (Wyatt 
Technology). 
 
Crystallization trials of His-tagged SimR were set-up using an OrxyNano robot 
(Douglas Instruments Ltd) in sitting-drop vapour diffusion format with 96-well MRC 
plates (Molecular Dimensions) using a variety of commercially available screens 
(Molecular Dimensions and Qiagen) at a constant temperature of 20°C. Drops 
consisted of 0.3 l protein solution mixed with 0.3 l precipitant solution and the 
reservoir volume was 50 μl; the protein concentration was approximately 5 mg ml-1. 
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Improved crystals were subsequently obtained by refining the successful conditions 
in a hanging-drop format using 24-well VDX plates (Molecular Dimensions) over a 
reservoir volume of 1 ml.  
 
Crystals of N-terminally His-tagged SimR-apo (both native and SeMet labelled) 
were obtained from 2% (w/v) polyethylene glycol (PEG)-10000, 0.2 M ammonium 
acetate in 0.1 M Bis-Tris (pH 5.5). Subsequently, C-terminally His-tagged protein 
was found to yield better quality crystals from the same conditions. All SimR-apo 
crystals were cryoprotected by supplementing the crystallization solution with 30% 
(w/v) PEG-1500.  
 
SD8 and SC4 were isolated from S. antibioticus Tü 6040 as described (Schimana et 
al., 2000; Holzenkampfer et al., 2002). Both compounds were dissolved in DMSO 
and then added to C-terminally His-tagged protein to a final concentration of 500 µM, 
with the final concentration of DMSO not exceeding 2% (v/v). Crystals of the SimR-
SD8 complex grew from 25% (w/v) PEG 1000 in 0.1 M sodium acetate (pH 4.6) and 
were cryoprotected by supplementing the crystallization solution with 32% (w/v) 
PEG 1500. Crystals of the SimR-SC4 complex grew from 28% (v/v) PEG-400, 0.2 
M CaCl2 in 0.1 M HEPES (pH 7.5). Due to the presence of PEG-400 in the mother 
liquor, no further cryoprotection was required for these crystals.  
 
2.13.2 Structure determination and refinement of SimR-apo and the SimR-SD8 
and SimR-SC4 complexes 
All crystals were flash-cooled by plunging into liquid nitrogen and then mounted in 
Unipuck cassettes before being robotically mounted onto the goniostat on either 
station I02, I03 or I04 at the Diamond Light Source (Oxford, UK) and were 
maintained at -173
o
C with a Cryojet cryocooler (Oxford Instruments). Diffraction 
data were recorded using an ADSC Quantum 315 CCD detector. The resultant data 
were integrated using MOSFLM (Leslie, 2006) and subsequently scaled by SCALA 
(Evans, 2006). Native data were collected from an apo crystal of the N-terminally 
His-tagged SimR to 2.3-Å resolution in space group H32. Solvent content estimation 
gave a value of 45% based on a single copy of the monomer in the asymmetric unit. 
A single apo SeMet-labelled crystal of N-terminally His-tagged SimR was used to 
collect a selenium anomalous peak data set at 3.4 Å resolution with the wavelength 
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set to 0.9763 Å. Experimental phases were determined by the single-wavelength 
anomalous dispersion method using the SHELX suite (Sheldrick, 2008) implemented 
through the HKL2MAP graphical user interface (Pape and Schneider, 2004). 
Substructure solution was performed with SHELXD, and seven of the expected nine 
selenium sites in the native sequence were located. This solution gave a figure-of-
merit of 0.541 to 3.4-Å resolution after phasing in SHELXE. After density 
modification with PARROT (Cowtan, 2010) a partial backbone trace was obtained 
with BUCCANEER (Cowtan, 2006). At the same time, an approximate molecular 
replacement solution was obtained from the 2.3-Å resolution native data set using the 
BALBES pipeline (Long et al., 2008) (with a molecular replacement score of 2.63), 
which selected the structure of Sco6599 as a template (PDB accession code 2HXI, 
sequence identity with SimR 25.4%). The BUCCANEER model and the BALBES 
solution were then brought to the same origin after visual inspection in COOT 
(Emsley and Cowtan, 2004). The BALBES model was subsequently rebuilt against 
the experimentally-phased electron density map at 3.4-Å resolution and then refined 
against the 2.3-Å resolution native data set using REFMAC5 (Murshudov et al., 
1997). At this stage the model contained only 118 residues and had Rwork and Rfree 
values of 50.6 and 51.7%, respectively. The refined model phases were then 
combined with the experimental phase information using the program SIGMAA 
(Read, 1986) to give improved phases. Further iterations of rebuilding, refinement 
and phase combination were performed until a model consisting of 165 residues was 
obtained, with corresponding Rwork and Rfree values of 36.3% and 40.0%, respectively. 
The work-flow is summarised in the Fig. 2.2. Thereafter, the model was refined 
against a new data set (but for C-terminally His-tagged SimR-apo instead) collected 
to 1.95 Å resolution, whereupon the electron density maps were significantly 
improved. Additional cycles of rebuilding and refinement yielded a model consisting 
of 238 residues, with corresponding Rwork and Rfree values of 20.5% and 23.4%, 
respectively.  
 
The SD8 and SC4 complexes with SimR each yielded new crystal forms both 
containing two SimR protomers per asymmetric unit. In both cases, the structures 
were solved by molecular replacement using the structure of the C-terminally His-
tagged SimR-apo monomer as the search model. The SimR-SD8 structure was 
solved using MOLREP (Vagin and Teplyakov, 2000), and the SimR-SC4 structure 
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Fig. 2.2. Strategy for solving the structure of SimR-apo (Courtesy of Dr. David 
Lawson) 
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using PHASER (McCoy et al., 2007). The two complex structures were then rebuilt 
and refined as for SimR-apo. All X-ray data collection and refinement statistics are 
summarized in Table 5.1.  
 
Difference electron density 'omit' maps were generated for the SD8 and SC4 ligands 
using phases calculated from the final model minus the ligand coordinates after 
simulated annealing refinement. This was performed from a starting temperature of 
5000 K after applying random shifts to the model ('shake' term set to 0.3) using 
PHENIX (Adams et al., 2002). Structural figures were generated using PyMOL 
(DeLano, 2002). 
 
Accession numbers 
Coordinates and structure factors for SimR-apo, SimR-SD8 and SimR-SC4 described 
herein have been deposited in the Protein Data Bank with accession numbers 2Y2Z, 
2Y30 and 2Y31, respectively. 
 
2.13.3 Protein crystallization and cryoprotection of the SimR-DNA complex 
C-terminally His-tagged SimR was purified and buffer-exchanged prior to 
crytallisation as described above. 
 
Pairs of DNA oligonucleotides of different lengths (16 to 21 base pairs) and ends 
(blunt or sticky ends) were ordered from Oligos etc® and were reconstituted using 
the crystallisation buffer [25 mM Tris-HCl (pH 8.4), 300 mM NaCl]. Oligo pairs 
were annealed overnight to form duplexes. The final concentration of the duplexes 
was 2mM. 
 
SimR and annealed oligonucleotides were mixed together in the ratio 1 SimR dimer 
to 1.2 double-stranded oligonucleotide and incubated at 20
o
C for 10 minutes before 
crystallization screening. Crystallization trials of SimR-DNA were set-up in hanging-
drop vapour diffusion format with 48-well VDX plates (Hampton Research) using a 
variety of commercially available screens (Emerald BioSystems and Hampton 
Research) at a constant temperature of 20 
o
C. Drops consisted of 1 μl SimR-DNA 
complex solution mixed with 1 μl precipitant solution and the reservoir volume was 
150 μl. Improved crystals were subsequently obtained by refining the successful 
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conditions in a hanging-drop format using 24-well VDX plates (Molecular 
Dimensions) over a reservoir volume of 1 ml.  
 
SimR-DNA crystals were obtained under several different screening conditions, but 
only with the blunt-ended 17mer DNA. The best crystals were obtained from 
solutions containing 10% (w/v) polyethylene glycol 8000, 0.2 M potassium chloride, 
0.1 M magnesium acetate in 0.05 M sodium cacodylate (pH 6.5) two weeks after set-
up. The crystals belonged to the orthorhombic space group P212121. The SimR-
17mer crystals were cryoprotected by a three-step transfer process in which ethylene 
glycol was added to the drop to a final concentration of 20%. 
 
2.13.4 Structure determination and refinement of the SimR-DNA complex 
All crystals were flash-cooled by plunging into liquid nitrogen and then mounted 
onto the goniostat at beamline 8.3.1 at the Advanced Light Source (Berkeley, 
California, US). The resultant data were integrated using MOSFLM (Leslie, 2006) 
and subsequently scaled by SCALA (Evans, 2006). Native intensity data were 
collected from a SimR-17mer crystal to 2.99 Å resolution. The reflections used to 
calculate the R-free value were selected in thin resolution shells to avoid bias 
resulting from the use of non-crystallographic symmetry (NCS) restraints in 
refinement. The structure of the complex was solved by molecular replacement using 
the structure of a subunit of C-terminally hexa-histidine-tagged apo SimR (PDB: 
2Y2Z) and an idealised B-DNA of the correct sequence as the search models in 
PHASER (McCoy et al., 2007). SimR-17mer crystals contained two SimR dimer-
DNA complexes in the asymmetric unit. The structure of the complex was then 
rebuilt in COOT (Emsley and Cowtan, 2004) and refined using REFMAC5 
(Murshudov et al., 1997) and PHENIX (Adams et al., 2002) with NCS restraints. In 
the final stages, TLS refinement was used with a total of 20 TLS domains, which 
were defined using the TLS motion determination server 
(http://skuld.bmsc.washington.edu/~tlsmd/) (Painter and Merritt, 2006). X-ray data 
collection and refinement statistics are summarized in Table 6.1. 
 
Structural figures were generated using PyMOL (DeLano, 2002). The local DNA 
helical parameters were calculated using Curves+ (Lavery et al., 2009). 
 
Chapter 2 Materials and Methods 
 
85 
Accession numbers 
Coordinates and structure factors for SimR-DNA complex described herein have 
been deposited in the Protein Data Bank with accession number 3ZQL. 
 
2.14 Global bioinformatic analysis of TFRs  
 
I searched the PFAM database (http://pfam.sanger.ac.uk) for proteins that match the 
Hidden Markov Model profile PF00440, identifying 23,137 TFR candidates. Protein 
sequences longer than 300 amino acid residues were removed to eliminate false 
positives, and highly similar orthologous TFRs were removed using Jalview with a 
threshold of 99% identity (Waterhouse et al., 2009), resulting in a non-redundant set 
of 12,715 TFRs.  
 
The non-redundant set of TFRs was divided into clusters of 200 sequences using 
USEARCH and UCLUST (Edgar, 2010). The amino acid sequences of the TFRs in 
each cluster were then aligned using MUSCLE (Edgar, 2004) to identify their N-
terminal extensions, which were defined as the amino acid sequences preceding the 
conserved core DBDs (See Fig. 6.1). The globular body of the TFRs was defined by 
excluding the N-terminal extension from the whole protein sequence. In-house Perl 
scripts were used to quantify the length of the N-terminal extension and the fractions 
of R+K or D+E residues within these extensions. The sequences of the N-terminal 
extensions were concatenated together and submitted to the Regional Order Neural 
Network (RONN) programme (Yang et al., 2005) to predict the disorder probability 
for each residue. QtiPlot (http://soft.proindependent.com/qtiplot.html) was used to 
produce histograms. 
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3.1 Introduction 
 
Although the interaction between SD8 and the GyrA had been dissected 
biochemically, a key remaining issue was to establish the in vivo target of the 
simocyclinones. Recent transcription profiling studies in E. coli suggested but did not 
prove that gyrase is the target (Oppegard et al., 2009). To address this issue, I 
selected spontaneous resistant mutants in E. coli and mapped the mutations. 
 
Wild-type E. coli and other Gram-negative bacteria are resistant to simocyclinones 
because the compounds cannot penetrate the outer membrane. The bilayer outer 
membrane of E. coli is asymmetrical in the sense that the outermost layer is 
composed of mainly lipopolysaccharides (LPS), while the innermost layer is 
comprised of phospholipids (Fig. 3.1). There are β-barrel proteins which span the 
bilayer, and there are lipoproteins that are attached to the inner surface of the outer 
membrane by a lipid anchor. The outer membrane serves as the general protective 
shield against many toxic compounds, such as detergents (e.g. bile salts) or 
antibiotics (e.g. chlorobiphenyl vancomycin or moenomycin).    
 
To isolate spontaneous SD8-resistant mutants, I therefore used an E. coli strain 
(imp4213) that carries an in-frame deletion in the imp (increased membrane 
permeability) gene (also known as ostA for organic solvent tolerant). E. coli cells 
carrying this allele are sensitive to antibiotics and detergents. imp is an essential gene 
that encodes a protein required for outer membrane assembly in E. coli. E. coli imp 
mutants have frequently been used to study the mechanism of action of compounds 
that cannot penetrate the outer membrane of wild-type E. coli. One such example is 
the use of an E. coli imp strain to study the glycopeptide mannopeptimycin, which is 
produced by Streptomyces hygroscopicus (Singh et al., 2003). 
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Figure. 3.1. The overall architecture of the cell envelope of wild-type E. coli and the 
imp4213 mutant. There are three main layers in the cell envelope. They are the inner 
membrane (IM), the peptidoglycan layer (PG) and the outer membrane (OM). The 
outer membrane is composed of the outermost lipopolysaccharide layer (LPS) and 
the innermost phospholipid layer (PL). Membrane-bound proteins are omitted for 
clarity.  
 
The wild-type OM acts as a barrier to some antibiotics (diamonds) or detergents such 
as bile salts (circles), which therefore cannot reach potential targets in the periplasm 
or cytoplasm. The imp4213 has a defect in the OM which now has an increased 
permeability to antibiotics and bile salts. Second-site suppressor mutations in the 
imp4213 mutant background (for example in this case in another OM biosynthetic 
gene, yfgL) can restore membrane impermeability. Because the imp4213 mutation is 
an in-frame deletion, it cannot revert. The figure is adapted from Ruiz et al. (2005). 
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3.2 The isolation of spontaneous mutants resistant to SD8  
 
Overnight cultures (300 µl) were plated on LB agar supplemented with SD8 to a 
final concentration of 10 µg/ml. Five independent overnight cultures were plated on 
separated SD8-supplemented plates in order to minimise the isolation of clonal 
mutants. Plates were incubated for 24-48 h and the resulting colonies were re-
streaked onto SD8-supplemented agar to confirm their resistance. A ~500-bp region 
of gyrA, corresponding to residues M26 to S172 of the protein, was amplified by 
PCR from the resistant colonies and the resulting fragments were gel-purified and 
sequenced. 
 
I isolated 31 spontaneous SD8-resistant mutants and found gyrA mutations in 22 of 
them, conferring one for the following amino acid changes: V44G, H45Y, H45Q, 
G81S and D87Y (Table 3.1). These amino acids are close to the bound SD8 
molecule in the GyrA-SD8 crystal structure, consistent with gyrase being the in vivo 
target (Fig. 3.2). Unlike the 22 gyrA mutants, the remaining nine isolates had also 
acquired resistance to bile salts (Table 3.1 and Fig. 3.3), showing they had restored 
outer membrane impermeability. Because the imp4213 mutation is an in-frame 
deletion, these nine isolates cannot be simple revertants.  However, several imp4213 
suppressor mutations that restore membrane impermeability to generic detergents 
such as bile salts have been mapped to other genes encoding further components of 
the outer membrane biosynthetic machinery (Ruiz et al., 2005). It is therefore likely 
that the remaining nine isolates are accounted for by such spontaneous second-site 
mutations. 
 
The work contained in this chapter was published as part of Edwards et al. (2009). 
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MUTATIONS V44G H45Y H45Q G81S D87Y 
SP1     √ 
SP2     √ 
SP3     √ 
SP4     √ 
SP5    √  
SP6.1    √  
SP6.2     √ 
SP6.3      
SP6.4      
SP6.5      
SP6.6   √   
SP7.1      
SP7.2      
SP7.3      
SP7.6     √ 
SP8.1 √     
SP8.2      
SP8.3     √ 
SP8.4     √ 
SP8.5      
SP8.6  √    
SP9.1    √  
SP9.2     √ 
SP9.3     √ 
SP9.5     √ 
SP9.6     √ 
SP10.1     √ 
SP10.3      
SP10.4      
SP10.5     √ 
SP10.6    √  
 
 
Table 3.1. Summary of the spontaneous mutations conferring resistance to SD8 in 
the E. coli imp genetic background. The 22 mutants carrying mutations in gyrA are 
shown in black and the nine mutants in which no gyrA mutation was found are 
shown in red.  
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Fig. 3.2. The spontaneous amino acid substitutions in GyrA giving rise to SD8 
resistance lie close to the bound antibiotic in the GyrA-SD8 crystal structure, 
consistent with gyrase being the in vivo target of SD8. 
 
Chapter 3 The in vivo target of SD8 
 
92 
           
Fig. 3.3. Spontaneous SD8-resistant mutants grown on (A) LB agar, and (B) 
McConkey agar. Bile salts are present in McConkey agar but absent from LB agar. 
Unlike the 22 spontaneous SD8-resistant mutants that carried gyrA mutations, the 
remaining nine isolates had also acquired resistance to bile salts. This suggests that 
they could be accounted for by spontaneous second-site mutations that are known to 
restore outer membrane impermeability to the imp mutants (Ruiz et al., 2005). 
A 
B 
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4.1 Introduction 
 
Aminocoumarin antibiotics are active against Gram-positive bacteria and function 
principally by inhibiting DNA gyrase (Maxwell and Lawson, 2003), an essential 
DNA topoisomerase found in all bacteria, which catalyses DNA supercoiling 
(Nollmann et al., 2007).  In addition, a likely secondary target of these compounds is 
topoisomerase IV, which is involved in chromosome decatenation (Hardy and 
Cozzarelli, 2003; Oppegard et al., 2009). All four known aminocoumarins are 
produced by Streptomyces species. The first three to be discovered, novobiocin, 
clorobiocin and coumermycin A1, each competitively inhibit the ATPase activity of 
the GyrB subunit of DNA gyrase and exhibit Ki values in the nanomolar range 
(Gormley et al., 1996). The most recently identified aminocoumarin antibiotic, SD8 
(Schimana et al., 2000) (Fig. 4.1), also inhibits DNA gyrase but was unexpectedly 
found to have a completely novel mode of action, binding instead to the GyrA 
subunit of the enzyme and preventing its binding to DNA (Flatman et al., 2005; 
Edwards et al., 2009). SD8 is a potent inhibitor of DNA gyrase supercoiling with an 
IC50 lower than that of novobiocin (Flatman et al., 2005; Oppegard et al., 2009). 
 
The genus Streptomyces accounts for the production of approximately two-thirds of 
the known antibiotics. They expel these compounds into their environment, typically 
the soil, most probably to give them a competitive advantage over other organisms 
that share the same ecological niche.  Because the antibiotic is often potentially lethal 
to the producing organism, there must be mechanisms to ensure that the machinery 
responsible for export of the mature antibiotic is in place at the time of biosynthesis.  
This export machinery may be sufficient to confer resistance to the antibiotic, or 
there may be additional resistance mechanisms. For example, in the case of the 
novobiocin, clorobiocin and coumermycin A1 producers, the principal mechanism of 
resistance is production of an aminocoumarin-resistant GyrB subunit (GyrB
R
), 
encoded within the biosynthetic cluster and activated during antibiotic production 
(Thiara and Cundliffe, 1988, 1989, 1993; Schmutz et al., 2003). The GyrB
R
 subunit 
replaces the sensitive subunit (GyrB
s
) in the (GyrA)2(GyrB)2 heterotetramer during 
the production phase. In addition, an aminocoumarin-resistant topoisomerase IV 
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Fig. 4.1. Structures of simocyclinone D8 (SD8) and its biosynthetic intermediate, 
simocyclinone C4 (SC4), and their IC50’s for E. coli DNA gyrase.  
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subunit, ParY
R
, encoded within the clorobiocin and coumermycin A1 biosynthetic 
clusters (but not the novobiocin biosynthetic cluster), also confers resistance to these 
antibiotics when introduced into a naïve host, presumably by an analogous 
mechanism (Schmutz et al., 2003). However, no DNA gyrase or topoisomerase IV 
subunits are encoded within the sim biosynthetic cluster (Galm et al., 2002; Trefzer 
et al., 2002), leaving unknown the mechanism of resistance in the producing 
organism, S. antibioticus Tü 6040. 
 
Within the sim cluster, among the genes responsible for the biosynthesis and linking 
of the four constituents of the antibiotic, are two divergently transcribed genes, 
simR2 (hereafter, simR) and simEX1 (hereafter, simX) (Galm et al., 2002; Trefzer et 
al., 2002). The SimR/SimX pair resembles the TetR/TetA repressor-efflux pump pair 
that causes widespread resistance to clinically important tetracyclines in several 
human pathogens (Chopra and Roberts, 2001). The similarity of SimR/SimX to 
TetR/TetA suggested they might be involved in simocyclinone efflux and, 
potentially, in simocyclinone resistance (Trefzer et al., 2002; Galm et al., 2002). 
 
Here I show that simX encodes a simocyclinone efflux pump, and that transcription 
of simX is controlled by SimR, which directly represses the simX and simR promoters 
by binding to two operator sites in the simR-simX intergenic region. I show that SD8  
abolishes DNA binding by SimR, providing an intimate mechanism that couples the 
biosynthesis of simocyclinone to its export.  In addition, I show that an intermediate 
in the biosynthetic pathway, SC4, which is essentially inactive as a DNA gyrase 
inhibitor, also induces simX expression in vivo and relieves DNA binding by SimR in 
vitro, suggesting a potential ‘feed-forward’ mechanism (Tahlan et al., 2007) that 
might ensure expression of the SimX efflux pump prior to the build-up of a toxic 
concentration of the mature, active antibiotic.  
 
4.2 simX encodes a simocyclinone efflux pump  
 
There are two pump-like transmembrane proteins encoded in the sim cluster, 
SimEX1 (hereafter SimX) and SimEX2 (Trefzer et al., 2002). To determine if either 
of these two proteins is involved in SD8 efflux, I expressed simX and simEX2 from 
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the strong constitutive promoter ermEp* using the integrative, single-copy vector 
pIJ10257 (Hong et al., 2005).  I introduced these constructs into the heterologous 
host S. lividans and compared the susceptibility of the resulting strains to SD8 (Fig. 
4.2). The strain carrying ermEp*-simEX2 had an MIC of 2 μg/ml, as did S. lividans 
alone, or S. lividans containing the parent vector, pIJ10257. In contrast, the strain 
carrying the ermEp*-simX construct had an MIC of 65 μg/ml. The ermEp*-simX 
construct did not confer resistance to the structurally related aminocoumarin DNA 
gyrase inhibitor novobiocin, nor to unrelated antibiotics such as erythromycin, 
lincomycin, rifampicin, bacitracin and nisin. Moreover, I constructed a S. 
antibioticus simX deletion mutant and showed that it was more sensitive to 
exogenous SD8 than the wild-type strain (Fig. 4.3). These results suggested that 
simX encodes a simocyclinone-specific efflux pump. Adjacent to simX is the 
divergent gene simR, encoding a potential transcriptional repressor of simX. I also 
cloned simX into an integrative vector under the control of its native promoter and in 
the absence of simR.  This construct only mildly enhanced resistance to SD8 in S. 
lividans, giving an MIC of 4 μg/ml. 
 
4.3 Mapping the transcription start points of simR and simX  
 
High resolution S1 nuclease mapping of the simR and simX promoters was 
performed using RNA isolated from the SD8 producing organism, S. antibioticus Tü 
6040 (Fig. 4.4A).  A single simR promoter (simRp) was identified, initiating 
transcription 20 bp upstream of the simR ATG start codon, and a single simX 
promoter (simXp) was identified, initiating transcription 47 bp upstream of the simX 
ATG start codon (Figs. 4.4A and 4.5).  In vitro run-off transcription experiments 
with purified S. coelicolor RNA polymerase confirmed the presence and locations of 
the simR and simX promoters (Fig. 4.4B).  
 
4.4 SimR regulates expression of simR and simX 
 
To investigate the regulation of simR and simX, simR and simX promoter activities 
were measured in the presence and absence of SimR, using the integrative luciferase  
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Fig. 4.2. Expression of the efflux pump simX confers SD8 resistance on a naive host, S. lividans. Approximately 5x10
4
 spores were 
spread on each R2 agar plate and paper discs impregnated with varying amounts of SD8 were applied to the freshly spread plates. The 
plates were incubated at 30
o
C for 4 days before scoring.  
Unit: μg 
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Fig. 4.3. The S. antibioticus simX deletion mutant is more sensitive to SD8 than the 
wild-type (WT) strain. Approximately 5x10
4
 spores were spread on each SMMS agar 
plate and paper discs impregnated with varying amounts of SD8 were applied to the 
freshly spread plates. The plates were incubated at 30
o
C for 4 days before scoring.  
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Fig. 4.4 (A) High-resolution S1 nuclease mapping of the 5' ends of the simR and 
simX transcripts using PCR-generated probes and RNA from the SD8 producing 
organism, S. antibioticus Tü 6040. The most likely transcription start points are 
indicated by the asterisks.  The G+A Maxam-Gilbert chemical sequencing ladder 
was generated using the same probe as the one used for S1 nuclease mapping assays. 
The size markers are a radiolabelled HinfI digest of ΦX174 DNA.  (B) Run-off 
transcription from the simR and simX promoters in vitro using purified S. coelicolor 
RNA polymerase and the templates illustrated containing the simR-simX intergenic 
region. Lane numbers correspond to the different templates shown in the illustration 
below.  
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Fig. 4.5. Sequence of the simR-simX intergenic region showing the simRp and simXp transcription start points and putative -10 
sequences, the simR and simX ribosome binding sites (RBS), the extent of the SimR DNaseI footprints on the OX and OR operators, and 
the imperfect inverted repeats within the footprints that may represent SimR binding motifs.  
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(luxAB) reporter plasmid pIJ5972 (Aigle et al., 2000; M. Paget, pers. comm.). 
Fragments carrying simRp and simXp were individually cloned into pIJ5972, and the 
resulting reporter constructs were introduced into S. lividans in order to probe simR 
and simX promoter activities in the absence of SimR. To measure simR and simX 
promoter activities in the presence SimR, an integrative plasmid (pIJ10469) carrying 
simR under the control of its own promoter was introduced into the strains already 
harbouring the promoter-probe plasmids. Transformants were grown on Difco 
Nutrient Agar to promote vegetative growth and delay aerial hyphal formation, 
which may interfere with diffusion of the luciferase substrate (n-decanal) and with 
light emission. Fig. 4.6 shows that simX and simR promoter activities were repressed 
100-fold and 12-fold, respectively, in the presence of simR.  
 
4.5 Purified SimR binds to the simR-simX intergenic region at two distinct 
operator sites  
 
The lux reporter data suggested that SimR is a repressor that regulates its own 
expression as well as that of simX.  To test this idea, I monitored SimR binding to the 
simR-simX intergenic region by electrophoretic mobility shift assay (EMSA). An N-
terminally His6-tagged derivative of SimR was overexpressed in E. coli and purified 
to homogeneity  (Fig. 4.7). Increasing concentrations of SimR were incubated with a 
radiolabelled probe spanning the simR-simX intergenic region and the complexes 
were resolved on a native gel. Purified SimR bound to the intergenic region at 
concentrations as low as 0.23 nM and, as the concentration of SimR increased, two 
sets of shifted protein-DNA complexes became evident, suggesting that there are two 
SimR binding sites in the simR-simX intergenic region (Fig. 4.8A).  
 
DNaseI footprinting on both DNA strands was used to map precisely the SimR 
operator sites within the simR-simX intergenic region. Two separate SimR binding 
sites were observed, consistent with the two shifted species seen in the EMSA 
experiments: the operator closer to simX was designated OX and the one closer to 
simR was designated OR (Figs. 4.5 and 4.9). Within the OX and OR footprints we 
identified imperfect inverted repeats that may represent the binding sequences for the 
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Fig. 4.6. Promoter activities of simR and simX in the presence and absence of simR. 
simRp-luxAB and simXp-luxAB transcriptional fusions were created in an integrative 
luciferase promoter-probe vector (pIJ5972) and assayed in S. lividans, in either the 
presence or absence of simR. Plasmid-containing S. lividans strains were grown on 
Difco Nutrient Agar in single wells of a 96-well microtiter plate (Sterilin) for three 
days. Each well was inoculated with approximately 5x10
4
 spores. Plates were 
exposed to filter paper impregnated with n-decanal for 5 min and luciferase activities 
were quantified using a NightOwl camera (Berthold) equipped with WinLight 
software (Berthold) using a 1 min exposure time. Values given correspond to the 
average of three biological replicates from three different spore stocks and standard 
errors are shown. 
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Fig. 4.7. Purification of N-terminally His-tagged SimR to apparent homogeneity. 
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Fig. 4.8. (A) Electrophoretic mobility shift assay showing binding of purified SimR 
to the simR-simX intergenic region. Bands corresponding to protein-DNA complexes 
(Bound) and free DNA (Free) are indicated. The final concentration of SimR is 
indicated above each lane. (B) Saturation curve of the data from EMSA experiments. 
EMSA data were collected and analysed on a PhosphoImager (FujiFilm) using Multi 
Gauge image analysis software (FujiFilm). Two independent EMSAs were carried 
out [one of which is shown in A] and the mean values calculated. Standard errors are 
shown. Saturation curves (Saturation fraction against concentration of protein) were 
fitted with SigmaPlot (See Experiment Procedures) to determine Kds. In all EMSA 
experiments, SimR was present in molar excess over the probe. 
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Fig. 4.9. DNaseI footprinting analysis of SimR binding to the simR-simX intergenic 
region. A DNA fragment containing the simR-simX intergenic region, 5'-end labelled 
on either the upper strand (left panel) or the lower strand (right panel), was exposed 
to DNaseI in the presence of increasing concentrations of SimR. The sequencing 
ladders were generated by subjecting the probes to Maxam-Gilbert G+A chemical 
sequencing. Regions protected from DNaseI cleavage (operators OX and OR) are 
indicated with vertical bars and inverted repeats within the DNaseI protected regions 
are indicated by convergent arrows; these features are also highlighted on the DNA 
sequence in Fig. 4.5.  
 
 
 
 
 
Chapter 4 Regulated efflux of simocyclinone 
 
107 
 
SimR homodimer. Fig. 4.5 shows these imperfect inverted repeats, the extent of the 
SimR DNaseI footprints on the sequence of the simR-simX intergenic region and the 
positions of the simRp and simXp transcription start points and putative -10 promoter 
sequences in relation to the two SimR operators. 
 
4.6 SimR binding to the two operators is non-cooperative  
 
In the DNaseI footprinting analysis, OX was occupied at a lower concentration of 
SimR than was OR, suggesting that OX has a higher affinity for SimR than OR. 
Competitive EMSA was employed to explore this issue further. In these experiments, 
unlabelled fragments containing either OX or OR were used to compete with a 
radioactively labelled simR-simX intergenic fragment containing both OX and OR. 
The final concentration of SimR used in the competitive EMSA experiments was set 
at 20 nM such that all the labelled probe was in complex with SimR in the absence of 
unlabelled competitor DNA. A thousand-fold excess of unlabelled OX-containing 
fragment out-competed the labelled intergenic probe (no complex formation between 
SimR and the labelled intergenic probe) (Fig. 4.10). However, the same excess of 
OR-containing fragment could not completely abolish SimR complex formation with 
the labelled intergenic probe (Fig. 4.8), confirming that SimR binds OX more tightly 
than OR.  
 
Using the EMSA data shown in Fig. 4.8, we determined the approximate equilibrium 
dissociation constants (Kds) for the two complexes to be 1.2 ± 0.4 nM for SimR-OX 
and 3.5 ± 1.4 nM for SimR-OR.  In order to determine whether there is cooperativity 
between SimR binding at OX and OR, we also determined the Kds of each SimR-
operator complex by EMSA using probes containing only OX or only OR (data not 
shown), instead of the full simR-simX intergenic region. The Kds were found to be 
0.9 ± 0.2 nM for SimR-OX and 3.6 ± 0.3 nM for SimR-OR. The Kds for the two 
SimR-operator complexes did not change substantially when the two operators were 
separated, suggesting that SimR binding to its two operators is non-cooperative. 
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Fig. 4.10. Competitive electrophoretic mobility shift assay comparing the binding 
affinity of SimR to OX and OR. All lanes contain SimR at a final concentration of 20 
nM and a constant amount of a radiolabelled simR-simX intergenic probe that carries 
both OX and OR.  The molar excess (over the radiolabelled probe) of a competing 
unlabelled fragment containing either OX or OR is indicated above each lane.  
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4.7 Exogenous SD8 induces expression of the SimX efflux pump in vivo 
 
In order to determine whether the simR and simX promoters respond to SD8 in vivo, I 
used the S. lividans luxAB reporter system to measure simRp and simXp activities in 
the presence of SimR and in response to exogenously added antibiotic. Fig. 4.11A 
shows the response curve of simR and simX promoter activity to increasing 
concentrations of SD8. Both promoters were induced by simocylinone D8, 
suggesting that the antibiotic can relieve SimR-mediated repression of both simRp 
and simXp. 0.6 μg/ml was the highest concentration tested because S. lividans is 
sensitive to simocylinone D8 (MIC = 2 μg/ml). 
 
4.8 SD8 dissociates SimR from the simR-simX intergenic region 
 
To determine if SimR responds directly to SD8, I examined the effect of the 
antibiotic on SimR-operator complex formation by EMSA (Fig. 4.12A). The SimR 
concentration was held constant and an increasing concentration of SD8 was 
introduced into the binding reaction. As the SD8 concentration increased, there was a 
progressive decrease in SimR-DNA complex formation and a concomitant liberation 
of free probe. 62.5 μM SD8 was sufficient to dissociate the SimR-DNA complexes 
almost completely. This effect was not due to DMSO, the SD8 solvent, as equivalent 
amounts of pure DMSO had no effect on SimR-DNA complex formation.  Further, to 
test specificity, we examined the effect of SD8 on the DNA-binding activity of ActR, 
a TetR homologue that regulates actinorhodin export in S. coelicolor (see 
Discussion) and found that 100 μM SD8 had no effect on ActR binding to its cognate 
operator (N.B. this experiment was carried out by Sang Kyun Ahn, Department of 
Biochemistry and Biomedical Sciences, McMaster University, Canada). These 
results show that SD8 is able to specifically disrupt SimR-DNA complex formation.   
 
 
 
 
 
 
Chapter 4 Regulated efflux of simocyclinone 
 
110 
 
 
 
Fig. 4.11. Induction of the simR and simX promoters in vivo by (A) SD8 and (B) the 
biosynthetic intermediate SC4. S. lividans containing pIJ10469 (carrying simR under 
its native promoter) together with luciferase promoter-probe plasmids pIJ10465 
(simXp-luxAB) or pIJ10466 (simRp-luxAB) were assayed. Values given correspond to 
the average of three biological replicates from three different spore stocks and 
standard errors are shown. For further details, see the legend to Fig. 4.6. 
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Fig. 4.12 Electrophoretic mobility shift assays showing that (A) SD8 and (B) its 
biosynthetic intermediate SC4 abolish SimR DNA-binding activity. All lanes contain 
a constant amount of SimR and radiolabelled simR-simX intergenic fragment 
containing both OX and OR. Bands corresponding to protein-DNA complexes 
(Bound) and free DNA (Free) are indicated. The final concentrations of SD8 or SC4 
are indicated above each lane.  
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4.9 An intermediate in the simocyclinone biosynthetic pathway induces simX in 
vivo and dissociates SimR from its operators in vitro 
 
In addition to SD8, I also tested the ability of SC4, a natural intermediate in the D8 
biosynthetic pathway, to induce the simR and simX promoters in vivo and to 
dissociate SimR from its operators in vitro. SC4 lacks the aminocoumarin ring 
present in the mature antibiotic (Fig. 4.1) and is essentially inactive as a DNA gyrase 
inhibitor; the SD8 IC50 = 0.1 μM, whereas the SC4 IC50 > 100 μM (Edwards et al., 
2009). SC4 induced the simR and simX promoters in vivo, although somewhat more 
weakly than the mature antibiotic (Fig. 4.11B). Because SC4 is not an active 
antibiotic, I was able to test higher concentrations than for SD8. Consistent with the 
in vivo inductions, SC4 also caused SimR to dissociate from its binding sites in vitro, 
although again somewhat more weakly than SD8; 250 μM SC4 was sufficient to 
abolish all complex formation (Fig. 4.12B). 
 
4.10 Discussion  
 
The work contained in this chapter shows that simX encodes a SD8 efflux pump and 
that the simX promoter is directly repressed by SimR, which binds to two operator 
sites in the simR-simX intergenic region. SD8 abolishes DNA binding by SimR, 
coupling the biosynthesis of simocyclinone to its export.  
 
SD8 is a potent inhibitor of DNA gyrase supercoiling (IC50 = 0.1 μM) (Flatman et 
al., 2005; Oppegard et al., 2009; Edwards et al., 2009).  The recent structure of the 
antibiotic bound to the DNA gyrase A subunit shows that the two moieties at the 
ends of SD8, the aminocoumarin ring and the angucyclic polyketide, bind to two 
separate, well-defined pockets within the GyrA DNA-binding saddle, linked by the 
intervening tetraene linker and D-olivose moieties (Edwards et al., 2009). Given the 
prominence of the aminocoumarin ring in the overall binding of the antibiotic to the 
GyrA subunit, it is not surprising that the biosynthetic intermediate SC4, which lacks 
the aminocoumarin ring (Fig. 4.1), is essentially inactive as a DNA gyrase inhibitor 
(IC50 >100 μM).  Importantly, however, although SC4 is not a DNA gyrase inhibitor, 
it can efficiently derepress SimR in vivo and in vitro.   
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The most striking analogy to the research presented here is the work of Nodwell and 
colleagues on the regulation of efflux of actinorhodin (Tahlan et al., 2007, 2008; Ahn 
et al., 2007; Hopwood, 2007; Willems et al., 2008).  Actinorhodin is a blue-
pigmented, six-ring polyketide antibiotic made by S. coelicolor (Bystrykh et al., 
1996).  Within the actinorhodin biosynthetic cluster are two co-transcribed genes, 
actA and actII-ORF3, encoding integral membrane proteins implicated in 
actinorhodin export (Caballero et al., 1991; Fernandez-Moreno et al., 1991).  
Expression of these two genes is regulated by a TetR-like protein, ActR, the product 
of the adjacent, divergently transcribed gene. Nodwell and colleagues have been 
characterising ligands that relieve repression by ActR. Importantly, they showed that, 
in addition to the mature six-ring antibiotic, three-ring intermediates from the 
biosynthetic pathway also relieve repression by ActR. From this, they suggested that 
the ability of actinorhodin intermediates to relieve repression by ActR might provide 
a ‘feed-forward’ mechanism that would ensure expression of the ActA efflux pump 
prior to the build-up of a toxic concentration of the mature antibiotic (Tahlan et al., 
2007, 2008; Ahn et al., 2007; Hopwood, 2007; Willems et al., 2008). Similarly, the 
ability of an inactive simocyclinone intermediate to relieve repression by SimR 
might also act as a biosynthetic checkpoint to ensure feed-forward regulation of 
simocyclinone export. 
 
As applied to simocyclinone (or actinorhodin) export, the feed-forward hypothesis is 
speculative. I have shown that the pathway intermediate SC4 induces simX 
expression in vivo when applied exogenously. However, for a feed-forward 
mechanism to operate in the producing organism, SC4 or other SimR-binding 
pathway intermediates would have to accumulate in the cytoplasm to a concentration 
high enough to trigger simX expression, and the cytoplasmic concentrations of 
pathway intermediates are hard to determine experimentally.  However, there are 
other examples in the literature where the TetR-like protein blocks expression not 
only of the exporter gene, but also of late biosynthetic genes, and in these cases it 
seems that an intermediate in the pathway must be responsible for inducing 
expression of these genes (i.e. feed-forward activation), since induction of the late 
biosynthetic enzymes is required to generate the mature antibiotic. 
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In the landomycin A producer, Streptomyces cyanogenus, a TetR-family regulator, 
LanK, represses expression of lanJ, encoding a putative landomycin A efflux pump 
(Ostash et al., 2008).  LanK is derepressed by mature landomycin A, which carries a 
hexasaccharide chain, but also by intermediates in the pathway that carry only a 
pentasaccharide or a trisaccharide chain (Ostash et al., 2008). However, lanJ is co-
transcribed with several downstream biosynthetic genes involved in late 
glycosylation steps. As a consequence, LanK couples production of intermediates not 
only to assembly of the export machinery, but also to expression of late biosynthetic 
enzymes that attach the final sugars to produce mature landomycin A (Ostash et al., 
2008).  A more complex example concerns the biosynthesis of the clinically 
important anti-cancer agents daunorubicin and doxorubicin made by Streptomyces 
peucetius. In this system, binding of daunorubicin-doxorubicin pathway 
intermediates like rhodomycin D appears to de-repress the TetR-like regulator DnrO, 
activating a cascade involving two further transcription factors, DnrN and DnrI, that 
leads to expression of the resistance genes and of late biosynthetic genes (Otten et 
al., 1995; Jiang and Hutchinson, 2006).    
 
In addition to repressing the simX promoter, SimR also directly negatively regulates 
its own expression. In other systems, negative autoregulation has been shown to 
confer specific functions that are absent in systems that have simple regulation. 
Many of these studies on the design principles of genetic circuits that incorporate 
negative autoregulation have exploited TetR, the founding member of the family to 
which SimR belongs (Becskei and Serrano, 2000; Rosenfeld et al., 2002; D. Madar 
and U. Alon, pers. comm.). These studies show that negative autoregulatory 
feedback loops in gene circuits can provide stability, thereby limiting stochastic 
fluctuations in the system (Becskei and Serrano, 2000). In addition, negative 
autoregulation can speed the response time of the transcription network to a stimulus 
(Rosenfeld et al., 2002), and it can broaden the dynamic range of the input signal to 
which the downstream genes respond (D. Madar and U. Alon, pers. comm.).  
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5.1 Introduction 
 
TFRs function as homodimers. Each monomer consists of two domains, an N-
terminal DBD containing a HTH motif, and a C-terminal LBD (Ramos et al., 2005). 
The LBDs are extremely diverse in amino acid sequence and it is therefore not 
generally possible to model these domains based on existing structures with any 
confidence, nor to predict potential ligands (Ramos et al., 2005; Yu et al., 2010). In 
addition to TetR, the structures of several other TFRs have been determined with 
relevant ligands, and also with bound DNA, enabling their mechanisms of repression 
and derepression to be elucidated (Chapter 1). In those cases where derepression has 
been analysed by comparing DNA-bound and ligand-bound structures, it is brought 
about through the stabilisation, by the binding of the ligand, of a conformation in 
which the recognition helices are too far apart to simultaneously bind to adjacent 
major grooves of DNA. These mechanisms necessarily invoke allosteric 
communication between the LBDs and DBDs.  
 
SD8 (Fig. 4.1) is a potent DNA gyrase inhibitor produced by S. antibioticus, with an 
IC50 ~ 0.1 μM for inhibition of DNA supercoiling (Schimana et al., 2000; Flatman et 
al., 2005; Edwards et al., 2009). SD8 is exported from the producing organism by a 
specific efflux pump, SimX, and the transcription of simX is repressed by SimR, a 
TFR that binds to two distinct operators in the intergenic region between the 
divergently transcribed simR and simX genes (Chapter 4 and Le et al., 2009). SD8 
abolishes DNA-binding by SimR, inducing expression of the SimX efflux pump, and 
this provides an intimate mechanism that couples the biosynthesis of simocyclinone 
to its export (Chapter 4 and Le et al., 2009).  
 
In order to gain insight into the molecular mechanism of ligand-mediated SimR 
derepression, I have solved the crystal structures of SimR, alone and in complexes 
with SD8 and its biosynthetic intermediate SC4, which lacks the AC moiety of the 
mature antibiotic (Fig. 4.1), but still derepresses SimR, albeit less efficiently 
(Chapter 4 and Le et al., 2009). The structures show an extensive ligand-binding 
pocket spanning both monomers in the functional dimeric unit and suggest a 
derepression mechanism that involves rigid-body motions of the subunits relative to 
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one another, coupled with a putative locking mechanism to restrict further 
conformational change.  
 
5.2 The structure of ligand-free SimR 
 
The structure of ligand-free SimR (SimR-apo) was determined at 1.95-Å resolution. 
X-ray data collection and refinement statistics are summarised in Table 5.1. There is 
a single copy of the SimR monomer in the asymmetric unit (ASU) and the final 
model comprises residues 7-244 of the 259-residue native sequence. A biologically-
relevant homodimer is generated through the application of 2-fold crystallographic 
symmetry (Fig. 5.1). The secondary structure of SimR is almost entirely α-helical, 
being composed of 11 helices that span residues 29-43 (α1), 50-57 (α2), 61-67 (α3), 
71-84 (α4), 96-113 (α5), 116-120 (α6), 130-144 (α7), 150-181 (α8), 185-202 (α9), 
206-216 (α10) and 222-243 (α11) (Figs. 5.1 and 5.2). There are, in addition, two 
short β-strands near the N-terminus (residues 18-19 and 26-27), which form a β-
hairpin. The SimR monomer can be divided into two domains, an N-terminal DNA-
binding domain (DBD) and a C-terminal ligand-binding domain (LBD). The DBD 
consists of the β-hairpin and helices α1 to α3. Helices α2 and α3 form a helix-turn-
helix (HTH) motif that is stabilized by packing against α1. By analogy with other 
TFRs, the HTH is predicted to interact with the major groove of DNA, with the 
recognition helix, α3, providing the majority of base-specific interactions. In 
addition, the N-terminal β-hairpin motif of SimR appears to be ideally placed to 
make minor groove interactions. Consistent with this proposal, there are a total of 
four Arg residues in the range 18-25 (Fig. 5.2), which could interact favourably with 
the negatively charged phosphate backbone of DNA. These residues contribute to the 
prominent electropositive surface patch that overlaps the recognition helix in SimR-
apo (Fig. 5.3).  
 
The last eight helices (α4-α11) make up the LBD responsible for small-molecule 
ligand binding and forming the interface between the two subunits of the dimer. 
Dimerization occurs largely through a pair of helices, α8 and α11, from each SimR 
monomer that form a four-helix bundle (Fig. 5.1). The dimerization interface is 
further enhanced by the α9-α10 segment, which forms an extended 'arm' that wraps 
around the LBD of the opposing monomer (Fig. 5.1) (Note that the distinctive kink 
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Data set
a
 
Native 
apo (N-
tag) 
SeMet 
apo (N-
tag) 
Native 
apo (C-
tag) 
SD8 
complex 
(C-tag) 
SC4 
complex 
(C-tag) 
Data collection      
Space Group H32 H32 H32 C2 P6522 
Cell parameters (Å/°) 
a = b = 
116.62, c 
= 110.58 
a = b = 
116.11, c 
= 110.35 
a = b = 
116.06, c 
= 109.38 
a = 
147.37, b 
= 83.91, c 
= 45.47, β 
= 90.94 
a = b = 
86.57, c = 
349.86 
Solvent content (%) 45 45 48 47 61 
Beamline
b
 I03 I03 I02 I04 I02 
Wavelength  (Å) 0.9763 0.9763 0.9700 0.9400 0.9700 
Resolution range
c
 (Å) 
48.50 - 
2.30 (2.42 
- 2.30) 
48.37 - 
3.40 (3.58 
- 3.40) 
48.04 - 
1.95 (2.06 
- 1.95) 
42.39 - 
2.30 (2.42 
- 2.30) 
63.06 - 
2.30 (2.42 
- 2.30) 
Unique reflections
c
 12693 
(1786) 
4076 
(585) 
20761 
(3005) 
23951 
(2988) 
34449 
(4983) 
Completeness
c
 (%)
 98.0 
(95.2) 
99.9 
(100.0) 
99.8 
(100.0) 
97.0 
(83.4) 
97.3 
(98.5) 
Redundancy
c
 5.0 (3.8) 
15.2 
(15.7) 
7.8 (7.9) 2.9 (2.3) 8.4 (8.5) 
Rmerge
c, d
 0.093 
(0.523) 
0.158 
(0.422) 
0.070 
(0.570) 
0.077 
(0.229) 
0.109 
(0.372) 
 Mean I/ (I)
c
 10.2 (2.3) 14.4 (6.8) 20.6 (3.8) 10.3 (3.3) 15.4 (5.4) 
Wilson B value (Å
2
) 57.9 78.4 31.8 30.7 28.8 
Refinement      
Reflections: 
working/free
e
   
19717/10
44 
22723/12
27 
32723/17
26 
Rwork
f
 - - 0.205 0.200 0.198 
Rfree
f 
- - 0.234 0.270 0.246 
Coordinate error
g
 (Å) - - 0.149 0.265 0.210 
Ramachandran 
favoured/allowed
h
 (%) - - 97.2/98.8 98.2/99.8 
99.0/100.
0 
Ramachandran outliers
h
 - - 3 1 0 
rmsd bond distances (Å) - - 0.018 0.017 0.017 
rmsd bond angles (º)  - - 1.57 1.46 1.58 
Contents of model - -    
Protein residues in each 
chain (totals in 
brackets) 
- - 
A: 7-244 
(238) 
A: 5-11, 
27-246 
(227) 
B: 8-10, 
28-247 
(223) 
A: 6-247 
(242) 
B: 5-15, 
26-246 
(230) 
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SD8/SC4 molecules - - 0 2 2 
Polyethylene glycol 
molecules 
- - 0 0 2 
Calcium ions - - 0 0 1 
Chloride ions - - 0 6 8 
Water molecules - - 121 164 277 
Temperature factors (Å
2
)      
Main chain atoms   36.9 24.4 19.3 
Side chain atoms   39.9 25.6 21.6 
SD8/SC4 molecules   - 23.8 23.7 
Polyethylene glycol 
molecules 
  - - 37.2 
Calcium ions   - - 24.3 
Chloride ions   - 60.0 37.9 
Water molecules   20.4 22.8 25.1 
Overall   37.3 24.9 21.0 
PDB accession code - - 2Y2Z 2Y30 2Y31 
a 
Protein was either N-terminally (N-tag) or C-terminally (C-tag) His tagged.  
b
 I02, I03, I04 = beamlines at the Diamond Light Source (Oxfordshire, UK).   
c
 The figures in brackets indicate the values for outer resolution shell. 
d
 Rmerge = ∑hkl ∑i |Ii(hkl)  I(hkl) |/ ∑hkl ∑iIi(hkl), where Ii(hkl) is the ith observation of 
reflection hkl and I(hkl)  is the weighted average intensity for all observations i of 
reflection hkl. 
e
 The data sets were split into "working" and "free" sets comprising 95% and 5% of the 
data, respectively. The free set was not used for refinement. 
f
 The R-factors Rwork and Rfree are calculated as follows: R = (| Fobs - Fcalc |)/ | Fobs | x 
100, where Fobs and Fcalc are the observed and calculated structure factor amplitudes, 
respectively. 
g
 Estimate of the overall coordinate errors calculated in REFMAC5 based on Rfree 
(Murshudov et al., 1997).  
h
 As calculated using MOLPROBITY (Chen et al., 2010).  
 
 
Table 5.1. Summary of SimR X-ray data and model parameters 
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Fig. 5.1. Crystal structures of ligand-free (SimR-apo) and 
SD8 bound (SimR-SD8) forms of SimR. The top panel 
uses a cylindrical helix representation to highlight the 
secondary structure of SimR-apo with key features 
labelled. The two subunits of the homodimer are 
distinguished by cyan and yellow colouration, and the 
two recognition helices are shown in magenta.  Where 
appropriate this colour scheme is adopted throughout the 
subsequent figures. Note the α9-α10 arm that engages 
with the opposing subunit. The lower panels compare 
SimR-apo and SimR-SD8 in cartoon representation 
viewed from the front (left) and from the top (right), with 
the SD8 molecules shown in red space-filling 
representation. The separations of the recognition helices 
are indicated. The labels AC and PK refer to the 
aminocoumarin and polyketide moieties of SD8, 
respectively.  
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Fig. 5.2. Structure-based multiple sequence alignment of SimR with 
S. coelicolor ActR and E. coli TetR. The initial alignment was 
generated using the SSM server (Krissinel and Henrick, 2004) with 
the ligand-free structures (PDB: 2OPT and 1BJZ for ActR and 
TetR, respectively). This was subsequently adjusted manually with 
reference to the superposed structures, and then displayed using 
ESPript (Gouet et al., 1999). Strictly conserved residues are 
highlighted with pink shading. Secondary structure elements for 
SimR are shown above the alignment, where α = α-helix, β = β-
strand. Residues involved in binding SD8 (selected on the basis of 
being < 4.0 Å from the ligand) are highlighted with yellow and cyan 
shading to denote the subunit. Similarly, residues involved in 
actinorhodin binding by ActR (PDB: 3B6A) and tetracycline 
binding by TetR (PDB: 1BJY) are highlighted with the same colour 
scheme. Green shading indicates residues involved in DNA binding 
by TetR (PDB: 1QPI). Grey shading indicates regions in ActR 
(residues 178-187) and TetR (residues 152-164) that were not 
modelled in the ligand-free structures. The red bars denote regions 
of SimR that show the most significant conformational changes 
between the ligand-bound and ligand-free structures. The inverted 
blue triangles mark key residues referred to in the text. 
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Fig. 5.3. Molecular surface representations of SimR-apo.  (A) Molecular surface 
coloured as for Fig. 5.1, highlighting the arrangement of the subunits and the 
presentation of the recognition helices (magenta). (B) Molecular surface showing 
electrostatic surface potentials (red = electronegative, white = neutral, blue = 
electropositive). The left-hand panels show the front view and the right-hand panels 
show the bottom view. Note the overlap between the recognition helices and distinct 
electropositive regions. For this figure, all missing side chains were modelled in 
energetically favourable conformations (applies to Arg19, Arg25, Arg91 and Arg243 
in both subunits).  
 
 
 
 
A 
B 
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in α9 is important for ligand binding; see below). In fact, all of helices α7-α11 from 
each subunit are involved to varying degrees in dimerization. Overall, this gives rise 
to an extensive dimer interface of 2475 Å
2
 accounting for 17.5% of the solvent-
accessible surface of an isolated monomer, as calculated by the Protein Interactions, 
Surfaces and Assemblies server (PISA; http://www.ebi.ac.uk/msd-
srv/prot_int/pistart.html) (Krissinel and Henrick, 2005). Within the core of each 
subunit, there is a substantial cavity (Fig. 5.4A). The two cavities of the dimer are 
linked via a narrow pore that passes through the centre of the dimer, and they each 
connect to bulk solvent through channels that pass between the two helices of the α9-
α10 arm (Fig. 5.4A).  
 
5.3 Comparison of the SimR structure with other TetR family members 
 
The closest structural homologues of SimR were identified using the DALI server 
(http://ekhidna.biocenter.helsinki.fi/dali_server/) (Holm and Sander, 1995) (Fig. 5.5). 
This gave a total of 12 hits from the non-redundant database with Z scores of greater 
than 15.0. The top hit was S. coelicolor ActR with bound actinorhodin (PDB code 
3B6A) (Willems et al., 2008) with a Z score of 18.7, a sequence identity of 25% and 
a root-mean-square deviation (rmsd) of 2.6 Å after superposition of single subunits. 
Hit number 6 was E. coli TetR with bound tetracycline (PDB code 1BJY; Z score 
17.0; sequence identity 18%; rmsd 2.6 Å) (Orth et al., 1999).  
 
In a recent systematic survey of TFR protein structures, TetR itself, together with 
ActR, were placed in a distinct subclass of structures (Yu et al., 2010). One of the 
characteristics of this subclass is a long insertion between α8 and the C-terminal α-
helix. This corresponds to the  α9-α10 arm of SimR. By contrast, CgmR from 
Corynebacterium glutamicum (PDB code 2ZOY; ligand-free form) is more typical of 
the majority of known TFR structures, having no such insertion (Itou et al., 2010) 
(Fig. 5.5B). As a consequence, the dimer interface of CgmR is less extensive than 
that of SimR-apo at 1819 Å
2
 (as calculated by PISA). In addition, several TFRs have 
a significantly longer α1 helix, the N-terminus of which may make additional 
contacts to DNA as seen in QacR, CgmR and DesT (Grkovic et al., 2001; Itou et al., 
2010; Miller et al., 2010; Schumacher et al., 2002). 
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Fig. 5.4. The ligand-binding pocket of SimR. (A) Molecular surface representations 
of the ligand-free and ligand-bound structures of SimR focussing on the right-hand 
pocket shown in Fig. 5.1; ligands are shown with grey carbon atoms. The top panels 
show a front view and the lower panels show a top view as a thin slice through the 
molecule. Grey shading denotes regions within the molecular boundary. The 
asterisks indicate narrow channels leading to equivalent cavities in the other halves 
of the dimers. (B) Simulated annealing omit maps at 2.3 Å resolution for SimR-SC4 
and SimR-SD8 (contoured at 3 ) are shown in blue superposed on their respective 
ligands; the protein is shown in semi-transparent cartoon representation. The right-
hand panel illustrates the relative positions of the ligands for SimR, ActR and TetR 
after superposition of their respective structures.  
A 
B 
Chapter 5 Crystal structures of SimR-apo and SimR-ligand complexes 
 
125 
 
Fig. 5.5. Comparison of SimR structures to other TetR family transcriptional 
regulators. Throughout, cylindrical helix representations are used to simplify the 
comparisons, and the standard colour scheme is adopted for SimR; the second 
protein is shown in grey with the recognition helices in orange. For the comparison 
with DesT (E) the ligands are shown as sticks with SD8 in red and palmitoyl-CoA in 
black.  Rmsd values are based on dimer-upon-dimer superpositions.  
B A 
C D 
E 
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Tyr42 in TetR lies in the middle of the recognition helix (α3) and forms important 
interactions with DNA in the TetR-tetO complex (Orth et al., 2000). This residue is 
reasonably well conserved in TFRs and the Cα atom serves as a reference point for 
measuring the separation of the recognition helices in a homodimer (Yu et al., 2010). 
In DNA-bound structures, this separation lies in the range 34.7 to 38.8 Å, roughly 
corresponding to the distance of 34 Å between consecutive major grooves in 
standard B-form DNA (Grkovic et al., 2001; Itou et al., 2010; Miller et al., 2010; 
Orth et al., 2000; Schumacher et al., 2002). By contrast, in apo-TFR structures the 
helix separation is highly variable, but is typically not compatible with DNA binding 
(Yu et al., 2010). The equivalent residue in SimR is Tyr65 and the Cα-Cα separation 
is 42.3 Å in SimR-apo (Fig. 5.1). Thus, we conclude that the conformation seen in 
SimR-apo is also not compatible with DNA binding (Fig. 5.5D). 
 
5.4 Ligand-bound structures of SimR 
 
SC4 is a biosynthetic intermediate of SD8 (Fig. 4.1) that is essentially inactive as a 
DNA gyrase inhibitor (Edwards et al., 2009). However, like the mature antibiotic, 
SC4 derepresses SimR; when applied exogenously, it induces expression of the 
SimX efflux pump in vivo, and it relieves DNA binding by SimR in vitro (Chapter 4 
and Le et al., 2009).  Structures of the complexes formed between SimR and the 
mature antibiotic SD8 (SimR-SD8), and with SC4 (SimR-SC4), were determined at 
2.3 Å resolution. In both cases, crystals of the complexes were formed by co-
crystallization with the respective ligands and gave rise to new crystal forms. Each 
structure was solved by molecular replacement using the SimR-apo structure as the 
template and, in both cases, there were two copies of the SimR subunit in the ASU, 
corresponding to the biological dimer. In contrast to the SimR-apo structure, most of 
the N-terminal polypeptide chain prior to α1 in the ligand-bound structures was 
poorly resolved; only in one monomer of SimR-SC4 was the β-hairpin visible. For 
both complexes, electron density for two copies of the corresponding ligand per 
SimR dimer was clearly present, occupying equivalent sites related by two-fold non-
crystallographic symmetry (Figs. 5.4B and 5.6).  
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Fig. 5.6. The ligand-binding pocket of SimR. Stereoviews of the images shown in 
Fig. 4b with the addition of protein side chains, where (A) shows SimR-SD8 and (B) 
shows SimR-SC4. Simulated annealing omit maps at 2.3 Å resolution (contoured at 
3 ) are shown in blue superposed on their respective ligands, which are shown with 
grey carbon atoms; the protein is shown in semi-transparent cartoon representation. 
 
 
B 
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At the protein backbone level, the two ligand-bound structures of SimR were similar. 
In pairwise superpositions of individual subunits, the rmsd values were in the range 
0.66 to 0.75 Å, and a dimer-upon-dimer superposition gave a value of 0.74 Å. In 
comparisons between the SimR-apo and the two ligand-bound structures at the 
subunit level, the most striking difference is the concerted upward shift of the α9-α10 
arm upon ligand binding (Fig. 5.7A). Superpositions of individual ligand-bound 
subunits upon the SimR-apo subunit, based only on residues in the subunit core (i.e. 
excluding α9-α10, specifically residues 182-221), gave remarkably low rmsd values 
in the range 1.01 to 1.09 Å. Thus, the cores are extremely similar and, most 
importantly, the relative orientations of LBDs and DBDs within each subunit remain 
essentially unchanged upon ligand binding. At the dimer level, differences between 
the SimR-apo and the ligand-bound structures of SimR become more pronounced 
due to a twisting motion at the dimer interface. As a result, dimer-upon-dimer 
superpositions (using core residues) gave larger values of 2.13 and 2.04 Å, for SimR-
SD8 vs. SimR-apo and SimR-SC4 vs. SimR-apo, respectively. This twisting motion 
is more noticeable in comparisons where only one subunit in each dimer is used for 
the superposition (Fig. 5.8). When viewed from the side of the dimer, one subunit 
rotates relative to the other by around 8°. The axis of rotation passes through 
equivalent points in each subunit roughly at the interface between the LBD and DBD 
just above the midpoint of α3. Because the pivot point is close to the DBD, this small 
rotation has very little effect on the separation of the recognition helices (Fig. 5.8); 
values of 41.7 and 42.6 Å were obtained for SimR-SD8 and SimR-SC4, respectively, 
being comparable to the value of 42.3 Å obtained for the SimR-apo structure (Fig. 
5.1). The upward motion of the α9-α10 arm upon ligand binding is, in part, 
correlated with the movement of the adjacent subunit (Figs. 5.7 and 5.8). This is 
because each arm is closely associated with the opposing subunit and many of the 
interactions are retained, including several hydrogen bonds at the extremities of the 
arm (C-terminal end of α9 and N-terminal end of α10). 
 
As a result of the subunit rotation, the C-termini move closer together. For example, 
the separation of the terminal residues of α11 (i.e. Arg243), decreases from 17.6 to 
10.1 Å upon SD8 binding (Fig. 5.8); being remote from the pivot point, 
conformational differences are more exaggerated here. In addition, there is more 
subunit overlap, such that there is a modest increase in the dimer interface area from  
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Fig. 5.7 Conformational differences between SimR-apo and SimR-SD8. (A) 
Superposition of all crystallographically independent subunits from all three SimR 
structures (five in total) based only on the core residues (i.e. not including the α9-α10 
arms). Only the left-hand subunits from Fig. 2 are shown. (B) Close-up views 
illustrating the conformational changes in α10 and in the α6-α7 loop. Also shown in 
the right-hand panels is the Glu177-His125-Glu76 hydrogen-bonding network that is 
present in both structures. The SD8 molecules are shown in stick representation in 
(a) red or (b) grey carbons (see also Fig. 5.10).  
B 
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Front view Side view
*
+ SD8
~8
SimR-apo
SimR-SD8
17.6 Å
10.1 Å
 
 
Fig. 5.8. Rotation of SimR subunits stabilised by ligand binding. Structures of SimR-
apo and SimR-SD8 together with schematic representations illustrating the rotation 
of the subunits relative to one another. For this figure only, the 'front view' shows the 
dimer with the plane of the interface perpendicular to the paper (it differs from the 
'front view' used elsewhere by a ~25° rotation around the vertical axis). In order to 
emphasize the subunit rotation, the cyan-coloured subunits are shown fixed in the 
same relative orientations. This can be clearly seen in the side view where the yellow 
subunit rotates by ~8° relative to the cyan subunit; the approximate pivot point is 
indicated by the asterisk. The distances separating the terminal residues of α11 (i.e. 
Arg243) in the two structures are marked. 
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2475 Å
2
 to 2759 Å
2
 upon SD8 binding. Non-bonded protein-protein interactions 
across the interfaces are extensive in both conformational states, although there is a 
slight increase in the number of pairwise interatomic distances under 4 Å, from 297 
in SimR-apo to 336 in SimR-SD8. More significant is the increase in the number of 
protein-protein hydrogen bonds from 18 in SimR-apo to 30 in SimR-SD8 (values 
from PDBsum; http://www.ebi.ac.uk/pdbsum/) (Laskowski, 2001). Further analysis 
indicates that 12 of these are retained between the two structures. These comprise 
contacts between the α9-α10 arm of one subunit and the α6-α7 loop and α7 of the 
other, and between the α6-α7 loop of one subunit and α8 of the other.  
 
5.5 The simocyclinone binding site in SimR 
 
The SD8 and SC4 ligands bind to the same sites in their respective complexes with 
SimR, such that moieties common to both molecules occupy equivalent positions in 
the binding pocket (Figs. 5.4 and 5.6). Thus, only a detailed description of the 
protein-ligand interactions for SimR-SD8 is necessary. The SD8 molecule is bound 
in an extended conformation spanning almost 30 Å, making substantial contacts with 
both subunits of the homodimer (Figs. 5.6 and 5.9). The AC end is completely buried 
in the core of the SimR dimer, in a pocket formed by residues from α4, α5, α7 and α8 
and several of the intervening loops from one SimR monomer. The α6-α7 loop 
adopts a different conformation in the ligand-bound structures, thereby avoiding a 
steric clash between Trp121 and the AC moiety. Otherwise, the AC pocket is 
essentially preformed at the protein backbone level in SimR-apo, only requiring a 
few side chains to reposition themselves, most notably, Gln135, Gln136 and Asn161. 
By contrast, the PK end is partially exposed to bulk solvent in a peripheral site that is 
formed almost exclusively by helices α9 and α10 (i.e. the extended arm) of the other 
monomer. The lower part of the PK binding site is present in SimR-apo and 
corresponds to the 'saddle' resulting from the kink in α9 (Fig. 5.1). The upper part of 
the site is completed in the ligand-bound form as the result of the conformational 
changes in the α9-α10 arm described below, principally the unwinding of α10. In 
between the AC and PK moieties, the cavity widens considerably (Fig. 5.4). This is 
where the linker and the olivose sugar are accommodated.  
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Fig. 5.9. Schematic representation of the SD8-binding pocket of SimR. The ligand is 
shown in red and all residues within 4 Å of it are shown in black. Dotted lines 
indicate hydrogen bonds and green arcs indicate non-bonded interactions. The two 
water molecules (labelled 'W') that link Gln136 to the olivose moiety of SD8 are 
shaded blue. The grey line delineates the boundary between the two subunits. For 
clarity all hydrogens have been omitted.  
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What is particularly striking about the binding of SD8 is that despite the ligand 
having 19 atoms that could either donate or accept a hydrogen bond, it makes a 
maximum of only five direct hydrogen bonds to SimR (Figs. 5.6 and 5.9). However, 
this is compensated by the extensive van der Waals contacts with the protein.  
 
When comparing the SimR-SD8 and SimR-SC4 structures, we observed several 
minor differences due to the absence of the AC moiety in SC4. The side chains of 
Gln135 and Gln136, which are displaced in SimR-SD8 due to the presence of the AC 
moiety, in SimR-SC4 adopt conformations similar to those found in SimR-apo (Fig. 
5.6). Similarly, the α4-α5 surface loop differs slightly in SimR-SC4 due to the lack of 
an interaction between Thr86 and the ligand. Since these small differences appear to 
influence neither the dimer interface nor the DBD, they are unlikely to explain why 
SC4 is less effective than SD8 at derepressing SimR in vitro (Chapter 4 and Le et al., 
2009). Rather, we speculate that this is simply a consequence of the fewer favourable 
interactions that SC4 makes with the protein due to the lack of an AC moiety, which 
is likely to result in a reduced binding affinity of SC4 for SimR.  
 
SD8 is a potent inhibitor of DNA gyrase, and functions by a novel mechanism, 
binding to the GyrA subunit and preventing DNA binding (Flatman et al., 2005). 
Recently, the crystal structure of the GyrA-SD8 complex was determined, revealing 
the structural basis of enzyme inhibition (Edwards et al., 2009). SD8 binds to GyrA 
in an extended conformation with the PK and AC moieties occupying two separate 
binding pockets. As might be expected, there is no correspondence between the 
ligand-binding pockets in GyrA and SimR. 
 
In free solution, the tetraene linker of SD8 would be predicted to be linear, due to the 
conjugated double bond system, as is observed in GyrA-SD8 (Edwards et al., 2009) 
However, in SimR-SD8, the tetraene linker of SD8 is curved. This presumably 
occurs because the relative orientations of the AC and PK pockets are incompatible 
with the linker remaining linear. Even in SimR-SC4, the tetraene linker exhibits 
some curvature.  
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5.6 Comparison to other TetR family ligand-binding sites 
 
The LBDs of TFRs are significantly more variable than their DBDs, reflecting the 
plethora of ligands that can be bound (Yu et al., 2010). Moreover, the manner in 
which ligands are bound is highly variable. Even in comparisons between SimR-SD8 
and the ligand-bound forms of the structurally closely related ActR and TetR, it is 
clear that there is little correspondence when the structures are superposed (Fig. 
5.4B). The long axis of actinorhodin crosses that of SD8 at an angle of roughly 70°, 
while the majority of tetracycline aligns loosely with the tetraene linker, rather than 
with one of the ring systems of SD8. Where structures of TFRs in complex with their 
cognate ligands have been determined, the cognate ligands are bound predominantly 
by one subunit of the biological dimer: in ActR there is only one contact with the 
second subunit, while in TetR there is none (Fig. 5.2). By contrast, simocyclinone 
makes substantial contacts with both subunits of the dimer (Figs. 5.1, 5.2, 5.4, 5.6 
and 5.9), with the majority of the contacts to the second subunit involving the α9-α10 
arm. The extent of the SD8 binding pocket is also unusual; the only other example 
showing a pocket of comparable length is the palmitoyl-CoA complex of DesT (PDB 
code 3LSJ) (Miller et al., 2010). However, in this case, the pocket entrance is at the 
top of the subunit and the ligand lies roughly perpendicular to SD8, interacting 
mainly with a single subunit (Fig. 5.5E).   
 
5.7 Conformational changes in SimR captured upon ligand binding 
 
Available evidence suggests that apo-TFRs sample a range of conformations and that 
ligand-binding captures one of these conformations, rather than inducing the 
conformational change (Reichheld et al., 2009; Yu et al., 2010). As a consequence, 
we have assumed here that the same is true of SimR.  
 
In a superposition of the subunits from the various SimR structures, the upward shift 
of the α9-α10 arm in the ligand-bound form is the most striking difference (Fig. 
5.7A). Presumably the α9-α10 arm is carried along with the neighbouring subunit 
when the two subunits rotate relative to one another as part of the normal dynamic 
behaviour of the system, and this conformational state is captured on ligand binding 
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(Fig. 5.8). However, the arm does not move entirely as a rigid body: although α9 is 
essentially unchanged, the C-terminal end of α10 partially unwinds (it becomes two 
residues shorter), and the now extended α10-α11 loop moves even further upward, 
causing the remainder of α10 to tilt upward. The loop is stabilized in its new 
conformation by additional inter-subunit hydrogen bonds involving Asp151 in α8 
(Figs. 5.7B and 5.10). The net effect of these motions is that the channel connecting 
the central cavity to bulk solvent in SimR-apo closes, and a new one opens adjacent 
to it, which is wide enough to accommodate the PK moieties of SD8 and SC4 (Fig. 
5.4). A more subtle effect of the upward arm motion is that the C-terminal end of α8 
bends towards the opposing subunit, leading to a number of minor conformational 
changes in the α8 - α9 loop.  
 
In all three SimR structures, there are two symmetry-related hydrogen-bonding 
networks that lie on either side of the pivot and link Glu177 in α8 of one subunit to 
His125 in the α6-α7 loop of the other subunit, which in turn is hydrogen-bonded to 
Glu76 in α4 of the same subunit (Figs. 5.7 and 5.10). These networks may be 
important for tethering the subunits to one another and restraining inter-subunit 
rotations. The portion of the α6-α7 loop C-terminal to His125 remains unchanged, 
whereas the N-terminal portion moves downward in the ligand-bound structures. At 
the protein backbone level, the motion seems relatively minor. However, the side 
chains of two bulky residues, namely Trp121 and Arg122, flip downwards, with the 
tip of the latter moving by some 17 Å into the dimer interface, where it is salt-
bridged to Glu176 in α8 of the opposing subunit (Figs. 5.7 and 5.10), thereby 
reciprocating the link between α8 and the α6-α7 loop, involving Glu177 and His125, 
described above.  
 
In SimR-apo, the two monomer cores (i.e. excluding the α9-α10 arms) present 
relatively flat surfaces to one another, and thus could potentially slide past each other 
without steric restraint. However, in the ligand-bound form, the two copies of 
Arg122 project across the dimer interface into pockets in the surfaces of the opposing 
monomers (Fig. 5.11). Thus, they may act as retaining pins, effectively locking the 
subunits together.  
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Fig. 5.10. Detail of differences between SimR-apo and SimR-SD8 structures. 
Stereoviews comparing the conformations of α10 and the α6-α7 loop in (A) SimR-
apo and (B) SimR-SD8. Also shown is the Glu177-His125-Glu76 hydrogen bonding 
network that is present in both structures. The SD8 molecules are shown in stick 
representation with grey carbons for (B).  
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Fig. 5.11 Putative derepression mechanism of SimR. Semi-transparent cartoon and 
molecular surface representations of (A) SimR-apo and (B) SimR-SD8. The left-
hand panels show the front view and the right-hand panels show the bottom view. 
The symmetry equivalent Arg122 residues are coloured blue (and shown in stick 
representation for the cartoons) and the ends of the side chains are indicated by the 
black arrows; SD8 molecules are shown as red sticks. In SimR-SD8 the inter-
digitation of the Arg122 side chains is most apparent in the right-hand panels.  
 
 
B 
A 
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5.8 The mechanism of derepression in SimR 
 
It is widely accepted that the derepression of TFRs involves allosteric mechanisms, 
since their ligand-binding sites are remote from their DBDs (Ramos et al., 2005; Yu 
et al., 2010). It may be significant that the majority of characterised TFR ligand-
binding sites are contained almost entirely within individual subunits, and that for 
those TFRs for which ligand-bound and DNA-bound structures are available, the 
allosteric mechanism involves conformational changes transmitted largely within the 
same subunit (Itou et al., 2010; Miller et al., 2010; Orth et al., 1999; Orth et al., 
2000; Schumacher et al., 2001). The binding of ligands to these sites captures a 
conformational state in which the DBD (the recognition helix in particular) is 
repositioned relative to the LBD such that the dimer is prevented from binding to 
cognate DNA. Nevertheless, inter-subunit communication appears to play a role in 
some systems, e.g. QacR (Schumacher et al., 2001) and CgmR (Itou et al., 2010), as 
the binding of ligands by one subunit can render the other subunit incapable of doing 
the same. In SimR, the binding of SD8 stabilises a number of conformational 
changes, the most significant of which occur at the dimer interface. These changes 
have the effect of repositioning the two subunits of the dimer relative to one another, 
and locking them in this new configuration. It seems likely that the side chain of 
Arg122 in the α6-α7 loop is important for this locking mechanism (Fig. 5.11). 
Moreover, it also seems likely that further rigidity is imparted on the system by the 
ligand, which threads through both subunits. Indeed, the induced curvature of the 
tetraene linker of bound SD8 may be indicative of the forces required to maintain the 
protein in the derepressed state.  
 
In the derepression mechanism of TetR, the principal changes upon ligand binding 
are an upward movement of the α6-α7 loop (i.e. away from the DBD), a partial 
unwinding of α6, and a 'pendulum-like' swing of α4 around its C-terminal end that 
repositions the DBD relative to the LBD such that the two recognition helices move 
further apart to a configuration that would abrogate binding to DNA (Hinrichs et al., 
1994; Kisker et al., 1995; Orth et al., 1998; Orth et al., 1999; Orth et al., 2000). By 
contrast, in SimR, although there are changes in the α6-α7 loop, it moves down 
instead of up, and there is no unwinding of α6. Furthermore, α4 does not swing at all, 
and thus the relative dispositions of the LBDs and DBDs within individual subunits 
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of SimR remain essentially unchanged. Therefore in both SimR-apo and SimR-SD8, 
the recognition helices are too far apart to allow SimR to bind DNA (Fig. 5.1). This 
is also true for the apo and ligand-bound states of TetR and ActR (Orth et al., 1998; 
Willems et al., 2008). 
 
How does ligand binding prevent SimR from binding to DNA? It has been assumed 
that the ligand-free form of SimR is sufficiently dynamic in solution that it can 
readily sample different conformational states. Davidson and colleagues performed 
equilibrium unfolding experiments on wild-type TetR and proposed that the 
thermodynamic coupling of TetR domains, in particular, the rigidification of the 
DBDs upon ligand binding, underlies the allosteric response in TetR (Reichheld et 
al., 2009).  For SimR, we speculate that a DNA-binding conformation could be 
achieved largely through rigid-body motions of the subunits about a pivot point 
towards the upper end of the LBD, without invoking significant repositioning of the 
DBDs relative to the LBDs. Such a conformational change would be disfavoured in 
the ligand-bound structures due to a combination of factors, including the rigidity 
imposed on the system by the ligand threading through both subunits and the 
increased number of favourable inter-subunit contacts, in particular, the inter-
digitation of the Arg122 side chains (Fig. 5.11), together preventing DNA binding by 
SimR-SD8.  
 
5.9 Conclusion and Summary 
 
SimR is a TetR-family transcriptional regulator that provides a mechanism that 
couples the biosynthesis of the antibiotic simocyclinone to its export in the producing 
organism S. antibioticus. I have determined the crystal structures of the protein in the 
absence of ligands and in complexes with the mature antibiotic, simocyclinone D8, 
and with the biosynthetic intermediate, SC4. SimR displays the α-helical fold typical 
of TFRs and exists as a homodimer. In addition to the usual nine helices, the SimR 
monomer has an insertion of two extra helices, prior to the C-terminal helix, which 
together form an arm that wraps around the opposing subunit. This feature is only 
found in a subfamily of TFRs that includes ActR and TetR, which are close structural 
homologues of SimR (Yu et al., 2010). Furthermore, SimR has an N-terminal, Arg-
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rich β-hairpin motif that is not observed in other TFR structures, which appears to be 
ideally placed to engage with phosphate groups in the minor groove of DNA. This 
possibility is addressed in Chapter 6. 
 
The ligand-bound structures of SimR reveal an extended binding pocket that, 
unusually for TFRs, spans both subunits in the functional dimer. Interactions with 
one subunit almost exclusively involve the α-helical arm, which is reconfigured in 
the ligand-bound form. Through comparisons of these structures, we are able to 
postulate a derepression mechanism for SimR that involves rigid-body motions of the 
subunits relative to one another, coupled with a locking mechanism that most likely 
prevents further conformational change, holding the DBDs too far apart for DNA 
binding. SimR vividly illustrates the versatility of TFRs in their ability to recognise 
and respond to diverse ligands.  
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The crystal structure of the TetR family 
transcriptional repressor SimR bound to DNA and 
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6.1 Introduction 
 
To date, the structures of only four TFRs bound to cognate DNA have been 
determined (TetR, DesT, CgmR and QacR), and it is clear that the mode of operator 
recognition differs from one member of the TFR family to another (Itou et al., 2010; 
Miller et al., 2010; Orth et al., 2000; Schumacher et al., 2002). For example, the 
tetracycline efflux pump repressor, TetR, binds as a dimer to a 15-bp operator and 
deforms the binding site by 17
o
, bending away from the protein in order to optimise 
the position of its HTH for specific base pair interaction (Orth et al., 2000). By 
contrast, the multidrug efflux pump repressor from Staphylococcus aureus, QacR, 
binds its cognate DNA site as a dimer of dimers and bends its operator by just 3
o
, but 
widens the major groove to create an optimal DNA environment for a second QacR 
dimer to bind cooperatively nearby (Schumacher et al., 2002).  
 
I have determined the structures of apo (unliganded) SimR and SimR in complex 
with either SD8 or its biosynthetic intermediate SC4 (Le et al., 2011b and Chapter 
5). These structures revealed the same overall domain architecture for SimR as for 
other TFRs, including a classical HTH motif. However, SimR possesses an 
additional arginine-rich N-terminal extension that precedes the core DBD, which is 
significantly longer than those present in the four TFRs for which protein-DNA 
crystal structures are available (TetR, DesT, CgmR and QacR) (Fig. 6.1). With the 
exception of three residues, this 28 amino acid residue extension is disordered in 
both subunits in the SimR-SD8 structure, and it is only partially ordered in one 
subunit in the SimR-SC4 structure (Le et al., 2011b and Chapter 5). Consistent with 
this, the N-terminal extension of SimR is predicted to be disordered in solution.  
 
Here, I show by deletion analysis that the flexible N-terminal extension of SimR 
plays an important role in DNA binding, and I present the crystal structure of SimR 
bound to its operator sequence, which shows that this extension binds in the minor 
groove adjacent to the major groove occupied by the classical HTH motif. Although 
the N-terminal extension is hypersensitive to proteolysis in vitro, it becomes 
protease-resistant upon binding cognate DNA. Together these data suggest that the 
N-terminal  
Chapter 6 The role of the N-terminal extension of SimR in DNA binding 
 
143 
 
 
 
         
 
Fig. 6.1. Alignment of the amino acid sequence of SimR with the four other TFRs for which protein-DNA crystal structures 
are available (DesT, TetR, CgmR and QacR), showing the HTH motif, the core DBD and the N-terminal extension, herein 
termed the TFR arm present in SimR. For each TFR, amino acid residues that interact with the bases of the cognate DNA 
operator are highlighted in red, and those that contact the phosphate backbone are highlighted in green. Conserved residues 
are boxed.  
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extension transitions from a disordered to an ordered state upon DNA binding. 
Bioinformatic analysis of the entire TetR family shows that an N-terminal extension rich 
in positively charged residues is a feature of the majority of TFRs. Finally, comparison 
of the SimR-DNA and SimR-SD8 complexes reveals the conformational changes 
required to interchange between DNA- and ligand-bound states, which largely involve 
rigid-body motions of the subunits relative to one another.  
 
6.2 N-terminally truncated SimR derivatives bind DNA with reduced affinity 
 
SimR possesses a 28-residue N-terminal extension that precedes the core DBD, herein 
termed the TFR arm (Fig. 6.1), which carries four arginine residues at positions 18, 19, 
22, and 25. This TFR arm is significantly longer than those in TetR, DesT, CgmR and 
QacR (Fig. 6.1), the four TFRs for which DNA-protein crystal structures are available 
(Itou et al., 2010; Miller et al., 2010; Orth et al., 2000; Schumacher et al., 2002). To 
determine if the TFR arm of SimR is involved in DNA binding, we made C-terminally 
His-tagged SimR derivatives with progressively shorter N-terminal extensions and tested 
them for binding to the simR-simX intergenic region by EMSA. Wild-type SimR and 
SimR derivatives with 10, 15, 22 or 25 amino acid residues deleted from the N-terminus 
were overexpressed and purified (Fig. 6.2). Increasing concentrations of protein were 
incubated with a DNA probe spanning the simR-simX intergenic region and the 
complexes were resolved on native polyacrylamide gels (Fig. 6.3). The simR-simX 
intergenic region contains two SimR operators: OR closer to simR, and a higher affinity 
binding site, OX, closer to simX (Le et al., 2009 and Chapter 4). The lower and upper sets 
of shifted protein-DNA complexes seen in Fig. 6.3 correspond, respectively, to single 
and double occupancy of these two SimR-binding sites (Le et al., 2009). SimR DNA 
binding affinity was reduced ~30-fold when 10 or 15 amino acid residues were deleted 
from the N-terminus, and was reduced by at least 120-fold when 22 or 25 amino acid 
residues were removed (Fig. 6.3). These results suggested the TFR arm plays a role in 
DNA binding.  
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Fig. 6.2. Purified wild-type SimR and N-terminally truncated SimR derivatives. All 
SimR variants are C-terminally His tagged.  
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Fig. 6.3. Electrophoretic mobility shift assay (EMSA) showing the binding of purified wild-type and N-terminally truncated 
derivatives of SimR to the simR-simX intergenic region. Bands correspond to SimR-DNA complexes (Bound) and free DNA 
(Free) are indicated. The final concentration of SimR is indicated above each lane.  
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6.3 The TFR arm becomes protease-resistant upon DNA binding  
 
The 28-amino acid TFR arm of SimR has a high proportion of disorder-promoting 
amino acids and is predicted by the Proteins Disorder Prediction System (PrDOS; 
http://prdos.hgc.jp/cgi-bin/top.cgi) and by the Regional Order Neural Network (RONN; 
http://www.strubi.ox.ac.uk/RONN) servers to be disordered in solution (Fig. 6.4). 
Additionally, with the exception of three residues (residues 8 to 10, here termed the 
anchor string) this extension is disordered in both monomers in the SimR-SD8 structure, 
and it is only partially ordered in one monomer in the SimR-SC4 structure (Le et al., 
2011b and Chapter 5). The TFR arm is ordered in the SimR-apo structure, but its 
structure is the likely result of crystal packing (Fig. 6.5). 
 
Because disordered regions are often hypersensitive to proteolysis (Receveur-Brechot et 
al., 2006), we examined the sensitivity of SimR to trypsin. The TFR arm was rapidly 
digested, leaving a much more stable product with an N-terminus at either residue Ser20 
or Ser23 (Fig. 6.6 and Fig. 6.7). Taken together, these observations suggest that the TFR 
arm is solvent exposed and displays conformational flexibility in solution in the absence 
of cognate DNA.  
 
Since many unstructured regions exhibit increased resistance to proteolysis on binding 
of a partner (Dyson and Wright, 2005; Receveur-Brechot et al., 2006), we determined 
the effect of DNA binding on the sensitivity of the TFR arm to trypsin. Addition of 25- 
or 31-bp DNA duplexes spanning the OX operator substantially decreased the rate of 
SimR proteolysis, suggesting that DNA binding renders the TFR arm more resistant to 
trypsin (Fig. 6.6). Consistent with this interpretation, proteolysis was not inhibited when 
a 15-bp OX DNA duplex that is unable to bind to SimR was incubated with SimR (Fig. 
6.6 and Fig. 6.8A). In total, these experiments suggest that the TFR arm transitions from 
a disordered or conformationally flexible state to a more ordered, rigid state upon DNA 
binding.  
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Fig. 6.4. Disorder probability profile plot for SimR from the PrDOS and RONN server. 
PrDOS and RONN predict that at least 28 N-terminal amino acids (red) and the 12 C-
terminal residues (red) are disordered.  
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Fig. 6.5. In the SimR-apo structure the TFR arm is ordered because it is stabilised by 
interaction with two other symmetry-related arms. The three symmetry-related TFR 
arms are shown in red, blue and magenta. Inter-strand hydrogen bonds (dotted black 
lines) between the main chain O of Pro13 and the NH of Glu14 contribute to the 
stabilisation. There is only one SimR-apo monomer in the asymmetric unit.  
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Fig. 6.6. Limited tryptic proteolysis of SimR in the presence or absence of DNA. SimR 
was incubated either alone or with the OX operator DNA duplexes indicated, before the 
addition of trypsin. Note that the 15mer DNA duplex does not bind SimR (see Fig. 
6.8A). After SDS-PAGE, SimR species were visualised by Coomassie blue staining. The 
major product of tryptic digestion (arrowed) was shown by Edman sequencing to have 
an N-terminus corresponding to Ser 20 or Ser23 of wild-type SimR.  
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Fig. 6.7. A limited proteolysis time course shows that the TFR arm of SimR is highly 
susceptible to trypsin, consistent with it being conformationally flexible in solution. N-
terminal sequencing of the most prominent band after 5 min digestion (arrowed) showed 
that the band is composed of two closely-migrated SimR fragments. One fragment is 
with the N-terminus at residue Ser23 (4 pmoles), while the other fragment starts with 
Ser20 (2-3 pmoles). 
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Fig. 6.8. Electrophoretic mobility shift assays (A) using wild-type SimR and 
radiolabelled DNA duplexes of different length encompassing the wild-type OX 
operator. (B) using wild-type SimR and radiolabelled DNA duplexes encompassing the 
symmetrical operators based on either the right-half repeat or the left-half repeat. 
Binding reaction mixtures were resolved on 8% (w/v) native PAGE gels. 
A 
B 
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6.4 The structure of SimR bound to its DNA operator 
 
To understand how SimR binds to its operator sequence and to shed light on the role of 
the TFR arm in DNA binding, we crystallized SimR in complex with DNA. We tested 
DNA duplexes from 17 to 21 bp in length and found that only the minimal, blunt-ended 
17-bp duplex crystallized in complex with SimR. The 17-bp DNA duplex used was the 
OX operator (TTCGTACGGTGTATGAA), but carrying two base-pair changes to 
generate a near perfect inverted repeat (5'-TTCGTACGGCGTACGAA-3'), which bound 
SimR at least as tightly as the wild-type 17-bp DNA duplex (Fig. 6.8B). We solved the 
structure of full-length SimR (residues 1-259) in complex with this 17-bp DNA duplex 
to 2.99 Å resolution (Fig. 6.9A). X-ray data collection and refinement statistics are 
summarised in Table 6.1. The asymmetric unit (ASU) contained two SimR dimers, each 
bound to a 17-bp DNA duplex. The two SimR dimer-DNA complexes are essentially 
identical [root mean square deviation (RMSD) between complexes for the Cα backbone 
= 0.15 Å], and thus only one complex is discussed throughout (Fig. 6.9A). The 
conformation of bound DNA is mostly regular B-form but is bent away from the SimR 
dimer by ~15
o
 (see below and Fig. 6.18A). The bases at the end of adjacent DNA 
duplexes stack and interact to form a pseudo-continuous double-helical DNA filament 
running through the crystal (Fig. 6.9B and Fig. 6.10).  
 
6.5 Interactions between the HTH motif and the major groove 
 
 
The core DBD is composed of helices α1 to α3 (residues 29-67). Helix α2 (residues 49-
58) and the recognition helix α3 (residues 61-67) form the HTH motif which packs 
against α1 for stabilisation (Fig. 6.9A). Surprisingly, the recognition helix makes no 
canonical hydrogen bonds with the bases.  However, the side chain of Met62 makes a 
series of contacts to three different bases including van der Waals to C3 (C  to C
5
), and 
an uncommon electrostatic interaction between the Sδ atom and the face of the base of 
T12, which is analogous to Sδ stacking over the aromatic side chains of tryptophan, 
 
Data set SimR-DNA (17mer) 
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Data collection  
Space Group P212121 
Cell parameters (Å/°) a = 85.8, b = 112.6, c = 163.7  
Solvent content (%) 62.5 
Wavelength (Å) 1.11 
Resolution range
a
 (Å) 92.78-2.99 (3.15-2.99) 
Unique reflections
a
 (#) 31030 (4547) 
Completeness
a
 (%)
 
95.2 (96.5) 
Redundancy
a
  3.1 (3.1)  
Rmerge
b 
(%) 10.0 (59.1) 
 <I>/< I> 8.3 (1.8) 
Wilson B value (Å
2
) 53.4 
Refinement  
Rcryst
c
 (based on 95% of data) 20.9 
Rfree
c
 (based on 5% of data)
 
25.1 
Coordinate error
d
 (Å) 0.420 
Ramachandran favoured
e
 (%) 98.0 
Ramachandran outliers
e 
(%) 0.22 
rmsd bond distances (Å) 0.010 
rmsd bond angles (º)  1.22 
Mean B-value for protein (Å
2
) 57.6 
Mean B-value for the DNA (Å
2
) 54.6 
Contents of model  
Protein residues in each chain (totals in 
brackets) 
A: 7-241  B: 7-15 and 26-242  C: 7-242 D: 7-15 
and 26-242 
DNA nucleotides E and F, G and H : 1-17 
PDB accession code 3ZQL 
a
 The figures in brackets indicate the values for highest resolution shell. 
b
 Rmerge = ∑hkl ∑i |Ii(hkl)  I(hkl) |/ ∑hkl ∑iIi(hkl), where Ii(hkl) is the ith observation of reflection 
hkl and I(hkl)  is the weighted average intensity for all observations i of reflection hkl. 
c
 The R-factors Rcryst and Rfree are calculated as follows: R = (| Fobs - Fcalc |)/ | Fobs | x 100, 
where Fobs and Fcalc are the observed and calculated structure factor amplitudes, respectively. 
d
 Estimate of the overall coordinate errors calculated in REFMAC5 based on Rfree (Murshudov et 
al., 1997)  
e
 As calculated using MOLPROBITY (Chen et al., 2010)  
 
 Table 6.1.  Summary of SimR-DNA X-ray data and model parameters 
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Fig. 6.9. Structure of the SimR-17mer 
complex (A) in isolation or (B) showing the 
adjacent DNA duplexes in the crystal. A 
cylindrical helix representation is used to 
highlight the secondary structure of SimR 
with key features labelled in (A). One 
subunit of the biological-relevant dimer is 
shown in grey and one in green. The 
recognition helix α3 is shown in magenta, 
the TFR arm is shown in blue, and the N- 
and C-termini are labelled. The anchor 
string of the TFR arm (residues 8-11) is 
shown as a red tube cartoon. The dotted 
blue line represents the disordered TFR arm 
in the left-hand SimR subunit. In (B) only 
the DNA components of the adjacent 
symmetry complexes are shown in order to 
highlight the pseudo-continuous DNA 
filament running through the crystal (See 
also Fig. 6.10 and Fig. 6.14).  
 
B 
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Fig. 6.10. Structure of the SimR-17mer duplex in the context of the crystal. 
Complementary DNA strands are shown in magenta and green. Neighbouring DNA 
duplexes stack and interact to form pseudo-continuous double-helical DNA filaments 
running through the crystal. 
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histidine and phenylalanine (Pal and Chakrabarti, 2001) (Fig. 6.11). This interaction is 
buttressed by van der Waals contacts to the C
7
 methyl group of T12.  The SD atom of 
Met62 also accepts a hydrogen bond from the N
6 
hydrogen bond donor of A13. Another 
key interaction involved in the DNA sequence recognition mechanism of SimR is the 
stacking of the side chain of residue Tyr66 with the C7 exocyclic methyl groups of T1 
and T2. This interaction explains in great part why SimR has a higher affinity for the OX 
operator, which has this pair of thymines, than for OR, which has a pair of guanines at 
these positions (Le et al., 2009 and Chapter 4). The dominant recognition helix 
interactions are with the phosphate backbone. For each operator half-site, there are 
hydrogen bonds between the hydroxyl group of Ser63 and the phosphate group of C3, 
between the hydroxyl group of Tyr65 and the phosphate group of T12, and between 
Tyr67 and the phosphate group of T2 (Fig. 6.11). Just outside helix α3, the backbone 
NH group of Gly60 hydrogen bonds with the phosphate group of C3. On binding DNA, 
the recognition helix adopts a 310 helical conformation, in contrast to the canonical α-
helical conformation seen in the structures of SimR-apo and SimR-simocyclinone 
complexes (Le et al., 2009 and Chapter 4). This conformational alteration in the 
recognition helix on DNA binding is also observed in TetR, and is believed to facilitate 
intimate interaction with the DNA (Orth et al., 2000).  
 
Three residues in helix α2 contribute to DNA binding, with the side chain hydroxyl 
group of Ser49 forming a hydrogen bond with the phosphate backbone of C10 and the 
backbone NH group of Met50 forming a hydrogen bond with the phosphate backbone of 
G11 (Fig. 6.11). The guanidinium group of Arg51 is involved in direct base recognition 
by bifurcated hydrogen bonds from NH2 to the O
6
 and N
7
 acceptors of G11. Other 
interactions between SimR and the major groove are hydrogen bonds between the amino 
group of Lys71 and the phosphate group of G11, and between the backbone NH group 
of Lys71 and the phosphate group of T12. Lys71 lies at the N-terminus of helix α4 at the 
very beginning of the LBD, just outside the core HTH motif of the DBD. This residue is 
highly conserved among TFRs and the equivalent lysine in TetR also forms a hydrogen 
bond with the phosphate backbone (Orth et al., 2000). 
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Fig. 6.11. (A) Interactions between the HTH motif and the major groove. Stick representations of the interacting residues are 
shown in magenta. The Cα backbone of recognition helix α3 is shown in magenta and that of helix α2 is shown in green. 
Hydrogen bonds are represented by dotted black lines. The interacting bases are labelled and only the ring frames are shown 
for non-interacting bases.  
A 
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Fig. 6.11. (B) Schematic representation of SimR-DNA contacts. For simplicity, only a recognition half-site and the first four 
base pairs of an adjacent duplex are shown. Interactions between amino acid residues and the bases of the cognate DNA 
operator are indicated by red arrows, and those between amino acid residues and the phosphate backbone are represented by 
green arrows. Amino acid residues belonging to TFR arm are shown in red. 
B 
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TFRs frequently rely on phosphate backbone contacts to mediate interaction with the 
DNA. In an extreme case, the DesT-DNA interface involves 11 phosphate backbone 
contacts but only two specific interactions with a pair of guanine bases within each half 
site (Miller et al., 2010). In contrast, TetR and QacR make extensive direct hydrogen-
bond contacts with the bases (Orth et al., 2000; Schumacher et al., 2002). In this sense, 
SimR is perhaps more similar to DesT than to TetR or QacR in its DNA sequence 
recognition mechanism. Thus, although the overall structure of the DBD in TFRs is 
conserved, it is clear that the mode of operator recognition differs from one member of 
the TFR family to another (Itou et al., 2010; Miller et al., 2010; Orth et al., 2000; 
Schumacher et al., 2002). TFRs recycle conserved residues and inventively employ non-
conserved ones within the DBD for either base-specific hydrogen bond formation or for 
phosphate backbone contacts (Fig. 6.1). It seems that there is no deterministic set of 
rules for TFR-DNA recognition.  
 
6.6 Interactions between the TFR arm and the minor groove 
 
If the structure of a single SimR-DNA complex is viewed in isolation, it can be seen that 
the TFR arm does not make contact with the cognate DNA duplex (Fig. 6.9A). Instead, 
the TFR arm binds the minor groove of the adjacent DNA duplex in the pseudo-filament 
(Fig. 6.9B). This binding to the minor groove is mediated through arginine residues that 
sit at the tip of the TFR arm (Figs. 6.11B, 6.12 and 6.13B). Specifically, N2 of the 
guanidinium group of Arg18 forms a hydrogen bond with O
2 
of C3, whilst its N1 
interacts with the O
2
 of T2, the guanidinium group of Arg22 forms two salt bridges to 
the phosphate backbone of C3 and G4 (Figs. 6.11B and 6.12). The electropositive side 
chain of Arg18 is deeply buried in this minor groove (Fig. 6.12), where the 
electronegative potential of the phosphate backbone is focused (Rohs et al., 2009; Rohs 
et al., 2010). This helps anchor the tip of the TFR arm in the minor groove. A third 
arginine in the flexible TFR arm, Arg19, does not contact DNA in the structure reported 
here (Fig. 6.12 and 6.13). However, given the noncovalent nature of the DNA pseudo-
filament, we considered the possibility that Arg19 might be involved in DNA binding in  
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Fig. 6.12. Interactions between the TFR arm and the minor groove. The Cα backbone of the TFR arm is shown in blue and 
stick representations of arginine residues Arg18, Arg19, Arg22 and Arg25 are shown in magenta. Hydrogen bonds are 
represented by dotted black lines. The interacting bases are labelled and only the ring frames are shown for non-interacting 
bases. 
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Fig. 6.13. Simulated annealing omit maps at 2.99Å resolution, contoured at 2.5 σ for (A)  
the DNA, and (B) residues 18-25 of the TFR arm. The arm is shown in blue, and 
residues Arg18, Arg19, Arg22 and Arg25 in green.  
 
 
 
 
 
B 
A 
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truly continuous double-stranded DNA. To examine this possibility, we mutagenised 
Arg19 to alanine and assayed the resulting protein for its ability to bind to the simR-simX 
intergenic region by EMSA. SimR R19A bound DNA with an affinity equal to that of 
wild-type SimR (Fig. 6.14), suggesting Arg19 does not contribute to DNA binding. In 
contrast, when we constructed SimR R18A and SimR R22A variants, we found that each 
exhibited an approximate 15-fold reduction in binding affinity (Fig. 6.14), consistent 
with roles for R18 and R22 in DNA binding, as suggested by the structure of the SimR-
DNA complex.  
 
Initially, it was difficult to understand why SimR variants lacking just 10 or 15 amino 
acids N-terminal residues should have reduced DNA binding affinity, given that they 
retain the interacting arginine residues. In the previously solved structures of apo-SimR 
and SimR-ligand complexes, although the TFR arm is mostly disordered, residues 8 to 
10, herein termed the anchor string, are always visible in electron density maps (Le et 
al., 2011b and Chapter 5), probably because this string of amino acid residues is 
stabilised by van der Waals interactions with the cleft between the LBD and the DBD. It 
therefore seems likely that this short segment, highlighted in red in Fig. 6.9, serves as an 
anchoring point for the TFR arm to loop back onto the body of SimR. This arrangement 
may be important for restricting the flexibility of the TFR arm, so that it is poised 
appropriately to interact with the minor groove. Deleting 10 or 15 amino acids from the 
N-terminus would remove this anchor point, destabilising loop formation and reducing 
DNA binding affinity. The more severe deletions, removing 22 or 25 amino acids, 
further reduce binding affinity because they remove the interacting arginine residues 
themselves.  
 
In the crystal structure of the SimR-DNA complex, the TFR arm is seen in one SimR 
subunit but is disordered in the other subunit (Fig. 6.9). From an inspection of the end-
to-end base stacking between adjacent DNA duplexes within the crystal, it is clear that 
the two ends are not equivalent. The stacking at the right-hand end (as viewed in Fig. 
6.15) allows the neighbouring DNA strands to transit smoothly across the gap, 
producing a relatively normal minor groove. However, on the left-hand end the strands 
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Fig. 6.14. Electrophoretic mobility shift assay showing the binding of the purified wild-
type or R18A, R19A, R22A and Y67A derivatives of SimR to the simR-simX intergenic 
region. Bands correspond to SimR-DNA complexes (Bound) and free DNA (Free) are 
indicated. Final concentration of SimR is indicated above each lane.  
 
Point mutations to substitute specific positions in the HTH motif (Y67) or the TFR arm 
(R18, R19, R22) of SimR were introduced using a modified QuikChange site-directed 
mutagenesis procedure (Stratagene). The mutation Y67A, which is located outside the 
TFR arm and makes a DNA phosphate backbone contact, serves as a control for this 
experiment. 
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Fig. 6.15. Non-equivalent stacking between 
adjacent DNA duplexes in the crystal 
pseudo-filament creates two different minor 
grooves. Only the DBD of SimR is shown. 
At the right-hand end of the central DNA 
duplex the base stacking allows the DNA 
phosphate backbone to transit smoothly 
(dotted lines) between adjacent duplexes, 
creating a relatively normal minor groove. 
At the left-hand end of the central DNA 
duplex the base stacking causes the 
phosphate backbone to veer away to avoid a 
steric clash (dotted lines), producing an 
abnormal minor groove. Adjacent DNA 
duplexes are shown in contrasting colours.  
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veer away to avoid a steric clash while maintaining base pair stacking, producing a much 
wider minor groove (Fig. 6.15). It seems likely that the TFR arm is unable to interact 
with this “abnormal” minor groove and is therefore disordered in the crystal. In the 
structure of the SimR-17mer duplex, apart from the interaction of the anchor string with 
the body of SimR, the only contacts made by the TFR arm are with the minor groove of 
DNA (Fig. 6.9 and Fig. 6.10). Based on the crystal structure of the SimR-DNA complex 
and the results of the proteolysis-protection assays, we propose that the TFR arm 
transitions from a disordered or conformationally flexible state to a more ordered state 
upon binding to its cognate DNA. 
 
6.7 N-terminally truncated SimR derivatives have a smaller footprint on DNA than 
wild-type SimR 
 
We used DNaseI protection to compare the footprints of wild-type SimR and the N-
terminally truncated SimRs on the OX and OR operators in the simR-simX intergenic 
region (Fig. 6.16A). In each case, saturating amounts of SimR protein were used to 
ensure complete protection of the binding sites. The footprint for wild-type SimR was 
comparable with that reported previously (Le et al., 2009 and Chapter 4). In contrast, in 
the footprints generated using the N-terminally truncated SimR proteins, the edge of the 
protected region retracted at both ends of the footprint when compared to the footprint of 
full-length SimR (Fig. 6.16). Specifically, when N-terminally truncated proteins were 
used, on the upper DNA strand the OR footprint retracted by two base pairs at the left 
edge and by one base pair at the right edge (Fig. 6.16). No retraction of the OR footprint 
was apparent on the lower DNA strand. When N-terminally truncated proteins were 
used, on the upper DNA strand the left edge of the OX footprint retracted by one base 
pair, while no retraction was apparent at the right edge (Fig. 6.16). On the lower DNA 
strand, the OX footprint receded by one base pair at both ends. These observations 
indicates that the TFR arm sterically hinders DNaseI, protecting one additional  
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Fig. 6.16. (A) DNaseI footprinting analysis of the binding of wild-type and N-terminally 
truncated derivatives of SimR to the simR-simX intergenic region. A DNA fragment 
containing the simR-simX intergenic region, 5'-end labelled on either the upper strand 
(left panel) or the lower strand (right panel), was exposed to DNaseI in the presence of 
saturating concentrations of SimR protein (200 nM for wild-type SimR, SimRΔN10 and 
A 
B 
(cont next page) 
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SimRΔN15; 400 nM for SimRΔN22 and SimRΔN25). The sequencing ladders were 
generated by subjecting the probes to Maxam-Gilbert G+A chemical sequencing. 
Regions protected from DNaseI cleavage (operators OX and OR) by wild-type SimR are 
indicated by solid vertical bars, and those protected by the N-terminally truncated SimR 
derivatives are indicated by open bars. Inverted repeats within the DNaseI protected 
regions are indicated by convergent arrows. (B) Sequence of the simR-simX intergenic 
region summarising the DNaseI footprinting data. Regions protected by wild-type SimR 
are indicated by solid lines, and those protected by the N-terminally truncated SimR 
derivatives are indicated by dotted lines. Also indicated are the simRp and simXp 
transcription start points and putative -10 sequences, the simR and simX ribosome 
binding sites (RBS), and the imperfect inverted repeats within the footprints. 
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phosphodiester bond from cleavage by the nuclease. Each SimR mutant protein 
produced the same footprint, regardless of whether 10, 15, 22 or 25 amino acids had 
been deleted from the N-terminus, consistent with the idea that residues 8 to 10, (i.e. the 
anchor string), are needed for the TFR arm to be fully functional, as discussed above. 
Note that the retraction of the footprint occurs at both ends of the operator, suggesting 
that the TFR arms of both monomers in the SimR dimer function in solution. We also 
performed a complementary experiment to determine the binding affinity of wild-type 
SimR to three DNA duplexes of different lengths (15, 17 and 23 bp) spanning the OX 
inverted repeat sequence. The 23-bp duplex bound SimR more strongly than the minimal 
17-bp duplex, showing that DNA flanking the core 17-bp inverted repeat contributes to 
SimR binding (Fig. 6.8A). The 15-bp duplex failed to bind SimR (Fig. 6.8A). In 
addition, although the minimal 17-bp duplex binds to SimR relatively well (Fig. 6.8A), 
it is unable to protect the TFR arm of SimR from tryptic digestion, while a 23mer 
reduced the rate of proteolysis considerably Fig. 6.17). Taken together, these 
observations suggest that, in solution, the TFR arm interacts with DNA outside the core 
17-bp OX operator, consistent with the SimR-DNA structure, which shows dimer-DNA 
interactions spanning 21 base pairs. 
 
Among the five TFRs for which protein-DNA crystal structures are available (TetR, 
DesT, CgmR, QacR and SimR; Fig. 6.1), only SimR possesses a flexible TFR arm that 
undergoes a transition to an ordered state upon DNA binding. DesT has a 12-amino acid 
residue N-terminal extension (Fig. 6.1) but it is not disordered, instead forming part of 
an extended helix α1. Residues Arg5 and Lys9 of this short N-terminal extension in 
DesT nevertheless contribute to DNA binding (Miller et al., 2010), which is unusual 
because the main role of helix α1 is in stabilising the HTH motif (α2 to α3). Residues N-
terminal to the core DBD in two other TFRs, Neisseria gonorrhoeae MtrR (11 amino 
acids) and Streptomyces coelicolor ActR (32 amino acids) have also been suggested to 
be involved in DNA binding (Hoffmann et al., 2005; Willems et al., 2008), implying a 
possible common role for TFR N-terminal extensions when present (see also the global  
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Fig. 6.17. Limited trypsin proteolysis of SimR with binding DNA. SimR was incubated 
with either a 17mer or a 23mer DNA duplexes encompassing the inverted repeat of OX 
operator before trypsin digestion. While a 17mer duplex binds to SimR (See also Fig. 
6.8), it is unable to protect the N-terminal extension from trypsin digestion as well as the 
23mer duplex.   
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TFR bioinformatic analysis presented below). Similar kinds of extensions have been 
identified in at least two other families of DNA-binding proteins. For example, members 
of the eukaryotic Hox family recognise nearly identical major groove sequences through 
the recognition helix of their homeodomain but use an extended arm to insert into the 
minor groove to enhance binding specificity (Joshi et al., 2007). A related example is 
phage lambda repressor, which has a conventional HTH motif and an additional N-
terminal extension that promotes DNA binding, in this case by interacting with the 
major groove (Beamer and Pabo, 1992). A comprehensive analysis of all available 
protein-DNA structures has shown that the binding of arginine residues to narrow minor 
grooves is a widely used mechanism in protein-DNA recognition. This readout 
mechanism exploits the fact that narrow minor grooves, often associated with A-tracts, 
strongly enhance the negative electrostatic potential of the DNA (Rohs et al., 2009; 
Rohs et al., 2010). However, it should be noted that the minor groove bound by the TFR 
arm of SimR is not associated with an A-tract, which likely contributes to its slightly 
enlarged groove width (Fig. 6.19).  
 
6.8 The arginine- and lysine-rich TFR arm is likely to be a common feature of TetR 
family members 
 
We searched the PFAM database (http://pfam.sanger.ac.uk/) for proteins that match the 
Hidden Markov Model profile PF00440, identifying 12,715 non-redundant TFRs (see 
Materials and Methods for further details). The amino acid sequences of these TFRs 
were then aligned using MUSCLE (Edgar, 2004) to identify the core DBD and any N-
terminal extension. 28% had N-terminal extensions of less than 10 amino acids, 44% 
had N-terminal extensions of 11-20 amino acids, 17% had N-terminal extensions of 21-
30 amino acids, and 11% had N-terminal extensions longer than 31 amino acids. 
Further, the fraction of Arg and Lys residues in these N-terminal extensions (mean value 
= 20.5%) was almost double the frequency found in the globular body of the TFRs 
(mean value = 11.4%) (Fig. 6.18A). Finally, the RONN server predicts that the majority 
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of these N-terminal extensions are likely to be disordered in solution (Fig. 6.18B). It 
therefore seems likely that a conformationally malleable DNA-binding N-terminal 
extension is a common feature of TFRs. 
 
6.9 DNA bending induced by SimR binding 
 
DNA helical parameters were analysed using the Curves+ programme (Lavery et al., 
2009). The overall conformation of the 17-bp duplex is B-DNA, with an average helical 
twist of 33.7
o 
(compared to a helical twist value of 36.0
o
 for an idealised B-form DNA). 
It should be noted that individual steps might show significant deviations from the 
average value. The global bending of DNA is ~15
o
 (Fig. 6.19A). Since bending is most 
affected by the base step roll and twist angles (Dickerson, 1998), we plotted the roll and 
twist angles against the base steps to pinpoint the source of bending (Fig. 6.19B). There 
are two significant positive rolls (10 to 10.7
o
) centred around base steps 6-7-8 in the 
operator half-site and symmetrically around steps 9-10-11 of the opposite half-site (Fig. 
6.19B). The increase in roll angle coincides with the decrease in twist angle (26.7
o
 to 
26.9
o
) (Fig. 6.19B). The average global roll and twist angles are 2.9
o
 and 33.4
o
, 
respectively. Thus local kinks around those base steps produce a global bend in the 
DNA, rather than a smooth bending. Moreover, there is a significant increase in the 
width of the minor groove from base step 6 through to base step 12, while the major 
groove width is just below the value for an idealised B-form DNA (Fig. 6.19C). Since 
the average distance between the two recognition helices in the SimR-DNA complex is 
36.8 Å (assessed as the distance between the Cα atom of Tyr65 in each subunit (Yu et 
al., 2010), greater than the distance between two consecutive major grooves in idealised 
B-DNA (34 Å), it is likely that the bending and the unwinding of the central DNA steps 
might be necessary for optimal positioning of the HTH motifs in adjacent major 
grooves. Lastly, although the sequence of the 17-bp duplex used in this study is a perfect 
inverted repeat with the exception of the central GC base-pair, the groove width and roll 
parameters are not symmetrical across this central base-pair. This reflects the 
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Fig. 6.18. Bioinformatic analysis of  (A) the fraction of R+K or D+E residues in the N-
terminal extension or in the globular body of  12,715 non-redundant TFRs (B) the 
disorder probability of residues in either the N-terminal extension or in the globular 
body. Residues with probability greater than 0.5 (dashed line) are predicted to be 
disordered. 
 
A 
B 
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Fig. 6.19. DNA parameters as calculated by the Curves+ programme (Lavery et al., 
2009). (A) The bound DNA in SimR-DNA complex is globally bent by ~15o. The 
curved blue rod illustrates the helical axis of the bound DNA. The phosphate backbone 
of the DNA is shown in yellow and the SimR dimer is shown as green cartoon. (B) The 
roll and twist angle for each base pair step of the bound DNA. (C) The major and minor 
groove width of the bound DNA. The corresponding values for an ideal B-form DNA 
are also included for comparison. 
A B 
C 
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non-equivalent end-to-end interactions between neighbouring DNA duplexes described 
above (Fig. 6.15). 
 
6.10 Comparison of the SimR-DNA and SimR-simocyclinone complexes suggests 
the mechanism of derepression 
 
In chapter 5, I speculated about the mechanism of simocyclinone-mediated derepression, 
based on a comparison of the structures of SimR-apo and the SimR-SD8 complex (Le et 
al., 2011b and Chapter 5). However, it was apparent that SimR-apo had not crystallised 
in its DNA-binding form, since the distance between the recognition helices in SimR-
apo was 42.3 Å (measured from the separation of the Cα atoms of the central Tyr65 
residues), a spacing incompatible with binding to two consecutive major grooves (Le et 
al., 2011b and Chapter 5). Moreover, this spacing was comparable to the corresponding 
value of 41.7 Å obtained for the SimR-SD8 complex. Indeed, TFR apo-proteins in 
general do not crystallize in their DNA-binding form (Yu et al., 2010). The helix 
separation obtained for SimR-DNA was significantly shorter at 36.8 Å (averaged over 
the two complexes in the ASU), this value lying within the range of 34.7 to 38.8 Å 
observed in other TFR-DNA complexes (Miller et al., 2010; Yu et al., 2010). The major 
structural differences between the repressed, DNA-bound conformation of SimR and the 
derepressed, SD8-bound conformation, result from a 16° rotation of the subunits relative 
to one another roughly about the centre of the dimer interface (Fig. 6.20 and Fig. 6.21). 
This re-defines many of the inter-subunit contacts, although the interface areas remain 
similar at 2795 Å
2
 and 2640 Å
2
 on average for SimR-SD8 and SimR-DNA, respectively 
[as calculated by the Protein Interactions, Surfaces and Assemblies server (PISA, 
http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html) (Krissinel and Henrick, 2005)]. 
However, five reciprocated inter-subunit hydrogen bonds (i.e. ten in total) are preserved 
between the two conformational states. These link the C-terminal end of α8 and the α9-
α10 wrapping arm to the LBD of the adjacent subunit. As a consequence, when the  
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Fig. 6.20. Structures of SimR-simocyclinone and SimR-DNA together with schematic 
representations illustrating the rigid-body rotation of the subunits relative to one another. 
In order to emphasize the subunit rotation, the grey coloured subunits are shown fixed in 
the same relative orientations. This can be clearly seen in the side view where the green 
subunit rotates by ~16° relative to the grey subunit; the approximate pivot point is 
indicated by the asterisk (See also Fig. 6.21 and Fig. 6.22). The distances separating the 
recognition helices α3 and α3' in the two structures are indicated.   
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Fig. 6.21. Comparison of the crossing angles of helices 8 and 11 with 8’ and 11’ 
at the dimer interface in the SimR-SD8 (left panels) and SimR-DNA complexes (right 
panels). The view corresponds to the side view in Fig. 6.20. Overall, one subunit rotates 
relative to the other by ~16° which correlates with the change in the crossing angle of  
helices 11 and 11’. In both structures, helices 8 and 8’ are slightly bent roughly 
where they cross; there is a further bend in each helix towards its C-terminus in the 
DNA-bound form.  This bending is coupled to the movement of the 9- 10 wrapping 
arm (see also Fig. 6.20 and Fig. 6.22). 
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subunits rotate, the α9-α10 wrapping arm moves with the adjacent subunit and the C-
terminal end of α8 bends (Fig. 6.21). Pairwise superpositions of individual subunits 
taken from the SimR-SD8 and SimR-DNA structures based on the subunit cores (i.e., 
inclusive of residues 29-168 plus 222-247 and exclusive of the TFR arm, the C-terminal 
end of α8 and the α9-α10 wrapping arm) gave RMSD values in the range 0.85 to 0.96 Å, 
indicating that the cores move essentially as rigid bodies at the protein backbone level 
and, importantly, there is no significant re-orientation of the DBD with respect to the 
LBD, in contrast to the "pendulum-like" motion seen in TetR (Fig. 6.22) (Orth et al., 
2000; Ramos et al., 2005). 
 
Nevertheless, the crystal structures do not convey the dynamic behaviour of the system 
and, as has been illustrated for other TFRs (Reichheld et al., 2009; Yu et al., 2010), in 
the absence of ligands or DNA, the protein is generally highly flexible and capable of 
sampling a variety of conformations, presumably including those akin to both the ligand-
bound and DNA-bound states. The binding of SD8, a relatively hydrophobic molecule, 
contributes to the hydrophobic core of the SimR dimer; this will have a stabilising effect 
on the overall structure, locking it into a relatively rigid, low-energy state. Moreover, the 
combination of the threading of the ligand through both subunits and the projection of 
the side chain of Arg122 into the opposing subunit contribute to the rigidification of the 
system (Le et al., 2011b and Chapter 5). The flexibility of the apo form is important to 
enable the TFR arms and the recognition helices to engage optimally with the DNA. The 
resulting favourable protein-DNA interactions will have a stabilising effect on this 
conformation of SimR. Moreover, in the DNA binding conformation the repositioning of 
the C-terminal end of helix α8 appropriately places it to make salt bridges to the DBD of 
the same subunit and to that of the opposing subunit, especially between Arg179 and 
Glu46, and between Arg180 and Glu72, respectively. These interactions, not present in 
the SD8-bound form, will further stabilise the DNA-bound conformation of SimR.   
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Fig. 6.22. Superposition of single subunits from the SimR-SD8 complex (grey) and the 
SimR-DNA complex (green) based on residues 29-168 plus 222-247 inclusive. The red 
arrows denote the direction of the conformational shifts upon transit from the DNA-
bound to the SD8-bound form i.e. the bending of the C-terminal end of helix 8 (1) and 
the upward movement of the wrapping arm comprised of helices 9 and 10 (2).  The 
inset shows the reverse view of the DBDs which illustrates their correspondence as a 
result of the superposition.  
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7.1 Attempts to test the ‘feed-forward’ hypothesis 
 
The simocyclinone biosynthetic intermediate SC4 (Fig. 4.1) lacks the aminocoumarin 
moiety and is essentially inactive as a DNA gyrase inhibitor (Edwards et al., 2009). 
However, we have shown that SC4 induces simX expression in vivo when added 
exogenously and efficiently relieves DNA binding by SimR in vitro (Chapter 4; Le et al., 
2009). Similar observations have previously been made by Nodwell and colleagues 
working on the control of efflux of actinorhodin, the blue-pigmented polyketide 
antibiotic made by S. coelicolor (Tahlan et al., 2007 and Hopwood, 2007). Expression of 
the actinorhodin efflux pump is regulated by the repressor ActR. The Nodwell 
laboratory showed that, in addition to the mature six-ring antibiotic, three-ring 
intermediates from the biosynthetic pathway also relieve repression of the actinorhodin 
efflux pump by ActR (Tahlan et al., 2007). These observations in the actinorhodin and 
simocyclinone systems raise the exciting possibility of a feed-forward mechanism, in 
which bio-inactive intermediates ensure expression of the efflux pump prior to the build-
up of a toxic concentration of the potentially lethal mature antibiotic (Tahlan et al., 
2007; Hopwood 2007; Le et al., 2009).  
 
As applied to simocyclinone (or actinorhodin) export, the feed-forward hypothesis is 
speculative. For a feed-forward mechanism to operate in the producing organism, SC4 
or other SimR-binding pathway intermediates would have to accumulate in the 
cytoplasm of S. antibioticus to a concentration high enough to trigger simX expression, 
and it is possible that pathway intermediates are channelled between biosynthetic 
enzymes such that their cytoplasmic concentration is zero and SimR is never exposed to 
them. However, the crystal structures of SimR, alone and in complex with SD8 or SC4 
(Chapter 5; Le et al., 2010) suggest a way to test the feed-forward hypothesis directly. 
Our structure of the repressor-ligand complex shows that the polyketide end of SD8 lies 
at the mouth of the drug-binding cavity whereas the aminocoumarin end lies at the far 
end of the cavity buried deep within the protein (Fig. 5.4A). It might therefore be 
possible to mutagenize SimR to occlude the aminocoumarin-binding pocket, creating 
SimR* proteins that can bind the intermediate SC4 (which lacks the aminocoumarin 
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ring) but cannot accept the mature antibiotic. These intermediate-specific SimR* 
proteins could then be used as biosensors in vivo to determine if SimR experiences 
pathway intermediates in the producing organism and hence to test the feed-forward 
hypothesis directly, and to answer a key question in antibiotic research - are biosynthetic 
intermediates released into the cytoplasm during antibiotic production? 
 
From the crystal structures of the SimR-SD8 and SimR-SC4 complexes, I identified the 
amino acids that delineate the aminocoumarin end of the simocyclinone binding pocket 
(Fig. 5.9). In an attempt to create SimR* proteins, I generated and purified the 19 mutant 
SimR proteins described in Table 7.1 and tested their ability to bind DNA, and to 
respond to SD8 and to the intermediate SC4. These amino acid substitutions caused a 
wide range of changes in the behaviour of SimR (Table 7.1). However, none of the 
mutant proteins showed the desired properties of a SimR* protein, i.e. the ability to bind 
cognate DNA with the same affinity as wild-type SimR, and the ability to respond to the 
intermediate SC4 but not to the mature antibiotic SD8. Therefore, I have not yet been 
able to test the "feed-forward" hypothesis in S. antibioticus.  
 
If suitable SimR* proteins are identified in the future, the next step would be to confirm 
the behavior of these mutant proteins in vivo. I would introduce the mutant simR alleles 
(on the integrative plasmid pMS82) into S. lividans carrying either a simRp-lux or 
simXp-lux reporter fusion promoter and then expose these strains to exogenously added 
intermediate C4 and to simocyclinone, as described for the wild-type simR allele in 
Chapter 4 and Le et al. (2009). Assuming the simR* alleles behaved appropriately in S. 
lividans, they could then be used to test the feed-forward hypothesis directly and to 
determine if the pathway intermediates exist freely in the cytoplasm of the producer, S. 
antibioticus, using the SimR* proteins as biosensors. To achieve this, PCR-targeting 
would be used to exactly replace the wild-type simR allele in S. antibioticus with the 
simR* allele that responds to SC4 but not SD8. The existing simRp-lux or simXp-lux 
reporter fusions would be introduced into these strains and the activity of the reporters 
would be monitored through a time-course during growth in production medium. In 
parallel, wild-type S. antibioticus containing the lux reporter fusions (and the wild-type  
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  +      Greater sensitivity to SD8 or SC4 than wild-type SimR 
WT    Wild-type behaviour 
  –       Decreased DNA-binding affinity relative to wild-type SimR 
ND    Not determined 
 
 
Table 7.1. Mutations of amino acids that delinate the simocyclinone binding pocket of 
SimR and their effect on DNA binding affinity, and on derepression by SD8 and SC4. 
 
 
 
 
 
 
 
 
 
 
Mutations 
DNA binding 
affinity 
Derepression by 
SD8 
Derepression by 
SC4 
 
K107A 
I83W 
T86W 
L88W 
H219A 
V139W 
Q135A/K/R 
Q136A 
Q136W 
L212A 
M189A 
A103F 
W128A 
L140A 
L154A 
Y160W 
Y160A 
K107R Q135E E165Q 
K107R Q135D E165Q 
 
WT 
WT 
– – 
WT 
WT 
WT 
WT 
WT 
– 
– – 
– – 
– – 
– – – 
– – 
– – 
WT 
unable to purify 
unable to purify 
unable to purify 
 
++ 
++ 
ND 
++ 
++ 
+ 
WT 
WT 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
 
 
++ 
+ 
ND 
+ 
++ 
+ 
WT 
WT 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
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simR allele) would be monitored as a control. If the lux reporters are induced 
(derepressed) only in the strain carrying wild-type SimR, it would show that only mature 
simocyclinone accumulates in the cytoplasm to a concentration sufficient to trigger 
expression of the efflux pump. In contrast, if the reporters are also induced in the 
presence of the intermediate-specific SimR proteins, it would show that C4 (or earlier 
intermediates) are released into the cytoplasm and that a feed-forward mechanism does 
occur in the producing organism. 
 
7.2 Is simX the simocyclinone resistance determinant in S. antibioticus? 
 
A remaining unresolved question is whether the efflux pump SimX is the resistance 
determinant to SD8 in the producing organism, S. antibioticus.  In the streptomycetes 
that produce the aminocoumarins novobiocin (Streptomyces sphaeroides), clorobiocin 
(Streptomyces roseochromogenes), and coumermycin A1 (Streptomyces rishiriensis), 
expression of an aminocoumarin-resistant GyrB
R
 gyrase subunit encoded within the 
biosynthetic gene cluster is turned on during antibiotic production, hence conferring 
resistance (Thiara and Cundliffe, 1988, 1989, 1993; Schmutz et al., 2003). The absence 
of an equivalent gyrB resistance gene in the simocyclinone biosynthetic gene cluster was 
initially a surprise when the sim locus was sequenced, until it was subsequently and 
unexpectedly shown that simocyclinone has a completely different mode of action, 
binding instead to the GyrA subunit of the enzyme (Flatman et al., 2005; Edwards et al., 
2009).  However, no gyrA resistance gene is present within the sim cluster either (Galm 
et al., 2002; Trefzer et al., 2002). Expressing simX from the strong, constitutive 
promoter, ermEp*, conferred simocyclinone resistance on the heterologous host S. 
lividans (MIC 65 μg/ml instead of 2 μg/ml for S. lividans alone), showing that SimX can 
act as an effective resistance determinant when expressed at appropriate levels. However, 
the MIC was only 4 μg/ml when simX was expressed from its own promoter in the 
absence of SimR. This could reflect additional levels of simX regulation that have yet to 
be uncovered. For example, in addition to its repression by SimR, it is possible that simX 
expression in S. antibioticus might also be activated by a simocyclinone pathway-
specific activator that is absent from S. lividans (e.g. SimR2, see below).  
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Based on precedent, resistance genes seem invariably to be associated with the 
biosynthetic gene cluster in antibiotic-producing streptomycetes. However, one other 
possibility I considered was that the DNA gyrase of S. antibioticus might be innately 
insensitive to SD8, such that the antibiotic has no target in the producing organism. To 
begin to address this possibility, I have isolated the S. antibioticus gyr genes. The 
genome of S. antibioticus has not been sequenced, and so I employed ligation-mediated 
PCR to clone the native gyrA and gyrB genes from S. antibioticus, and then determine 
their sequence. The cloning of these genes will allow me to use genetic and biochemical 
methods to determine whether S. antibioticus DNA gyrase is sensitive to SD8.   
 
7.3 Other transcriptional regulators encoded in the simocyclinone biosynthetic 
cluster, SimR2 and SimR3 
 
Encoded within the simocyclinone biosynthetic cluster are two additional transcriptional 
regulators, SimR2 and SimR3 (Fig. 1.8). Investigating the roles of SimR2 and SimR3 
would reveal whether they also regulate simX, and thus have a potential role in SD8 
resistance. Moreover, such research can shed light on the interplay between the three 
transcription regulators within the sim cluster in integrating and coordinating the 
biosynthesis of a complex antibiotic. 
 
simR2 encodes a so-called atypical response regulator (ARR). In bacteria, some response 
regulators lack the conserved residues important for the phosphorylation that causes 
typical response regulators to switch their output response, suggesting their activity may 
be controlled by alternative regulatory mechanisms (Aínsa et al., 1999; Guthrie et al., 
1998; Wang et al., 2009).  ARRs are found in a wide range of bacteria and are involved 
in the regulation of bacterial growth and development, secondary metabolite 
biosynthesis, iron transport, cell movement, and virulence (Raghavan and Groisman, 
2010). Several ARRs have been shown to play key roles in Streptomyces biology, for 
example WhiI is required for differentiation in S. coelicolor (Aínsa et al., 1999), RedZ is 
required for production of the antibiotic undecylprodigionine in S. coelicolor (Guthrie et 
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al., 1998) and JadR1 is required for production of the antibiotic jadomycin in S. 
venezuelae (Wang et al., 2009). All three of these proteins have degenerate 
phosphorylation pockets and RedZ actually carries a valine in place of the aspartate 
residue that is normally the site of phosphorylation (Guthrie et al., 1998). Finally, all 
these ARRs are ‘orphan’ RRs – they are not genetically linked to a sensor kinase gene, 
as is most usually the case with typical response regulators. These data suggest that 
ARRs are likely to respond to some other input, but until recently the nature of that input 
had not been demonstrated. Wang et al. (2009) recently showed that JadR1 is a 
transcriptional activator of certain promoters in the jadomycin biosynthetic cluster and 
that the binding of jadomycin to the N-terminal domain (the domain normally subject to 
phosphorylation in conventional RRs) causes JadR1 to dissociate from its target 
promoters. Similarly, they showed that the ARR RedZ directly activates transcription of 
at least one promoter (redDp) in the undecylprodigionine biosynthetic gene cluster and 
that binding of undecylprodigionine to RedZ causes it to dissociate from its target 
(Wang et al., 2009). These results provide a mechanism for autoregulation of antibiotic 
biosynthesis by binding of the end product to an ARR.  Strikingly, the ARR SimR2 is 
the closest homologue of JadR1 in the databases (42% sequence identity), raising the 
likelihood that its activity will be controlled by simocyclinone and/or its biosynthetic 
intermediates.  
 
The third transcription factor encoded within the sim cluster, SimR3, is a member of the 
MarR family of ligand-responsive transcriptional regulators (Wilkinson and Grove, 
2006). Most members of the MarR family function as repressors that lose their affinity 
for their DNA binding sites in response to their cognate ligand (Wilkinson and Grove, 
2006; Perera et al., 2009), but at least some members of the family mediate 
transcriptional activation in response to ligand (Zhao et al., 2008). The presence of a 
gene encoding a MarR family member within the sim cluster suggests that it will control 
expression of one or more promoters in the cluster and that its activity will in turn be 
regulated by a small molecule effector ligand. Most MarR proteins bind negatively 
charged phenolic compounds (Wilkinson and Grove, 2006). If this were true of SimR3, 
then a likely candidate for its cognate effector ligand would be one or more of the 
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anionic phenolic intermediates in the pathway that generates the aminocoumarin moiety 
of simocyclinone.   
 
I have constructed null mutations in each of simR, simR2 and simR3 in S. antibioticus. 
We also have a mini-array, suitable for both transcriptional profiling and ChIP-on-chip, 
covering the sim biosynthetic cluster and sequenced flanking DNA (~84 kb in total). We 
aim to use this mini-array to examine expression of each gene in the sim biosynthetic 
cluster in the wild type and in the constructed simR2 and simR3 null mutants in a time 
course during growth in production medium. In addition, we also have polyclonal 
antibodies against both regulators and aim to use these antisera to perform time-resolved 
ChIP-chip experiments on S. antibioticus grown in production medium, taking samples 
before, during and after antibiotic production phase, to define which promoters within 
the cluster are bound in vivo by each regulator and when. These experiments will reveal 
whether simX is also regulated by SimR2 or SimR3.  
 
An additional experiment to address whether simX functions as the simocyclinone 
resistance determinant would be to introduce simR2 (and/or simR3) into the S. lividans 
strain already carrying simX-simR.  If simX is subject to activation by SimR2 (ARR 
family), as well as repression by SimR, then such a strain should exhibit high-level 
resistance to SD8. 
 
I have already overexpressed SimR2 and SimR3 in E. coli in soluble forms. Following 
on from the ChIP-chip and transcriptional profiling experiments, we will use the purified 
proteins for in vitro studies. We will PCR amplify target promoters identified in the sim 
cluster, radiolabel them, and use EMSA and DNaseI footprinting to confirm which 
promoters within the sim cluster are direct regulatory targets for SimR2 and SimR3. 
Once these in vitro assays are established, EMSA experiments will be performed in the 
presence of simocyclinone and various simocyclinone intermediates to determine if the 
DNA-binding activities of SimR2 (ARR family) and SimR3 (ligand-responsive MarR 
family) are controlled by the mature antibiotic and/or pathway intermediates. Most 
MarR proteins bind anionic phenolic compounds (Wilkinson and Grove, 2006). As a 
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consequence, we will initially test anionic phenolic intermediates from the 
aminocoumarin pathway as effector ligands for SimR3, before testing intermediates 
from other parts of the simocyclinone pathway.  
 
Such research has the potential to examine how metabolite signalling within the 
simocyclinone pathway coordinates and integrates expression of the ~50 proteins 
involved in the biosynthesis of the mature antibiotic. Since there is now strong evidence 
that these metabolite signalling mechanisms are likely to be widespread within 
streptomycete antibiotic biosynthetic pathways, these results could even prove relevant 
to knowledge-based improvements in the yield of commercially important antibiotics.  
 
7.4 Engineering the simocyclinone biosynthetic cluster to create novel antibiotics 
 
Although the SD8-producing organism, S. antibioticus, can be manipulated genetically 
(Galm et al., 2002; Trefzer et al., 2002), it is very unattractive as a genetic system. As a 
consequence, although the ~84-kb gene cluster responsible for the biosynthesis of 
simocyclinone has been sequenced, it has not been realistic to engineer the cluster in the 
producing organism.  Therefore, in order to efficiently investigate the roles of the 
biosynthetic genes within the sim cluster, we need to heterologously express the sim 
cluster in an experimentally convenient model Streptomyces species, such as S. lividans, 
S. coelicolor or Streptomyces venezuelae.  
 
The sim cluster was originally isolated on a series of overlapping cosmid clones (Galm 
et al., 2002; Trefzer et al., 2002), but it would be technically extremely difficult to 
reconstruct the entire sim cluster as a single contiguous clone from these original 
cosmids. To circumvent this problem, we commissioned BioS+T (Montreal, Canada) to 
construct a library of S. antibioticus DNA in the E. coli-Streptomyces shuttle PAC vector, 
pESAC-13 (a derivative of pPAC-S1; Sosio et al., 2000), which accepts insets of up to 
~150 kb. From this library we have identified 8 clones that carry the entire sim cluster. 
These PAC constructs will be introduced into e.g. S. lividans by conjugation and the 
resulting strains will be assayed for their ability to make simocyclinones. If the sim 
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cluster is expressed in a heterologous host, it will mean that we can now genetically 
manipulate the cluster at will in E. coli (using, for example, Lambda-Red PCR-targeting; 
see Chapter 2 for more detail on the method) and then conjugate it into e.g. S. lividans to 
see what products are made.  
 
It is interesting to uncover novel chemistry and to be able to rationally engineer existing 
antibiotics to improve their potency or to overcome resistance. The biosynthesis of 
simocyclinone implies the existence of novel chemistry. For example, the modular 
polyketide synthase (PKS) responsible for assembly of the tetraene dicarboxylic linker 
for the aminocoumarin and angucycline "warheads" that bind synergistically to gyrase is 
unusual in that several domains expected to be required for tetraene assembly appear to 
be absent. Specifically, dehydratase (DH) domains are missing from modules 2 and 4 
and a ketroreductase (KR) domain is missing from module 2 of the PKS (Fig. 1.9). It has 
been proposed by Trefzer et al. (2002) that these missing catalytic activities are supplied 
to the PKS in trans by the SimC6 and SimC7 proteins (Fig. 1.9). The role of these 
proteins in tetraene assembly could be examined by creating in-frame deletions in the 
genes encoding them (simC6 and simC7) and investigating their effect on SD8 
production. Depending on the specificity of downstream enzymes in the biosynthetic 
pathway, the mutants may produce analogues of SD8 with an altered dicarboxylic acid 
linker or simocyclinone production may be abolished and the isolated aminocoumarin 
and angucycline moieties may accumulate instead.  
 
The crystal structure of DNA gyrase-SD8 showed the antibiotic crosslinking the AC and 
PK pockets of separate GyrA subunits (Edwards et al., 2009; Fig. 1.10). However, 
modelling and analytical ultracentrifugation data presented by Edwards et al. (2009) 
suggest that a single simocyclinone molecule in a ‘strained’ or ‘bent’ conformation can 
bridge between the AC and PK pockets within the same GyrA subunit. This ‘bent’ 
conformation might occur more readily if the conjugated system of double bonds in the 
tetraene linker was disrupted, thereby making simocyclinone more flexible and, 
potentially at least, a more potent DNA gyrase inhibitor. Therefore, in addition to the 
simC6 and simC7 mutagenesis experiments described above, it would also be interesting 
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to prevent tetraene (2,4,6,8-Decatetraenoyl) chain assembly altogether by deleting the 
simC1ABC Type I polyketide synthase genes, and then trying to make novel derivatives 
of simocyclinone by ‘mutasynthesis.’ In this approach, chemically synthesised tetraene 
substrate analogues, e.g. 2,4,6,8-Decatetraenoyl and 2,4,6-Octatrienoyl N-
acetylcysteamine thioesters, would be fed to the simC1ABC mutant. Again, depending 
on the specificity of downstream enzymes in the biosynthetic pathway, this 
mutasynthetic approach may produce analogues of SD8 with an altered dicarboxylic 
acid linker. 
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the canonical TnaC sequence, indicating that even
residues unrelated to the stalling process can adopt
a distinct conformation within the exit tunnel. This
notion is supported by a cryo-EM structure of a
yeast 80S ribosome-nascent chain complex stalled
during the translation of a truncated dipeptidyl-
aminopeptidase B (DP120) mRNA at 6.1 Å res-
olution (27). Although the DP120 sequence
has no stalling capacity, density for this nascent
chain is visible, indicating a preferred conforma-
tion within the exit tunnel (Fig. 4D). Notably, the
DP120 nascent chain follows a different path
from that reported here for TnaC (Fig. 4, E and
F). Clearly the chemical and electrostatic properties
of the tunnel environment play a pivotal role in
facilitating this kind of distinct nascent chain
behavior (3, 4). The finding that nascent chains
with little or no sequence conservation interact
with the exit tunnel in a distinct manner and adopt
individual conformations may be important not
only for initial folding events (1–3) but also for
the variety of nascent chain–mediated regulatory
mechanisms (5).
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A Crystal Structure of the
Bifunctional Antibiotic Simocyclinone
D8, Bound to DNA Gyrase
Marcus J. Edwards,1 Ruth H. Flatman,1 Lesley A. Mitchenall,1 Clare E.M. Stevenson,1
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David M. Lawson,1 Anthony Maxwell1*
Simocyclinones are bifunctional antibiotics that inhibit bacterial DNA gyrase by preventing
DNA binding to the enzyme. We report the crystal structure of the complex formed between the
N-terminal domain of the Escherichia coli gyrase A subunit and simocyclinone D8, revealing two
binding pockets that separately accommodate the aminocoumarin and polyketide moieties of the
antibiotic. These are close to, but distinct from, the quinolone-binding site, consistent with our
observations that several mutations in this region confer resistance to both agents. Biochemical
studies show that the individual moieties of simocyclinone D8 are comparatively weak inhibitors of
gyrase relative to the parent compound, but their combination generates a more potent inhibitor. Our
results should facilitate the design of drug molecules that target these unexploited binding pockets.
Bacterial diseases remain a major problembecause of the emergence of drug-resistantbacteria combined with the dearth of new
antibacterial agents. Despite extensive efforts, there
remain relatively few effective drug targets for
antibacterials. One of these is the enzyme DNA
gyrase, a DNA topoisomerase that controls the
topology of DNA (1, 2). Topoisomerases are
classified into two types, I and II, depending on
whether they catalyze reactions involving the tran-
sient breakage of one or both strands of DNA.
Gyrase is the only type II DNA topoisomerase
that can catalyze DNA supercoiling; this reaction
is driven by the free energy of adenosine triphos-
phate (ATP) hydrolysis (3). Gyrase consists of
two subunits, GyrA and GyrB (97 kD and 90 kD,
respectively, in Escherichia coli), which form
an A2B2 complex in the active enzyme. Because
gyrase is essential in bacteria and lacking in hu-
mans, it is a valuable drug target (4). The com-
plexity of the gyrase supercoiling reaction presents
multiple opportunities for intervention. Two well-
known groups of gyrase-specific antibacterial
agents are quinolones and aminocoumarins. Fluo-
roquinolones, such as ciprofloxacin, are highly
successful drugs (5), but their usefulness is di-
minishing as a consequence of bacterial resist-
ance (6). Aminocoumarins, e.g., novobiocin and
clorobiocin, are less successful clinically because
of toxicity and solubility issues but are very well
characterized in terms of their mode of action on
gyrase (7), including several crystal structures
(8–11). Aminocoumarins act by competitively
inhibiting the binding of ATP to theGyrB subunit
(11). The cloning and sequencing of the biosyn-
thetic pathways for the aminocoumarins novobi-
ocin, clorobiocin, and coumermycin A1 and the
application of bioengineering methodologies
(12) have enabled the production of a series of
modified aminocoumarins with varying potencies
against their targets, gyrase and topoisomerase IV
(13, 14). This work has raised the possibility of
engineering antibacterial agents targeted to gyrase
that are based on natural antibiotics.
Simocyclinone D8 (SD8) was isolated from
Streptomyces antibioticus Tü 6040 (15–18). The
antibiotic consists of a chlorinated aminocoumarin
(AC) linked to an angucyclic polyketide (PK) via
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a tetraene linker and a D-olivose sugar (Fig. 1).
Because of the presence of the AC moiety, the
expectation was that SD8 would target the aden-
osine triphosphatase (ATPase) domain of GyrB.
Although SD8 is a potent inhibitor of E. coli
gyrase, it does not inhibit the intrinsicGyrBATPase
activity. Instead, SD8 binds to the N-terminal do-
main of GyrA and prevents DNA binding (19).
In hindsight, this is not surprising because SD8
lacks the decorated noviose sugar that is attached
to the 7-OH of the AC ring and is involved in the
majority of the interactions with GyrB in other
aminocoumarins (8–11). In contrast to quinolones
and aminocoumarins,which can act on both gyrase
and its close relative topoisomerase IV, SD8 is
potent against gyrases from E. coli and Staphy-
lococcus aureus but much less effective against
topoisomerase IV from these species (20).
We have crystallized the N-terminal domain
of GyrA (GyrA59) complexed with SD8 and de-
termined the crystal structure at 2.6-Å resolution
by molecular replacement from the structure of
unliganded GyrA59 that was previously deter-
mined (21). Our structure reveals a ligand-stabilized
homotetramer of GyrA59 subunits consisting of
two A59 dimers cross-linked by four molecules
of SD8 (Fig. 2). The tetraene linker of SD8 acts
as an extended rod, about 10 Å long, that holds
the AC and PK moieties apart. Each GyrA sub-
unit has distinct pockets that accept the AC and
PK groups, respectively, of two separate SD8
molecules; both pockets lie in the predicted DNA
binding saddle. Additional lobes of electron den-
sity adjacent to the PKmoiety have beenmodeled
as Mg2+ ions (Fig. 3A and fig. S1). Although
each subunit interacts with two SD8 molecules,
because each of these molecules is shared by two
subunits from opposing dimers, the stoichiome-
try remains 1:1, consistent with previous exper-
iments (19). In addition to the SD8-mediated
dimer-dimer interactions, there is about 1500 Å2
of protein-protein interface. This includes 12 hy-
drogen bonds, 10 of which involve residues span-
ning Leu17 to Asp23, a region just before a-helix
1 that was not visible in the original GyrA59
structure (21). Superposition of the SD8 complex
and ligand-free GyrA59 structures gives root
mean square deviation values below 1Å, both for
Fig. 1. Structure of simocyclinone D8 and analogs. IC50 values for inhibition of supercoiling by gyrase:
for D8, 0.6 mM; C4, 70 mM; MGD8N2A, 50 mM.
Fig. 2. Crystal structure of theGyrA59-simocyclinone
complex. The protein is depicted in cartoon rep-
resentation, the SD8 molecules are shown as red
sticks, and their associated Mg2+ ions as small
spheres. (A) Structure of the GyrA59 dimer and the
four SD8 molecules it interacts with. (B) Structure
of the SD8-mediated tetramer (dimer of dimers).
(C) Close-up of the red boxed region in (B) showing
a section through the complex containing two SD8
molecules. The same color scheme is adopted as for
(A) and (B), but the GyrA59 subunits are represented
as semi-transparent molecular surfaces. Regions with
a white background are either outside the complex
or between the subunits; regions with a gray back-
ground are within the molecular envelopes. Key res-
idues (23) that are close to the SD8 molecule in the
foreground are displayed in stick representation.
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subunit-subunit and dimer-dimer comparisons,
indicating that there are no major conformational
changes upon ligand binding (fig. S2). Intrigu-
ingly, a single SD8 molecule can be modeled
in a “bent” conformation such that it bridges
between the AC and PK pockets of the same
subunit, while maintaining essentially the same
contacts with the protein seen in the crystal struc-
ture (fig. S3). This places the tetraene linker close
to, and possibly interacting with, a-helix 4.
To investigate the oligomeric state in solution,
we performed a series of molecular weight (MW)
studies. Analytical ultracentrifugation (table S2)
showed that theMWofGyrA59 in the absence of
SD8 or at low ligand:protein ratios (<~3:1) was
~120 kD, suggesting a dimer, whereas at high
ligand:protein ratios (>~4:1) GyrA59 had a MW
of ~250 kD, consistent with a tetramer. By using
nanoelectrospray ionization mass spectrometry
(nanoESI MS) under conditions where noncova-
lent interactions are preserved, we assessed the
binding of SD8 to GyrA59 and full-length GyrA.
In the absence of SD8, both proteins had MWs
consistent with dimers (fig. S4). Titration of SD8
into solutions containing the proteins showed di-
meric species with either one or two SD8 mole-
cules bound at ligand:protein ratios of <~2:1.
With a ligand:protein ratio of 3:1, we began to see
formation of a tetrameric species, which increased
with increasing SD8 concentrations to become the
predominant species at ~7.5:1 (fig. S4). These
experiments showed small amounts of three SD8
molecules bound per dimer but no evidence of
four, suggesting that a tetramer readily forms once
four molecules are bound (fig. S4). We suggest
that the dimeric species, observed at limiting lig-
and concentrations, might represent a single SD8
molecule bound to the AC and PK pockets within
the same subunit (fig. S3).
To probe the importance of the two binding
pockets, we analyzed the interactions of GyrA59
with simocyclinone analogs lacking either the PK
or the AC moiety (Fig. 1). Simocyclinone C4 is a
naturally occurring intermediate in the SD8 path-
way that lacks theACmoiety;MGD8N2A,which
lacks the PK moiety, was generated by chemical
hydrolysis of SD8. The parent compound has a
minimum inhibitory concentration (IC50) value
of 0.6 mM for inhibition of gyrase supercoiling,
whereas IC50 values of 70 and 50 mM were ob-
tained for analogs lacking either the AC or the PK
moiety, respectively (Fig. 1). Although inhibition is
greatly reduced, the fact that these SD8 analogs
have some activity suggests that cross-linking of the
twoGyrAdimers is not a prerequisite for inhibition.
One key issue was to establish the in vivo
target of simocyclinones; recent transcriptional
profiling studies (20) suggest but do not prove
that gyrase is the target. To address this, we se-
lected spontaneous resistant mutants in E. coli.
Wild-type E. coli and other Gram-negative bacte-
ria are resistant to simocyclinones because the
compounds cannot penetrate the outer membrane
(15); we therefore used an E. coli strain (NR698)
that is sensitive because it carries an in-frame de-
Fig. 3. Binding of SD8 to GyrA. (A) Simulated annealing omit electron density map for SD8
contoured at 6 s and superposed on the final coordinates of the ligand (27). (B) Schematic figure
detailing protein-ligand interactions in the GyrA59-SD8 complex. Red dotted lines represent
hydrogen bonds and the single halogen bond (indicated by yellow arrow; see fig. S1). Interactions
with the Mg2+ ions are shown as pale blue dashed lines. The side chains of Arg121 and Tyr122 (in
the active site) point toward the SD8 molecule across the dimer interface and could interact with it
via water molecules (blue shaded circles labeled “W”) coordinated to a Mg2+ ion. Similarly, His80
likely makes a water-mediated interaction with the second Mg2+ ion. Nonbonded interactions are
represented by the linked green ovals, which encircle the groups involved; subunit boundaries are
delineated by gray lines.
Table 1. Properties of simocyclinone- and quinolone-resistant GyrA mutants. NA indicates not
applicable. Mutant H78A is not active; KD for simocyclinone is ~10 times that of wild type. S83W
data is from (19).
GyrA mutation Relative IC50 (supercoiling)
Simocyclinone Ciprofloxacin
Wild type 1 (0.6 mM)* 1 (0.7 mM)*
Mutations in the simocyclinone-binding site
Aminocoumarin-binding pocket mutations
H45A 9.1 2.2
R91A 20 1.1
Polyketide-binding pocket mutations
H78A NA NA
H80A 230 2.8
Mutations in both pockets
H45A and H80A >500 2.3
Mutations in the quinolone-resistance–determining region of GyrA
G81D 40 24
S83W 10 30
A84P 38 28
D87A 7.2 5.2
D87Y 57 30
S83A and D87A 8.3 12
*Actual IC50 values are given in parentheses.
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letion in the imp (increased membrane perme-
ability) gene (22). We isolated 31 spontaneous
simocyclinone-resistant mutants and in each case
sequenced a ~500–base pair (bp) region of gyrA,
corresponding to residues Met26 to Ser172 of the
protein. We found gyrAmutations in 22 of them,
conferring one of the following amino acid
changes: V44→G44 (V44G) (23), H45Y, H45Q,
G81S, andD87Y (fig. S5). These amino acids are
close to the bound SD8 molecule in the crystal
structure, consistent with gyrase being the in vivo
target. Unlike the 22 gyrAmutants, the remaining
nine isolates had also acquired resistance to bile
salts, suggesting that they could be accounted for
by spontaneous second-site mutations that are
known to restore outer membrane impermeability
to the imp mutant (22).
On the basis of the spontaneous mutations
and the crystal structure information, we made
selected site-directed mutations in GyrA to probe
its interaction with SD8 in vitro. The mutant
proteins, together with wild-type GyrB, were
assayed for DNA supercoiling in the presence of
SD8 (Table 1). Mutations in either the AC (His45
and Arg91) or the PK (His80 and Gly81) pocket
showed simocyclinone-resistant supercoiling. SD8
binding to an inactive mutant in the PK pocket,
H78A (23), was investigated by surface-plasmon
resonance using the GyrA59 protein. The mutant
showed decreased binding affinity for SD8 (KD
values were 1.3 mM for wild type and 10.4 mM
for H78A) and had a near-identical far-ultraviolet
circular dichroism spectrum to wild-type GyrA,
suggesting that it was properly folded.
Quinolone-resistant mutationsmap to both gyrA
and gyrB in regions known as the quinolone-
resistance determining regions [QRDRs (24, 25)].
In the case of E. coli GyrA, the QRDR occurs
between amino acids 67 and 106 with mutations
identified at Ala67, Gly81, Asp82, Ser83, Ala84,
Asp87, and Gln106 (26), mostly occurring either
in or just before a-helix 4 (21) (fig. S5). From the
published structures of quinolone-DNA cleavage
complexes of Streptococcus pneumoniae topo IV
(27), we can infer the location of the quinolone-
binding site in GyrA, which is adjacent to but not
overlapping the SD8 binding sites (Fig. 4). The
quinolones do not make substantive contacts with
the topo IV ParC protein, being closest to the
equivalents of residues Gly81 to Ala84 and Asp87
in GyrA. Therefore, at least some of the muta-
tions in the QRDR of GyrA most likely have
indirect effects on quinolone binding. Given the
proximity of the quinolone and SD8 binding
sites, we investigatedwhether there was any cross-
resistance between the two types of inhibitor. SD8-
resistant mutants were tested for their susceptibility
to the fluoroquinolone ciprofloxacin, and a range
of ciprofloxacin-resistant mutants were tested for
their susceptibility to SD8 (Table 1).
Mutations in the simocyclinone-binding pockets
(AC and PK) result in near–wild-type amounts of
susceptibility to ciprofloxacin (Table 1); QRDR
mutations in a-helix 4 of GyrA confer increased
resistance to both ciprofloxacin and SD8. None
of these amino acids makes direct contacts with
bound SD8 (Fig. 3B); given the low resolution of
the quinolone-DNA-topo IV complex structures,
it is not possible to precisely define any ligand-
protein interactions, but it is likely that substitutions
at positions 81 to 84 and 87 inGyrAwould have an
effect on drug binding. The prevalence ofmutations
at Ser83 and Asp87 in quinolone-resistant clinical
isolates supports this assertion (26). In the case of
SD8, it is possible that mutations in a-helix 4 of
GyrA, which lies between the AC and PK bind-
ing pockets, can affect the proposed bridging of the
two binding sites by the tetraene linker (fig. S3).
Given the global concerns over drug-resistant
bacterial diseases, work on SD8 raises the pros-
pect of developing agents that exploit its bifunc-
tionalmode of antibiotic action on awell-validated
target. Alternatively, designing monofunctional
compounds with enhanced affinity for one or the
other of the binding sites may prove fruitful.
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Fig. 4. Stereo view showing a superposition of GyrA59-SD8 and the clinafloxacin-DNA cleavage complex
of topo IV [Protein Data Bank (PDB) code 3FOE], focusing on the drug-binding sites in one half of the
GyrA/ParC dimers (28). The protein backbones are shown as ribbons and the drug molecules in stick
representation, with GyrA59-SD8 in red, ParC-clinafloxacin in green, and the DNA from the latter
structure in yellow. For clarity, the ParE subunits have been omitted from 3FOE. The SD8 and clinafloxacin
binding sites are adjacent but do not overlap. This figure illustrates how SD8 would interfere with DNA
binding; this would also be the case if the drug were bound in the “bent-over” conformation proposed in
fig. S3. The arrow indicates the position of a-helix 4.
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Summary
Because most antibiotics are potentially lethal to the
producing organism, there must be mechanisms to
ensure that the machinery responsible for export of
the mature antibiotic is in place at the time of
biosynthesis. Simocyclinone D8 is a potent DNA
gyrase inhibitor produced by Streptomyces antibioti-
cus Tü 6040. Within the simocyclinone biosynthetic
cluster are two divergently transcribed genes, simR
and simX, encoding proteins that resemble the
TetR/TetA repressor–efflux pump pair that cause
widespread resistance to clinically important
tetracyclines. Engineered expression of simX from a
strong, heterologous promoter conferred high level
simocyclinone D8 resistance on Streptomyces liv-
idans, showing that simX encodes a simocyclinone
efflux pump. Transcription of simX is controlled by
SimR, which directly represses the simX and simR
promoters by binding to two operator sites in the
simX–simR intergenic region. Simocyclinone D8 abol-
ishes DNA binding by SimR, providing a mechanism
that couples the biosynthesis of simocyclinone to its
export. In addition, an intermediate in the biosynthetic
pathway, simocyclinone C4, which is essentially inac-
tive as a DNA gyrase inhibitor, also induces simX
expression in vivo and relieves simX repression by
SimR in vitro.
Introduction
Aminocoumarin antibiotics are active against Gram-
positive bacteria and function principally by inhibiting DNA
gyrase (Maxwell and Lawson, 2003), an essential DNA
topoisomerase found in all bacteria, which catalyses DNA
supercoiling (Nollmann et al., 2007). In addition, a likely
secondary target of these compounds is topoisomerase
IV, which is involved in chromosome decatenation (Hardy
and Cozzarelli, 2003; Oppegard et al., 2009). All four
known aminocoumarins are produced by Streptomyces
species. The first three to be discovered, novobiocin, clo-
robiocin and coumermycin A1, each competitively inhibit
the ATPase activity of the GyrB subunit of DNA gyrase
and exhibit Ki values in the nanomolar range (Gormley
et al., 1996). The most recently identified aminocoumarin
antibiotic, simocyclinone D8 (Schimana et al., 2000)
(Fig. 1), also inhibits DNA gyrase but was unexpectedly
found to have a completely novel mode of action, binding
instead to the GyrA subunit of the enzyme and preventing
its binding to DNA (Flatman et al., 2005; M.J. Edwards
et al., unpubl. data). Simocyclinone D8 is a potent inhibitor
of DNA gyrase supercoiling with an IC50 lower than that of
novobiocin (Flatman et al., 2005; Oppegard et al., 2009).
The genus Streptomyces accounts for the production of
approximately two-thirds of the known antibiotics. They
expel these compounds into their environment, typically
the soil, most probably to give them a competitive advan-
tage over other organisms that share the same ecological
niche. Because the antibiotic is often potentially lethal to
the producing organism, there must be mechanisms to
ensure that the machinery responsible for export of the
mature antibiotic is in place at the time of biosynthesis.
This export machinery may be sufficient to confer resis-
tance to the antibiotic, or there may be additional resis-
tance mechanisms. For example, in the case of the
novobiocin, clorobiocin and coumermycin A1 producers,
the principal mechanism of resistance is production of an
aminocoumarin-resistant GyrB subunit (GyrBR), encoded
within the biosynthetic cluster and activated during antibi-
otic production (Thiara and Cundliffe, 1988; 1989; 1993;
Schmutz et al., 2003). The GyrBR subunit replaces the
sensitive subunit (GyrBs) in the (GyrA)2(GyrB)2 heterotet-
ramer during the production phase. In addition, an
aminocoumarin-resistant topoisomerase IV subunit,
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ParYR, encoded within the clorobiocin and coumermycin
A1 biosynthetic clusters (but not the novobiocin biosyn-
thetic cluster), also confers resistance to these antibiotics
when introduced into a naïve host, presumably by an
analogous mechanism (Schmutz et al., 2003). However,
no DNA gyrase or topoisomerase IV subunits are
encoded within the simocyclinone D8 (sim) biosynthetic
cluster (Galm et al., 2002; Trefzer et al., 2002), leaving
unknown the mechanism of resistance in the producing
organism, Streptomyces antibioticus Tü 6040.
Simocyclinone D8 consists of four different parts, with a
halogenated aminocoumarin at one end connected to an
angucyclic polyketide at the other end via a tetraene linker
and a D-olivose sugar (Galm et al., 2002; Trefzer et al.,
2002) (Fig. 1). Within the sim cluster, among the genes
responsible for the biosynthesis and linking of the four
constituents of the antibiotic, are two divergently tran-
scribed genes, simR2 (hereafter, simR) and simEX1 (here-
after, simX) (Galm et al., 2002; Trefzer et al., 2002). The
SimR/SimX pair resembles the TetR/TetA repressor–efflux
pump pair that causes widespread resistance to clinically
important tetracyclines in several human pathogens
(Chopra and Roberts, 2001). TetR represses transcription
of the divergently transcribed tetA gene, encoding a
proton-dependent tetracycline efflux pump. Binding of tet-
racycline to the C-terminal domain of TetR causes it to lose
affinity for its operators, derepressing expression of tetA,
which confers high-level resistance to the drug (Hillen and
Berens, 1994; Kisker et al., 1995; Orth et al., 2000; Ramos
et al., 2005). The similarity of SimR/SimX to TetR/TetA
suggested they might be involved in simocyclinone efflux
and, potentially, in simocyclinone resistance (Galm et al.,
2002; Trefzer et al., 2002).
Here we show that simX encodes a simocyclinone
efflux pump, and that transcription of simX is controlled by
SimR, which directly represses the simX and simR pro-
moters by binding to two operator sites in the simR–simX
intergenic region. We show that simocyclinone D8 abol-
ishes DNA binding by SimR, providing an intimate mecha-
nism that couples the biosynthesis of simocyclinone to its
export. In addition, we show that an intermediate in the
biosynthetic pathway, simocyclinone C4 (Fig. 1), which
is essentially inactive as a DNA gyrase inhibitor, also
induces simX expression in vivo and relieves DNA binding
by SimR in vitro, suggesting a potential ‘feed-forward’
mechanism (Tahlan et al., 2007) that might ensure
expression of the SimX efflux pump prior to the build-up of
a toxic concentration of the mature, active antibiotic.
Results
SimX encodes a simocyclinone efflux pump
There are two pump-like transmembrane proteins
encoded in the sim cluster, SimEX1 (hereafter SimX) and
SimEX2 (Trefzer et al., 2002). To determine if either of
these two proteins is involved in simocyclinone D8 efflux,
we expressed simX and simEX2 from the strong consti-
tutive promoter ermEp* using the integrative, single-copy
vector pIJ10257 (Hong et al., 2005). We introduced these
constructs into the heterologous host S. lividans and com-
pared the susceptibility of the resulting strains to simocy-
clinone D8. The strain carrying ermEp*–simEX2 had an
MIC of 2 mg ml-1, as did S. lividans alone, or S. lividans
containing the parent vector, pIJ10257. In contrast, the
strain carrying the ermEp*–simX construct had an MIC of
Fig. 1. Structures of simocyclinone D8 and its biosynthetic intermediate, simocyclinone C4, and their IC50s for Escherichia coli DNA gyrase.
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65 mg ml-1. The ermEp*–simX construct did not confer
resistance to the structurally related aminocoumarin DNA
gyrase inhibitor novobiocin, nor to unrelated antibiotics
such as erythromycin, lincomycin, rifampicin, bacitracin
and nisin. These results suggested that simX encodes a
simocyclinone-specific efflux pump. Adjacent to simX is
the divergent gene simR, encoding a potential transcrip-
tional repressor of simX. We also cloned simX into an
integrative vector under the control of its native promoter
and in the absence of simR. This construct (pIJ10461)
only mildly enhanced resistance to simocyclinone D8 in
S. lividans, giving an MIC of 4 mg ml-1.
Mapping the transcription start points of simR and simX
High-resolution S1 nuclease mapping of the simR and
simX promoters was performed using RNA isolated from
the simocyclinone D8 producing organism, S. antibioticus
Tü 6040 (Fig. 2A). A single simR promoter (simRp) was
identified, initiating transcription 20 bp upstream of the
simR ATG start codon, and a single simX promoter
(simXp) was identified, initiating transcription 47 bp
upstream of the simX ATG start codon (Fig. 2A and 3). In
vitro run-off transcription experiments with purified
S. coelicolor RNA polymerase confirmed the presence
and locations of the simR and simX promoters (Fig. 2B).
SimR regulates expression of simR and simX
To investigate the regulation of simR and simX, we mea-
sured simR and simX promoter activities in the presence
and absence of SimR, using the integrative luciferase
(luxAB) reporter plasmid pIJ5972 (Aigle et al., 2000;
M. Paget, pers. comm.). Fragments carrying simRp
and simXp were individually cloned into pIJ5972, and
the resulting reporter constructs were introduced into
Fig. 2. A. High-resolution S1 nuclease mapping of the 5′ ends of the simR and simX transcripts using PCR-generated probes and RNA from
the simocyclinone D8 producing organism, S. antibioticus Tü 6040. The most likely transcription start points are indicated by the asterisks. The
G+A Maxam–Gilbert chemical sequencing ladder was generated using the same probe as the one used for S1 nuclease mapping assays.
The size markers are a radiolabelled HinfI digest of FX174 DNA.
B. Run-off transcription from the simR and simX promoters in vitro using purified S. coelicolor RNA polymerase and the templates illustrated
containing the simR–simX intergenic region. Lane numbers correspond to the different templates shown in the illustration below.
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S. lividans in order to probe simR and simX promoter
activities in the absence of SimR. To measure simR and
simX promoter activities in the presence SimR, an inte-
grative plasmid (pIJ10469) carrying simR under the
control of its own promoter was introduced into the strains
already harbouring the promoter-probe plasmids. Trans-
formants were grown on Difco Nutrient Agar to promote
vegetative growth and delay the formation of aerial
hyphae, which may interfere with diffusion of the
luciferase substrate (n-decanal) and with light emission.
Figure 4 shows that simX and simR promoter activities
were repressed 100-fold and 12-fold, respectively, in the
presence of simR.
Purified SimR binds to the simR–simX intergenic region
at two distinct operator sites
The lux reporter data suggested that SimR is a repressor
that regulates its own expression as well as that of simX.
To test this idea, we monitored SimR binding to the simR–
simX intergenic region by electrophoretic mobility shift
assay (EMSA). An N-terminally His6-tagged derivative of
SimR was overexpressed in Escherichia coli and purified
to homogeneity. Increasing concentrations of SimR were
incubated with a radiolabelled probe spanning the simR–
simX intergenic region and the complexes were resolved
on a native gel. Purified SimR bound to the intergenic
region at concentrations as low as 0.23 nM and, as the
concentration of SimR increased, two sets of shifted
protein–DNA complexes became evident, suggesting that
there are two SimR binding sites in the simR–simX inter-
genic region (Fig. 5A).
DNaseI footprinting on both DNA strands was used to
map precisely the SimR operator sites within the simR–
simX intergenic region. Two separate SimR binding sites
were observed, consistent with the two shifted species
seen in the EMSA experiments: the operator closer to
simX was designated OX and the one closer to simR was
Fig. 3. Sequence of the simR–simX intergenic region showing the simRp and simXp transcription start points and putative -10 sequences,
the simR and simX ribosome binding sites (RBS), the extent of the SimR DNaseI footprints on the OX and OR operators, and the imperfect
inverted repeats within the footprints that may represent SimR binding motifs.
Fig. 4. Promoter activities of simR and simX in the presence and absence of simR. simRp–luxAB and simXp–luxAB transcriptional fusions
were created in an integrative luciferase promoter-probe vector (pIJ5972) and assayed in S. lividans, in either the presence or absence of
simR. Plasmid-containing S. lividans strains were grown on Difco Nutrient Agar in single wells of a 96-well microtitre plate (Sterilin) for 3 days.
Each well was inoculated with approximately 5 ¥ 104 spores. Plates were exposed to filter paper impregnated with n-decanal for 5 min and
luciferase activities were quantified using a NightOwl camera (Berthold) equipped with WinLight software (Berthold) using a 1 min exposure
time. Values given correspond to the average of three biological replicates from three different spore stocks and standard errors are shown.
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designated OR (Figs 3 and 6). Within the OX and OR foot-
prints we identified imperfect inverted repeats that
may represent the binding sequences for the SimR
homodimer. Figure 3 shows these imperfect inverted
repeats, the extent of the SimR DNaseI footprints on the
sequence of the simR–simX intergenic region and the
positions of the simRp and simXp transcription start points
and putative -10 promoter sequences in relation to the
two SimR operators.
SimR binding to the two operators is non-cooperative
In the DNaseI footprinting analysis, OX was occupied at a
lower concentration of SimR than was OR, suggesting that
OX has a higher affinity for SimR than OR. Competitive
EMSA was used to explore this issue further. In these
experiments, unlabelled fragments containing either OX or
OR were used to compete with a radioactively labelled
simR–simX intergenic fragment containing both OX and
OR. The final concentration of SimR used in the competi-
tive EMSA experiments was set at 20 nM such that all
the labelled probes were in complex with SimR in
the absence of unlabelled competitor DNA. A 1000-fold
excess of unlabelled OX-containing fragment out-
competed the labelled intergenic probe (no complex for-
mation between SimR and the labelled intergenic probe)
(Fig. 7). However, the same excess of OR-containing frag-
ment could not completely abolish SimR complex forma-
tion with the labelled intergenic probe (Fig. 7), confirming
that SimR binds OX more tightly than OR.
Using the EMSA data shown in Fig. 5, we determined
the approximate equilibrium dissociation constants (Kds)
for the two complexes to be 1.2  0.4 nM for SimR-OX
and 3.5  1.4 nM for SimR-OR. In order to determine
whether there is cooperativity between SimR binding at
OX and OR, we also determined the Kds of each SimR–
operator complex by EMSA using probes containing only
OX or only OR (data not shown), instead of the full simR–
simX intergenic region. The Kds were found to be
0.9  0.2 nM for SimR-OX and 3.6  0.3 nM for SimR-OR.
The Kds for the two SimR–operator complexes did not
change substantially when the two operators were sepa-
rated, suggesting that SimR binding to its two operators is
non-cooperative.
Exogenous simocyclinone D8 induces expression of the
SimX efflux pump in vivo
In order to determine whether the simR and simX promot-
ers respond to simocyclinone D8 in vivo, we used the
S. lividans luxAB reporter system to measure simRp and
simXp activities in the presence of SimR and in response
to exogenously added antibiotic. Figure 8A shows the
response curve of simR and simX promoter activity to
Fig. 5. A. Electrophoretic mobility shift assay
showing binding of purified SimR to the
simR–simX intergenic region. Bands
corresponding to protein–DNA complexes
(Bound) and free DNA (Free) are indicated.
The final concentration of SimR is indicated
above each lane.
B. Saturation curve of the data from EMSA
experiments. EMSA data were collected and
analysed on a PhosphorImager (FujiFilm)
using Multi Gauge image analysis software
(FujiFilm). Two independent EMSAs were
carried out [one of which is shown in (A)] and
the mean values calculated. Standard errors
are shown. Saturation curves (saturation
fraction against concentration of protein) were
fitted with SigmaPlot (see Experimental
procedures) to determine Kds. In all EMSA
experiments, SimR was present in molar
excess over the probe.
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increasing concentrations of simocyclinone D8. Both
promoters were induced by simocylinone D8, suggesting
that the antibiotic can relieve SimR-mediated repression
of both simRp and simXp. The highest concentration
tested was 0.6 mg ml-1 because S. lividans is sensitive to
simocylinone D8 (MIC = 2 mg ml-1).
Simocyclinone D8 dissociates SimR from the
simR–simX intergenic region
To determine if SimR responds directly to simocyclinone
D8, we examined the effect of the antibiotic on SimR–
operator complex formation by EMSA (Fig. 9A). The SimR
concentration was held constant and an increasing con-
centration of simocyclinone D8 was introduced into the
binding reaction. As the simocyclinone D8 concentration
increased, there was a progressive decrease in SimR–
DNA complex formation and a concomitant liberation of
free probe; 62.5 mM simocyclinone D8 was sufficient to
dissociate the SimR–DNA complexes almost completely.
This effect was not due to DMSO, the simocyclinone D8
solvent, as equivalent amounts of pure DMSO had no
effect on SimR–DNA complex formation (data not shown).
Furthermore, to test specificity, we examined the effect of
simocyclinone D8 on the DNA binding activity of ActR, a
TetR homologue that regulates actinorhodin export in
Fig. 6. DNaseI footprinting analysis of SimR
binding to the simR–simX intergenic region. A
DNA fragment containing the simR–simX
intergenic region, 5′ end-labelled on either the
upper strand (left panel) or the lower strand
(right panel), was exposed to DNaseI in the
presence of increasing concentrations of
SimR. The sequencing ladders were
generated by subjecting the probes to
Maxam–Gilbert G+A chemical sequencing.
Regions protected from DNaseI cleavage
(operators OX and OR) are indicated with
vertical bars and inverted repeats within the
DNaseI protected regions are indicated by
convergent arrows; these features are also
highlighted on the DNA sequence in Fig. 3.
Fig. 7. Competitive electrophoretic mobility
shift assay comparing the binding affinity of
SimR to OX and OR. All lanes contain SimR at
a final concentration of 20 nM and a constant
amount of a radiolabelled simR–simX
intergenic probe that carries both OX and OR.
The fold excess (over the radiolabelled probe)
of a competing unlabelled fragment containing
either OX or OR is indicated above each lane.
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Streptomyces coelicolor (see Discussion) and found that
100 mM simocyclinone D8 had no effect on ActR binding
to its cognate operator (data not shown). These results
show that simocyclinone D8 is able to specifically disrupt
SimR–DNA complex formation.
An intermediate in the simocyclinone biosynthetic
pathway induces simX in vivo and dissociates SimR
from its operators in vitro
In addition to simocyclinone D8, we also tested the ability
of simocyclinone C4, a natural intermediate in the D8
biosynthetic pathway, to induce the simR and simX pro-
moters in vivo and to dissociate SimR from its operators in
vitro. Simocylinone C4 lacks the aminocoumarin ring
present in the mature antibiotic (Fig. 1) and is essentially
inactive as a DNA gyrase inhibitor; the simocyclinone
D8 IC50 = 0.1 mM, whereas the simocyclinone C4
IC50 > 100 mM (M.J. Edwards et al., unpubl. data).
Simocyclinone C4 induced the simR and simX promoters
in vivo, although somewhat more weakly than the mature
antibiotic (Fig. 8B). Because simocyclinone C4 is not an
active antibiotic, we were able to test higher concentra-
tions than for simocyclinone D8. Consistent with the in
vivo inductions, simocyclinone C4 also caused SimR to
dissociate from its binding sites in vitro, although again
somewhat more weakly than simocyclinone D8; 250 mM
simocyclinone C4 was sufficient to abolish all complex
formation (Fig. 9B).
Discussion
This report shows that simX encodes a simocyclinone D8
efflux pump and that the simX promoter is directly
repressed by SimR, which binds to two operator sites in
the simR–simX intergenic region. Simocyclinone D8 abol-
ishes DNA binding by SimR, coupling the biosynthesis of
simocyclinone to its export.
Simocyclinone D8 is a potent inhibitor of DNA gyrase
supercoiling (IC50 = 0.1 mM) (Flatman et al., 2005; Oppe-
gard et al., 2009; M.J. Edwards et al., unpubl. data). The
recent structure of the antibiotic bound to the DNA gyrase
Fig. 8. Induction of the simR and simX
promoters in vivo by (A) simocyclinone D8
and (B) the biosynthetic intermediate
simocyclinone C4. S. lividans containing
pIJ10469 (carrying simR under its native
promoter) together with luciferase
promoter-probe plasmids pIJ10465
(simXp–luxAB) or pIJ10466 (simRp–luxAB)
were assayed. Values given correspond to the
average of three biological replicates from
three different spore stocks and standard
errors are shown. For further details, see the
legend of Fig. 4.
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A subunit shows that the two moieties at the ends of
simocyclinone D8, the aminocoumarin ring and the
angucyclic polyketide, bind to two separate, well-defined
pockets within the GyrA DNA binding saddle, linked by
the intervening tetraene linker and D-olivose moieties (M.J.
Edwards et al., unpubl. data). Given the prominence of the
aminocoumarin ring in the overall binding of the antibiotic
to the GyrA subunit, it is not surprising that the biosynthetic
intermediate simocyclinone C4, which lacks the aminocou-
marin ring (Fig. 1), is essentially inactive as a DNA gyrase
inhibitor (IC50 > 100 mM). Importantly, however, although
simocyclinone C4 is not a DNA gyrase inhibitor, it can
efficiently derepress SimR in vivo and in vitro.
The most striking analogy to the research presented
here is the work of Nodwell and colleagues on the regu-
lation of efflux of actinorhodin (Ahn et al., 2007; Hopwood,
2007; Tahlan et al., 2007; 2008; Willems et al., 2008).
Actinorhodin is a blue-pigmented, six-ring polyketide
antibiotic made by S. coelicolor (Bystrykh et al., 1996).
Within the actinorhodin biosynthetic cluster are two
co-transcribed genes, actA and actII-ORF3, encoding
integral membrane proteins implicated in actinorhodin
export (Caballero et al., 1991; Fernandez-Moreno et al.,
1991). Expression of these two genes is regulated by a
TetR-like protein, ActR, the product of the adjacent, diver-
gently transcribed gene. Nodwell and colleagues have
been characterizing ligands that relieve repression by
ActR. Importantly, they showed that, in addition to the
mature six-ring antibiotic, three-ring intermediates from
the biosynthetic pathway also relieve repression by ActR.
From this, they suggested that the ability of actinorhodin
intermediates to relieve repression by ActR might provide
a ‘feed-forward’ mechanism that would ensure expression
of the ActA efflux pump prior to the build-up of a toxic
concentration of the mature antibiotic (Ahn et al., 2007;
Hopwood, 2007; Tahlan et al., 2007; 2008; Willems et al.,
2008). Similarly, the ability of an inactive simocyclinone
intermediate to relieve repression by SimR might also act
as a biosynthetic checkpoint to ensure feed-forward regu-
lation of simocyclinone export.
As applied to simocyclinone (or actinorhodin) export,
the feed-forward hypothesis is speculative. We have
shown that the pathway intermediate simocyclinone
C4 induces simX expression in vivo when applied
exogenously. However, for a feed-forward mechanism to
operate in the producing organism, simocyclinone C4 or
other SimR-binding pathway intermediates would have to
accumulate in the cytoplasm to a concentration high
enough to trigger simX expression, and the cytoplasmic
concentrations of pathway intermediates are hard to
determine experimentally. However, there are other
examples in the literature where the TetR-like protein
blocks expression not only of the exporter gene, but also
of late biosynthetic genes, and in these cases it seems
that an intermediate in the pathway must be responsible
for inducing expression of these genes (i.e. feed-forward
Fig. 9. Electrophoretic mobility shift assays
showing that (A) simocyclinone D8 and (B) its
biosynthetic intermediate simocyclinone C4
abolish SimR DNA binding activity. All lanes
contain a constant amount of SimR and
radiolabelled simR–simX intergenic fragment
containing both OX and OR. Bands
corresponding to protein–DNA complexes
(Bound) and free DNA (Free) are indicated.
The final concentrations of simocyclinone D8
or simocyclinone C4 are indicated above each
lane.
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activation), as induction of the late biosynthetic enzymes
is required to generate the mature antibiotic.
In the landomycin A producer, Streptomyces cyanoge-
nus, a TetR-family regulator, LanK, represses expression
of lanJ, encoding a putative landomycin A efflux pump
(Ostash et al., 2008). LanK is derepressed by mature
landomycin A, which carries a hexasaccharide chain, but
also by intermediates in the pathway that carry only a
pentasaccharide or a trisaccharide chain (Ostash et al.,
2008). However, lanJ is co-transcribed with several down-
stream biosynthetic genes involved in late glycosylation
steps. As a consequence, LanK couples production of
intermediates not only to assembly of the export machin-
ery, but also to expression of late biosynthetic enzymes
that attach the final sugars to produce mature landomycin
A (Ostash et al., 2008). A more complex example con-
cerns the biosynthesis of the clinically important antican-
cer agents daunorubicin and doxorubicin made by
Streptomyces peucetius. In this system, binding of
daunorubicin–doxorubicin pathway intermediates like
rhodomycin D appears to derepress the TetR-like regula-
tor DnrO, activating a cascade involving two further tran-
scription factors, DnrN and DnrI, which leads to
expression of the resistance genes and of late biosyn-
thetic genes (Otten et al., 1995; Jiang and Hutchinson,
2006).
In addition to repressing the simX promoter, SimR also
directly negatively regulates its own expression. In other
systems, negative autoregulation has been shown to
confer specific functions that are absent in systems that
have simple regulation. Many of these studies on the
design principles of genetic circuits that incorporate nega-
tive autoregulation have exploited TetR, the founding
member of the family to which SimR belongs (Becskei
and Serrano, 2000; Rosenfeld et al., 2002; D. Madar and
U. Alon, pers. comm.). These studies show that negative
autoregulatory feedback loops in gene circuits can
provide stability, thereby limiting stochastic fluctuations in
the system (Becskei and Serrano, 2000). In addition,
negative autoregulation can speed the response time of
the transcription network to a stimulus (Rosenfeld et al.,
2002), and it can broaden the dynamic range of the input
signal to which the downstream genes respond (D. Madar
and U. Alon, pers. comm.).
An unresolved issue is the basis of resistance to simocy-
clinone D8 in the producing organism. In the strepto-
mycetes that produce the aminocoumarins novobiocin
(Streptomyces sphaeroides), clorobiocin (Streptomyces
roseochromogenes) and coumermycin A1 (Streptomyces
rishiriensis), expression of an aminocoumarin-resistant
GyrBR gyrase subunit encoded within the biosynthetic
gene cluster is turned on during antibiotic production,
conferring resistance (Thiara and Cundliffe, 1988; 1989;
1993; Schmutz et al., 2003). The absence of an equivalent
gyrB resistance gene in the simocyclinone biosynthetic
gene cluster was an initial surprise when the sim locus was
sequenced, until it was subsequently and unexpectedly
shown that simocyclinone has a completely different mode
of action, binding instead to the GyrA subunit of the
enzyme (Flatman et al., 2005; M.J. Edwards et al., unpubl.
data). However, no GyrAR subunit is encoded within the
sim cluster either (Galm et al., 2002; Trefzer et al., 2002).
Expressing simX from the strong, constitutive promoter,
ermEp*, conferred simocyclinone resistance on the heter-
ologous host S. lividans (MIC 65 mg ml-1 instead of
2 mg ml-1 for S. lividans alone), showing that SimX can act
as an effective resistance determinant when expressed at
appropriate levels. However, the MIC was only 4 mg ml-1
when simX was expressed from its own promoter in the
absence of SimR. This may reflect additional levels of
simX regulation that have yet to be uncovered. For
example, in addition to its repression by SimR, it is pos-
sible that simX expression in S. antibioticus might also be
activated by a simocyclinone pathway-specific activator
that is absent from S. lividans. Alternatively, it is possible
that SimX-mediated efflux is not the principal simocycli-
none resistance mechanism in S. antibioticus.
Experimental procedures
Bacterial strains, plasmids, oligonucleotides, culture
conditions and conjugal plasmid transfer from E. coli to
Streptomyces spp.
Strains, plasmids and oligonucleotides are described in
Table 1. Unless stated otherwise, S. lividans 1326 was grown
on SFM (Kieser et al., 2000) and S. antibioticus Tü 6040 was
grown on MYMTap [0.4% (w/v) maltose, 0.4% (w/v) Yeast
Extract, 1% (w/v) Malt Extract, supplemented trace elements;
made up in tap water]. For conjugal transfer into Streptomy-
ces (Paget et al., 1999), plasmids were introduced into the
dam dcm hsdS E. coli strain ET12567, which carries the
non-transmissible, oriT-mobilizing plasmid pUZ8002 (Paget
et al., 1999). All cloned PCR fragments were verified by
sequencing.
Fermentation, isolation and purification of simocyclinone
D8 and simocyclinone C4
Simocyclinone D8 was isolated as described by Schimana
et al. (2000). Briefly, S. antibioticus Tü 6040 was fermented in
a complex medium consisting of 2% (w/v) mannitol and 2%
(w/v) soybean meal in a 20 l fermentor, and simocyclinones
were extracted from the mycelium with methanol. Pure
simocyclinone D8 was obtained after reversed-phase HPLC
using Nucleosil-100 C-18 material and 0.01% trifluoroacetic
acid-acetonitrile gradient elution, resulting in a dark yellow
powder after drying. Pure simocyclinone C4 was isolated
using essentially the same procedure, but fermentation was
carried out in a defined medium containing 20% (v/v) glycerol
and 0.15% (w/v) L-arginine to maximize simocyclinone C4
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production (Theobald et al., 2000). The nature and purity of
the simocyclinone D8 and C4 samples were confirmed by
nuclear magnetic resonance spectroscopy and liquid
chromatography-mass spectrometry (Holzenkämpfer et al.,
2002; M.J. Edwards, pers. comm.)
Construction of simX and simEX2 expression plasmids
and minimal inhibitory concentration (MIC)
determinations
simX and simEX2 were amplified by PCR using primers
carrying NdeI (upstream) and HindIII (downstream) sites [for
simX, simEX1-F-NdeI and simEX1-R-HindIII; for simEX2,
simEX2-F-NdeI and simEX2-R-HindIII (Table 1)]. To express
the simX and simEX2 genes from the ermEp* promoter, the
fragments were cloned into NdeI-HindIII-cut pIJ10257
(Table 1) to generate pIJ10480 and pIJ10481 respectively. To
express simX from its own promoter, a fragment containing
the simX coding sequence and 122 bp of DNA upstream of
the simX translation start codon was amplified by PCR using
the primers intRX-138-F and simR-int-simX-R (Table 1), and
cloned into the SmaI site of pUC19. The resulting construct
was digested with BamHI and EcoRI and the insert was
cloned into BamHI-EcoRI-cut pSET152 to give pIJ10461.
Constructs were transferred into S. lividans by conjugation.
Table 1. Bacterial strains, plasmids and primers used in this study.
Relevant genotype/comments Source/reference
Strains
Streptomyces
S. antibioticus Tü 6040 Environmental isolate; original producer of simocyclinone D8 Schimana et al. (2000)
S. lividans 1326 Wild-type SLP2+ SLP3+ Kieser et al. (2000)
E. coli
ET12567 (pUZ8002) ET12567 containing helper plasmid pUZ8002 Paget et al. (1999)
Plasmids
pSET152 FC311 attP-int derived integration vector for the conjugal transfer of DNA
from E. coli to Streptomyces (AprR)
Bierman et al. (1992)
pMS82 FBT1 attP-int derived integration vector for the conjugal transfer of DNA
from E. coli to Streptomyces (HygR)
Gregory et al. (2003)
pIJ5972 Integrative Streptomyces promoter-probe plasmid based on TTA codon-free
derivatives of the luxAB reporter genes
Aigle et al. (2000);
M. Paget, pers. comm.
pIJ10257 Integrative expression vector based on the strong, constitutive ermE* promoter
(ermEp*)
Hong et al. (2005)
pIJ10461 pSET152 carrying simX under the control of its own promoter, without simR This study
pIJ10465 pIJ5972 simXp–luxAB This study
pIJ10466 pIJ5972 simRp–luxAB This study
pIJ10469 pMS82 carrying simR under the control of its native promoter This study
pIJ10480 pIJ10257 ermEp*–simX This study
pIJ10481 pIJ10257 ermEp*–simEX2 This study
pIJ10490 pET28a derivative expressing His6-tagged SimR This study
Primers
pX-F-EcoRI GAATTCGAGCACGAACTCCTGCTGGC
pX-R-BamHI GGATCCGACCACCACTTCCTCGGACTGG
pR-F-BamHI GGATCCTCCCCAGCTGCTCTGGCGTACACC
pR-R-EcoRI GAATTCGTGAACGTACCGACCATCAGGCCG
MS82-simR-F-HindIII GGCAAGCTTTCAAGCCAGTGCTGGACGTTCC
MS82-simR-R-KpnI AACGGTACCAACGGCATCCTCATCTGGCATGACC
intRX-138-F AAAGATATCCTCGTTCATCCACACTCCCC
intRX-138-R AAAGGATCCATCTGGCATGACCACCACTTC
intOX-123-F CCAATTGCGCTACGCTCCTTC
intOX-123-R CCTGCGCGGAGCCTCCGGAC
intOR-130-F CACCCTCGGTGTCGGCCACC
intOR-130-R AACGAGAACGAACCCGTCAG
simEX1-F-NdeI GAGCATATGCCAGATGAGGATGCCGTTGC
simEX1-R-HindIII TAGAAGCTTCTATCCGGCATTCCGAGCCG
simEX2-F-NdeI GGGCATATGACCAGTTTCCAAGTCCAG
simEX2-R-HindIII GGGAAGCTTACCTCCCGGCCGCAGTAGACC
simR-int-simX-R CTATCCGGCATTCCGAGCCG
S1-probeX-F GTAGAGGGACATCGTGCCGGC
S1-probeX-R GGCCGAGCAGTACGGCCAGC
S1-probeR-F GTGTCGGCCACCTTGACGGC
S1-probeR-R CCACCGAGCTCTCCGACGATCG
Invitro1-F GAACGATCTGGTCACGGCTC
Invitro1-R AGCAGTACGGCCAGCACCCC
Invitro2-R GCAGCGCCGTACCGACGATCACC
Invitro3-F CATCGACGCCGCCTCGACACCC
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For MIC determinations, approximately 5 ¥ 104 spores
were added to each well of a 96-well microtitre plate (Sterilin),
containing a twofold simocyclinone D8 dilution series in
SMMS medium (Kieser et al., 2000). The plates were evalu-
ated everyday for 5 days after inoculation, and the MIC was
defined as the lowest concentration at which no growth was
observed. Simocyclinone D8 was dissolved in DMSO with the
final concentration of DMSO in the agar not to exceed 1%
(v/v).
Construction of luxAB reporter plasmids and luciferase
activity measurements
To probe simXp and simRp activities in the absence of SimR,
the promoter regions (500 bp upstream of the translation start
codons) were amplified by PCR using upstream primers car-
rying an EcoRI site and downstream primers carrying a
BamHI site [primers pX-F-EcoRI and pX-R-BamHI for simXp;
pR-F-BamHI and pR-R-EcoRI for simRp (Table 1)]. The
simXp and simRp promoter fragments were cloned into
EcoRI-BamHI-cut pIJ5972, an integrative, Streptomyces
promoter-probe plasmid based on TTA codon-free derivatives
of the luxAB reporter genes (Aigle et al., 2000; M. Paget,
pers. comm.), to create plasmids pIJ10465 and pIJ10466,
respectively, and these reporter constructs were transferred
by conjugation into S. lividans. To probe simXp and simRp
activities in the presence of SimR, a plasmid carrying simR
under the control of its own promoter (pIJ10469) was trans-
ferred by conjugation into strains already harbouring the
promoter-probe plasmids pIJ0465 and pIJ10466. To con-
struct pIJ10469, simR with its promoter was amplified by
PCR using an upstream primer carrying a HindIII site and a
downstream primer carrying a KpnI site [primers MS82-simR-
F-HindIII and MS82-simR-R-KpnI (Table 1)] and the fragment
was cloned into HindIII-KpnI-cut pMS82.
Plasmid-containing strains were grown on Difco Nutrient
Agar in single wells of a 96-well microtitre plate (Sterilin) for
3 days. Each well was inoculated with approximately 5 ¥ 104
spores. Plates were exposed to filter paper impregnated with
n-decanal for 5 min and luciferase activities were quantified
using a NightOwl camera (Berthold) equipped with WinLight
software (Berthold) using a 1 min exposure time. Values
given correspond to the average of three biological replicates
from three different spore stocks.
Overexpression and purification of SimR
The simR gene was chemically synthesized with codon opti-
mization (Genescript) for expression in E. coli and ligated into
pET28a (Novagen) to give pIJ10490, which was introduced
into E. coli BL21 (DE3) pLys. Recombinant His6-SimR was
purified from a 250 ml LB culture induced with a 0.5 mM final
concentration of IPTG at 30°C for 4 h. The cell pellet was
re-suspended in 20 ml Buffer A [10 mM Tris-HCl, pH 7.8,
150 mM NaCl, 50 mM imidazole, 1¥ Complete Mini, EDTA-
free protease inhibitor (Roche)], sonicated (20 s at
10 microns for three cycles), and the lysate was clarified by
centrifugation. The filtered cell lysate was loaded onto a 1 ml
Ni-loaded Hi-Trap Chelating HD column (GE Healthcare) and
His-tagged SimR was eluted with Buffer B [10 mM Tris-HCl,
pH 7.8, 150 mM NaCl, 500 mM imidazole] and dialysed into
Storage Buffer [10 mM Tris-HCl, pH 7.8, 150 mM NaCl, 10%
(v/v) glycerol]. The resulting preparation of SimR was 98%
pure as judged by SDS-PAGE and was stored at -80°C.
Electrophoretic mobility shift assays and determination
of dissociation constants (Kds)
The EMSA DNA probe spanning the entire simR–simX inter-
genic region was amplified by PCR using primers intRX-
138-F and intRX-138-R (Table 1) and then 5′ end-labelled
using [g32-P]-ATP and T4 polynucleotide kinase (New
England Biolabs). The competitor DNA carrying only OR was
amplified using primers intOR-130-F and intOR-130-R, and
the competitor DNA carrying only OX was amplified using
primers intOX-123-F and intOX-123-R (Table 1). Binding of
SimR to DNA was carried out in 20 ml EMSA buffer [20 mM
Tris, pH 8.0, 1 mg poly(dI-dC), 1 mM EDTA, 100 mM NaCl,
0.5 mM DTT, 8% (v/v) glycerol] containing 0.1 nM radiola-
belled DNA (approximately 8000 c.p.m.) and varying
amounts of SimR. After incubation at 30°C for 5 min, the
binding reaction mixtures were loaded on 5% (w/v) native
polyacrylamide gels and run in TBE buffer at 120 V for
45 min. The effect of simocyclinone D8 and simocyclinone C4
on the ability of SimR to bind DNA was tested by adding the
compounds to the EMSA buffer. The simocyclinone D8 and
simocyclinone C4 stock solutions were made up in 100%
DMSO.
EMSA data were collected and analysed on a Phosphor-
Imager (FujiFilm) using Multi Gauge image analysis software
(FujiFilm). Two independent EMSAs were carried out for each
probe and mean values were calculated. In order to calculate
Kds for SimR binding to each operator when the two operator
sites were separated, saturation curves (percentage of probe
bound against concentration of protein) were fitted using
SigmaPlot (one site saturation model). For Kds of each
operator when the two sites were coupled, a random-order
binding model was used, where Y = [S]/(2(Kd1 + [S])) + [S]/
(2(Kd2 + [S])), in which Y is the fractional saturation, Kd1 and
Kd2 are dissociation constant of SimR binding to OX and OR
operators, respectively, and [S] is the concentration of
protein. The fractional saturation was calculated from inten-
sities of EMSA bands in each lane (Fig. 5A) as followed,
Y = (0.5*intensity of middle band + intensity of top band)/
(intensity of all bands in a lane). The equation was then fitted
using SigmaPlot to determine Kds.
DNaseI footprinting
Templates for DNaseI footprinting were amplified by PCR
using one unlabelled primer and one primer 5′ end-labelled
using [g32-P]-ATP and T4 polynucleotide kinase (New
England Biolabs). The primers were intRX-138-F and intRX-
138-R (Table 1), the same pair used to generate the simR–
simX intergenic region probe for the EMSA experiments.
DNaseI footprinting assays were performed in 40 ml EMSA
buffer containing approximately 180 000 c.p.m. radiolabelled
DNA and varying amounts of SimR. After incubation at room
temperature for 5 min, 10 ml of DNaseI (10 units in 10 mM
CaCl2) was added and the incubation was continued for a
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further 60 s. Reactions were stopped by adding 140 ml
DNaseI stop solution (200 mM unbuffered sodium acetate,
30 mM EDTA, 0.15% SDS and 0.1 mg ml-1 yeast tRNA), the
samples were precipitated with ethanol, and the pellets were
dried and dissolved in 5 ml Sequencing Loading Dye [80%
(v/v) formamide, 10 mM NaOH, 1 mM EDTA, 0.1% (w/v)
xylene cyanol and 0.1% (w/v) bromophenol blue]. After
heating at 80°C for 3 min and cooling on ice, the samples
were run on a 6% (w/v) polyacrylamide/8 M urea sequencing
gel, which was dried and analysed using a PhosphorImager
(FujiFilm). A G+A sequencing ladder was generated from the
template DNA by chemical sequencing (Maxam and Gilbert,
1980).
RNA preparation, S1 nuclease protection analysis and
in vitro run-off transcription
For RNA preparation, approximately 109 S. antibioticus
spores were germinated by heat-shock treatment in 5 ml TES
buffer (0.05 M, pH 8) at 50°C for 10 min, then diluted with an
equal volume of double-strength germination medium [1%
(w/v) Difco yeast extract, 1% (w/v) Difco casaminoacids, 0.01
M CaCl2] and incubated with shaking at 37°C for 6 h (modi-
fied from Kieser et al., 2000). Germinated spores were inocu-
lated into NMMP (Kieser et al., 2000) and incubated with
shaking for a further 15 h at 30°C. RNA was prepared essen-
tially as described by Hesketh et al. (2007), but with minor
modifications taken from the Qiagen RNA Extraction Kit pro-
cedure (Qiagen). Probes for S1 nuclease protection analysis
were generated by PCR using a 5′ end-labelled oligonucle-
otide internal to the ORF and an unlabelled upstream primer
[for simXp, primers S1-probeX-F and S1-probeX-R; for
simRp, primers S1-probeR-F and S1-probeR-R; (Table 1)].
Hybridizations were carried out in sodium trichloroacetic acid
buffer at 45°C overnight after denaturation at 65°C for 10 min
(Kieser et al., 2000). A G+A sequencing ladder was gener-
ated by chemical sequencing (Maxam and Gilbert, 1980).
RNA polymerase containing a mixture of sigma factors was
purified as described previously (Buttner et al., 1988) from
S. coelicolor M600 grown to exponential phase in YEME
(Kieser et al., 2000). In vitro transcription was carried out as
described previously (Buttner et al., 1987). Three different
templates for in vitro run-off transcription were generated by
PCR that differed in their left or right ends, to allow the simR
and simX transcripts to be identified unambiguously. Tem-
plates were generated using the following primers: Template
1, Invitro1-F and Invitro1-R; Template 2, Invitro1-F and
Invitro2-R; Template 3, Invitro3-F and Invitro1-R (Table 1).
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Crystals of SimR were grown by vapour diffusion. The protein crystallized with
trigonal symmetry and X-ray data were recorded to a resolution of 2.3 A˚ from a
single crystal at the synchrotron. SimR belongs to the TetR family of bacterial
transcriptional regulators. In the absence of the antibiotic simocyclinone, SimR
represses the transcription of a divergently transcribed gene encoding the
simocyclinone efflux pump SimX in Streptomyces antibioticus by binding to
operators in the simR–simX intergenic region. Simocyclinone binding causes
SimR to dissociate from its operators, leading to expression of the SimX efflux
pump. Thus, SimR represents an intimate link between the biosynthesis of
simocyclinone and its export, which may also provide the mechanism of self-
resistance to the antibiotic in the producer strain.
1. Introduction
Most antibiotics are potentially lethal to the producing organism and
therefore there must be mechanisms to ensure that the machinery
responsible for the export of the mature antibiotic is in place at the
time of biosynthesis. Simocyclinone (Schimana et al., 2000) is a potent
DNA gyrase inhibitor that is produced by Streptomyces antibioticus
Tu¨ 6040 (Edwards et al., 2009; Flatman et al., 2005; Oppegard et al.,
2009). Within the simocyclinone-biosynthetic cluster are two diver-
gently transcribed genes, simR and simX, that encode proteins that
resemble the TetR/TetA repressor–efflux pump pair that causes
widespread resistance to clinically important tetracyclines (Chopra &
Roberts, 2001). Transcription of simX is controlled by SimR, which
directly represses the simX and simR promoters by binding to two
operator sites in the simX–simR intergenic region (Le et al., 2009).
Simocyclinone abolishes DNA binding by SimR, inducing expression
of the SimX efflux pump and thus providing a mechanism that
couples the biosynthesis of simocyclinone to its export. TetR-family
transcriptional regulators are widespread in the bacterial kingdom
(Ramos et al., 2005) and there are representative structures of over
100 of these in the Protein Data Bank (Yu et al., 2010). However, the
mode of action has been fully elucidated at the molecular level for
relatively few of these proteins (Orth et al., 2000; Schumacher et al.,
2001; Itou et al., 2010; Miller et al., 2010; Reichheld et al., 2009; Yu et
al., 2010). Here, we report the crystallization and preliminary X-ray
analysis of SimR as the first step towards determining the molecular
basis of its action.
2. Materials and methods
2.1. Protein expression and purification and crystallization
The simR gene of S. antibioticus Tu¨ 6040, encoding a protein of
259 amino acids, was chemically synthesized and codon-optimized
(GenScript) for expression in Escherichia coli and then ligated into
the pETM11-NdeI plasmid to give the expression vector pIJ10495.
The SimR protein produced from this vector has an N-terminal TEV
protease-cleavable His tag. This adds a further 26 amino acids to the
native protein (with sequence MKHHHHHHPMSDYDIPTTENLY-
FQGA), giving a total deduced molecular mass of 32 222 Da. The
# 2011 International Union of Crystallography
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expression vector pIJ10495 was transformed into E. coli strain BL21
(DE3) pLysS and a 7 ml overnight culture of the cells was used
to inoculate a 500 ml culture of Luria–Bertani medium containing
50 mg ml1 kanamycin and 30 mg ml1 chloramphenicol. The cells
were grown at 310 K to an OD600 nm of around 0.4. The culture was
then cooled to 293 K and dimethylsulfoxide (DMSO) was added to
a final concentration of 0.15%(v/v) before induction of protein
expression by the addition of isopropyl -d-thiogalactopyranoside to
a final concentration of 0.3 mM. The addition of DMSO was essential
for a high yield of soluble SimR, probably because it induces the
expression of chaperones that assist in the folding of SimR in vivo.
The culture was left shaking for 3 h at 303 K. Harvested cells were
resuspended in 50 mM Tris–HCl pH 8.4, 300 mM NaCl, 5%(v/v)
glycerol containing Complete EDTA-free protease-inhibitor cocktail
(Roche) and lysed by sonication (three cycles of 20 s with 40 s resting
on ice in between each cycle). The cell debris was removed by
centrifugation at 84 000g for 30 min and the supernatant was filtered
through a 0.45 mm membrane. It was then applied onto a 1 ml Ni-
loaded Hi-Trap Chelating HP column (GE Healthcare) connected to
an A¨KTA FPLC system (Pharmacia) that had been equilibrated with
buffer A (50 mM Tris–HCl pH 8.4, 300 mM NaCl, 50 mM imidazole).
Protein was eluted from the column using an increasing (50–500 mM)
imidazole gradient in the same buffer. SimR fractions were identified
using SDS–PAGE, pooled together and concentrated to approxi-
mately 5–10 mg ml1 using a Vivaspin 6 10 kDa cutoff concentrator
(Vivascience). His-tagged SimR is prone to precipitation and further
purification by gel-filtration chromatography resulted in very poor
yields (data not shown). Although attempts to cleave the affinity tag
with TEV protease were successful (as judged by SDS–PAGE), the
resultant sample still adhered to the Ni-affinity resin when reapplied
onto the Hi-Trap Chelating HP column and could not be eluted even
with buffer containing 1.0M imidazole (data not shown). Therefore,
for all subsequent preparations a single-column purification
procedure was used and the His tag was not cleaved. Directly after
SDS–PAGE analysis the pooled fractions were exchanged into crys-
tallization buffer (25 mM Tris–HCl pH 8.4, 300 mM NaCl) using a
Zeba desalting micro column (Thermo Scientific).
Dynamic light scattering (DLS) was used to monitor the solution
properties of the purified sample. For this purpose, approximately
30 ml protein solution was centrifuged through a 0.1 mm Ultrafree
filter (Millipore) to remove particulate material before introduction
into a 12 ml microsampling cell. The cell was inserted into a DynaPro
Titan molecular-sizing instrument at 293 K (Wyatt Technology). A
minimum of ten scattering measurements were obtained and the
resulting data were analysed using theDYNAMICS software package
(Wyatt Technology).
Crystallization trials of His-tagged SimR were set up using an
OryxNano robot (Douglas Instruments Ltd) in sitting-drop vapour-
diffusion format with 96-well MRC plates (Molecular Dimensions)
using a variety of commercially available screens (Molecular
Dimensions and Qiagen) at a constant temperature of 293 K. Drops
consisted of 0.3 ml protein solution mixed with 0.3 ml precipitant
solution and the reservoir volume was 50 ml; the protein concentra-
tion was approximately 5 mg ml1. Improved crystals were
subsequently obtained by refining the successful conditions in a
hanging-drop format using 24-well VDX plates (Molecular
Dimensions) over a reservoir volume of 1 ml.
2.2. X-ray data collection
Crystals were mounted for X-ray data collection using LithoLoops
(Molecular Dimensions) and were flash-cooled by plunging into
liquid nitrogen and stored in Uni-puck cassettes prior to transport to
the synchrotron. Crystals were subsequently transferred robotically
to the goniostat on station I03 of the Diamond Light Source
(Oxfordshire, England) and maintained at 100 K with a Cryojet
cryocooler (Oxford Instruments). Diffraction data were recorded
using an ADSC Quantum 315 CCD detector with the wavelength set
to 0.9763 A˚ and were then processed using MOSFLM (Leslie, 2006)
and SCALA (Evans, 2006).
3. Results and discussion
N-terminally His-tagged SimR was overexpressed and purified with
an approximate yield of 40 mg protein from 500 ml culture and was
judged to be greater than 95% pure by SDS–PAGE analysis. DLS
analysis gave a peak accounting for 99.9% of the mass of the sample
with a polydispersity of 16.5%. From these results the molecular size
was estimated at 70 kDa, being close to the value expected for a SimR
homodimer (64 kDa).
Preliminary crystals of SimR grew within two weeks of setup with
17%(w/v) PEG 10 000, 0.2M ammonium acetate in 0.1M bis-tris pH
5.5 as the precipitant. Improved crystals were subsequently obtained
overnight from 2%(w/v) PEG 10 000, 0.2M ammonium acetate in
0.1M bis-Tris pH 5.5, with maximum dimensions of approximately
200  100  100 mm (Fig. 1). We found that subjecting SimR stock
solutions to heat treatment prior to setting up crystallizations resulted
in better quality crystals. SimR (10 mg ml1) was incubated at 310 K
for 2 min and then cooled in running water at 283 K for 1 min and
the solution was cleared of precipitated protein by centrifugation
through a Millipore 0.1 mm Ultrafree filter before crystallization.
SimR crystals were cryoprotected by a three-step transfer (25, 50 and
100% cryosolution) to the final cryosolution [crystallization solution
with the addition of 30%(w/v) PEG 1500 in place of an equivalent
volume of water].
Native X-ray data were collected from a single SimR crystal: a total
of 200  0.45 oscillation images were recorded in a continuous
sweep to a maximum resolution of 2.3 A˚. Indexing was consistent
with a rhombohedral lattice, with unit-cell parameters a = b = 116.62,
c = 110.58 A˚. Analysis using the program POINTLESS (Evans, 2006)
indicated that the space group was H32. Data-collection and
processing statistics are summarized in Table 1. Estimation of the
content of the asymmetric unit indicated that a single His-tagged
SimR subunit was most likely, giving a solvent content of 45% and a
crystal-packing parameter (VM) of 2.25 A˚
3 Da1 (Matthews, 1968).
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Figure 1
Single crystals of SimR, with approximate dimensions of 200  100  100 mm.
A partial molecular-replacement solution for SimR was obtained
with the BALBES pipeline (Long et al., 2008; with an MR score of
2.63) using the structure of an S. coelicolor putative transcriptional
regulator (PDB code 2hxi; 25.4% sequence identity to SimR; K. Tan,
X. Xu, H. Zheng, A. Savchenko, A. Edwards & A. Joachimiak, un-
published work) as the search model. This template was also the top
hit that was found by the FUGUE fold-prediction server (http://
tardis.nibio.go.jp/fugue/prfsearch.html; Shi et al., 2001) based on the
amino-acid sequence of SimR, with a Z score of 31.2. In addition, a
3.4 A˚ resolution single-wavelength anomalous dispersion data set was
collected from a crystal of selenomethionine-substituted protein (not
shown). The combination of these two sources of phase information
enabled us to solve the SimR structure. Full details of the structure-
determination process and refinement of the resultant model will be
reported elsewhere.
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Table 1
Summary of X-ray data for SimR.
Values in parentheses are for the outer resolution shell.
No. of crystals 1
Beamline I03, Diamond Light Source, England
Wavelength (A˚) 0.9763
Detector ADSC Quantum 315 CCD
Crystal-to-detector distance (mm) 368.6
Rotation range per image () 0.45
Total rotation range () 90.0
Resolution range (A˚) 48.50–2.30 (2.42–2.30)
Space group H32
Unit-cell parameters (A˚) a = b = 116.62, c = 110.58
Mosaicity () 0.79
Total no. of measured intensities 63659 (6804)
Unique reflections 12693 (1786)
Multiplicity 5.0 (3.8)
Mean I/(I) 10.2 (2.3)
Completeness (%) 98.0 (95.2)
Rmerge† 0.093 (0.523)
Rmeas‡ 0.104 (0.604)
Wilson B value (A˚2) 57.9
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rmeas =
P
hkl ½N=ðN  1Þ1=2
Pi jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith observation of
reflection hkl, hI(hkl)i is the weighted average intensity for all observations i of
reflection hkl and N is the number of observations of reflection hkl.
doi:10.1016/j.jmb.2011.02.035 J. Mol. Biol. (2011) 408, 40–56
Contents lists available at www.sciencedirect.com
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Streptomyces antibioticus, is exported from the producing organism by the
SimX efflux pump. The expression of simX is under the control of SimR, a
member of the TetR family of transcriptional regulators. SimR represses
simX transcription by binding to operators in the intergenic region between
simR and simX. Previously, we have shown that the mature antibiotic SD8 or
its biosynthetic intermediate, simocyclinone C4, can dissociate SimR from its
operators, leading to derepression of simX and export of SD8 from the cell.
This provides a mechanism that couples the biosynthesis of the antibiotic to
its export. Here, we report the crystal structures of SimR alone and in
complex with either SD8 or simocyclinone C4. The ligand-binding pocket is
unusual compared to those of other characterized TetR-family transcrip-
tional regulators: the structures show an extensive ligand-binding pocket
spanning both monomers in the functional dimeric unit, with the
aminocoumarin moiety of SD8 buried in the protein core, while the
angucyclic polyketide moiety is partially exposed to bulk solvent. Through
comparisons of the structures, we postulate a derepression mechanism for
SimR that invokes rigid-body motions of the subunits relative to one
another, coupled with a putative locking mechanism to restrict further
conformational change.© 2011 Elsevier Ltd. All rights reserved.ress:
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TetR-family transcriptional regulators (TFRs) are
abundant and widespread in bacteria.1 The majority
function as repressors and they are known princi-
pally because well-characterized members of the
family control genes whose products are involved in
antibiotic resistance. Other members regulate genes
involved in diverse processes, including the biosyn-
thesis of secondary metabolites (e.g., Streptomyces
coelicolor CprB) and the pathogenicity of both Gram-
negative (e.g., Vibrio cholerae HapR) and Gram-
positive bacteria (e.g., Bacillus cereus HlyIIR).1 Mostd.
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Fig. 1. Structures of simocyclinone D8 and its biosynthetic intermediate, simocyclinone C4.
41SimR-Apo and SimR–Ligand ComplexesTFRs are believed to respond to small molecules,
but cognate ligands have been identified for only a
handful of family members. The best-characterized
member of the family is Escherichia coli TetR itself,
which confers resistance to the antibiotic tetracy-
cline by regulating the expression of the tetracycline
efflux pump, TetA.2 In the absence of tetracycline,
TetR binds to the intergenic region between the
divergently transcribed tetR and tetA at two
operator sites.3,4 This action represses the transcrip-
tion of both tetA and tetR itself. When TetR binds
tetracycline, it loses affinity for these operators,
leading to derepression of tetA and the export of
tetracycline from the cell.5 Representative crystal
structures for ligand-free, ligand-bound, and DNA-
bound forms of TetR have been determined.6,7
TFRs function as homodimers. Each monomer
consists of two domains, an N-terminal DNA-
binding domain (DBD) containing a helix-turn-
helix (HTH) motif and a C-terminal ligand-binding
domain (LBD).1 LBDs are extremely diverse in
amino acid sequence, and it is therefore not generally
possible to model these domains based on existing
structures with any confidence, nor to predict
potential ligands.1,8 In addition to TetR, the struc-
tures of three further TFRs have been determined
with relevant ligands, and also with bound DNA,Fig. 2. Crystal structures of ligand-free (SimR-apo) and SD
cylindrical helix representation to highlight the secondary st
subunits of the homodimer are distinguished by cyan and yell
in magenta. Where appropriate, this colour scheme is adopted
that engages with the opposing subunit. The lower panels com
viewed from the front (left) and from the top (right), with the
The separations of the recognition helices are indicated. The lab
moieties of SD8, respectively.enabling their mechanisms of repression and dere-
pression to be elucidated. Two of these, Staphylococ-
cus aureus QacR9 and Corynebacterium glutamicum
CgmR,10 like TetR, repress the transcription of efflux
pump genes and lose affinity for the operator sites of
these genes upon binding small molecules. The
fourth protein, DesT from Pseudomonas aeruginosa,
differs in that it responds to the ratio of two ligands.
It controls the composition of membrane lipids by
acting as a repressor of a desaturase; when unsatu-
rated fatty acid is bound to DesT, the protein has
high affinity for its cognate DNA, but loses this
affinity when saturated fatty acid is bound.11 Four
other TFRs have been crystallized in complex with
cognate ligands. These include two further efflux
pump regulators, Pseudomonas putida TtgR12 and S.
coelicolor ActR.13 ActR controls the efflux of the
antibiotic actinorhodin in the producer; the structure
reveals a binding pocket that accommodates one
molecule of the mature hexacyclic antibiotic or two
molecules of a tricyclic intermediate that also
efficiently derepresses ActR.13,14 The remaining
two examples are Mycobacterium tuberculosis EthR,
which represses expression of a mono-oxygenase
required for the activation of the pro-drug
ethionamide,15–17 and E. coli MphR, a repressor of
the macrolide 2′-phosphotransferase I resistance8-bound (SimR–SD8) forms of SimR. The top panel uses a
ructure of SimR-apo with key features labelled. The two
ow colouration, and the two recognition helices are shown
throughout the subsequent figures. Note the α9–α10 arm
pare SimR-apo and SimR–SD8 in cartoon representation
SD8 molecules shown in red space-filling representation.
els AC and PK refer to the aminocoumarin and polyketide
Fig. 2 (legend on previous page)
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43SimR-Apo and SimR–Ligand Complexesgene.18 In those cases where derepression has been
analysed by comparing DNA-bound and ligand-
bound structures,6,7,9–11 it is brought about through
the stabilisation, by the binding of the ligand, of a
conformation inwhich the recognition helices are too
far apart to simultaneously bind to adjacent major
grooves of DNA. These mechanisms necessarily
invoke allosteric communication between the LBDs
and DBDs.
Simocyclinone D8 (SD8) is a potent DNA gyrase
inhibitor produced by Streptomyces antibioticus, with
an IC50 ∼0.1 μM for inhibition of DNA super-
coiling.19–21 It consists of four moieties: a chlorinated
aminocoumarin (AC) at one end, connected to an
angucyclic polyketide (PK) at the other end, via a
tetraene linker and a D-olivose sugar (Fig. 1).22–24
SD8 is exported from the producing organism by a
specific efflux pump, SimX, and the transcription of
simX is repressed by SimR, a TFR that binds to two
distinct operators in the intergenic region between
the divergently transcribed simR and simX genes.25
SD8 abolishes DNA binding by SimR, inducing
expression of the SimX efflux pump, and this
provides an intimate mechanism that couples the
biosynthesis of simocyclinone to its export.25
In order to gain insight into the molecular
mechanism of ligand-mediated SimR derepression,
we have solved the crystal structures of SimR,
alone and in complexes with SD8 and its biosyn-
thetic intermediate simocyclinone C4 (SC4), which
lacks the AC moiety of the mature antibiotic (Fig. 1)
but still derepresses SimR, albeit less efficiently.25
The structures show an extensive ligand-binding
pocket spanning both monomers in the functional
dimeric unit and suggest a derepression mechanism
that involves rigid-body motions of the subunits
relative to one another, coupled with a putative
lockingmechanism to restrict further conformational
change.†http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html
‡http://ekhidna.biocenter.helsinki.fi/dali_server/Results and Discussion
The structure of ligand-free SimR
The structure of ligand-free SimR (SimR-apo)
was determined at 1.95-Å resolution. There is a
single copy of the SimR monomer in the asymmetric
unit (ASU), and the final model comprises residues
7–244 of the 259–residue native sequence. A
biologically relevant homodimer is generated
through the application of 2-fold crystallographic
symmetry (Fig. 2). The secondary structure of SimR
is almost entirely α-helical, being composed of 11
helices that span residues 29–43 (α1), 50–57 (α2), 61–
67 (α3), 71–84 (α4), 96–113 (α5), 116–120 (α6), 130–
144 (α7), 150–181 (α8), 185–202 (α9), 206–216 (α10),
and 222–243 (α11) (Figs. 2 and 3). There are, inaddition, two short β-strands near the N-terminus
(residues 18–19 and 26–27), which form a β-hairpin.
The SimR monomer can be divided into two
domains, an N-terminal DBD and a C-terminal
LBD. The DBD consists of the β-hairpin and helices
α1 to α3. Helices α2 and α3 form an HTH motif that
is stabilised by packing against α1. By analogy with
other TFRs, the HTH is predicted to interact with the
major groove of DNA, with the recognition helix, α3,
providing the majority of base-specific interactions.
In addition, the N-terminal β-hairpin motif of SimR
appears to be ideally placed to make minor groove
interactions. Consistent with this proposal, there are
a total of four Arg residues in the range 18–25 (Fig. 3),
which could interact favourably with the negatively
charged phosphate backbone of DNA. These resi-
dues contribute to the prominent electropositive
surface patch that overlaps the recognition helix in
SimR-apo (Supplementary Fig. S1).
The last eight helices (α4–α11) make up the LBD
responsible for small-molecule ligand binding and
forming the interface between the two subunits of the
dimer. Dimerization occurs largely through a pair of
helices, α8 and α11, from each SimR monomer that
form a four-helix bundle (Fig. 2). The dimerization
interface is further enhanced by the α9–α10 segment,
which forms an extended ‘arm’ thatwraps around the
LBD of the opposingmonomer (Fig. 2). (Note that the
distinctive kink in α9 is important for ligand binding;
see below.) In fact, all of helices α7–α11 from each
subunit are involved to varying degrees in dimeriza-
tion. Overall, this gives rise to an extensive dimer
interface of 2475 Å2 accounting for 17.5% of the
solvent-accessible surface of an isolated monomer, as
calculated by the Protein Interactions, Surfaces and
Assemblies server (PISA†).28 Within the core of each
subunit, there is a substantial cavity (Fig. 4a). The two
cavities of the dimer are linked via a narrow pore that
passes through the centre of the dimer, and they each
connect to bulk solvent through channels that pass
between the two helices of the α9–α10 arm (Fig. 4a).
Comparison of the SimR structure with other
TetR family members
The closest structural homologues of SimR were
identified using the DALI server‡ (Supplementary
Fig. S2).29 This gave a total of 12 hits from the
nonredundant database with Z scores of greater
than 15.0. The top hit was S. coelicolor ActR with
bound actinorhodin [Protein Data Bank (PDB) code
3B6A],13 with a Z score of 18.7, a sequence identity
of 25%, and a root-mean-square deviation (rmsd) of
2.6 Å after superposition of single subunits. Hit
number 6 was E. coli TetR with bound tetracycline
Fig. 3. Structure-based multiple sequence alignment of SimR with S. coelicolor ActR and E. coli TetR. The initial
alignment was generated using the SSM server (http://www.ebi.ac.uk/msd-srv/ssm/),26 with the ligand-free structures
(PDB codes 2OPT and 1BJZ for ActR and TetR, respectively). This was subsequently adjusted manually with reference to
the superposed structures and then displayed using ESPript.27 Strictly conserved residues are highlighted with pink
shading. Secondary-structure elements for SimR are shown above the alignment, where α stands for α-helix and β
represents β-strand. Residues involved in binding SD8 (selected on the basis of being b4.0 Å from the ligand) are
highlighted with yellow and cyan shading to denote the subunit. Similarly, residues involved in actinorhodin binding by
ActR (PDB code 3B6A) and tetracycline binding by TetR (PDB code 1BJY) are highlighted with the same colour scheme.
Green shading indicates residues involved in DNA binding by TetR (PDB code 1QPI). Grey shading indicates regions in
ActR (residues 178–187) and TetR (residues 152–164) that were not modelled in the ligand-free structures. The red bars
denote regions of SimR that show the most significant conformational changes between the ligand-bound and ligand-free
structures. The inverted blue triangles mark key residues referred to in the text.
44 SimR-Apo and SimR–Ligand Complexes(PDB code 1BJY6; Z score, 17.0; sequence identity,
18%; rmsd, 2.6 Å). In a recent systematic survey of
TFR protein structures, TetR itself, together with
ActR, were placed in a distinct subclass of
structures.8 One of the characteristics of this subclass
is a long insertion between α8 and the C-terminal
α-helix. This corresponds to the α9–α10 arm of SimR.By contrast, CgmR from C. glutamicum (PDB code
2ZOY; ligand-free form)30 is more typical of the
majority of known TFR structures, having no such
insertion (Supplementary Fig. S2b). As a conse-
quence, the dimer interface of CgmR is less extensive
than that of SimR-apo at 1819 Å2 (as calculated by
PISA). In addition, several TFRs have a significantly
Fig. 4. The ligand-binding pocket of SimR. (a) Molecular surface representations of the ligand-free and ligand-bound
structures of SimR, focussing on the right-hand pocket shown in Fig. 2; ligands are shown with grey carbon atoms. The
top panels show a front view and the lower panels show a top view as a thin slice through the molecule. Grey shading
denotes regions within the molecular boundary. The asterisks indicate narrow channels leading to equivalent cavities in
the other halves of the dimers. (b) Simulated annealing omit maps at 2.3-Å resolution for SimR–SC4 and SimR–SD8
(contoured at 3σ) are shown in blue superposed on their respective ligands; the protein is shown in semi-transparent
cartoon representation (see also Supplementary Fig. S3). The right-hand panel illustrates the relative positions of the
ligands for SimR, ActR, and TetR after superposition of their respective structures.
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46 SimR-Apo and SimR–Ligand Complexeslonger α1 helix, the N-terminus of which may make
additional contacts to DNA as seen in QacR, CgmR,
and DesT.10,11,31,32
Tyr42 in TetR lies in the middle of the recognition
helix (α3) and forms important interactions with
DNA in the TetR–tetO complex.7 This residue is
reasonably well conserved in TFRs, and the Cα atom
serves as a reference point for measuring the
separation of the recognition helices in a homo-
dimer.8 In DNA-bound structures, this separation
lies in the range 34.7 to 38.8 Å,7,10,11,31,32 roughly
corresponding to the distance of 34 Å between
consecutive major grooves in standard B-form
DNA. By contrast, in apo-TFR structures, the helix
separation is highly variable but is typically not
compatible with DNA binding.8 The equivalent
residue in SimR is Tyr65 and the Cα–Cα separation is
42.3 Å in SimR-apo (Fig. 2). Thus, we conclude that the
conformation seen in SimR-apo is also not compatible
with DNA binding (Supplementary Fig. S2d).
Ligand-bound structures of SimR
SC4 is a biosynthetic intermediate of SD8 (Fig. 1)
that is essentially inactive as a DNA gyrase
inhibitor.19 However, like the mature antibiotic,
SC4 derepresses SimR; when applied exogenously,
it induces expression of the SimX efflux pump in vivo,
and it relieves DNA binding by SimR in vitro.25
Structures of the complexes formed between SimR
and the mature antibiotic SD8 (SimR–SD8), andwith
SC4 (SimR–SC4), were determined at 2.3-Å resolu-
tion. In both cases, crystals of the complexes were
formed by co-crystallization with the respective
ligands and gave rise to new crystal forms. Each
structure was solved by molecular replacement
using the SimR-apo structure as the template, and
in both cases, there were two copies of the SimR
subunit in the ASU, corresponding to the biological
dimer. In contrast to the SimR-apo structure, most of
the N-terminal polypeptide chain prior to α1 in the
ligand-bound structures was poorly resolved; only
in one monomer of SimR–SC4 was the β-hairpin
visible. For both complexes, electron density for two
copies of the corresponding ligand per SimR dimer
was clearly present, occupying equivalent sites
related by 2-fold noncrystallographic symmetry
(Fig. 4b; Supplementary Fig. S3). At the protein
backbone level, the two ligand-bound structures of
SimR were closely similar. In pairwise superposi-
tions of individual subunits, the rmsd values were in
the range 0.66 to 0.75 Å, and a dimer-upon-dimer
superposition gave a value of 0.74 Å. In comparisons
between the SimR-apo and the two ligand-bound
structures at the subunit level, the most striking
difference is the concerted upward shift of the
α9–α10 arm upon ligand binding (Fig. 5a). Super-
positions of individual ligand-bound subunits upon
the SimR-apo subunit, based only on residues in thesubunit core (i.e. excluding α9–α10, specifically
residues 182–221), gave remarkably low rmsd values
in the range 1.01 to 1.09 Å. Thus, the cores are
extremely similar, andmost importantly, the relative
orientations of LBDs and DBDs within each subunit
remain essentially unchanged upon ligand binding.
At the dimer level, differences between the SimR-apo
and ligand-bound structures of SimR become more
pronounced due to a twisting motion at the dimer
interface. As a result, dimer-upon-dimer superposi-
tions (using core residues) gave larger values of 2.13
and 2.04Å for SimR-SD8 versus SimR-apo and SimR–
SC4 versus SimR-apo, respectively. This twisting
motion is more noticeable in comparisons where
only one subunit in each dimer is used for the
superposition (Fig. 6). When viewed from the side of
the dimer, one subunit rotates relative to the other by
around 8°. The axis of rotation passes through
equivalent points in each subunit roughly at the
interface between the LBD and DBD just above the
midpoint of α3. Because the pivot point is close to the
DBD, this small rotation has very little effect on the
separation of the recognition helices (Fig. 6); values
of 41.7 and 42.6 Å were obtained for SimR-SD8 and
SimR–SC4, respectively, being comparable to the
value of 42.3 Å obtained for the SimR-apo structure
(Fig. 2). The upwardmotion of the α9–α10 arm upon
ligand binding is, in part, correlated with the
movement of the adjacent subunit (Figs. 5 and 6).
This is because each arm is closely associated with
the opposing subunit and many of the interactions
are retained, including several hydrogen bonds at
the extremities of the arm (C-terminal end of α9 and
N-terminal end of α10).
As a result of the subunit rotation, the C-termini
move closer together. For example, the separation of
the terminal residues of α11 (i.e., Arg243) decreases
from 17.6 to 10.1 Å upon SD8 binding (Fig. 6); being
remote from the pivot point, conformational differ-
ences are more exaggerated here. In addition, there
is more subunit overlap, such that there is a modest
increase in the dimer interface area from 2475 to
2759 Å2 upon SD8 binding. Nonbonded protein–
protein interactions across the interfaces are exten-
sive in both conformational states, although there is
a slight increase in the number of pairwise inter-
atomic distances under 4 Å, from 297 in SimR-apo to
336 in SimR–SD8. More significant is the increase in
the number of protein–protein hydrogen bonds,
from 18 in SimR-apo to 30 in SimR–SD8 (values from
PDBsum§).33 Further analysis indicates that 12 of
these are retained between the two structures. These
comprise contacts between the α9–α10 arm of one
subunit and the α6–α7 loop and α7 of the other, and
between the α6–α7 loop of one subunit and α8 of the
other.
Fig. 5 (legend on next page)
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Fig. 6. Rotation of SimR subunits stabilised by ligand binding. Structures of SimR-apo and SimR–SD8 together with
schematic representations illustrating the rotation of the subunits relative to one another. For this figure only, the ‘front
view’ shows the dimer with the plane of the interface perpendicular to the paper (it differs from the ‘front view’ used
elsewhere by a ∼25° rotation around the vertical axis). In order to emphasize the subunit rotation, the cyan-coloured
subunits are shown fixed in the same relative orientations. This can be clearly seen in the side view where the yellow
subunit rotates by ∼8° relative to the cyan subunit; the approximate pivot point is indicated by the asterisk. The distances
separating the terminal residues of α11 (i.e., Arg243) in the two structures are marked.
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The SD8 and SC4 ligands bind to the same sites in
their respective complexes with SimR, such that
moieties common to both molecules occupy equiv-
alent positions in the binding pocket (Fig. 4;
Supplementary Fig. S3). Thus, only a detailed
description of the protein–ligand interactions for
SimR–SD8 is necessary. The SD8 molecule is bound
in an extended conformation spanning almost 30 Å,
making substantial contacts with both subunits of
the homodimer (Fig. 7; Supplementary Fig. S3). The
AC end is completely buried in the core of the SimR
dimer, in a pocket formed by residues from α4, α5,
α7, and α8 and several of the intervening loops from
one SimR monomer. The α6–α7 loop adopts a
different conformation in the ligand-bound struc-Fig. 5. Conformational differences between SimR-apo and
independent subunits from all three SimR structures (five in to
α9–α10 arms). Only the left-hand subunits from Fig. 2 are s
changes in α10 and in the α6–α7 loop. Also shown in the r
bonding network that is present in both structures. The SD8 m
(b) carbons (see also Supplementary Fig. S4).tures, thereby avoiding a steric clash between
Trp121 and the AC moiety. Otherwise, the AC
pocket is essentially preformed at the protein
backbone level in SimR-apo, only requiring a few
side chains to reposition themselves, most notably,
Gln135, Gln136, and Asn161. By contrast, the PK
end is partially exposed to bulk solvent in a
peripheral site that is formed almost exclusively by
helices α9 and α10 (i.e., the extended arm) of the
other monomer. The lower part of the PK binding
site is present in SimR-apo and corresponds to the
‘saddle’ resulting from the kink in α9 (Fig. 2). The
upper part of the site is completed in the ligand-
bound form as the result of the conformational
changes in the α9–α10 arm described below,
principally the unwinding of α10. In between the
AC and PKmoieties, the cavity widens considerablySimR–SD8. (a) Superposition of all crystallographically
tal) based only on the core residues (i.e., not including the
hown. (b) Close-up views illustrating the conformational
ight-hand panels is the Glu177–His125–Glu76 hydrogen-
olecules are shown in stick representation in red (a) or grey
Fig. 7. Schematic representation of the SD8-binding pocket of SimR. The ligand is shown in red and all residues within
4 Å of it are shown in black. Dotted lines indicate hydrogen bonds, and green arcs indicate nonbonded interactions. The
two water molecules (labelled ‘W’) that link Gln136 to the olivose moiety of SD8 are shaded blue. The grey line delineates
the boundary between the two subunits. For clarity, all hydrogens have been omitted.
49SimR-Apo and SimR–Ligand Complexes(Fig. 4). This is where the linker and the olivose
sugar are accommodated. What is particularly
striking about the binding of SD8 is that despite
the ligand having 19 atoms that could either donate
or accept a hydrogen bond, it makes a maximum of
only five direct hydrogen bonds to SimR (Fig. 7;
Supplementary Fig. S3). However, this is compen-
sated by the extensive van der Waals contacts with
the protein.
When comparing the SimR–SD8 and SimR–SC4
structures, we observed several minor differences
due to the absence of the ACmoiety in SC4. The side
chains of Gln135 and Gln136 in SimR–SC4, which
are displaced in SimR–SD8 due to the presence of
the ACmoiety, adopt conformations similar to those
found in SimR-apo (Supplementary Fig. S3). Simi-
larly, the α4–α5 surface loop differs slightly in
SimR–SC4 due to the lack of an interaction between
Thr86 and the ligand. Since these small differences
appear to influence neither the dimer interface nor
the DBD, they are unlikely to explain why SC4 is less
effective than SD8 at derepressing SimR in vitro.25
Rather, we speculate that this is simply a conse-
quence of the fewer favourable interactions that SC4
makes with the protein due to the lack of an AC
moiety, which is likely to result in a reduced binding
affinity of SC4 for SimR.
SD8 is a potent inhibitor of DNA gyrase and
functions by a novel mechanism, binding to the GyrA
subunit and preventingDNAbinding.20 Recently, the
crystal structure of the GyrA–SD8 complex was
determined, revealing the structural basis of enzyme
inhibition.19 SD8 binds to GyrA in an extended
conformation, with the PK and AC moieties occupy-
ing two separate binding pockets. As might beexpected, there is no correspondence between the
ligand-binding pockets in GyrA and SimR.
In free solution, the tetraene linker of SD8 would
be predicted to be linear, due to the conjugated
double bond system, as is observed in GyrA–SD8.19
However, in SimR–SD8, the tetraene linker of SD8
is curved. This presumably occurs because the
relative orientations of the AC and PK pockets are
incompatible with the linker remaining linear. Even
in SimR–SC4, the tetraene linker exhibits some
curvature.
Comparison to other TetR family ligand-binding
sites
The LBDs of TFRs are significantly more variable
than their DBDs, reflecting the plethora of ligands
that can be bound.8 Moreover, the manner in which
ligands are bound is highly variable. Even in
comparisons between SimR–SD8 and the ligand-
bound forms of the structurally closely related ActR
and TetR, it is clear that there is little correspondence
when the structures are superposed (Fig. 4b). The
long axis of actinorhodin crosses that of SD8 at an
angle of roughly 70°, while the majority of tetracy-
cline aligns loosely with the tetraene linker, rather
than with one of the ring systems of SD8. Where
structures of TFRs in complex with their cognate
ligands have been determined, the cognate ligands
are bound predominantly by one subunit of the
biological dimer: in ActR there is only one contact
with the second subunit, while in TetR there is none
(Fig. 3). By contrast, simocyclinone makes substan-
tial contacts with both subunits of the dimer (Figs. 2,
3, 4, and 7; Supplementary Fig. S3), with the
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involving the α9–α10 arm. The extent of the SD8
binding pocket is also unusual; the only other
example showing a pocket of comparable length is
the palmitoyl–CoA complex of DesT (PDB code
3LSJ).11 However, in this case, the pocket entrance is
at the top of the subunit and the ligand lies roughly
perpendicular to SD8, interacting mainly with a
single subunit (Supplementary Fig. S2e).
Conformational changes in SimR captured upon
ligand binding
Available evidence suggests that apo-TFRs sam-
ple a range of conformations and that ligand-
binding captures one of these conformations, rather
than inducing the conformational change.8,34 As a
consequence, we have assumed here that the same is
true of SimR.
In a superposition of the subunits from the various
SimR structures, the upward shift of the α9–α10 arm
in the ligand-bound form is the most striking
difference (Fig. 5a). Presumably, the α9–α10 arm is
carried along with the neighbouring subunit when
the two subunits rotate relative to one another as part
of the normal dynamic behaviour of the system, and
this conformational state is captured on ligand
binding (Fig. 6). However, the arm does not move
entirely as a rigid body: although α9 is essentially
unchanged, the C-terminal end of α10 partially
unwinds (it becomes two residues shorter), and the
now extended α10–α11 loop moves even further
upward, causing the remainder ofα10 to tilt upward.
The loop is stabilised in its new conformation by
additional intersubunit hydrogen bonds involving
Asp151 in α8 (Fig. 5b; Supplementary Fig. S4).
The net effect of these motions is that the channel
connecting the central cavity to bulk solvent in SimR-
apo closes, and a new one opens adjacent to it, which
is wide enough to accommodate the PK moieties of
SD8 and SC4 (Fig. 4). A more subtle effect of the
upward arm motion is that the C-terminal end of α8
bends towards the opposing subunit, leading to a
number of minor conformational changes in the
α8–α9 loop.
In all three SimR structures, there are two
symmetry-related hydrogen-bonding networks
that lie on either side of the pivot and link Glu177
in α8 of one subunit to His125 in the α6–α7 loop of
the other subunit, which in turn is hydrogen-bonded
to Glu76 in α4 of the same subunit (Fig. 5;
Supplementary Fig. S4). These networks may be
important for tethering the subunits to one another
and restraining intersubunit rotations.
The portion of the α6–α7 loop C-terminal to His125
remains unchanged, whereas the N-terminal portion
moves downward in the ligand-bound structures. At
the protein backbone level, the motion seems
relatively minor. However, the side chains of twobulky residues, namely, Trp121 and Arg122, flip
downward, with the tip of the latter moving by some
17 Å into the dimer interface, where it is salt-bridged
to Glu176 in α8 of the opposing subunit (Fig. 5;
Supplementary Fig. S4), thereby reciprocating the link
between α8 and the α6–α7 loop, involving Glu177
and His125, described above. In SimR-apo, the two
monomer cores (i.e., excluding the α9–α10 arms)
present relatively flat surfaces to one another, and
thus could potentially slide past each other without
steric restraint. However, in the ligand-bound form,
the two copies of Arg122 project across the dimer
interface into pockets in the surfaces of the opposing
monomers (Fig. 8). Thus, they may act as retaining
pins, effectively locking the subunits together.
The mechanism of derepression in SimR
It is widely accepted that the derepression of TFRs
involves allosteric mechanisms, since their ligand-
binding sites are remote from their DBDs.1,8 It may
be significant that the majority of characterized TFR
ligand-binding sites are contained almost entirely
within individual subunits, and that for those TFRs
for which ligand-bound and DNA-bound structures
are available, the allosteric mechanism involves
conformational changes transmitted largely within
the same subunit.6,7,9–11 The binding of ligands to
these sites captures a conformational state in which
the DBD (the recognition helix in particular) is
repositioned relative to the LBD such that the
dimer is prevented from binding to cognate DNA.
Nevertheless, intersubunit communication appears
to play a role in some systems (e.g., QacR9 and
CgmR)10 as the binding of ligands by one subunit
can render the other subunit incapable of doing the
same. In SimR, the binding of SD8 stabilises a
number of conformational changes, the most signif-
icant of which occur at the dimer interface. These
changes have the effect of repositioning the two
subunits of the dimer relative to one another and
locking them in this new configuration. It seems
likely that the side chain of Arg122 in the α6–α7 loop
is important for this locking mechanism (Fig. 8).
Moreover, it also seems likely that further rigidity is
imparted on the system by the ligand, which threads
through both subunits. Indeed, the induced curva-
ture of the tetraene linker of bound SD8 may be
indicative of the forces required to maintain the
protein in the derepressed state.
In the derepression mechanism of TetR, the
principal changes upon ligand binding are an
upward movement of the α6–α7 loop (i.e., away
from the DBD), a partial unwinding of α6, and a
‘pendulum-like’ swing of α4 around its C-terminal
end that repositions the DBD relative to the LBD
such that the two recognition helices move further
apart to a configuration that would abrogate binding
to DNA.6,7,35–37 By contrast, in SimR, although there
Fig. 8. Putative derepression mechanism of SimR. Semi-transparent cartoon and molecular surface representations of
(a) SimR-apo and (b) SimR–SD8. The left-hand panels show the front view and the right-hand panels show the bottom
view. The symmetry equivalent Arg122 residues are coloured blue (and shown in stick representation for the cartoons)
and the ends of the side chains are indicated by the black arrows; SD8molecules are shown as red sticks. In SimR–SD8, the
interdigitation of the Arg122 side chains is most apparent in the right-hand panels.
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instead of up, and there is no unwinding of α6.
Furthermore, α4 does not swing at all, and thus the
relative dispositions of the LBDs and DBDs within
individual subunits of SimR remain essentially
unchanged. Therefore, in both SimR-apo andSimR–SD8, the recognition helices are too far apart
to allow SimR to bind DNA (Fig. 2). This is also true
for the apo and ligand-bound states of TetR37 and
ActR.13
How does ligand binding prevent SimR from
binding to DNA? It has been assumed that the
52 SimR-Apo and SimR–Ligand Complexesligand-free form of SimR is sufficiently dynamic in
solution that it can readily sample different confor-
mational states. Davidson and colleagues performed
equilibrium unfolding experiments on wild-type
TetR and proposed that the thermodynamic cou-
pling of TetR domains, in particular, the rigidifica-
tion of the DBDs upon ligand binding, underlies the
allosteric response in TetR.34 For SimR, we speculate
that a DNA-binding conformation could be
achieved largely through rigid-body motions of
the subunits about a pivot point towards the upper
end of the LBD, without invoking significant
repositioning of the DBDs relative to the LBDs.
Such a conformational change would be disfa-
voured in the ligand-bound structures due to a
combination of factors, including the rigidity im-
posed on the system by the ligand threading
through both subunits and the increased number
of favourable intersubunit contacts, in particular, the
interdigitation of the Arg122 side chains (Fig. 8),
together preventing DNA binding by SimR–SD8.
Conclusion and summary
SimR is a TetR-family transcriptional regulator
that provides a mechanism that couples the biosyn-
thesis of the antibiotic simocyclinone to its export in
the producing organism S. antibioticus. We have
determined the crystal structures of the protein in
the absence of ligands and in complexes with the
mature antibiotic SD8 and with the biosynthetic
intermediate SC4. SimR displays the α-helical fold
typical of TFRs and exists as a homodimer. In
addition to the usual nine helices, the SimR
monomer has an insertion of two extra helices,
prior to the C-terminal helix, which together form an
arm that wraps around the opposing subunit. This
feature is only found in a subfamily of TFRs that
includes ActR and TetR, which are close structural
homologues of SimR.8 Furthermore, SimR has an
N-terminal, Arg-rich β-hairpin motif that is not
observed in other TFR structures, which appears to
be ideally placed to engage with phosphate groups
in the minor groove of DNA.
The ligand-bound structures of SimR reveal an
extended binding pocket that, unusually for TFRs,
spans both subunits in the functional dimer.
Interactions with one subunit almost exclusively
involve the α-helical arm, which is reconfigured in
the ligand-bound form. Through comparisons of
these structures, we are able to postulate a
derepression mechanism for SimR that involves
rigid-body motions of the subunits relative to one
another, coupled with a locking mechanism that
most likely prevents further conformational change,
holding the DBDs too far apart for DNA binding.
SimR vividly illustrates the versatility of TFRs in
their ability to recognise and respond to diverse
ligands.Materials and Methods
Protein overexpression and purification
The simR gene of S. antibioticus Tü 6040 encoding a 259-
amino-acid protein was chemically synthesized with
codon optimization (Genscript) for expression in E. coli
and was subsequently engineered for expression with
either an N-terminal or a C-terminal His6-tag for nickel-
affinity purification. Construction of the vector for
expression of N-terminally tagged protein, pIJ10495, has
been described.38 This encodes a protein with an
additional 26 amino acids at the N-terminus of the native
sequence (with sequence MK-H6-PMSDYDIPTTEN-
LYFQGA), giving a total molecular weight of 32,222. For
expression with a C-terminal tag, the gene was amplified
by PCR using an upstream primer carrying an NdeI site
[R2-Cter-shrt-F: 5′-GATCATATGAACGAAAAC-
GAACCGGTGAG-3′] and a downstream primer carrying
an XhoI site [R2-Cter-shrt-R: 5′-GATCTCGAGCGC-
CAGCGCCGGGCGTTCGC-3′]. The amplified DNA frag-
ment was 5′-phosphorylated, cloned into SmaI-cut
pUC18, and verified by DNA sequencing. The simR
coding sequence was excised by NdeI/XhoI digestion
and cloned into NdeI–XhoI-cut pET20b, giving rise to the
overexpression plasmid (pIJ10499). This encodes a protein
with an additional 8 amino acids at the C-terminus of the
native sequence (with sequence LE-H6), giving a total
molecular weight of 30,197.
For N-terminally His-tagged SimR expression, vector
pIJ10495 was introduced into E. coli BL21(pLysS), and a
7-ml overnight culture was used to inoculate 500 ml of
Luria-Bertani medium containing 50 mg kanamycin and
15 mg chloramphenicol. The cells were grown at 37 °C to
OD600 of ∼0.4. The culture was cooled to 20 °C, and 0.7 ml
of dimethylsulfoxide (DMSO) was added before induction
of protein expression by the addition of IPTG to a final
concentration of 0.3 mM. The addition of DMSO was
essential for a high yield of soluble SimR, presumably
because it artificially induces the expression of chaperones
that assist in the folding of SimR in vivo. The culture was
incubated with shaking for 3 h at 30 °C. Harvested cells
were resuspended in 50 mM Tris-HCl (pH 8.4), 300 mM
NaCl, 5% (v/v) glycerol, containing a Complete EDTA-
free protease inhibitor cocktail (Roche), and lysed by
sonication (three cycles of 20 s with 40-s resting on ice in
between each cycle). The cell debris was removed by
centrifugation at 84,000g for 30 min, and the supernatant
was filtered through a 0.45-μm membrane before being
applied to a 1-ml Ni-loaded Hi-Trap Chelating HP column
(GE Healthcare) that had been equilibrated with buffer A
[50 mM Tris-HCl (pH 8.4), 300 mM NaCl, 50 mM
imidazole]. Protein was eluted from the column using
an increasing (50 to 500 mM) imidazole gradient in the
same buffer. SimR fractions were identified using SDS-
PAGE, pooled together, and concentrated to approxi-
mately 5–10 mg ml−1 using a Vivaspin 6 10-kDa cutoff
concentrator (Vivascience). The concentrated protein was
immediately exchanged into crystallization buffer
[25 mM Tris-HCl (pH 8.4), 300 mM NaCl] using a
Zeba desalting micro-column (Thermo Scientific).
Selenomethionine-(SeMet)-labelled SimR was obtained
by the metabolic inhibition method.39 E. coli BL21(pLysS)
cells containing pIJ10495 were grown in 2 l of M9 medium
53SimR-Apo and SimR–Ligand Complexesat 37 °C. When OD600 reached∼0.4, lysine, phenylalanine,
and threonine were added to a final concentration of
100 mg l−1 each, and isoleucine, leucine, valine, and SeMet
were added to a final concentration of 50 mg l−1 each. The
culture was incubated for a further 30 min at 37 °C and
then induced with 1 mM IPTG for 3 h. The purification of
SeMet-labelled SimR followed the protocol describedTable 1. Summary of SimR X-ray data and model parameters
Data seta
Native apo
(N-tag)
SeMet apo
(N-tag)
Data collection
Space group H32 H32
Cell parameters (Å/°) a=b=116.62,
c=110.58
a=b=116.11,
c=110.35
Solvent content (%) 45 45
Beamlineb I03 I03
Wavelength (Å) 0.9763 0.9763
Resolution rangec (Å) 48.50–2.30
(2.42–2.30)
48.37–3.40
(3.58–3.40)
Unique reflectionsc 12,693 (1786) 4076 (585)
Completenessc (%) 98.0 (95.2) 99.9 (100.0)
Redundancyc 5.0 (3.8) 15.2 (15.7)
Rmerge
c,d 0.093 (0.523) 0.158 (0.422)
Mean I/σ(I)c 10.2 (2.3) 14.4 (6.8)
Wilson B value (Å2) 57.9 78.4
Refinement
Reflections: working/freee
Rwork
f — —
Rfree
f — —
Coordinate errorg (Å) — —
Ramachandran
favoured/allowedh (%)
— —
Ramachandran outliersh — —
rmsd bond distances (Å) — —
rmsd bond angles (°) — —
Contents of model — —
Protein residues in each chain
(total no. of residues)
— —
SD8/SC4 molecules — —
PEG molecules — —
Calcium ions — —
Chloride ions — —
Water molecules — —
Temperature factors (Å2)
Main-chain atoms
Side-chain atoms
SD8/SC4 molecules
PEG molecules
Calcium ions
Chloride ions
Water molecules
Overall
PDB accession code — —
a Protein was either N-terminally (N-tag) or C-terminally (C-tag) H
b I02, I03, I04: beamlines at the Diamond Light Source (Oxfordshir
c The figures in parentheses indicate the values for outer resolution
d Rmerge=∑hkl∑i|Ii(hkl)− 〈I(hkl)〉|/∑hkl∑iIi(hkl), where Ii(hkl) is the it
intensity for all observations i of reflection hkl.
e The data sets were split into ‘working’ and ‘free’ sets comprising 9
refinement.
f The R-factors Rwork and Rfree are calculated as follows: R=∑(|Fobs
calculated structure factor amplitudes, respectively.
g Estimate of the overall coordinate errors calculated in REFMAC5
h Calculated using MOLPROBITY.52above except that all buffers were degassed and contained
0.5 mM DTT to prevent protein oxidation.
C-terminally His-tagged SimR was produced from the
overexpression plasmid pIJ10499 using the same proce-
dure as for the N-terminally His-tagged protein, except
that the medium was supplemented with 25 mg carbeni-
cillin in place of kanamycin.Native apo
(C-tag)
SD8 complex
(C-tag)
SC4 complex
(C-tag)
H32 C2 P6522
a=b=116.06,
c=109.38
a=147.37, b=83.91,
c=45.47, β=90.94
a=b=86.57,
c=349.86
48 47 61
I02 I04 I02
0.9700 0.9400 0.9700
48.04–1.95
(2.06–1.95)
42.39–2.30
(2.42–2.30)
63.06–2.30
(2.42–2.30)
20,761 (3005) 23,951 (2988) 34,449 (4983)
99.8 (100.0) 97.0 (83.4) 97.3 (98.5)
7.8 (7.9) 2.9 (2.3) 8.4 (8.5)
0.070 (0.570) 0.077 (0.229) 0.109 (0.372)
20.6 (3.8) 10.3 (3.3) 15.4 (5.4)
31.8 30.7 28.8
19,717/1044 22,723/1227 32,723/1726
0.205 0.200 0.198
0.234 0.270 0.246
0.149 0.265 0.210
97.2/98.8 98.2/99.8 99.0/100.0
3 1 0
0.018 0.017 0.017
1.57 1.46 1.58
A: 7–244 (238) A: 5–11, 27–246 (227) A: 6–247 (242)
B: 8–10, 28–247 (223) B: 5–15, 26–246 (230)
0 2 2
0 0 2
0 0 1
0 6 8
121 164 277
36.9 24.4 19.3
39.9 25.6 21.6
— 23.8 23.7
— — 37.2
— — 24.3
— 60.0 37.9
20.4 22.8 25.1
37.3 24.9 21.0
2Y2Z 2Y30 2Y31
is tagged.
e, UK).
shell.
h observation of reflection hkl and 〈I(hkl)〉 is the weighted average
5% and 5% of the data, respectively. The free set was not used for
−Fcalc|)/∑|Fobs|×100, where Fobs and Fcalc are the observed and
based on Rfree.
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54 SimR-Apo and SimR–Ligand ComplexesProtein crystallization and cryoprotection
Crystallization screens and optimizations were per-
formed as described,38 using a protein concentration of
approximately 5 mg ml− 1 and a temperature of 20 °C
throughout. Crystals of N-terminally His-tagged SimR-
apo (both native and SeMet labelled) were obtained from
2% (w/v) polyethylene glycol (PEG)-10000, 0.2 M ammo-
nium acetate in 0.1 M Bis-Tris (pH 5.5). Subsequently,
C-terminally His-tagged protein was found to yield better-
quality crystals from the same conditions. All SimR-apo
crystals were cryoprotected by supplementing the crystal-
lization solution with 30% (w/v) PEG-1500.
Simocyclinones D8 and C4 were isolated from S.
antibioticus Tü 6040 as described.21,22 Both compounds
were dissolved in DMSO and then diluted in crystalliza-
tion buffer [25 mM Tris-HCl (pH 8.4), 300 mM NaCl] to a
concentration of 500 μMprior to mixing with C-terminally
His-tagged SimR: an equal volume of 10 mg ml− 1 protein
was slowly titrated into the above solution, with thorough
mixing, to give a final concentration of 5 mg ml− 1 SimR.
The final concentration of DMSO did not exceed 1% (v/v).
Crystals of the SimR–SD8 complex grew from 25% (w/v)
PEG-1000 in 0.1 M sodium acetate (pH 4.6) and were
cryoprotected by supplementing the crystallization solu-
tion with 32% (w/v) PEG-1500. Crystals of the SimR–SC4
complex grew from 28% (v/v) PEG-400, 0.2 M CaCl2 in
0.1 M Hepes (pH 7.5). Due to the presence of PEG-400 in
the mother liquor, no further cryoprotection was required
for these crystals.
Structure determination and refinement
All crystals were flash-cooled by plunging into liquid
nitrogen and then mounted in Unipuck cassettes before
being robotically mounted onto the goniostat on station
I02, I03, or I04 at the Diamond Light Source (Oxford, UK)
and were maintained at −173 °C with a Cryojet cryocooler
(Oxford Instruments). Diffraction data were recorded
using an ADSC Quantum 315 CCD detector. The resultant
data were integrated using MOSFLM40 and subsequently
scaled by SCALA.41 Native data were collected from an
apo crystal of the N-terminally His-tagged SimR to 2.3-Å
resolution in space group H32, as described.38 Solvent
content estimation gave a value of 45% based on a single
copy of the monomer in the ASU. A single apo SeMet-
labelled crystal of N-terminally His-tagged SimRwas used
to collect a selenium anomalous peak data set at 3.4-Å
resolution with the wavelength set to 0.9763 Å. Experi-
mental phases were determined by the single-wavelength
anomalous dispersion method using the SHELX suite42
implemented through the HKL2MAP graphical user
interface.43 Substructure solution was performed with
SHELXD, and seven of the expected nine selenium sites in
the native sequence were located. This solution gave a
figure-of-merit of 0.541- to 3.4-Å resolution after phasing in
SHELXE. After density modification with PARROT,44 a
partial backbone trace was obtained with BUCCANEER.45
At the same time, an approximate molecular replacement
solution was obtained from the 2.3-Å-resolution native
data set using the BALBES pipeline46 (with a molecular
replacement score of 2.63), which selected the structure of
Sco6599 as a template (PDB accession code 2HXI; sequence
identity with SimR, 25.4%). The BUCCANEER model andthe BALBES solution were then brought to the same
origin after visual inspection in COOT.47 The BALBES
model was subsequently rebuilt against the experimen-
tally phased electron density map at 3.4-Å resolution and
then refined against the 2.3-Å-resolution native data set
using REFMAC5.48 At this stage, the model contained
only 118 residues and had Rwork and Rfree values of
50.6% and 51.7%, respectively. The refined model phases
were then combined with the experimental phase
information using the program SIGMAA49 to give
improved phases. Further iterations of rebuilding,
refinement, and phase combination were performed
until a model consisting of 165 residues was obtained,
with corresponding Rwork and Rfree values of 36.3% and
40.0%, respectively. Thereafter, the model was refined
against a new data set (but for C-terminally His-tagged
SimR-apo instead) collected to 1.95-Å resolution, whereup-
on the electron density maps were significantly improved.
Additional cycles of rebuilding and refinement yielded a
model consisting of 238 residues, with corresponding Rwork
and Rfree values of 20.5% and 23.4%, respectively.
The SD8 and SC4 complexes with SimR each yielded
new crystal forms containing two SimR protomers per
ASU. In both cases, the structures were solved by
molecular replacement using the structure of the C-
terminally His-tagged SimR-apo monomer as the search
model. The SimR–SD8 structure was solved using
MOLREP,50 and the SimR–SC4 structure using PHASER.51
The two complex structures were then rebuilt and refined
as for SimR-apo. All X-ray data collection and refinement
statistics are summarized in Table 1.
Difference electron density ‘omit’ maps were generated
for the SD8 and SC4 ligands using phases calculated from
the final model minus the ligand coordinates after
simulated annealing refinement (Fig. 4; Supplementary
Fig. S3). This was performed from a starting temperature
of 5000 K after applying random shifts to the model
(‘shake’ term set to 0.3) using PHENIX.53 Structural
figures were generated using PyMOL.54
Accession numbers
Coordinates and structure factors for the three SimR
structures described herein have been deposited in the
Protein Data Bank with accession numbers 2Y2Z, 2Y30,
and 2Y31.
Supplementary materials related to this article can be
found online at doi:10.1016/j.jmb.2011.02.035Acknowledgements
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ABSTRACT
SimR, a TetR-family transcriptional regulator (TFR),
controls the export of simocyclinone, a potent DNA
gyrase inhibitor made by Streptomyces antibioticus.
Simocyclinone is exported by a specific efflux pump,
SimX and the transcription of simX is repressed by
SimR, which binds to two operators in the
simR-simX intergenic region. The DNA-binding
domain of SimR has a classical helix-turn-helix
motif, but it also carries an arginine-rich
N-terminal extension. Previous structural studies
showed that the N-terminal extension is disordered
in the absence of DNA. Here, we show that the
N-terminal extension is sensitive to protease
cleavage, but becomes protease resistant upon
binding DNA. We demonstrate by deletion analysis
that the extension contributes to DNA binding, and
describe the crystal structure of SimR bound to its
operator sequence, revealing that the N-terminal ex-
tension binds in the minor groove. In addition, SimR
makes a number of sequence-specific contacts to
the major groove via its helix-turn-helix motif.
Bioinformatic analysis shows that an N-terminal ex-
tension rich in positively charged residues is a
feature of the majority of TFRs. Comparison of the
SimR–DNA and SimR–simocyclinone complexes
reveals that the conformational changes associated
with ligand-mediated derepression result primarily
from rigid-body rotation of the subunits about the
dimer interface.
INTRODUCTION
The genus Streptomyces accounts for the production of
approximately two-thirds of the known antibiotics (1,2).
By producing and expelling these compounds into their
environment, these bacteria likely acquire a competitive
advantage over other organisms inhabiting the same eco-
logical niche. One such antibiotic, simocyclinone, a potent
inhibitor of DNA gyrase produced by Streptomyces
antibioticus Tu¨ 6040 (3–5), consists of a chlorinated
aminocoumarin connected to an angucyclic polyketide at
the other end via a tetraene linker and a D-olivose sugar
(6,7). Because antibiotics are often potentially lethal to the
producing organism, there must be mechanisms to ensure
that the machinery responsible for export of the mature
antibiotic is in place at the time of biosynthesis. In the case
of simocyclinone, such a mechanism is speciﬁed by two
genes, simR and simX, embedded within the simocyclinone
(sim) biosynthetic gene cluster (8–10). The SimR/SimX
pair resembles the TetR/TetA repressor–efﬂux pump
pair that confers resistance to clinically important tetra-
cyclines in several human pathogens (11). Simocyclinone
is exported from the producing organism by the SimX
efﬂux pump, a member of the major facilitator superfam-
ily. The transcription of simX is repressed by SimR,
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a TetR-family transcriptional regulator (TFR) that binds
to two distinct operators in the intergenic region between
the divergently transcribed simR and simX genes (9).
Simocyclinone abolishes DNA binding by SimR,
inducing expression of the SimX efﬂux pump, providing
a mechanism that couples the biosynthesis of
simocyclinone to its export (9).
TFRs are one of the major families of transcriptional
regulators in bacteria (12,13). They function as
homodimers, with each subunit consisting of two
domains: an N-terminal DNA-binding domain (DBD)
containing a helix-turn-helix (HTH) motif, and a
C-terminal ligand-binding domain (LBD) (12,13). While
the LBDs are diverse in amino acid sequence, reﬂecting
the wide range of molecules to which different TFRs
respond, the HTH DNA-binding motif is conserved and
readily predicted bioinformatically. To date, the structures
of only four TFRs bound to cognate DNA have been
determined (TetR, DesT, CgmR and QacR), and it is
clear that the mode of operator recognition differs from
one member of the TFR family to another (14–17). For
example, the tetracycline efﬂux pump repressor, TetR,
binds as a dimer to a 15-bp operator and deforms the
binding site by 17, bending away from the protein in
order to optimize the position of its HTH for speciﬁc
base pair interaction (16). In contrast, the multidrug
efﬂux pump repressor from Staphylococcus aureus,
QacR, binds its cognate DNA site as a dimer of dimers
and bends its operator by just 3, but widens the major
groove to create an optimal DNA environment for a
second QacR dimer to bind cooperatively nearby (17).
Recently, we determined the structures of apo
(unliganded) SimR and SimR in complex with either
simocyclinone D8 (SD8) or its biosynthetic intermediate
simocyclinone C4 (SC4) (18). These structures revealed the
same overall domain architecture for SimR as for other
TFRs, including a classical HTH motif. However, SimR
possesses an additional arginine-rich N-terminal extension
that precedes the core DBD, which is signiﬁcantly longer
than those present in the four TFRs for which protein–
DNA crystal structures are available (TetR, DesT, CgmR
and QacR) (Figure 1). With the exception of three
residues, this 28 amino acid residue extension is disordered
in both subunits in the SimR–SD8 structure, and it is only
partially ordered in one subunit in the SimR–SC4 struc-
ture (18). Consistent with this, the N-terminal extension of
SimR is predicted to be disordered in solution.
Here, we show by deletion analysis that the ﬂexible
N-terminal extension of SimR plays an important role in
DNA binding, and we present the crystal structure of
SimR bound to its operator sequence, which shows that
this extension binds in the minor groove adjacent to the
major groove occupied by the classical HTH motif.
Although the N-terminal extension is hypersensitive to
proteolysis in vitro, it becomes protease resistant upon
binding cognate DNA. Together these data suggest that
the N-terminal extension transitions from a disordered to
an ordered state upon DNA binding. Bioinformatic
analysis of the entire TetR family shows that an
N-terminal extension rich in positively charged residues
is a feature of the majority of TFRs. Finally, comparison
of the SimR–DNA and SimR–SD8 complexes reveals the
conformational changes required to interchange between
DNA- and ligand-bound states, which largely involve
rigid-body motions of the subunits relative to one another.
MATERIALS AND METHODS
Protein overexpression and puriﬁcation
The simR gene of Streptomyces antibioticus Tu¨ 6040
encoding a 259 amino acid protein was chemically
synthesized with codon optimization (Genscript) for
expression in Escherichia coli and was subsequently engin-
eered for expression with a C-terminal hexa-histidine
(His6) tag for nickel afﬁnity puriﬁcation. Construction of
the vector for expression of C-terminally tagged protein,
pIJ10499, has been described previously (18). This results
in a puriﬁed protein with an additional 8 amino acid
residues at the C-terminus of the native sequence
(with sequence LEHHHHHH), giving a total molecular
weight of 30 197Da.
For expression of N-terminally truncated SimR (lacking
10, 15, 22 or 25 amino acid residues from the N-terminus),
the gene was ampliﬁed by PCR using a downstream
primer carrying a XhoI site [R2-full-CtagHis-R: 50-GAT
CTCGAGCGCCAGCGCCGGGCGTTCGC-30] and
an upstream primer carrying an NdeI site
.   .         .        .                        .      .   .      .
MNENEPVSIWMHPEPAGRRSARSHRTLSRDQIVRAAVKVAD.TEGVEAASMRRVAAELGAGTMSLYYYVPTKEDL
................MASPRAEQKQQTRHALMSAARHLMESGRGFGSLSLREVTRAAGIVPAGFYRHFSDMDQL
......................MMSRLNRESVIDAALELLN.ETGIDGLTTRKLAQKLGIEQPTLYWHVKNKRAL
.......................MRTSKKEMILRTAIDYIG.EYSLETLSYDSLAEATGLSKSGLIYHFPSRHAL
.........................MNLKDKILGVAKELFI.KNGYNATTTGEIVKLSESSKGNLYYHFKTKENL
SimR
DesT
TetR
CgmR
QacR
a1 a2 a3N-terminal extension
The HTH
The core DBD
1                         10                           20       30                           40              50                           60                  70                 
Figure 1. Alignment of the amino acid sequence of SimR with the four other TFRs for which protein–DNA crystal structures are available (DesT,
TetR, CgmR and QacR), showing the HTH motif, the core DBD and the N-terminal extension present in SimR, herein termed the TFR arm.
For each TFR, amino acid residues that interact with the bases of the cognate DNA operator are highlighted in red, and those that contact the
phosphate backbone are highlighted in green. Conserved residues are boxed.
2 Nucleic Acids Research, 2011
 at BBSRC on August 18, 2011
n
a
r.o
xfordjournals.org
D
ow
nloaded from
 
[R2-M10-trunc-F-NdeI (for SimR-10): GCCCATATG
ATGCATCCGGAACCGGCCGG; R2-A15-trunc-
F-NdeI (for SimR-15): GCCCATATGGCCGGTCGT
CGCAGCGCGCG; R2-S22-trunc-F-NdeI (for
SimR-22): GCCCATATGAGCCACCGTACCCTGA
GCCG; R2-T25-trunc-F-NdeI (for SimR-25): GCCCA
TATGACCCTGAGCCGCGATCAGATTG]. The amp-
liﬁed DNA fragment was 50-phosphorylated, cloned into
SmaI-cut pUC18 and veriﬁed by DNA sequencing. The
simR alleles were excised by NdeI/XhoI digestion and
cloned into NdeI–XhoI-cut pET20b, giving rise to the
overexpression plasmids pIJ10500 (10), pIJ10501
(15), pIJ10502 (22) and pIJ10503 (25). All deriva-
tives of SimR were C-terminally His-tagged and puriﬁed
as described for wild-type SimR (18).
Protein crystallization and cryoprotection
Directly after nickel-afﬁnity puriﬁcation, fractions of
full-length SimR were pooled and concentrated using a
Vivaspin 6 30-kDa cut-off concentrator (Vivascience) to
10–12mgml1 (200 mM SimR dimer). The concentrated
protein was exchanged into crystallization buffer [25mM
Tris–HCl (pH 8.4), 300mM NaCl] using a Zeba desalting
micro-column (Thermo Scientiﬁc). Complementary pairs
of DNA oligonucleotides with different lengths (16–21 bp)
and ends (blunt or sticky ends) were ordered from Oligos
etc and DNA duplexes were reconstituted by annealing
oligonucleotide pairs overnight in crystallization buffer at
a ﬁnal concentration of 2mM.
SimR and annealed oligonucleotides were mixed
together in the ratio 1 SimR dimer to 1.2 double-stranded
oligonucleotide and incubated at 20C for 10min before
crystallization screening. Crystallization trials of SimR–
DNA were set-up in hanging-drop vapour diffusion
format with 48-well VDX plates (Hampton Research)
using a variety of commercially available screens
(Emerald BioSystems and Hampton Research) at a
constant temperature of 20C. Drops consisted of 1 ml
SimR–DNA complex solution mixed with 1 ml precipitant
solution and the reservoir volume was 150 ml. Improved
crystals were subsequently obtained by reﬁning the suc-
cessful conditions in a hanging-drop format using 24-well
VDX plates (Molecular Dimensions) over a reservoir
volume of 1ml.
SimR–DNA crystals were obtained under several differ-
ent screening conditions, but only with the blunt-ended
17-mer DNA. The best crystals were obtained from solu-
tions containing 10% (w/v) polyethylene glycol 8000,
0.2M potassium chloride, 0.1M magnesium acetate in
0.05M sodium cacodylate (pH 6.5) 2weeks after set-up.
The crystals belonged to the orthorhombic space group
P212121. The SimR–17-mer crystals were cryoprotected
by a three-step transfer process in which ethylene glycol
was added to the drop to a ﬁnal concentration of 20%.
Structure determination and reﬁnement
All crystals were ﬂash-cooled by plunging into liquid
nitrogen and then mounted onto the goniostat at
beamline 8.3.1 at the Advanced Light Source (Berkeley,
CA, USA). The resultant data were integrated using
MOSFLM (19) and subsequently scaled by SCALA
(20). Native intensity data were collected from a SimR–
17-mer crystal to 2.99 A˚ resolution. The reﬂections used to
calculate the R-free value were selected in thin resolution
shells to avoid bias resulting from the use of
non-crystallographic symmetry (NCS) restraints in reﬁne-
ment. The structure of the complex was solved by molecu-
lar replacement using the structure of a subunit of
C-terminally hexa-histidine-tagged apo SimR (PDB:
2Y2Z) and an idealized B-DNA of the correct sequence
as the search models in PHASER (21). SimR–17mer
crystals contained two SimR dimer–DNA complexes in
the asymmetric unit. The structure of the complex was
then rebuilt in COOT (22) and reﬁned using REFMAC5
(23) and PHENIX (24) with NCS restraints. In the ﬁnal
stages, TLS reﬁnement was used with a total of 20 TLS
domains, which were deﬁned using the TLS motion deter-
mination server (http://skuld.bmsc.washington.edu/
tlsmd/) (25). X-ray data collection and reﬁnement stat-
istics are summarized in Table 1.
Structural ﬁgures were generated using PyMOL (26).
The local DNA helical parameters were calculated using
Curves+ (27).
Table 1. Selected crystallographic data
Data set SimR–DNA (17-mer)
Data collection
Space group P212121
Cell parameters (A˚/) a=85.8, b=112.6, c=163.7
Solvent content (%) 62.5
Wavelength (A˚) 1.11
Resolution rangea (A˚) 92.78–2.99 (3.15–2.99)
Unique reﬂectionsa (#) 31 030 (4547)
Completenessa (%) 95.2 (96.5)
Redundancya 3.1 (3.1)
Rmerge
b (%) 10.0 (59.1)
<I>/<sI> 8.3 (1.8)
Wilson B value (A˚2) 53.4
Reﬁnement
Rcryst
c (based on 95% of data) 20.9
Rfree
c (based on 5% of data) 25.1
Coordinate errord (A˚) 0.420
Ramachandran favourede (%) 98.0
Ramachandran outlierse (%) 0.22
RMSD bond distances (A˚) 0.010
RMSD bond angles () 1.22
Mean B-value for protein (A˚2) 57.6
Mean B-value for the DNA (A˚2) 54.6
Contents of model
Protein residues in each chain
(totals in brackets)
A: 7–241 B: 7–15 and
26–242 C: 7–242 D: 7–15
and 26–242
DNA nucleotides E and F, G and H : 1–17
PDB accession code 3ZQL
aThe ﬁgures in brackets indicate the values for highest resolution shell.
bRmerge=
P
hkl
P
i |Ii(hkl)  hI(hkl)i|/
P
hkl
P
iIi(hkl), where Ii(hkl) is
the ith observation of reﬂection hkl and hI(hkl)i is the weighted average
intensity for all observations i of reﬂection hkl.
cThe R-factors Rcryst and Rfree are calculated as follows: R=P
(|FobsFcalc |)/
P
| Fobs |  100, where Fobs and Fcalc are the
observed and calculated structure factor amplitudes, respectively.
dEstimate of the overall coordinate errors calculated in REFMAC5
based on Rfree (23).
eAs calculated using MOLPROBITY (45).
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Electrophoretic mobility shift assays
The electrophoretic mobility shift assay (EMSA) DNA
probe spanning the entire simR–simX intergenic region
(138 bp), containing both the OX and OR operators, was
ampliﬁed by PCR and 50-end labelled using [g32-P] ATP
and T4 polynucleotide kinase (New England Biolabs).
Binding of wild-type or mutated SimR to DNA was
carried out in 20 ml EMSA Buffer [20mM Tris (pH 8.0),
1 mg calf-thymus DNA, 100mM NaCl, 8% (v/v) glycerol]
containing 0.1 nM radiolabelled DNA (8000 cpm) and
varying amounts of SimR. After incubation at 22C for
10min, the binding reaction mixtures were loaded on 5%
(w/v) native polyacrylamide gels and run in TBE buffer at
100V for 45min. EMSA data were collected and analysed
on a PhosphoImager (FujiFilm) using Multi Gauge image
analysis software (FujiFilm).
DNase I footprinting
Templates for DNase I footprinting were ampliﬁed by
PCR using one unlabelled primer and one primer 50-end
labelled using [g32-P] ATP and T4 polynucleotide kinase
(New England Biolabs). The primers were the same pair
used to generate the simR–simX intergenic region probe
for the EMSA experiments. DNase I footprinting assays
were performed in 40 ml EMSA buffer containing
180 000 cpm radiolabelled DNA and varying amounts
of SimR. After incubation at 22C for 10min, 10 ml DNase
I solution (10 U in 10mM CaCl2) was added and the in-
cubation was continued for a further 60 s. Reactions were
stopped by adding 140 ml DNase I stop solution (200mM
unbuffered sodium acetate, 30mM EDTA, 0.15% SDS
and 0.1mgml1 yeast tRNA), the samples were
precipitated with ethanol and the pellets were dried and
dissolved in 5 ml Sequencing Loading Dye [80% (v/v)
formamide, 10mM NaOH, 1mM EDTA, 0.1% (w/v)
xylene cyanol and 0.1% (w/v) bromophenol blue]. After
heating at 80C for 3min and cooling on ice, the samples
were run on a 6% (w/v) polyacrylamide/8M urea
sequencing gel, which was dried and analysed using a
PhosphoImager (FujiFilm). A G+A sequencing ladder
was generated from the template DNA by chemical
sequencing (28).
Limited proteolysis and protease protection assays
For limited proteolysis assays, 1 nmol of wild-type SimR
was incubated with 1 pmol bovine trypsin (Sigma) in a
total volume of 100 ml buffer [50mM Tris (pH 8.0),
20mM CaCl2 and 150mM NaCl] at 4
C. For protease
protection assays, 1 nmol wild-type SimR was incubated
with equimolar amounts of 15, 25 or 31-mer
double-stranded oligonucleotide containing the SimR OX
operator in a total reaction volume of 100 ml for 5min at
4C before addition of 1 pmol bovine trypsin. The 20 ml
samples were then taken at 5-min time intervals. Reactions
were stopped by adding SDS–PAGE loading buffer,
boiled for 5min, and analysed using SDS–PAGE.
Proteins were transferred to PVDF membrane by
electroblotting, stained with Coomasie blue and proteo-
lytically resistant species were identiﬁed by N-terminal
sequencing at the Protein & Nucleic Acid Chemistry
Facility, University of Cambridge.
Global bioinformatic analysis of TFRs
We searched the PFAM database (http://pfam.sanger.ac.
uk) for proteins that match the Hidden Markov Model
proﬁle PF00440, identifying 23 137 TFR candidates.
Protein sequences longer than 300 amino acid residues
were removed to eliminate false positives, and highly
similar orthologous TFRs were removed using Jalview
with a threshold of 99% identity (29), resulting in a
non-redundant set of 12 715 TFRs.
The non-redundant set of TFRs was divided into
clusters of 200 sequences using USEARCH and
UCLUST (30). The amino acid sequences of the TFRs
in each cluster were then aligned using MUSCLE (31) to
identify their N-terminal extensions, which were deﬁned as
the amino-acid sequences preceding the conserved core
DBDs (Figure 1). The globular body of the TFRs was
deﬁned by excluding the N-terminal extension from the
whole protein sequence. In-house Perl scripts were used
to quantify the length of the N-terminal extension and the
fractions of R+K or D+E residues within these extensions.
The sequences of the N-terminal extensions were
concatenated together and submitted to the Regional
Order Neural Network (RONN) programme (32) to
predict the disorder probability for each residue. QtiPlot
(http://soft.proindependent.com/qtiplot.html) was used to
produce histograms.
RESULTS AND DISCUSSION
N-terminally truncated SimR derivatives bind DNA with
reduced afﬁnity
SimR possesses a 28-residue N-terminal extension that
precedes the core DBD, herein termed the TFR arm
(Figure 1), which carries four arginine residues at pos-
itions 18, 19, 22 and 25. This TFR arm is signiﬁcantly
longer than those in DesT, TetR, CgmR and QacR
(Figure 1), the four TFRs for which DNA–protein
crystal structures are available (14–17). To determine if
the TFR arm of SimR is involved in DNA binding, we
made C-terminally His-tagged SimR derivatives with pro-
gressively shorter N-terminal extensions and tested them
for binding to the simR–simX intergenic region by EMSA.
Wild-type SimR and SimR derivatives with 10, 15, 22 or
25 amino acid residues deleted from the N-terminus were
overexpressed and puriﬁed (Supplementary Figure S1).
Increasing concentrations of protein were incubated with
a DNA probe spanning the simR–simX intergenic region
and the complexes were resolved on native polyacrylamide
gels (Figure 2). The simR–simX intergenic region contains
two SimR operators: OR closer to simR, and a higher
afﬁnity binding site, OX, closer to simX (9). The lower
and upper sets of shifted protein–DNA complexes seen
in Figure 2 correspond, respectively, to single and
double occupancy of these two SimR-binding sites (9).
SimR DNA-binding afﬁnity was reduced 30-fold when
10 or 15 amino acid residues were deleted from the
N-terminus, and was reduced by at least 120-fold when
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22 or 25 amino acid residues were removed (Figure 2).
These results suggested the TFR arm plays a role in
DNA binding.
The TFR arm becomes protease resistant upon DNA
binding
The 28-amino acid TFR arm of SimR has a high propor-
tion of disorder-promoting amino acids and is predicted
by the Proteins Disorder Prediction System (PrDOS;
http://prdos.hgc.jp/cgi-bin/top.cgi) and by the Regional
Order Neural Network (RONN; http://www.strubi.ox
.ac.uk/RONN) servers to be disordered in solution
(Supplementary Figure S2). Additionally, with the excep-
tion of three residues (residues 8–10, here termed the
anchor string), this extension is disordered in both
monomers in the SimR–SD8 structure, and it is only par-
tially ordered in one monomer in the SimR–SC4 structure
(18). The TFR arm is ordered in the SimR–apo structure,
but its structure is the likely result of crystal packing
(Supplementary Figure S3).
Because disordered regions are often hypersensitive to
proteolysis (33), we examined the sensitivity of SimR to
trypsin. The TFR arm was rapidly digested, leaving a
much more stable product with a N-terminus at either
residue Ser20 or Ser23 (Figure 3 and Supplementary
Figure S4). Taken together, these observations suggest
that the TFR arm is solvent exposed and displays con-
formational ﬂexibility in solution in the absence of
cognate DNA.
Since many unstructured regions exhibit increased re-
sistance to proteolysis on binding of a partner (33,34),
we determined the effect of DNA binding on the sensitiv-
ity of the TFR arm to trypsin. Addition of 25- or 31-bp
DNA duplexes spanning the OX operator substantially
decreased the rate of SimR proteolysis, suggesting that
DNA binding renders the TFR arm more resistant to
trypsin (Figure 3). Consistent with this interpretation, pro-
teolysis was not inhibited when a 15-bp OX DNA duplex
that is unable to bind to SimR was incubated with SimR
(Figure 3 and Supplementary Figure S5A). In total, these
experiments suggest that the TFR arm transitions from a
disordered or conformationally ﬂexible state to a more
ordered, rigid state upon DNA binding.
The structure of SimR bound to its DNA operator
To understand how SimR binds to its operator sequence
and to shed light on the role of the TFR arm in DNA
binding, we crystallized SimR in complex with DNA. We
tested DNA duplexes from 17 to 21 bp in length and found
that only the minimal, blunt-ended 17-bp duplex
crystallized in complex with SimR. The 17-bp DNA
duplex used was the OX operator (5
0-TTCG
TACGGTGTATGAA-30), but carrying 2 bp changes to
generate a near perfect inverted repeat (50-TTCGTACG
GCGTACGAA-30), which bound SimR at least as tightly
as the wild-type 17-bp DNA duplex (Supplementary
Figure S5B). We solved the structure of full-length SimR
(residues 1–259) in complex with this 17-bp DNA duplex
Bound
Free
Bound
0    0.8  1.6   3.1 12.5  25  50  200 nM 0   0.8  1.6   3.1 12.5  25   50       200 nM 0    0.8  1.6  3.1 12.5  25   50   200 nM
0    0.8  1.6   3.1  12.5  25   50   200 nM 0    0.8  1.6   3.1  12.5  25   50   200 nM
Free
Bound
SimR ΔN10 SimR ΔN15
SimR ΔN22 SimR ΔN25
SimR WT
Figure 2. Electrophoretic mobility shift assay (EMSA) showing the binding of puriﬁed wild-type and N-terminally truncated derivatives of SimR to
the simR–simX intergenic region. Bands correspond to SimR–DNA complexes (Bound) and free DNA (Free) are indicated. The ﬁnal concentration
of SimR is indicated above each lane.
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to 2.99 A˚ resolution (Figure 4A). X-ray data collection
and reﬁnement statistics are summarized in Table 1.
The asymmetric unit contained two SimR dimers, each
bound to a 17-bp DNA duplex. The two SimR dimer–
DNA complexes are essentially identical [root mean
square deviation (RMSD) between complexes for the Ca
backbone=0.15 A˚], and thus only one complex is dis-
cussed throughout (Figure 4A). The conformation of
bound DNA is mostly regular B-form but is bent away
from the SimR dimer by 15 (see below and
Supplementary Figure S10A). The bases at the end of
adjacent DNA duplexes stack and interact to form a
pseudo-continuous double-helical DNA ﬁlament running
through the crystal (Figure 4B and Supplementary
Figure S6).
Interactions between the HTH motif and the major groove
The core DBD is composed of helices a1–a3 (residues 29–
67). Helix a2 (residues 49–58) and the recognition helix a3
(residues 61–67) form the HTH motif which packs against
a1 for stabilization (Figure 4A). Surprisingly, the recogni-
tion helix makes no canonical hydrogen bonds with the
bases. However, the side chain of Met62 makes a series of
contacts to three different bases including van der Waals
to C3 (Cb to C5), and an uncommon electrostatic inter-
action between the S atom and the face of the base of T12,
which is analogous to S stacking over the aromatic side
chains of tryptophan, histidine and phenylalanine (35)
(Figure 5). This interaction is buttressed by van der
Waals contacts to the C7 methyl group of T12. The S
atom of Met62 also accepts a hydrogen bond from the
N6 hydrogen bond donor of A13. Another key interaction
involved in the DNA sequence recognition mechanism of
SimR is the stacking of the side chain of residue Tyr66
with the C7 exocyclic methyl groups of T1 and T2. This
interaction explains in great part why SimR has a higher
afﬁnity for the OX operator, which has this pair of
thymines, than for OR, which has a pair of guanines at
these positions (9). The dominant recognition helix inter-
actions are with the phosphate backbone. For each
operator half-site, there are hydrogen bonds between the
hydroxyl group of Ser63 and the phosphate group of C3,
between the hydroxyl group of Tyr65 and the phosphate
group of T12 and between Tyr67 and the phosphate group
of T2 (Figure 5). Just outside helix a3, the backbone NH
group of Gly60 hydrogen bonds with the phosphate group
of C3. On binding DNA, the recognition helix adopts a 310
helical conformation, in contrast to the canonical a-helical
conformation seen in the structures of SimR–apo and
SimR–simocyclinone complexes (9). This conformational
alteration in the recognition helix on DNA binding is also
observed in TetR, and is believed to facilitate intimate
interaction with the DNA (16).
Three residues in helix a2 contribute to DNA binding,
with the side chain hydroxyl group of Ser49 forming a
hydrogen bond with the phosphate backbone of C10
and the backbone NH group of Met50 forming a
hydrogen bond with the phosphate backbone of G11
(Figure 5). The guanidinium group of Arg51 is involved
in direct base recognition by bifurcated hydrogen bonds
from the NZ2 atom to the O6 and N7 acceptors of G11.
Other interactions between SimR and the major groove
are hydrogen bonds between the amino group of Lys71
and the phosphate group of G11, and between the
backbone NH group of Lys71 and the phosphate group
of T12. Lys71 lies at the N-terminus of helix a4 at the very
beginning of the LBD, just outside the core HTH motif of
the DBD. This residue is highly conserved among TFRs
and the equivalent lysine in TetR also forms a hydrogen
bond with the phosphate backbone (16).
0    5  10  15
SimR only SimR + 31mer 
DNA
SimR + 15mer 
DNA
SimR + 25mer 
DNA
0    5  10  15 min 0     5  10  15 0    5  10  15 min
Ladder(kDa)
29
24
TACGCTCCTTCTTCGTACGGTGTATGAATACGACGCG
ATGCGAGGAAGAAGCATGCCACATACTTATGCTGCGC
15mer
25mer
31mer
. .
.5’
5’.
Figure 3. Limited tryptic proteolysis of SimR in the presence or absence of DNA. SimR was incubated either alone or with the OX operator DNA
duplexes indicated, before the addition of trypsin. Note that the 15-mer DNA duplex does not bind SimR (Supplementary Figure S5A). After
SDS–PAGE, SimR species were visualized by Coomassie blue staining. The major product of tryptic digestion (arrowed) was shown by Edman
sequencing to have an N-terminus corresponding to Ser20 or Ser23 of wild-type SimR.
6 Nucleic Acids Research, 2011
 at BBSRC on August 18, 2011
n
a
r.o
xfordjournals.org
D
ow
nloaded from
 
α1
α2α3 α3
α4
α5
α6
α7
α8
α9
α10
α11
N-terminal extension
Ligand-binding
domain
DNA-binding 
domain
N
C
Anchor string
90°
A
B
Figure 4. Structure of the SimR–17-mer complex (A) in isolation or (B) showing the adjacent DNA duplexes in the crystal. A cylindrical helix
representation is used to highlight the secondary structure of SimR with key features labelled in (A). One subunit of the biological-relevant dimer is
shown in grey and one in green. The recognition helix a3 is shown in magenta, the TFR arm is shown in blue and the N- and C-termini are labelled.
The anchor string of the TFR arm (residues 8–11) is shown as a red tube cartoon. The dotted blue line represents the disordered TFR arm in the
left-hand SimR subunit. In (B) only the DNA components of the adjacent symmetry complexes are shown in order to highlight the
pseudo-continuous DNA ﬁlament running through the crystal (See also Supplementary Figure S6 and Figure 7).
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Figure 5. (A) Interactions between the HTH motif and the major groove. Stick representations of the interacting residues are shown in magenta.
The Ca backbone of recognition helix a3 is shown in magenta and that of helix a2 is shown in green. Hydrogen bonds are represented by dotted
black lines. The interacting bases are labelled and only the ring frames are shown for non-interacting bases. (B) Schematic representation of
SimR–DNA contacts. For simplicity, only a recognition half-site and the ﬁrst 4 bp of an adjacent duplex are shown. Interactions between amino
acid residues and the bases of the cognate DNA operator are indicated by red arrows, and those between amino acid residues and the phosphate
backbone are represented by green arrows. Amino acid residues belonging to the TFR arm are shown in red.
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TFRs frequently rely on phosphate backbone contacts
to mediate interaction with the DNA. In an extreme case,
the DesT–DNA interface involves 11 phosphate backbone
contacts but only two speciﬁc interactions with a pair of
guanine bases within each half site (15). In contrast, TetR
and QacR make extensive direct hydrogen bond contacts
with the bases (16,17). In this sense, SimR is perhaps more
similar to DesT than to TetR or QacR in its DNA
sequence recognition mechanism. Thus, although the
overall structure of the DBD in TFRs is conserved, it is
clear that the mode of operator recognition differs from
one member of the TFR family to another (14–17). TFRs
recycle conserved residues and inventively employ
non-conserved ones within the DBD for either
base-speciﬁc hydrogen bond formation or for phosphate
backbone contacts (Figure 1). It seems that there is no
deterministic set of rules for TFR–DNA recognition.
Interactions between the TFR arm and the minor groove
If the structure of a single SimR–DNA complex is viewed
in isolation, it can be seen that the TFR arm does not
make contact with the cognate DNA duplex
(Figure 4A). Instead, the TFR arm binds the minor
groove of the adjacent DNA duplex in the pseudo-
ﬁlament (Figure 4B). This binding to the minor groove
is mediated through arginine residues that sit at the tip
of the TFR arm (Figures 5B and 6). Speciﬁcally, the
NZ2 atom of the guanidinium group of Arg18 forms
a hydrogen bond with the O2 of C3, while the NZ1 atom
interacts with the O2 of T2. In addition, the guanidinium
group of Arg22 forms two salt bridges to the phosphate
backbone of C3 and G4 (Figures 5B and 6). The electro-
positive side chain of Arg18 is deeply buried in this minor
groove (Figure 6), where the electronegative potential of
the phosphate backbone is focused (36,37). This helps
anchor the tip of the TFR arm in the minor groove.
A third arginine in the ﬂexible TFR arm, Arg19,
does not contact DNA in the structure reported here
(Figure 6). However, given the non-covalent nature of
the DNA pseudo-ﬁlament, we considered the possibility
that Arg19 might be involved in DNA binding in truly
continuous double-stranded DNA. To examine this pos-
sibility, we mutagenized Arg19 to alanine and assayed the
resulting protein for its ability to bind to the simR–simX
intergenic region by EMSA. SimR R19A-bound DNA
with an afﬁnity equal to that of wild-type SimR
(Supplementary Figure S7), suggesting Arg19 does not
contribute to DNA binding. In contrast, when we con-
structed SimR R18A and SimR R22A variants, we
found that each exhibited an approximate 15-fold reduc-
tion in binding afﬁnity (Supplementary Figure S7), con-
sistent with roles for R18 and R22 in DNA binding, as
suggested by the structure of the SimR–DNA complex.
Initially, it was difﬁcult to understand why SimR
variants lacking just 10 or 15N-terminal amino acid
residues should have reduced DNA-binding afﬁnity,
given that they retain the interacting arginine residues.
In the previously solved structures of apo–SimR and
SimR–ligand complexes, although the TFR arm is
mostly disordered, residues 8–10, herein termed the
anchor string, are always visible in electron density maps
(18), probably because this string of amino acid residues is
stabilized by van der Waals interactions with the cleft
between the LBD and the DBD. It therefore seems
likely that this short segment, highlighted in red in
Figure 4, serves as an anchoring point for the TFR arm
to loop back onto the body of SimR. This arrangement
may be important for restricting the ﬂexibility of the TFR
arm, so that it is poised appropriately to interact with the
minor groove. Deleting 10 or 15 amino acids from the
N-terminus would remove this anchor point, destabilizing
loop formation and reducing DNA-binding afﬁnity.
Figure 6. Interactions between the TFR arm and the minor groove. The Ca backbone of the TFR arm is shown in blue and stick representations of
arginine residues Arg18, Arg19, Arg22 and Arg25 are shown in magenta. Hydrogen bonds are represented by dotted black lines. The interacting
bases are labelled and only the ring frames are shown for non-interacting bases.
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The more severe deletions, removing 22 or 25 amino acids,
further reduce binding afﬁnity because they remove the
interacting arginine residues themselves.
In the crystal structure of the SimR–DNA complex, the
TFR arm is seen in one SimR subunit but is disordered in
the other subunit (Figure 4). From an inspection of the
end-to-end base stacking between adjacent DNA duplexes
within the crystal, it is clear that the two ends are
not equivalent. The stacking at the right-hand end
(as viewed in Figure 7) allows the neighbouring DNA
strands to transit smoothly across the gap, producing a
relatively normal minor groove. However, on the
left-hand end the strands veer away to avoid a steric
clash while maintaining base pair stacking, producing a
much wider minor groove (Figure 7). It seems likely that
the TFR arm is unable to interact with this ‘abnormal’
minor groove and is therefore disordered in the crystal.
In the structure of the SimR–17-mer duplex, apart from
the interaction of the anchor string with the body of
SimR, the only contacts made by the TFR arm are with
the minor groove of DNA (Figure 4 and Supplementary
Figure S6). Based on the crystal structure of the SimR–
DNA complex and the results of the proteolysis protection
assays, we propose that the TFR arm transitions from a
disordered or conformationally ﬂexible state to a more
ordered state upon binding to its cognate DNA.
N-terminally truncated SimR derivatives have a smaller
footprint on DNA than wild-type SimR
We used DNase I protection to compare the footprints of
wild-type SimR and the N-terminally truncated SimRs on
the OX and OR operators in the simR–simX intergenic
region (Figure 8A). In each case, saturating amounts of
SimR protein were used to ensure complete protection of
the binding sites. The footprint for wild-type SimR was
comparable with that reported previously (9). In contrast,
in the footprints generated using the N-terminally
truncated SimR proteins, the edge of the protected
region retracted at both ends of the footprint
when compared to the footprint of full-length SimR
(Figure 8). Speciﬁcally, when N-terminally truncated
proteins were used, on the upper DNA strand the OR
footprint retracted by two base pairs at the left edge and
by one base pair at the right edge (Figure 8). No retraction
of the OR footprint was apparent on the lower DNA
strand. When N-terminally truncated proteins were used,
on the upper DNA strand the left edge of the OX footprint
retracted by 1 bp, while no retraction was apparent at the
right edge (Figure 8). On the lower DNA strand, the OX
footprint receded by 1 bp at both ends. These observations
indicate that the TFR arm sterically hinders DNase I,
protecting additional phosphodiester bonds from
cleavage by the nuclease. Each SimR mutant protein
Figure 7. Non-equivalent stacking between adjacent DNA duplexes in the crystal pseudo-ﬁlament creates two different minor grooves. Only the
DBD of SimR is shown. At the right-hand end of the central DNA duplex the base stacking allows the DNA phosphate backbone to transit
smoothly (dotted lines) between adjacent duplexes, creating a relatively normal minor groove. At the left-hand end of the central DNA duplex the
base stacking causes the phosphate backbone to veer away to avoid a steric clash (dotted lines), producing an abnormal minor groove. Adjacent
DNA duplexes are shown in contrasting colours.
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produced the same footprint, regardless of whether 10, 15,
22 or 25 amino acids had been deleted from the
N-terminus, consistent with the idea that residues 8–10,
(i.e. the anchor string), are needed for the TFR arm to
be fully functional, as discussed above. Note that the re-
traction of the footprint occurs at both ends of the
operator, suggesting that the TFR arms of both
monomers in the SimR dimer function in solution.
We also performed a complementary experiment to
determine the binding afﬁnity of wild-type SimR to
three DNA duplexes of different lengths (15, 17 and
23 bp) spanning the OX inverted repeat sequence.
The 23-bp duplex bound SimR more strongly than the
minimal 17-bp duplex, showing that DNA ﬂanking the
core 17-bp inverted repeat contributes to SimR binding
(Supplementary Figure S5A). The 15-bp duplex failed to
Figure 8. (A) DNase I footprinting analysis of the binding of wild-type and N-terminally truncated derivatives of SimR to the simR–simX intergenic
region. A DNA fragment containing the simR–simX intergenic region, 50-end labelled on either the upper strand (left panel) or the lower strand (right
panel), was exposed to DNase I in the presence of saturating concentrations of SimR protein (200 nM for wild-type SimR, SimRN10 and
SimRN15; 400 nM for SimRN22 and SimRN25). The sequencing ladders were generated by subjecting the probes to Maxam-Gilbert G+A
chemical sequencing. Regions protected from DNase I cleavage (operators OX and OR) by wild-type SimR are indicated by solid vertical bars, and
those protected by the N-terminally truncated SimR derivatives are indicated by open bars. Inverted repeats within the DNase I protected regions are
indicated by convergent arrows. (B) Sequence of the simR–simX intergenic region summarizing the DNase I footprinting data. Regions protected by
wild-type SimR are indicated by solid lines, and those protected by the N-terminally truncated SimR derivatives are indicated by dotted lines. Also
indicated are the simRp and simXp transcription start points and putative 10 sequences, the simR and simX ribosome-binding sites (RBS), and the
imperfect inverted repeats within the footprints.
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bind SimR (Supplementary Figure S5A). In addition,
although the minimal 17-bp duplex binds to SimR rela-
tively well (Supplementary Figure S5A), it is unable to
protect the TFR arm of SimR from tryptic digestion,
while a 23-mer reduced the rate of proteolysis consider-
ably (Supplementary Figure S8). Taken together, these
observations suggest that, in solution, the TFR arm inter-
acts with DNA outside the core 17-bp OX operator, con-
sistent with the SimR–DNA structure, which shows
dimer–DNA interactions spanning 21 bp.
Among the ﬁve TFRs for which protein–DNA crystal
structures are available (DesT, TetR, CgmR, QacR and
SimR; Figure 1), only SimR possesses a ﬂexible TFR arm
that undergoes a transition to an ordered state upon DNA
binding. DesT has a 12 amino acid residue N-terminal
extension (Figure 1) but it is not disordered, instead
forming part of an extended helix a1. Residues Arg5
and Lys9 of this short N-terminal extension in DesT
nevertheless contribute to DNA binding (15), which is
unusual because the main role of helix a1 is in stabilizing
the HTH motif (a2– a3). Residues N-terminal to the core
DBD in two other TFRs, Neisseria gonorrhoeae MtrR (11
amino acids) and Streptomyces coelicolor ActR (32 amino
acids) have also been suggested to be involved in DNA
binding (38,39), implying a possible common role for TFR
N-terminal extensions when present (see also the global
TFR bioinformatic analysis presented below). Similar
kinds of extensions have been identiﬁed in at least two
other families of DNA-binding proteins. For example,
members of the eukaryotic Hox family recognize nearly
identical major groove sequences through the recognition
helix of their homeodomain but use an extended arm to
insert into the minor groove to enhance binding speciﬁcity
(40). A related example is phage lambda repressor, which
has a conventional HTH motif and an additional
N-terminal extension that promotes DNA binding, in
this case by interacting with the major groove (41). A
comprehensive analysis of all available protein–DNA
structures has shown that the binding of arginine
residues to narrow minor grooves is a widely used mech-
anism in protein–DNA recognition. This readout mechan-
ism exploits the fact that narrow minor grooves, often
associated with A-tracts, strongly enhance the negative
electrostatic potential of the DNA (36,37). However, it
should be noted that the minor groove bound by the
TFR arm of SimR is not associated with an A-tract, and
has a slightly enlarged width with respect to canonical B
DNA (Supplementary Figure S10C).
The arginine- and lysine-rich TFR arm is likely to be a
common feature of TetR family members
We searched the PFAM database (http://pfam.sanger.ac
.uk/) for proteins that match the Hidden Markov Model
proﬁle PF00440, identifying 12 715 non-redundant TFRs
(see Materials and methods for further details). The amino
acid sequences of these TFRs were then aligned using
MUSCLE (31) to identify the core DBD and any
N-terminal extension. Twenty-eight per cent had
N-terminal extensions of less than 10 amino acids, 44%
had N-terminal extensions of 11–20 amino acids, 17% had
N-terminal extensions of 21–30 amino acids and 11% had
N-terminal extensions >31 amino acids. Further, the
fraction of Arg and Lys residues in these N-terminal ex-
tensions (mean value=20.5%) was almost double the fre-
quency found in the globular body of the TFRs (mean
value=11.4%) (Supplementary Figure S9A). Finally,
the RONN server predicts that the majority of these
N-terminal extensions are likely to be disordered in
solution (Supplementary Figure S9B). It therefore seems
likely that a conformationally malleable, DNA-binding
N-terminal extension is a common feature of TFRs.
DNA bending induced by SimR binding
DNA helical parameters were analysed using the Curves+
programme (27). The overall conformation of the 17-bp
duplex is B-DNA, with an average helical twist of 33.7
(compared to a helical twist value of 36.0 for an idealized
B-form DNA). It should be noted that individual steps
might show signiﬁcant deviations from the average
value. The global bending of DNA is 15
(Supplementary Figure S10A). Since bending is most
affected by the base step roll and twist angles (42), we
plotted the roll and twist angles against the base steps to
pinpoint the source of bending (Supplementary Figure
S10B). There are two signiﬁcant positive rolls (10–10.7)
centred around base steps 6–7–8 in the operator half-site
and symmetrically around steps 9–10–11 of the opposite
half-site (Supplementary Figure S10B). The increase in
roll angle coincides with the decrease in twist angle
(26.7– 26.9) (Supplementary Figure S10B). The average
global roll and twist angles are 2.9 and 33.4, respectively.
Thus local kinks around those base steps produce a global
bend in the DNA, rather than a smooth bending.
Moreover, there is a signiﬁcant increase in the width of
the minor groove from base step 6 through to base step 12,
while the major groove width is just below the value for an
idealized B-form DNA (Supplementary Figure S10C).
Since the average distance between the two recognition
helices in the SimR–DNA complex is 36.8 A˚ [assessed as
the distance between the Ca atom of Tyr65 in each subunit
(13)], greater than the distance between two consecutive
major grooves in idealized B-DNA (34 A˚), it is likely that
the bending and the unwinding of the central DNA steps
might be necessary for optimal positioning of the HTH
motifs in adjacent major grooves. Lastly, although the
sequence of the 17-bp duplex used in this study is a
perfect inverted repeat with the exception of the central
GC base pair, the groove width and roll parameters are
not symmetrical across this central base pair. This reﬂects
the non-equivalent end-to-end interactions between neigh-
bouring DNA duplexes described above (Figure 7).
Comparison of the SimR–DNA and SimR–simocyclinone
complexes suggests the mechanism of derepression
In a previous report, we speculated about the mechanism
of simocyclinone-mediated derepression, based on a com-
parison of the structures of SimR–apo and the SimR–SD8
complex (18). However, it was apparent that SimR–apo
had not crystallized in its DNA-binding form, since
the distance between its recognition helices was 42.3 A˚,
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a spacing incompatible with binding to two consecutive
major grooves (18). Moreover, this spacing was compar-
able to the corresponding value of 41.7 A˚ obtained for the
SimR–SD8 complex. Indeed, TFR apo-proteins in general
do not crystallize in their DNA-binding form (13). The
helix separation obtained for SimR–DNA was signiﬁcant-
ly shorter at 36.8 A˚ (averaged over the two complexes in
the asymmetric unit), this value lying within the range of
34.7–38.8 A˚ observed in other TFR–DNA complexes
(13,15). The major structural differences between the re-
pressed, DNA-bound conformation of SimR and the de-
repressed, SD8-bound conformation, result from a 16
rotation of the subunits relative to one another roughly
about the centre of the dimer interface (Figure 9 and
Supplementary Figure S11). This re-deﬁnes many of the
inter-subunit contacts, although the interface areas remain
similar at 2795 and 2640 A˚2 for SimR–SD8 and SimR–
DNA, respectively [as calculated by the Protein
Interactions, Surfaces and Assemblies server (PISA,
http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html) (43)].
However, ﬁve reciprocated inter-subunit hydrogen bonds
(i.e. 10 in total) are preserved between the two conform-
ational states. These link the C-terminal end of a8 and the
a9–a10 wrapping arm to the LBD of the adjacent subunit.
As a consequence, when the subunits rotate, the a9–a10
wrapping arm moves with the adjacent subunit and the
C-terminal end of a8 bends (Supplementary Figure S11).
Pair-wise superpositions of individual subunits taken from
the SimR–SD8 and SimR–DNA structures based on the
subunit cores (i.e., inclusive of residues 29–168 plus 222–
247 and exclusive of the TFR arm, the C-terminal end of
a8 and the a9–a10 wrapping arm) gave RMSD values in
the range 0.85–0.96 A˚, indicating that the cores move es-
sentially as rigid bodies at the protein backbone level and,
importantly, there is no signiﬁcant re-orientation of the
DBD with respect to the LBD, in contrast to the
‘pendulum-like’ motion seen in TetR (Supplementary
Figure S12) (12,16). Nevertheless, the crystal structures
do not convey the dynamic behaviour of the system and,
as has been illustrated for other TFRs (13,44), in the
absence of ligands or DNA, the protein is generally
highly ﬂexible and capable of sampling a variety of con-
formations, presumably including those akin to both the
ligand- and DNA-bound states. The binding of SD8, a
relatively hydrophobic molecule, contributes to the hydro-
phobic core of the SimR dimer; this will have a stabilizing
effect on the overall structure, locking it into a relatively
rigid, low-energy state. Moreover, the combination of the
threading of the ligand through both subunits and the
projection of the side chain of Arg122 into the opposing
subunit contribute to the rigidiﬁcation of the system (18).
The ﬂexibility of the apo form is important to enable the
TFR arms and the recognition helices to engage optimally
with the DNA. The resulting favourable protein–DNA
interactions will have a stabilizing effect on this conform-
ation of SimR. Moreover, in the DNA binding
Figure 9. Structures of SimR–simocyclinone and SimR–DNA together with schematic representations illustrating the rigid-body rotation of the
subunits relative to one another. In order to emphasize the subunit rotation, the grey coloured subunits are shown ﬁxed in the same relative
orientations. This can be clearly seen in the side view where the green subunit rotates by 16 relative to the grey subunit; the approximate pivot
point is indicated by the asterisk (see also Supplementary Figures S11 and S12). The distances separating the recognition helices a3 and a30 in the two
structures are indicated.
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conformation, the repositioning of the C-terminal end of
helix a8 appropriately places it to make salt bridges to the
DBD of the same subunit and to that of the opposing
subunit, speciﬁcally between Arg179 and Glu46, and
between Arg180 and Glu72, respectively. These inter-
actions, not present in the SD8-bound form, will further
stabilize the DNA-bound conformation of SimR.
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